data_2kct_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kct _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.66 105.54 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -168.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.79 117.82 26.88 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.52 HD22 HD22 ' A' ' 77' ' ' LEU . 3.1 tt -123.62 142.9 50.6 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -121.76 141.25 51.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 0.0 109.302 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.26 -161.35 28.08 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.9 m -127.02 145.08 50.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.434 0.694 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.35 132.3 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.573 0.749 . . . . 0.0 109.972 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.86 156.56 17.41 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.444 0.698 . . . . 0.0 110.964 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.13 30.63 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.482 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -77.31 108.81 10.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.813 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.36 12.21 61.66 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.756 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.24 90.16 1.59 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -116.8 116.66 27.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.734 1.214 . . . . 0.0 109.877 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtt -89.98 161.81 15.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.524 HD22 HD12 ' A' ' 90' ' ' LEU . 79.3 mt -66.94 119.14 11.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.663 0.385 . . . . 0.0 110.681 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.97 98.07 0.27 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.351 1.06 . . . . 0.0 110.724 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.75 22.84 68.44 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.462 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 67' ' ' LEU . . . -143.26 149.14 47.25 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.729 0.812 . . . . 0.0 109.953 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.81 111.52 3.27 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.566 2.178 . . . . 0.0 112.076 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.29 179.33 31.23 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.986 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 11.1 p -149.28 134.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.807 0.843 . . . . 0.0 110.601 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -104.15 138.65 40.33 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.28 163.63 39.88 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -97.98 115.16 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 HD22 ' A' ' 55' ' ' LEU . 21.9 tp -79.66 108.87 13.54 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HG2' HG23 ' A' ' 86' ' ' THR . 58.0 mt-10 -78.01 110.36 12.88 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.298 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 124.339 1.056 . . . . 0.0 110.111 175.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 78' ' ' GLU . 35.2 p . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.45 129.57 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.41 98.21 8.11 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 107' ' ' ILE . 53.2 t -88.99 130.62 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.625 0.77 . . . . 0.0 109.986 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 HD22 ' A' ' 67' ' ' LEU . 37.0 tp -115.64 114.32 24.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.227 1.011 . . . . 0.0 108.939 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -112.86 128.87 56.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.086 1.354 . . . . 0.0 108.008 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 148.07 29.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.411 0.685 . . . . 0.0 109.433 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.78 -168.16 12.51 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.71 112.2 4.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.243 0.617 . . . . 0.0 110.582 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.11 117.13 68.18 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.029 0.932 . . . . 0.0 108.754 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 29.9 Cg_endo -59.44 151.3 69.62 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.693 2.262 . . . . 0.0 113.173 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -65.74 -25.12 67.14 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.728 0.811 . . . . 0.0 110.393 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.5 p -71.16 -23.87 62.14 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.992 1.317 . . . . 0.0 111.589 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.3 t80 -68.46 106.45 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -133.31 155.76 80.5 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.746 0.819 . . . . 0.0 109.101 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 110.3 2.17 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.523 2.148 . . . . 0.0 111.456 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.93 -11.71 9.37 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.044 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.2 t -81.55 124.41 38.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.456 0.702 . . . . 0.0 109.532 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.77 118.99 14.26 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 m -120.79 154.38 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.606 0.717 . . . . 0.0 111.785 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.55 115.14 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.426 HG23 HG11 ' A' ' 89' ' ' VAL . 37.9 pt -100.91 162.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.504 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 33.5 tt0 -148.67 132.76 17.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.18 -117.54 0.69 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 179.76 146.27 6.79 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 117.453 0.626 . . . . 0.0 112.539 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.98 114.57 27.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.22 134.51 48.82 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 123.593 0.558 . . . . 0.0 110.111 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.7 104.43 0.16 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.871 2.381 . . . . 0.0 111.85 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.07 -29.86 5.42 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.573 ' HG2' ' HE3' ' A' ' 119' ' ' LYS . 11.0 tp10 -91.29 132.64 36.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.4 -5.31 58.91 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.308 0.643 . . . . 0.0 112.284 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.2 p -114.64 137.46 51.87 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.323 0.511 . . . . 0.0 112.031 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.25 111.61 14.39 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.573 ' HE3' ' HG2' ' A' ' 115' ' ' GLU . 93.9 mttt -82.29 93.65 7.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.34 108.32 14.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.73 0.812 . . . . 0.0 110.043 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -19.62 57.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.589 0.755 . . . . 0.0 111.548 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 22.4 p -138.63 157.14 46.7 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.054 0.941 . . . . 0.0 110.107 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 tp -138.6 140.88 39.14 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.984 1.314 . . . . 0.0 108.235 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.8 ttm -136.53 118.77 15.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.348 0.659 . . . . 0.0 109.587 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -100.4 145.11 28.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.748 0.819 . . . . 0.0 110.157 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.432 . . . . 0.0 111.122 -177.808 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.239 0.546 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.88 146.13 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -123.33 114.27 19.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.181 0.992 . . . . 0.0 109.043 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tt -114.15 126.15 54.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.93 135.7 39.28 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.76 -174.15 38.47 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -124.12 140.84 52.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.225 1.01 . . . . 0.0 109.002 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.1 123.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.467 ' HB1' ' HG3' ' A' ' 78' ' ' GLU . . . -75.65 149.52 38.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.07 0.548 . . . . 0.0 111.265 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.53 27.35 1.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.822 0.849 . . . . 0.0 110.562 167.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -143.31 128.16 18.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.723 1.209 . . . . 0.0 107.869 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.76 6.76 88.17 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.694 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.87 85.4 2.82 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.3 m -107.45 111.88 24.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.277 1.431 . . . . 0.0 109.847 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtp -91.79 146.64 23.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.55 127.5 32.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.755 0.422 . . . . 0.0 111.677 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.51 118.43 18.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.123 0.969 . . . . 0.0 110.316 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.32 18.71 67.71 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 123.88 0.738 . . . . 0.0 114.068 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.52 12.36 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.579 0.752 . . . . 0.0 109.691 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.54 115.98 4.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.399 2.066 . . . . 0.0 111.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.58 -175.51 31.92 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.841 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.27 130.56 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 124.15 0.98 . . . . 0.0 110.399 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.468 HH12 HG23 ' A' ' 117' ' ' THR . 8.9 tpp180 -92.25 131.84 37.15 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 165.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.92 163.33 37.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.531 0.605 . . . . 0.0 109.611 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.12 106.5 17.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.29 115.77 14.18 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.765 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.496 ' HA ' HG21 ' A' ' 86' ' ' THR . 48.3 mt-10 -73.1 99.35 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.474 0.765 0 C-N-CA 124.347 1.059 . . . . 0.0 108.65 175.054 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 78' ' ' GLU . 71.4 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.19 137.76 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -79.89 146.27 32.25 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.75 119.53 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.0 94.16 7.82 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -89.56 125.16 35.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -116.41 110.11 18.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.477 0.711 . . . . 0.0 109.416 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.01 -173.98 35.28 Favored Glycine 0 N--CA 1.469 0.89 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.942 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 108.57 1.96 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.626 0.77 . . . . 0.0 111.763 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -81.67 118.03 70.57 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.401 0.681 . . . . 0.0 109.789 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.21 163.93 29.79 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.59 2.193 . . . . 0.0 112.556 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.72 -22.1 66.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.44 0.696 . . . . 0.0 110.691 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 p -82.21 -13.8 56.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.134 0.974 . . . . 0.0 111.833 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.06 107.0 6.84 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 103' ' ' VAL . 47.5 pttt -151.8 150.42 26.13 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.407 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.53 117.77 4.8 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.273 1.982 . . . . 0.0 111.243 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.35 11.64 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.044 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 100' ' ' LYS . 8.2 p -90.34 145.29 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 117.866 0.833 . . . . 0.0 110.283 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.04 131.63 39.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 151.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.805 0.812 . . . . 0.0 109.65 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.43 119.97 60.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.2 pt -107.94 137.37 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -114.28 145.98 41.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.24 -124.61 1.41 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.98 141.89 6.76 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 117.071 0.435 . . . . 0.0 112.657 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.8 tp -89.33 115.29 26.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.061 0.944 . . . . 0.0 108.592 173.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.55 134.41 32.56 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.56 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.74 90.79 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.954 2.436 . . . . 0.0 111.986 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.73 -45.48 0.65 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 117' ' ' THR . 2.2 mp0 -91.84 116.36 28.84 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.054 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.04 -17.67 63.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.109 0.563 . . . . 0.0 110.617 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 HH12 ' A' ' 74' ' ' ARG . 8.8 t -78.18 134.21 37.67 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -75.46 109.26 8.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -82.5 94.7 7.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.39 126.62 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.333 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.025 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p -138.57 165.03 27.94 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.741 0.816 . . . . 0.0 110.281 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.3 tp -135.19 137.28 42.52 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.698 1.199 . . . . 0.0 109.051 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 ttp -136.84 117.3 13.74 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.5 p -81.74 142.91 32.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.067 0.947 . . . . 0.0 109.887 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.4 mmpt? . . . . . 0 N--CA 1.483 1.215 0 C-N-CA 122.388 0.275 . . . . 0.0 111.599 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.242 0.675 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.82 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -137.01 118.95 15.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.852 0.861 . . . . 0.0 109.609 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.74 145.71 46.3 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -117.26 142.42 47.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.754 0.822 . . . . 0.0 109.365 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.32 -165.65 36.2 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.295 0.372 . . . . 0.0 112.828 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.2 m -119.28 147.19 44.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.771 0.828 . . . . 0.0 109.565 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.9 126.14 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 110.275 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.65 156.38 16.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.318 0.647 . . . . 0.0 110.064 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.02 59.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.283 0.633 . . . . 0.0 110.98 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.23 110.89 6.99 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.853 0.861 . . . . 0.0 109.466 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.61 16.16 71.61 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.679 0.612 . . . . 0.0 113.337 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.05 105.52 3.36 Favored 'General case' 0 C--N 1.359 1.022 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -143.74 137.56 28.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.573 1.149 . . . . 0.0 108.281 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.03 144.29 29.2 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.51 135.33 52.87 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.469 0.308 . . . . 0.0 110.848 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -65.7 109.89 2.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.97 0.908 . . . . 0.0 111.024 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.45 24.79 67.99 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.719 0.637 . . . . 0.0 113.801 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.5 130.06 10.39 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.534 0.734 . . . . 0.0 109.681 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 117.04 3.72 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.585 2.19 . . . . 0.0 110.499 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.33 176.23 28.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.622 0.576 . . . . 0.0 111.945 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.31 143.83 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.483 0.658 . . . . 0.0 110.489 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -112.44 132.23 55.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -153.86 162.27 41.36 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.832 0.453 . . . . 0.0 110.175 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.513 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 39.6 ttp180 -95.88 111.07 23.15 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 107' ' ' ILE . 22.0 tp -79.13 120.58 23.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.032 0.533 . . . . 0.0 109.93 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.33 95.35 2.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.484 1.261 0 O-C-N 124.33 1.019 . . . . 0.0 112.079 -175.441 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 20.9 p . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.61 122.66 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.749 0.82 . . . . 0.0 110.667 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.6 m95 -77.41 106.69 9.33 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.5 t -88.69 109.89 20.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.4 tp -93.18 97.09 10.43 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.379 1.049 . . . . 0.0 108.234 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -102.57 126.09 49.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.183 0.993 . . . . 0.0 109.026 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -111.7 130.57 55.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.354 0.662 . . . . 0.0 109.265 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.95 -166.49 21.39 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 110.84 3.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.546 0.738 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.69 131.89 59.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 109.537 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.02 140.96 58.55 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.802 2.335 . . . . 0.0 112.793 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.03 -24.57 65.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.234 0.54 . . . . 0.0 110.31 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -73.74 -15.06 61.22 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.816 1.246 . . . . 0.0 112.378 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -69.48 134.52 49.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.685 0.794 . . . . 0.0 110.009 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 103' ' ' VAL . 20.0 pttm -168.98 161.01 8.07 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.81 1.244 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.56 107.89 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.904 1.736 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.05 -9.34 8.47 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.811 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 100' ' ' LYS . 10.5 p -84.86 138.43 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 118.11 0.955 . . . . 0.0 109.478 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.91 116.28 19.97 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 125' ' ' THR . 22.2 m -113.33 153.26 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.54 0.686 . . . . 0.0 111.683 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.61 115.77 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.537 HD12 HD21 ' A' ' 77' ' ' LEU . 21.9 pt -100.39 139.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -148.71 142.88 26.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.21 -110.07 0.42 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.09 159.29 31.37 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 117.242 0.521 . . . . 0.0 112.445 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -123.85 143.02 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 0.0 108.813 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.76 147.09 54.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.26 0.624 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.61 72.59 4.34 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.079 2.519 . . . . 0.0 111.633 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.81 69.85 0.1 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.498 ' HG2' ' HE2' ' A' ' 119' ' ' LYS . 10.1 tp10 -172.64 141.05 1.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.789 0.835 . . . . 0.0 110.021 -173.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -86.29 -40.46 15.49 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.604 0.762 . . . . 0.0 109.642 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 69.0 p -83.92 121.32 27.2 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.598 -169.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.05 132.61 36.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.095 0.558 . . . . 0.0 110.114 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HE2' ' HG2' ' A' ' 115' ' ' GLU . 3.2 mptp? -93.23 96.55 10.07 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.24 99.68 9.44 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.932 0.493 . . . . 0.0 111.023 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -57.1 -33.07 66.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.889 0.875 . . . . 0.0 110.619 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p -138.05 141.15 40.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.579 1.152 . . . . 0.0 109.084 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.97 118.91 19.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 ptm -129.81 147.6 51.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.385 0.674 . . . . 0.0 109.502 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.424 HG22 HG13 ' A' ' 105' ' ' VAL . 60.4 p -100.53 152.51 20.32 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.804 0.841 . . . . 0.0 109.957 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.479 0.712 . . . . 0.0 110.562 176.166 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.72 136.84 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.342 0.657 . . . . 0.0 109.492 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.69 133.88 52.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.833 0.853 . . . . 0.0 108.995 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.83 139.56 38.21 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -110.42 143.38 40.8 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.403 1.081 . . . . 0.0 108.668 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.94 -173.76 42.78 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 117.876 0.307 . . . . 0.0 112.615 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.6 m -112.3 134.13 54.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.719 0.808 . . . . 0.0 110.057 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.92 122.56 19.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.188 0.995 . . . . 0.0 110.447 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.95 146.94 25.97 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.25 -10.93 58.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.07 116.61 14.9 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.52 1.128 . . . . 0.0 109.995 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.66 9.91 82.75 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 123.682 0.614 . . . . 0.0 113.727 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 4.3 tt -72.61 111.14 7.5 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 p -132.1 130.69 41.55 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.277 1.431 . . . . 0.0 109.137 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 86.9 mmm -85.0 136.48 33.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD13 ' HA3' ' A' ' 72' ' ' GLY . 84.2 mt -63.84 111.52 2.5 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -71.09 110.21 5.63 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 110.57 -167.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.84 22.61 77.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.055 -0.52 . . . . 0.0 113.125 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.5 126.87 7.61 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.36 1.064 . . . . 0.0 108.937 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.68 109.4 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.324 2.016 . . . . 0.0 111.672 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.427 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . 162.46 175.49 33.55 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 123.381 0.425 . . . . 0.0 112.181 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.57 148.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.406 0.682 . . . . 0.0 110.451 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -123.72 137.57 54.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.136 . . . . 0.0 108.256 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.688 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 33.3 p90 -159.88 175.73 12.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.848 0.859 . . . . 0.0 108.893 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 35.1 ptt180 -111.76 135.23 52.64 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 107' ' ' ILE . 24.9 tp -100.83 120.83 40.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.016 0.526 . . . . 0.0 109.939 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HA ' HG22 ' A' ' 86' ' ' THR . 34.3 mt-10 -80.35 97.95 7.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.198 0.599 . . . . 0.0 109.583 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.474 0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.164 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 78' ' ' GLU . 64.8 p . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.55 123.16 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 80.7 m95 -68.1 138.95 56.15 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.96 109.39 28.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.7 tp -93.9 95.77 9.29 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -98.1 124.56 42.68 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.17 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -110.71 143.23 41.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.194 0.998 . . . . 0.0 108.746 170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.63 15.28 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.28 125.05 22.36 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.062 0.545 . . . . 0.0 110.986 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.29 128.88 74.17 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.615 0.766 . . . . 0.0 110.18 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 22.2 Cg_endo -59.47 138.39 83.68 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.642 2.228 . . . . 0.0 111.736 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -68.04 -27.55 66.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.245 0.618 . . . . 0.0 111.808 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 t -71.79 -16.6 62.19 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.922 0.489 . . . . 0.0 111.501 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 84.4 t80 -69.81 137.09 51.54 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 123.105 0.562 . . . . 0.0 109.736 174.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -164.12 156.0 14.39 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.044 0.938 . . . . 0.0 109.282 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.515 ' HG3' HD13 ' A' ' 64' ' ' LEU . 29.3 Cg_exo -61.94 113.1 1.72 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.544 2.163 . . . . 0.0 111.129 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.23 -6.19 28.65 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.892 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 p -83.96 150.89 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 118.189 0.995 . . . . 0.0 108.835 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.63 ' HB3' ' HD3' ' A' ' 126' ' ' LYS . 46.9 mt-10 -77.16 145.12 37.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 17.0 m -136.14 154.92 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.224 1.01 . . . . 0.0 111.037 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.491 HD11 ' HE2' ' A' ' 124' ' ' MET . 55.8 mt -107.62 108.15 24.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 166.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 77' ' ' LEU . 43.8 pt -96.73 142.29 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -147.26 139.6 24.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 121' ' ' ARG . . . 163.93 -105.77 0.26 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.25 163.4 37.13 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.5 tp -134.56 131.45 37.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.24 147.13 33.7 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.328 0.651 . . . . 0.0 110.099 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.24 -37.82 80.91 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.266 2.644 . . . . 0.0 112.561 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.86 41.36 2.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.46 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -166.4 142.13 4.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.568 0.747 . . . . 0.0 110.545 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.86 -30.03 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.962 0.905 . . . . 0.0 110.796 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 t -90.21 134.3 34.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.164 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -75.58 127.16 32.47 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 108.549 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -83.97 105.32 14.76 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.39 112.39 19.88 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.438 ' HD2' ' HA2' ' A' ' 109' ' ' GLY . 6.5 ptm180 -68.49 -35.67 77.84 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 p -141.38 148.72 40.08 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.679 1.191 . . . . 0.0 109.094 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.9 tp -127.21 117.53 22.51 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.057 0.943 . . . . 0.0 108.493 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.491 ' HE2' HD11 ' A' ' 106' ' ' ILE . 54.7 ttp -131.45 145.98 52.04 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 82.5 p -91.07 163.36 14.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.166 0.508 . . . . 0.0 110.807 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 9.1 mtpm? . . . . . 0 CA--C 1.547 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 109.893 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.614 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 25.4 p . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 85.7 t -100.34 133.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.777 1.231 . . . . 0.0 108.688 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttt85 -96.59 107.74 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 77' ' ' LEU . 4.2 tt -116.66 141.0 48.77 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -120.75 143.6 48.7 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.946 0.898 . . . . 0.0 109.755 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.57 -162.06 27.51 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 7.6 m -131.31 140.28 49.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.005 0.922 . . . . 0.0 109.565 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.0 131.72 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.215 1.006 . . . . 0.0 111.555 -173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.549 ' HB3' ' HG3' ' A' ' 76' ' ' ARG . . . -94.56 154.39 17.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.226 0.611 . . . . 0.0 110.947 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 -36.66 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.584 0.753 . . . . 0.0 110.758 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -80.58 78.52 7.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.233 0.613 . . . . 0.0 109.881 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.8 0.82 2.48 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.022 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' A' ' 101' ' ' PRO . 5.7 tt -78.37 94.45 4.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 74' ' ' ARG . 86.5 m -103.07 110.63 22.63 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.688 1.195 . . . . 0.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.4 mmt -80.5 117.53 21.31 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.46 123.86 18.17 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 123.637 0.586 . . . . 0.0 111.223 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -71.61 99.89 2.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.983 0.913 . . . . 0.0 110.405 -171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.25 -36.92 2.89 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.563 -0.29 . . . . 0.0 112.995 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.74 131.41 87.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.344 0.657 . . . . 0.0 110.317 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.11 113.03 2.68 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.287 1.991 . . . . 0.0 111.059 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.02 -172.01 29.94 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.798 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.04 133.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.842 0.857 . . . . 0.0 110.179 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 4.8 tpp180 -92.73 141.94 27.91 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.27 174.86 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.581 0.752 . . . . 0.0 109.043 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.549 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.95 117.0 32.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 HD21 HD23 ' A' ' 55' ' ' LEU . 28.9 tp -80.15 109.77 14.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.834 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.461 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 43.2 mt-10 -71.92 100.87 2.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.972 179.373 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.3 p . . . . . 0 C--O 1.244 0.782 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -99.99 115.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -77.86 130.72 36.99 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.31 117.58 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 123.532 0.733 . . . . 0.0 109.348 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.6 tp -99.86 92.11 5.14 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -86.04 124.22 32.24 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.57 123.1 49.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.307 0.643 . . . . 0.0 109.725 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.72 -174.98 22.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 114.95 8.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.156 0.582 . . . . 0.0 110.189 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.82 133.46 51.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.999 0.92 . . . . 0.0 109.678 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HD2' HD22 ' A' ' 123' ' ' LEU . 55.4 Cg_endo -67.83 150.81 78.84 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.485 2.124 . . . . 0.0 112.139 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.87 -21.61 64.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.88 0.472 . . . . 0.0 110.459 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.8 p -70.46 -19.4 62.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.233 1.013 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -69.55 105.98 2.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.537 0.735 . . . . 0.0 109.462 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.423 ' O ' HG11 ' A' ' 103' ' ' VAL . 37.1 mtmm -131.99 156.56 79.96 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.74 1.216 . . . . 0.0 109.853 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HG3' HD11 ' A' ' 64' ' ' LEU . 27.9 Cg_exo -63.02 103.51 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.713 2.275 . . . . 0.0 111.509 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.16 -3.36 18.8 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 119.202 -0.776 . . . . 0.0 113.579 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 100' ' ' LYS . 7.9 p -79.17 139.39 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 118.309 1.054 . . . . 0.0 109.777 174.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.8 mt-10 -71.36 138.87 49.56 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 125' ' ' THR . 35.0 m -135.01 152.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-O 121.707 0.765 . . . . 0.0 110.724 175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.66 109.72 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.6 pt -98.15 152.81 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 31.8 tt0 -152.25 132.54 13.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.6 -147.64 11.56 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.44 133.06 9.05 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 118.392 1.096 . . . . 0.0 114.267 -174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.38 124.75 52.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.905 1.282 . . . . 0.0 108.822 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.4 138.48 41.67 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.58 -33.82 93.16 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.03 2.487 . . . . 0.0 113.175 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.74 -11.36 82.97 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.27 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.06 141.98 34.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.011 0.925 . . . . 0.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -88.48 -33.65 17.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.248 0.619 . . . . 0.0 110.534 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -83.89 129.09 34.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -79.35 121.22 24.86 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.675 ' HZ3' ' HB3' ' A' ' 119' ' ' LYS . 3.4 ttpm? -89.34 97.26 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.93 125.31 28.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.933 0.493 . . . . 0.0 110.591 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -79.58 -38.13 34.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.512 1.125 . . . . 0.0 109.251 172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -133.06 133.81 43.5 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.409 1.084 . . . . 0.0 108.699 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 96' ' ' PRO . 53.9 tp -117.89 108.99 15.99 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.6 ttm -102.82 125.21 49.47 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.536 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.5 p -82.25 123.49 29.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 124.289 1.035 . . . . 0.0 108.516 -175.581 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.24 0.569 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.2 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -97.79 108.2 20.87 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD22 HD21 ' A' ' 77' ' ' LEU . 4.0 tt -111.86 125.8 54.41 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -172.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.02 144.88 27.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.536 0.735 . . . . 0.0 109.123 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.79 -160.57 29.77 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.522 -0.371 . . . . 0.0 112.599 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 30.0 m -127.82 140.79 51.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.027 0.931 . . . . 0.0 109.676 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.94 133.27 31.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.36 43.55 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.484 0.49 . . . . 0.0 111.662 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.77 36.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.16 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.97 96.04 7.28 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.855 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.17 73.11 0.65 Allowed Glycine 0 N--CA 1.465 0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.138 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.6 tt -150.41 125.99 10.25 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.3 m -140.24 125.28 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.323 1.049 . . . . 0.0 109.332 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.1 mtp -96.91 162.64 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.136 0.574 . . . . 0.0 109.722 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.454 HD11 ' HA3' ' A' ' 72' ' ' GLY . 84.5 mt -86.48 105.86 17.08 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -63.71 114.88 4.27 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.915 0.886 . . . . 0.0 111.563 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.97 77.09 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.529 0.518 . . . . 0.0 113.624 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.94 142.23 44.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.38 1.072 . . . . 0.0 109.764 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.44 87.76 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' A' ' 67' ' ' LEU . . . 175.39 163.66 28.68 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.613 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 p -157.26 134.84 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.985 0.914 . . . . 0.0 110.115 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -103.89 137.29 42.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.196 0.998 . . . . 0.0 108.311 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 46.3 p90 -158.2 173.07 17.26 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -104.91 122.57 46.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 55' ' ' LEU . 23.5 tp -83.86 116.19 22.63 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.78 118.93 24.76 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.485 1.319 0 C-N-CA 123.342 0.657 . . . . 0.0 112.486 -173.547 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.3 134.46 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -79.63 144.02 34.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.29 118.36 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.865 0.866 . . . . 0.0 108.746 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.34 93.23 7.14 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -85.37 113.31 21.58 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -111.16 122.94 49.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.45 172.53 18.43 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.88 113.5 1.89 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.251 0.526 . . . . 0.0 110.926 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.86 120.4 81.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.82 146.09 80.16 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.896 2.397 . . . . 0.0 113.713 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.87 -27.5 68.27 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.654 0.782 . . . . 0.0 109.835 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.7 p -78.87 -7.66 58.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.96 1.304 . . . . 0.0 112.278 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.7 t80 -75.66 140.61 42.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.805 0.442 . . . . 0.0 109.817 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.497 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 61.0 pttt -162.07 161.45 21.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.955 0.902 . . . . 0.0 109.709 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.8 100.34 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.102 1.868 . . . . 0.0 111.519 167.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.68 -8.57 8.77 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.131 -0.816 . . . . 0.0 114.25 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 14.5 p -71.46 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 118.54 1.17 . . . . 0.0 111.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 39.7 mt-10 -72.61 125.56 27.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 171.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.426 HG13 HG12 ' A' ' 103' ' ' VAL . 27.9 m -128.16 155.61 39.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.898 0.856 . . . . 0.0 111.753 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 62.4 mt -114.75 107.93 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.479 HG23 HD11 ' A' ' 123' ' ' LEU . 29.6 pt -97.82 155.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.89 138.19 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.0 -127.04 1.35 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.755 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.37 153.0 24.45 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 117.043 0.421 . . . . 0.0 112.456 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 139.9 53.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.474 1.109 . . . . 0.0 108.727 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 136.0 45.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.51 109.69 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.204 . . . . 0.0 113.246 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.61 5.74 53.6 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.077 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.493 ' HG2' ' H ' ' A' ' 117' ' ' THR . 48.7 tt0 -96.53 153.09 18.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.596 0.759 . . . . 0.0 109.738 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.97 0.67 23.89 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.237 1.015 . . . . 0.0 111.213 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.493 ' H ' ' HG2' ' A' ' 115' ' ' GLU . 8.8 t -134.05 119.89 19.52 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.413 0.625 . . . . 0.0 110.453 -173.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -84.69 134.41 34.36 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.622 1.169 . . . . 0.0 110.25 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -95.14 111.31 23.16 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.71 116.68 28.76 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -23.36 44.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.143 0.577 . . . . 0.0 110.886 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -137.71 152.18 48.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.878 0.871 . . . . 0.0 110.045 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 107' ' ' ILE . 23.1 tp -136.92 123.5 20.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.645 1.178 . . . . 0.0 108.233 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.561 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 41.5 ttm -119.87 95.11 4.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.728 0.411 . . . . 0.0 110.282 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.4 p -75.19 137.43 41.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.339 0.656 . . . . 0.0 110.455 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.906 . . . . 0.0 110.85 -173.585 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 39.0 t -101.72 143.89 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -138.34 136.23 36.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.512 0.725 . . . . 0.0 109.814 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.24 163.97 21.35 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.6 0.714 . . . . 0.0 110.549 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -138.44 132.29 31.13 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.801 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.33 -161.39 33.85 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 5.0 m -124.14 146.15 48.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.07 127.83 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.933 0.893 . . . . 0.0 110.277 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 140.07 43.8 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.309 0.644 . . . . 0.0 110.13 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.02 55.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.084 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.6 124.13 51.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.575 0.75 . . . . 0.0 109.406 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.17 -0.94 43.91 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.567 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.49 96.12 4.02 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.7 m -118.57 121.07 39.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.435 1.094 . . . . 0.0 109.904 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.508 ' HE1' HG13 ' A' ' 95' ' ' VAL . 23.5 mmt -84.36 136.07 34.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.99 127.95 34.45 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.628 0.58 . . . . 0.0 111.506 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.23 117.25 12.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.678 0.791 . . . . 0.0 110.09 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.83 33.1 84.18 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.456 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.33 136.63 8.77 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 110.102 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.76 109.69 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.332 2.021 . . . . 0.0 110.709 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.76 171.4 33.68 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.466 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -150.62 153.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.65 0.78 . . . . 0.0 110.062 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 47.4 ttp180 -124.66 142.25 51.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -159.45 172.95 16.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.283 0.633 . . . . 0.0 109.316 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.483 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 87.6 mtm-85 -101.58 113.08 25.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.62 111.95 9.25 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 86' ' ' THR . 36.7 mt-10 -72.36 110.44 6.78 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 123.003 0.521 . . . . 0.0 111.458 -175.645 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 76' ' ' ARG . 68.3 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.79 143.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -74.92 142.33 44.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 49.1 t -127.62 108.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.5 tp -93.26 92.97 7.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -91.37 116.59 28.96 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.235 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -108.35 114.3 28.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.93 170.97 23.31 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 113.0 3.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.778 0.431 . . . . 0.0 110.329 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.508 HG13 ' HE1' ' A' ' 66' ' ' MET . 39.5 t -81.67 122.47 80.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 122.955 0.502 . . . . 0.0 110.126 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HD2' HD21 ' A' ' 123' ' ' LEU . 28.4 Cg_endo -60.74 148.49 91.68 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.761 2.307 . . . . 0.0 111.964 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.27 -16.3 61.92 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.417 0.687 . . . . 0.0 110.827 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.3 p -71.6 -23.69 61.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.149 0.98 . . . . 0.0 110.696 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' HA ' HG12 ' A' ' 103' ' ' VAL . 70.4 t80 -71.94 134.75 46.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.831 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -171.36 161.3 5.18 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.8 0.84 . . . . 0.0 109.435 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.1 105.68 0.41 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.276 1.984 . . . . 0.0 111.89 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.78 -10.8 11.17 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.754 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 99' ' ' PHE . 9.6 p -74.55 145.16 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.782 0.791 . . . . 0.0 109.654 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.3 mt-10 -84.32 138.67 32.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.69 155.32 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.036 0.922 . . . . 0.0 111.305 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.6 mt -115.17 108.51 25.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 18.4 pt -100.87 132.6 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.419 0.688 . . . . 0.0 109.859 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -127.97 130.81 49.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.57 -108.01 0.27 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . -177.17 142.63 5.86 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.715 0.757 . . . . 0.0 113.222 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.4 tp -93.87 126.4 39.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.903 0.881 . . . . 0.0 109.112 171.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . . . -83.25 138.33 42.19 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 123.436 0.46 . . . . 0.0 109.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.89 -17.68 60.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.887 2.392 . . . . 0.0 113.726 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.68 -10.67 18.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.504 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 112' ' ' ALA . 28.3 tt0 -117.07 120.98 40.0 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.13 -20.94 63.15 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.562 0.745 . . . . 0.0 112.709 -168.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -88.37 135.62 33.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.42 113.79 14.4 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 26.9 ttmt -85.7 94.57 9.13 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.66 123.05 27.29 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.52 0.728 . . . . 0.0 109.849 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -80.32 -41.22 25.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.255 0.622 . . . . 0.0 109.639 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.7 p -131.53 136.13 47.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.485 1.114 . . . . 0.0 108.843 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.493 HD21 ' HD2' ' A' ' 96' ' ' PRO . 59.6 tp -113.11 133.9 54.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.412 1.085 . . . . 0.0 108.632 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.9 ttp -136.29 103.05 5.17 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.786 0.434 . . . . 0.0 110.106 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.4 p -72.56 140.78 48.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.396 0.678 . . . . 0.0 110.012 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 123.594 0.758 . . . . 0.0 110.797 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 134.19 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.471 HH21 HD12 ' A' ' 106' ' ' ILE . 55.3 ttt180 -122.26 119.71 31.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.513 0.725 . . . . 0.0 109.219 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.43 161.2 20.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.585 0.754 . . . . 0.0 109.912 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -135.43 136.99 41.8 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.938 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 79' ' ' ASP . . . 176.52 -162.8 31.59 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.028 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 ' HG1' ' HG2' ' A' ' 104' ' ' GLU . 25.8 m -122.31 139.21 54.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.006 0.922 . . . . 0.0 109.749 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.64 130.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.618 1.167 . . . . 0.0 110.631 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.98 139.79 38.14 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.922 0.489 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -72.92 -40.44 65.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.311 0.644 . . . . 0.0 110.092 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.35 115.51 19.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.715 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 42.85 5.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.471 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.496 HD11 ' HG3' ' A' ' 101' ' ' PRO . 6.7 tt -111.85 99.46 8.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -109.79 116.66 32.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.301 1.04 . . . . 0.0 109.711 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.484 ' HG2' HG21 ' A' ' 73' ' ' VAL . 66.5 mtp -89.48 132.6 34.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.467 HD12 ' HA3' ' A' ' 72' ' ' GLY . 76.6 mt -63.39 126.48 27.61 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.658 0.598 . . . . 0.0 111.013 -172.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.63 132.22 33.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.914 0.885 . . . . 0.0 109.762 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.75 68.46 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.472 0.482 . . . . 0.0 113.661 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 138.47 10.15 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.07 0.948 . . . . 0.0 109.149 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 112.73 2.8 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.469 2.113 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.467 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 167.25 175.14 37.01 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 121.387 0.437 . . . . 0.0 113.402 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.501 ' HB ' HG21 ' A' ' 95' ' ' VAL . 8.1 p -146.91 161.3 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.949 0.9 . . . . 0.0 109.486 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -137.66 136.01 37.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -152.67 161.66 42.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.174 0.59 . . . . 0.0 109.758 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.62 104.98 17.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 tp -73.52 132.39 42.82 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.22 100.7 6.65 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.424 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 O-C-N 124.097 0.873 . . . . 0.0 111.84 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.66 139.91 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.328 1.051 . . . . 0.0 109.647 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.05 133.1 33.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 168.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.91 120.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -103.81 112.22 25.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -107.98 121.55 45.02 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.857 0.863 . . . . 0.0 108.915 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -103.53 117.72 35.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.654 0.782 . . . . 0.0 109.165 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.47 176.59 17.65 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.0 115.67 5.14 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.665 0.386 . . . . 0.0 110.043 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.501 HG21 ' HB ' ' A' ' 73' ' ' VAL . 43.2 t -80.11 127.45 76.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.454 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.22 138.89 16.66 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.495 2.797 . . . . 0.0 112.769 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.01 -24.13 65.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.39 0.676 . . . . 0.0 111.358 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -75.45 -13.23 60.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.959 0.904 . . . . 0.0 111.883 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -72.72 135.83 45.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.3 pttt -156.6 163.42 25.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.195 0.998 . . . . 0.0 108.741 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 28.9 Cg_exo -64.08 111.86 1.7 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.42 2.08 . . . . 0.0 111.41 168.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.49 0.57 37.43 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.727 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.49 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 7.4 p -77.87 149.55 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.847 0.824 . . . . 0.0 110.067 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HG2' ' HG1' ' A' ' 58' ' ' THR . 42.7 mt-10 -82.41 134.8 35.24 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.6 m -129.89 161.74 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.971 0.908 . . . . 0.0 111.65 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.471 HD12 HH21 ' A' ' 54' ' ' ARG . 62.8 mt -119.11 111.7 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 113.452 -1.704 . . . . 0.0 107.016 168.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.37 142.1 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.451 0.7 . . . . 0.0 109.27 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 8.0 tp10 -139.48 124.99 19.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.59 -106.08 0.23 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.55 143.29 5.16 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 117.787 0.793 . . . . 0.0 112.616 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.2 tp -90.7 116.29 28.45 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.64 126.93 72.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.163 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.66 95.28 0.11 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.845 2.363 . . . . 0.0 111.786 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.56 -41.04 1.27 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.63 135.29 33.57 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.949 0.899 . . . . 0.0 109.985 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.81 -26.86 57.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.132 0.573 . . . . 0.0 110.043 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -84.46 136.04 34.0 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.129 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.6 119.55 21.32 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.27 96.68 10.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.91 115.83 17.04 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.432 0.693 . . . . 0.0 110.044 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -79.45 -41.43 27.58 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.056 0.942 . . . . 0.0 109.631 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 75.0 p -132.28 140.88 48.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.39 1.076 . . . . 0.0 108.18 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.9 tp -127.29 143.38 51.24 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.946 0.499 . . . . 0.0 110.056 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.8 ttp -153.64 148.26 26.26 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 56.9 p -83.11 152.9 25.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 109.516 175.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.76 106.02 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.6 ' NH1' HG23 ' A' ' 106' ' ' ILE . 22.5 tpp180 -89.67 127.91 35.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 tt -132.82 130.35 39.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.45 139.0 43.82 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.96 -168.62 36.48 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 143.29 50.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.172 0.589 . . . . 0.0 110.604 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.23 119.59 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB2' HH21 ' A' ' 76' ' ' ARG . . . -69.89 142.85 52.93 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.664 0.602 . . . . 0.0 110.122 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.2 84.42 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.01 117.72 21.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.126 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.64 64.45 1.06 Allowed Glycine 0 C--N 1.339 0.702 0 O-C-N 123.444 0.465 . . . . 0.0 112.199 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tt -133.33 101.82 5.32 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -111.85 116.95 31.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.684 0.793 . . . . 0.0 110.342 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mmm -85.13 145.07 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.438 0.695 . . . . 0.0 109.959 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD13 ' HA3' ' A' ' 72' ' ' GLY . 86.6 mt -85.34 126.53 33.82 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.1 140.54 35.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.38 3.4 89.98 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 123.48 0.487 . . . . 0.0 113.433 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.4 140.3 4.13 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.103 0.961 . . . . 0.0 110.093 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.61 113.37 2.7 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.203 . . . . 0.0 111.734 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . 171.45 173.11 38.16 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.394 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.75 138.15 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.331 1.053 . . . . 0.0 110.223 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 16.3 ttm180 -108.0 137.08 46.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 165.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.04 154.27 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.456 HH21 ' HB2' ' A' ' 60' ' ' ALA . 18.6 ttp180 -92.84 96.88 10.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 HD12 ' A' ' 107' ' ' ILE . 42.0 tp -78.41 138.32 38.44 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.483 0.713 . . . . 0.0 110.225 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.573 ' HG2' HG22 ' A' ' 86' ' ' THR . 31.3 mt-10 -102.96 113.16 26.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 N--CA 1.482 1.167 0 O-C-N 123.81 0.694 . . . . 0.0 109.631 178.087 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 78' ' ' GLU . 40.9 p . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.5 t -102.85 141.74 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.117 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -79.27 136.63 37.1 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 91.5 t -123.39 118.43 54.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.83 92.28 7.85 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -94.59 116.0 28.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -112.46 144.27 42.19 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.05 -172.31 19.13 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.97 111.38 3.3 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.307 0.643 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.67 123.47 84.03 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.519 0.727 . . . . 0.0 109.09 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.98 145.71 68.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.173 1.915 . . . . 0.0 111.389 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.77 -16.79 64.5 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.591 0.756 . . . . 0.0 111.356 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.3 p -76.45 -19.9 57.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.42 1.088 . . . . 0.0 112.144 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -68.37 126.66 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.223 0.609 . . . . 0.0 109.542 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 103' ' ' VAL . 17.1 ptmt -156.06 165.82 17.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.191 0.596 . . . . 0.0 110.958 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.86 113.01 3.41 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.864 1.709 . . . . 0.0 110.955 170.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.08 -8.01 16.41 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.353 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 105' ' ' VAL . 12.7 p -83.02 142.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 117.425 0.612 . . . . 0.0 111.787 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.84 111.18 9.78 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 103' ' ' VAL . 27.7 m -105.7 153.6 7.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.792 0.805 . . . . 0.0 110.53 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.6 HG23 ' NH1' ' A' ' 54' ' ' ARG . 49.4 mt -122.18 105.59 16.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.415 HD12 HD22 ' A' ' 77' ' ' LEU . 39.2 pt -101.45 154.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.328 0.651 . . . . 0.0 110.246 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.2 tt0 -140.56 123.24 16.23 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 173.56 -121.18 0.84 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.77 166.71 39.9 Favored Glycine 0 C--O 1.241 0.556 0 CA-C-N 117.446 0.623 . . . . 0.0 112.441 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.6 tp -138.3 134.42 34.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.53 129.6 50.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 88.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.922 2.415 . . . . 0.0 111.91 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.65 -36.72 1.42 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -171.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.96 147.95 48.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.762 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.47 -45.02 11.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.728 0.811 . . . . 0.0 111.457 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -109.43 131.87 54.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.12 0.486 . . . . 0.0 111.002 -165.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.75 115.09 16.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.77 96.22 8.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.34 112.07 19.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.902 0.881 . . . . 0.0 110.156 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -60.16 -40.85 91.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.397 1.079 . . . . 0.0 110.399 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 1.7 m -135.41 149.31 49.59 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.885 -167.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.5 tp -137.21 140.33 41.64 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.259 1.024 . . . . 0.0 108.81 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 ttp -152.77 111.97 3.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 109.664 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.481 HG22 HG12 ' A' ' 105' ' ' VAL . 54.3 p -73.21 124.27 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.447 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -97.97 112.7 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -104.68 116.99 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.89 142.68 36.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -119.1 147.87 43.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.72 -170.3 43.4 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.447 ' HG1' ' HG2' ' A' ' 104' ' ' GLU . 23.7 m -116.37 140.65 49.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.271 1.028 . . . . 0.0 109.083 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -76.98 126.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.38 0.672 . . . . 0.0 110.238 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.62 150.56 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.394 0.678 . . . . 0.0 111.043 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.66 -31.69 41.49 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.358 0.599 . . . . 0.0 109.671 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.35 100.11 12.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.435 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.55 71.11 0.97 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 tt -144.82 104.59 4.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.1 m -125.17 119.04 27.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.894 1.278 . . . . 0.0 109.233 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.7 mtp -89.9 142.93 27.23 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.88 122.41 17.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 110.478 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.35 123.21 28.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.375 0.67 . . . . 0.0 109.879 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.37 72.21 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 123.607 0.567 . . . . 0.0 112.988 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.23 144.18 16.84 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.049 0.939 . . . . 0.0 109.33 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.88 117.29 4.87 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.262 1.975 . . . . 0.0 110.844 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.48 -175.04 30.5 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.287 174.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.44 132.17 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.319 1.048 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -92.98 131.25 38.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.1 159.63 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.233 0.54 . . . . 0.0 110.885 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -95.59 112.06 23.86 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.289 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.43 117.57 30.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.453 0.701 . . . . 0.0 109.88 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.45 107.9 18.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.241 1.016 . . . . 0.0 109.789 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.21 -1.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.737 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.87 137.15 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.8 m95 -82.63 144.94 29.95 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.4 t -132.38 121.91 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.87 94.01 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -83.38 118.42 23.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -109.1 111.02 22.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.09 174.22 28.51 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.79 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.27 115.04 5.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.967 0.507 . . . . 0.0 110.161 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -81.25 113.95 45.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.063 0.545 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.595 ' HD2' HD22 ' A' ' 123' ' ' LEU . 56.2 Cg_endo -67.28 151.76 80.33 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.443 2.096 . . . . 0.0 111.611 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.01 -16.94 64.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.519 1.127 . . . . 0.0 112.199 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 96' ' ' PRO . 12.2 t -70.55 -24.25 62.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.91 0.884 . . . . 0.0 111.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -68.04 121.6 16.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.752 0.821 . . . . 0.0 109.289 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' O ' HG12 ' A' ' 103' ' ' VAL . 23.6 pttm -165.62 157.54 12.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.431 0.693 . . . . 0.0 110.077 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.22 117.25 3.93 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.178 1.919 . . . . 0.0 111.758 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.49 -17.51 10.32 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.326 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 100' ' ' LYS . 6.0 p -95.06 147.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.863 0.831 . . . . 0.0 110.045 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG2' ' HG1' ' A' ' 58' ' ' THR . 43.6 mt-10 -85.97 130.37 34.56 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 125' ' ' THR . 27.6 m -111.03 155.55 12.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.857 0.837 . . . . 0.0 110.784 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.78 121.07 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.48 129.71 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.155 0.582 . . . . 0.0 110.503 -171.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.37 151.2 25.82 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.19 -119.63 0.89 Allowed Glycine 0 C--O 1.24 0.53 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.4 163.57 29.58 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.731 0.312 . . . . 0.0 112.606 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.0 tp -130.35 118.61 21.51 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 133.81 44.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.74 -24.3 41.05 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.679 2.253 . . . . 0.0 113.046 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.14 -18.1 78.85 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.558 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -108.61 156.61 19.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.141 0.977 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -109.61 26.39 10.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.715 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 5.0 t -133.96 121.22 21.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.353 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.29 130.59 35.61 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 108.945 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.682 ' HB3' ' HZ1' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.78 117.2 31.55 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.699 0.682 . . . . 0.0 109.186 174.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.76 128.69 55.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.94 0.896 . . . . 0.0 109.974 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.438 ' HD3' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -98.82 -8.87 25.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.8 0.44 . . . . 0.0 110.171 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -134.81 152.16 51.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.718 1.207 . . . . 0.0 109.637 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.595 HD22 ' HD2' ' A' ' 96' ' ' PRO . 37.3 tp -150.79 109.88 3.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.126 0.97 . . . . 0.0 108.385 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -135.93 114.03 11.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.648 0.779 . . . . 0.0 109.673 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.465 HG23 HG13 ' A' ' 105' ' ' VAL . 77.3 p -78.12 151.25 33.44 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.532 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 120.709 0.29 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -105.87 133.09 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -118.97 127.08 53.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.342 0.657 . . . . 0.0 109.505 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.6 mt -125.86 172.37 9.93 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.903 0.881 . . . . 0.0 109.785 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.26 147.89 49.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.776 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -170.74 42.15 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.6 m -121.54 144.34 48.78 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.37 115.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.34 0.656 . . . . 0.0 110.5 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.56 148.16 31.85 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.54 -5.66 46.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.648 0.779 . . . . 0.0 111.231 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.86 129.79 36.18 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.389 1.076 . . . . 0.0 110.05 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.31 15.69 78.85 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.266 0.354 . . . . 0.0 113.889 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.49 89.56 3.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -111.81 124.85 53.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.523 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.1 mmm -80.78 139.7 35.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.7 mt -67.53 133.26 49.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.3 0.5 . . . . 0.0 110.915 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -86.76 118.49 26.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.372 0.669 . . . . 0.0 109.857 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.54 5.0 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.486 0.491 . . . . 0.0 112.282 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.26 139.9 75.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.074 0.55 . . . . 0.0 110.108 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.64 135.79 24.59 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 121.986 1.791 . . . . 0.0 111.929 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.87 -168.58 26.4 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.631 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.18 132.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.381 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 79.3 ttt180 -102.6 138.17 39.86 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 170.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -158.13 168.21 27.71 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.919 0.488 . . . . 0.0 110.492 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 76.5 mtp180 -93.4 124.59 37.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.539 HD22 HD11 ' A' ' 107' ' ' ILE . 21.0 tp -105.26 125.76 51.34 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.423 0.689 . . . . 0.0 109.351 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.4 97.43 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t0 . . . . . 0 N--CA 1.476 0.866 0 O-C-N 124.101 0.875 . . . . 0.0 111.487 -173.368 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 19.6 p . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.69 134.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -73.77 126.24 29.92 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 86.8 t -107.57 106.25 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 tp -91.54 92.01 8.31 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -83.5 150.21 26.14 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.414 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HB2' ' HZ3' ' A' ' 92' ' ' LYS . 6.7 mtmp? -137.81 122.52 18.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.724 1.21 . . . . 0.0 108.71 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 121.46 -169.01 14.41 Favored Glycine 0 C--O 1.245 0.815 0 C-N-CA 123.464 0.554 . . . . 0.0 111.774 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 116.45 7.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.272 0.629 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.11 127.83 78.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.85 0.86 . . . . 0.0 109.958 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' O ' ' HB3' ' A' ' 99' ' ' PHE . 19.3 Cg_endo -58.41 132.83 50.97 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.036 1.824 . . . . 0.0 110.856 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.82 -26.36 68.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.109 0.564 . . . . 0.0 111.08 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 p -72.85 -13.27 61.25 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.118 0.967 . . . . 0.0 112.122 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 96' ' ' PRO . 63.0 t80 -64.32 121.22 13.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.926 0.89 . . . . 0.0 109.055 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -155.04 156.15 30.92 Favored Pre-proline 0 C--O 1.244 0.787 0 C-N-CA 124.002 0.921 . . . . 0.0 109.069 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.08 99.87 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.971 1.781 . . . . 0.0 110.464 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.55 -2.22 6.52 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.985 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -94.35 141.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 118.707 1.253 . . . . 0.0 110.414 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.56 117.38 15.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 125' ' ' THR . 18.0 m -110.25 150.23 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.722 0.773 . . . . 0.0 111.183 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.522 HD13 ' SD ' ' A' ' 124' ' ' MET . 47.6 mt -105.51 111.95 36.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.539 HD11 HD22 ' A' ' 77' ' ' LEU . 28.8 pt -98.27 140.91 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.8 133.1 23.19 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 162.44 -102.7 0.21 Allowed Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.93 147.25 5.25 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 117.482 0.641 . . . . 0.0 112.254 170.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -104.0 149.21 25.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.955 0.902 . . . . 0.0 109.584 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.71 151.41 46.22 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.723 0.809 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.44 -42.66 65.87 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.418 2.745 . . . . 0.0 113.682 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.48 29.55 8.25 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.031 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.15 128.62 40.44 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 0.0 110.266 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 -4.05 53.93 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -133.78 139.18 46.16 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -72.97 119.82 17.74 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 24.8 ttpt -70.26 96.23 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.415 ' HB2' HG11 ' A' ' 89' ' ' VAL . . . -86.39 102.34 13.94 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.348 0.594 . . . . 0.0 109.524 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -62.98 -41.49 99.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.66 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -135.57 143.4 45.64 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.539 -169.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 tp -136.25 125.13 24.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.522 ' SD ' HD13 ' A' ' 106' ' ' ILE . 31.9 ttm -121.47 151.42 40.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.429 HG22 HG13 ' A' ' 105' ' ' VAL . 72.5 p -108.6 145.43 34.9 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.773 0.32 . . . . 0.0 110.297 178.739 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.238 0.473 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.23 117.33 44.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -116.17 116.53 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -103.18 152.69 21.17 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.883 0.849 . . . . 0.0 109.897 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -128.0 121.4 29.71 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.3 -178.52 41.81 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -117.76 144.67 45.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.67 121.48 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.709 0.803 . . . . 0.0 110.528 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.6 149.63 40.0 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.074 0.55 . . . . 0.0 111.06 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.88 -32.91 40.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.456 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.53 102.76 14.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 20.68 10.93 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.97 117.62 30.45 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -147.58 137.14 22.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.89 0.876 . . . . 0.0 108.892 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 26.4 mmt -81.29 145.46 30.89 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -72.78 158.6 35.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.866 0.466 . . . . 0.0 112.201 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -115.01 155.96 26.0 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.267 1.027 . . . . 0.0 108.902 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.59 -2.97 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 116.369 -0.378 . . . . 0.0 113.984 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.96 147.96 1.34 Allowed Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.724 1.21 . . . . 0.0 108.625 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.69 148.41 77.7 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.154 1.903 . . . . 0.0 111.421 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.38 -171.8 25.64 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.37 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.9 129.56 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.121 0.968 . . . . 0.0 109.118 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 45.1 ttp180 -95.14 124.72 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.3 156.05 45.9 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -90.37 100.18 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.589 HD22 HD11 ' A' ' 107' ' ' ILE . 12.0 tp -72.54 106.75 4.73 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.417 0.687 . . . . 0.0 109.711 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.53 102.43 11.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.966 0.906 . . . . 0.0 111.602 -174.378 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.67 148.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.13 0.972 . . . . 0.0 109.096 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -83.46 145.23 29.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 82.7 t -129.96 121.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.18 0.592 . . . . 0.0 109.493 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.3 91.25 7.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.396 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -94.31 115.13 27.31 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -105.58 122.92 47.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.97 -162.63 28.35 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.472 0.482 . . . . 0.0 111.95 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.17 111.91 12.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.696 0.798 . . . . 0.0 110.815 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.66 117.12 66.45 Favored Pre-proline 0 N--CA 1.475 0.776 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.46 161.56 43.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.018 1.812 . . . . 0.0 112.591 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.32 -24.77 62.19 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.083 0.953 . . . . 0.0 110.555 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.8 p -70.79 -21.79 62.44 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.357 1.063 . . . . 0.0 111.642 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.492 ' HA ' HG11 ' A' ' 103' ' ' VAL . 54.0 t80 -71.66 121.56 19.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.6 pttt -145.74 159.81 46.15 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.486 1.115 . . . . 0.0 108.932 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.33 96.8 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.513 2.142 . . . . 0.0 111.887 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.7 1.35 10.83 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.277 -0.735 . . . . 0.0 113.956 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.549 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 8.4 p -75.49 141.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.026 0.913 . . . . 0.0 111.415 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.84 136.26 40.19 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.39 160.86 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.761 0.791 . . . . 0.0 112.598 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.451 HD11 ' HD3' ' A' ' 126' ' ' LYS . 60.7 mt -126.79 107.99 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.46 1.904 . . . . 0.0 105.902 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 77' ' ' LEU . 19.7 pt -111.51 146.68 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.341 0.656 . . . . 0.0 109.422 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -140.66 143.07 34.93 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.99 -122.12 0.99 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.87 140.21 6.64 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 117.409 0.604 . . . . 0.0 112.131 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.92 131.86 53.52 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.772 0.829 . . . . 0.0 109.227 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . . . -84.99 133.51 43.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.69 -31.45 92.04 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.444 2.762 . . . . 0.0 114.093 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.58 80.1 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.648 0.593 . . . . 0.0 113.483 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 36.3 mt-10 -112.85 162.31 15.95 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.837 0.827 . . . . 0.0 113.004 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.17 -43.77 9.16 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.722 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -90.84 129.1 36.92 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.836 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -77.97 123.96 27.43 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.98 0.912 . . . . 0.0 109.268 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.87 100.8 13.45 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.45 105.67 15.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.438 0.695 . . . . 0.0 109.65 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -70.62 -23.94 62.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.918 0.487 . . . . 0.0 110.346 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.8 p -137.23 152.65 50.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.21 1.004 . . . . 0.0 109.489 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -139.37 136.24 34.55 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.419 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 24.3 ttm -136.61 104.8 5.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.031 0.933 . . . . 0.0 108.735 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -70.47 122.75 20.26 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HD3' HD11 ' A' ' 106' ' ' ILE . 56.1 tptt . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 123.932 0.893 . . . . 0.0 109.466 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.12 110.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -109.58 114.19 27.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -111.36 138.0 48.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -112.44 145.29 40.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.93 -159.41 28.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 118.19 0.45 . . . . 0.0 112.763 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -131.67 145.68 51.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.92 0.888 . . . . 0.0 110.28 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.72 119.04 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.224 1.01 . . . . 0.0 110.464 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.98 143.41 47.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.765 0.826 . . . . 0.0 110.185 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.62 -41.05 47.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.533 0.733 . . . . 0.0 110.333 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.84 102.64 10.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.086 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 76' ' ' ARG . . . 104.29 42.95 1.81 Allowed Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.795 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.64 125.47 51.82 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -143.67 144.48 31.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.746 1.218 . . . . 0.0 109.668 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 71.9 mmm -81.29 149.46 28.95 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 mt -66.66 150.18 49.43 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.55 104.96 15.0 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.913 0.885 . . . . 0.0 110.334 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.19 33.92 88.53 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.635 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.51 146.86 20.28 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.44 0.696 . . . . 0.0 110.288 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.44 130.83 16.67 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.351 2.034 . . . . 0.0 110.275 170.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.62 -169.19 23.92 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 116.681 -0.236 . . . . 0.0 112.515 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.65 130.59 3.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 34.3 ttm180 -94.61 129.86 41.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.43 162.31 41.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 73.4 mtp180 -95.46 124.44 39.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.5 tp -99.76 116.51 32.01 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 109.517 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -79.38 116.89 19.88 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.412 1.085 . . . . 0.0 108.467 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.585 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.6 p . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.69 141.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.81 154.58 41.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 55.9 t -137.3 118.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.47 HD22 ' HE3' ' A' ' 92' ' ' LYS . 59.9 tp -93.01 92.67 7.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 108.77 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -90.91 123.41 34.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HE3' HD22 ' A' ' 90' ' ' LEU . 98.9 mttt -107.53 129.78 54.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 167.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.51 -165.98 26.27 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.452 0.47 . . . . 0.0 112.072 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.01 118.75 13.24 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.581 0.752 . . . . 0.0 111.224 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.15 115.85 63.54 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.013 0.925 . . . . 0.0 109.232 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.87 157.62 47.22 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.061 2.507 . . . . 0.0 114.19 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.49 -27.63 66.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.935 0.894 . . . . 0.0 110.326 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 t -80.58 -14.78 57.91 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CD1' HD22 ' A' ' 123' ' ' LEU . 68.5 t80 -78.14 114.05 16.66 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 154.92 49.43 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.174 0.989 . . . . 0.0 109.121 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.39 102.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.691 2.261 . . . . 0.0 112.414 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.57 -10.19 5.81 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.372 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 105' ' ' VAL . 13.6 p -78.1 136.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 117.662 0.731 . . . . 0.0 110.699 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -76.09 122.57 24.46 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 103' ' ' VAL . 28.0 m -123.83 155.15 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.971 0.891 . . . . 0.0 111.226 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.606 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 61.3 mt -114.34 109.4 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 89' ' ' VAL . 36.1 pt -97.19 153.76 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 38.5 tt0 -145.76 134.93 22.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.69 -114.6 0.59 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.53 166.2 39.42 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.96 123.02 42.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.07 0.948 . . . . 0.0 108.961 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.39 132.35 33.95 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.306 0.642 . . . . 0.0 109.785 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.49 89.34 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.095 2.53 . . . . 0.0 111.611 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.11 -39.65 0.52 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.57 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.95 129.37 35.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.395 0.678 . . . . 0.0 109.197 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.52 -16.29 61.28 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.085 168.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -95.23 126.5 40.59 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 111.871 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -76.48 114.88 15.69 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.013 1.325 . . . . 0.0 109.176 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -74.69 91.42 2.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.08 113.51 25.49 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.861 0.864 . . . . 0.0 110.472 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HG3' ' OG1' ' A' ' 122' ' ' THR . 25.6 ptt180 -74.66 -26.82 60.12 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.903 0.481 . . . . 0.0 110.006 172.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 17.8 m -126.67 145.9 50.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.745 0.818 . . . . 0.0 109.175 -169.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.439 HD22 ' CD1' ' A' ' 99' ' ' PHE . 47.2 tp -137.04 132.95 34.93 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.606 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 38.8 ttm -134.55 96.56 3.6 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.4 p -72.18 121.87 20.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.716 0.806 . . . . 0.0 109.792 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 0.0 111.388 -173.443 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.65 108.26 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -170.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -101.13 109.9 21.85 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.12 136.51 53.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -108.92 131.62 54.85 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.8 -174.26 32.49 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.4 m -128.28 139.4 52.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.144 0.978 . . . . 0.0 108.841 173.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.06 120.13 28.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.918 0.887 . . . . 0.0 108.983 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.29 57.58 Favored 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.694 0.621 . . . . 0.0 110.333 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.67 -18.64 59.57 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.667 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.55 109.19 21.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.975 . . . . 0.0 108.944 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.94 64.85 0.91 Allowed Glycine 0 C--N 1.346 1.096 0 O-C-N 123.146 0.279 . . . . 0.0 112.486 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -136.0 124.49 23.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 84.7 m -147.25 138.79 24.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.479 0.712 . . . . 0.0 110.128 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.421 ' HE1' HG21 ' A' ' 95' ' ' VAL . 80.1 mmm -82.7 153.29 25.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.341 0.657 . . . . 0.0 109.319 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.445 HD12 ' HZ2' ' A' ' 92' ' ' LYS . 63.0 mt -71.96 138.44 48.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.438 0.295 . . . . 0.0 111.008 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.82 112.89 5.81 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.955 0.902 . . . . 0.0 111.669 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.63 30.48 72.32 Favored Glycine 0 C--N 1.347 1.186 0 O-C-N 124.125 0.891 . . . . 0.0 113.349 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.91 138.48 11.9 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.337 0.655 . . . . 0.0 110.213 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 111.0 2.11 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.927 2.418 . . . . 0.0 110.898 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.99 177.43 35.98 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 91' ' ' TYR . 9.2 p -154.35 138.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -106.29 131.57 53.36 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -144.73 154.8 43.11 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -92.5 91.55 7.66 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.68 120.1 22.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.62 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.538 ' HG2' HG23 ' A' ' 86' ' ' THR . 36.5 mt-10 -92.45 105.19 17.41 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.9 t0 . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 124.679 1.192 . . . . 0.0 111.223 -174.706 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.538 HG23 ' HG2' ' A' ' 78' ' ' GLU . 18.0 p . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.0 t -108.4 135.5 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.37 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.6 130.77 34.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.46 116.41 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 tp -91.93 94.26 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.403 ' HD2' HG13 ' A' ' 73' ' ' VAL . 41.1 t80 -92.07 114.16 26.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.174 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HZ2' HD12 ' A' ' 67' ' ' LEU . 4.9 mptp? -91.16 123.13 34.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.13 169.83 12.66 Favored Glycine 0 N--CA 1.467 0.721 0 O-C-N 123.206 0.316 . . . . 0.0 112.653 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 120.18 12.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.235 0.614 . . . . 0.0 110.318 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.421 HG21 ' HE1' ' A' ' 66' ' ' MET . 60.3 t -82.28 124.42 78.33 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.179 0.991 . . . . 0.0 110.251 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HB2' HG21 ' A' ' 98' ' ' THR . 93.9 Cg_endo -75.61 155.46 40.14 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.726 2.284 . . . . 0.0 112.46 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -65.17 -22.37 66.9 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.788 0.835 . . . . 0.0 112.047 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.495 HG21 ' HB2' ' A' ' 96' ' ' PRO . 6.7 t -74.21 -24.44 59.33 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.511 0.724 . . . . 0.0 111.216 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 103' ' ' VAL . 75.3 t80 -73.32 109.86 7.17 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -141.32 159.76 59.81 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.021 0.929 . . . . 0.0 109.895 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.37 100.11 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.695 2.263 . . . . 0.0 111.574 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.86 -11.28 7.84 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.257 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 99' ' ' PHE . 5.4 p -72.17 146.96 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 117.489 0.644 . . . . 0.0 109.884 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 35.8 mt-10 -81.46 136.42 35.66 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 125' ' ' THR . 19.6 m -128.74 169.58 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 122.152 0.977 . . . . 0.0 111.701 177.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.46 HD12 ' HE3' ' A' ' 124' ' ' MET . 68.9 mt -136.25 107.75 6.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.896 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 118' ' ' PHE . 41.1 pt -98.16 149.51 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.909 0.884 . . . . 0.0 109.471 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 40.7 mt-10 -135.03 139.75 45.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.72 -120.82 0.97 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.2 168.77 41.9 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.808 0.304 . . . . 0.0 112.374 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.29 101.03 7.69 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.49 130.45 58.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.0 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.92 97.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.604 2.869 . . . . 0.0 112.416 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.13 -52.14 0.56 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.87 118.39 24.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.637 0.775 . . . . 0.0 109.886 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.17 -26.56 61.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.378 0.671 . . . . 0.0 109.653 168.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -86.2 141.28 29.43 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.497 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.433 ' CD1' HD13 ' A' ' 107' ' ' ILE . 54.6 t80 -76.5 118.04 18.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 109.702 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.32 97.11 4.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.104 0.962 . . . . 0.0 109.409 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.87 114.2 25.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.049 0.54 . . . . 0.0 110.592 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.57 -34.83 46.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.518 0.727 . . . . 0.0 110.802 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 13.6 p -138.4 146.32 42.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.775 0.83 . . . . 0.0 109.569 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 tp -136.61 111.95 9.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.27 1.028 . . . . 0.0 109.594 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.46 ' HE3' HD12 ' A' ' 106' ' ' ILE . 53.6 ttp -122.47 119.86 32.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 105' ' ' VAL . 45.8 p -72.23 146.78 47.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.809 0.337 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.73 118.34 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -91.94 121.59 33.68 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.94 138.81 51.07 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -120.35 154.45 35.04 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 109.882 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.19 -155.56 26.97 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 121.805 -0.236 . . . . 0.0 112.932 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -124.32 145.21 49.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.776 0.83 . . . . 0.0 109.737 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.28 120.51 36.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.64 33.47 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 124.017 0.823 . . . . 0.0 111.003 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.31 -17.78 51.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.413 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.75 127.72 33.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.434 0.693 . . . . 0.0 110.477 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 8.2 84.03 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.431 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.401 HD23 ' HE2' ' A' ' 99' ' ' PHE . 4.3 tt -69.55 103.83 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -116.2 113.7 23.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.518 1.127 . . . . 0.0 108.929 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.4 mtp -89.08 136.56 32.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.23 128.59 37.13 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.468 0.48 . . . . 0.0 110.112 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.58 112.34 24.22 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.43 0.692 . . . . 0.0 109.232 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.02 -30.53 9.91 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.023 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.42 141.99 23.64 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.746 0.818 . . . . 0.0 109.57 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.29 6.35 4.42 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.213 2.608 . . . . 0.0 114.112 -175.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.96 -170.66 44.24 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.424 0.452 . . . . 0.0 113.369 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.412 ' HB ' HG21 ' A' ' 95' ' ' VAL . 13.0 p -154.12 154.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.455 0.702 . . . . 0.0 110.73 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -121.78 138.45 54.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.624 1.17 . . . . 0.0 108.015 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -151.1 174.63 12.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -113.37 111.87 22.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.794 0.807 . . . . 0.0 109.83 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.0 tp -77.62 133.66 38.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.007 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 86' ' ' THR . 44.6 mt-10 -84.47 124.22 31.11 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.613 0.57 . . . . 0.0 110.555 174.362 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 78' ' ' GLU . 37.6 p . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.96 133.25 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -83.1 134.97 34.98 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.13 116.29 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.224 0.61 . . . . 0.0 109.485 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.3 tp -93.61 93.97 8.35 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.4 109.99 18.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.183 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.66 109.93 21.81 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 109.518 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.21 37.87 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.11 115.95 27.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 73' ' ' VAL . 97.9 t -80.18 118.69 73.68 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 122.735 0.414 . . . . 0.0 109.884 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.5 162.35 38.24 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.299 1.999 . . . . 0.0 112.439 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.3 -22.55 66.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.926 0.89 . . . . 0.0 111.185 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 p -67.67 -20.91 65.35 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.617 1.167 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.401 ' HE2' HD23 ' A' ' 64' ' ' LEU . 75.8 t80 -79.79 136.36 36.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.827 0.851 . . . . 0.0 109.521 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -163.89 162.49 16.45 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.969 0.908 . . . . 0.0 110.599 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.24 101.57 0.35 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.435 2.09 . . . . 0.0 110.517 164.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.21 62.51 0.67 Allowed Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.486 HG13 HG11 ' A' ' 105' ' ' VAL . 11.6 p -137.7 130.53 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -0.615 . . . . 0.0 110.285 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -69.85 132.65 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 165.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 125' ' ' THR . 15.2 m -139.06 159.37 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-O 122.081 0.943 . . . . 0.0 111.174 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.31 106.46 12.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 113.237 -1.801 . . . . 0.0 106.291 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.0 pt -100.87 161.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.254 0.621 . . . . 0.0 110.098 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.89 140.47 20.71 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.19 -108.57 0.27 Allowed Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.26 171.25 41.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.4 tp -128.69 127.71 42.67 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 139.03 43.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.241 0.616 . . . . 0.0 109.913 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.66 112.12 2.09 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.403 2.069 . . . . 0.0 112.179 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.38 -21.48 19.42 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.83 144.21 26.15 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 110.922 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.62 -34.76 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.811 0.444 . . . . 0.0 110.993 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -82.38 126.29 32.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.109 0.48 . . . . 0.0 110.795 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -77.6 122.54 25.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.846 0.858 . . . . 0.0 108.693 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -91.54 103.83 16.39 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.4 119.57 25.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -68.42 -42.49 78.88 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.272 1.029 . . . . 0.0 109.799 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -134.51 141.73 46.81 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 -170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -125.82 112.39 15.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.702 1.201 . . . . 0.0 108.566 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 ttp -118.55 106.0 12.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 105' ' ' VAL . 77.5 p -71.24 128.06 34.65 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 123.811 0.844 . . . . 0.0 109.207 -177.475 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 42.2 t -115.48 132.69 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 94.6 mtt180 -100.14 146.22 27.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.342 0.657 . . . . 0.0 110.177 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -133.82 126.6 30.89 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -115.66 108.33 16.25 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.98 -152.11 5.57 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 56.6 m -125.38 146.43 49.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.61 0.764 . . . . 0.0 109.815 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.68 120.04 33.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 124.012 0.925 . . . . 0.0 109.071 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.14 150.98 43.33 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.905 0.753 . . . . 0.0 111.007 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.55 45.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.624 0.769 . . . . 0.0 110.074 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.78 113.91 26.31 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.88 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.56 -1.14 45.92 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.224 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD12 ' HG3' ' A' ' 101' ' ' PRO . 5.4 tt -69.21 108.96 3.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -121.52 128.62 52.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.211 1.005 . . . . 0.0 108.861 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.468 ' HE2' HG11 ' A' ' 95' ' ' VAL . 25.7 mmt -83.06 154.91 24.17 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 172.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -86.3 35.61 0.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 26.42 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 128.078 2.551 . . . . 0.0 114.44 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.72 38.56 3.2 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.174 0.416 . . . . 0.0 113.05 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 133.75 4.38 Favored Pre-proline 0 C--O 1.241 0.618 0 C-N-CA 124.669 1.188 . . . . 0.0 108.694 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.72 115.64 3.51 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.468 2.112 . . . . 0.0 109.901 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.06 -174.4 33.27 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.501 0.5 . . . . 0.0 112.965 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.36 133.77 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.959 0.904 . . . . 0.0 110.057 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 46.2 ttm180 -106.36 124.32 49.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -149.33 160.77 43.12 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -96.45 111.48 23.57 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.86 105.05 10.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.75 121.42 19.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.6 t70 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 124.176 0.99 . . . . 0.0 110.825 -177.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 C--O 1.239 0.533 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.03 134.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -85.98 138.39 32.02 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 60.2 t -123.08 116.68 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.4 93.87 8.4 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -98.18 122.58 41.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.91 116.17 31.15 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.01 174.65 33.18 Favored Glycine 0 C--O 1.238 0.346 0 O-C-N 123.994 0.808 . . . . 0.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 112.78 4.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.468 HG11 ' HE2' ' A' ' 66' ' ' MET . 97.8 t -81.1 117.01 66.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.413 0.685 . . . . 0.0 109.471 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.01 171.23 18.53 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.182 1.921 . . . . 0.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.16 -22.27 59.49 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -63.54 -32.2 73.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.4 1.08 . . . . 0.0 109.796 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -76.52 120.91 22.38 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 166.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -161.35 155.63 19.25 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.505 0.722 . . . . 0.0 110.173 -174.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HG3' HD12 ' A' ' 64' ' ' LEU . 41.6 Cg_exo -57.98 107.79 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.649 2.232 . . . . 0.0 111.847 172.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.86 -25.14 5.62 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.237 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 p -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 117.44 0.62 . . . . 0.0 110.654 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.5 mt-10 -86.62 129.69 34.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 125' ' ' THR . 34.8 m -119.99 144.94 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.611 0.719 . . . . 0.0 111.068 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.92 107.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.66 143.69 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 25.9 mt-10 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.62 -100.29 0.14 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . 166.15 159.2 11.71 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 170.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.84 127.67 39.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.995 0.918 . . . . 0.0 109.237 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -82.98 135.34 45.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 -28.66 80.96 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.814 2.342 . . . . 0.0 113.377 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.05 -11.26 56.61 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.84 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 42.1 mt-10 -119.14 125.49 49.37 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.562 0.745 . . . . 0.0 110.159 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -61.43 -26.3 67.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.992 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 t -84.67 130.51 34.7 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.23 0.538 . . . . 0.0 111.284 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 10.2 t80 -77.07 116.15 17.47 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -97.51 114.37 26.24 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.28 30.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.165 0.986 . . . . 0.0 110.668 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -75.04 -26.36 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.142 0.577 . . . . 0.0 110.45 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 39.0 p -139.61 155.39 47.48 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.682 1.193 . . . . 0.0 108.836 174.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 tt -137.94 137.11 37.66 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 ttp -133.7 164.97 26.03 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.554 HG21 HG11 ' A' ' 105' ' ' VAL . 40.0 p -109.86 149.36 29.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.113 0.565 . . . . 0.0 109.913 173.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.21 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.004 0.43 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.64 127.78 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -113.84 134.27 54.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.792 0.437 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 163.95 16.93 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.222 1.009 . . . . 0.0 110.244 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -139.37 139.82 37.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.652 1.181 . . . . 0.0 108.368 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.94 30.44 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -123.2 148.68 45.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.588 1.155 . . . . 0.0 109.463 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.47 130.87 35.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.34 37.64 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.564 0.54 . . . . 0.0 110.919 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -70.89 -45.44 64.35 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.437 0.695 . . . . 0.0 109.608 170.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.63 120.58 30.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 52.12 1.93 Allowed Glycine 0 N--CA 1.468 0.782 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.9 tt -135.84 125.76 25.86 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -140.57 142.86 35.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.526 1.13 . . . . 0.0 108.807 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.6 mmt -95.02 147.88 22.93 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.99 123.66 22.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.05 124.88 41.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.351 0.661 . . . . 0.0 109.553 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.92 28.45 70.58 Favored Glycine 0 C--N 1.344 0.989 0 O-C-N 123.726 0.641 . . . . 0.0 111.9 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.33 131.48 2.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.784 1.233 . . . . 0.0 109.007 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 120.77 7.48 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 121.928 1.752 . . . . 0.0 111.771 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -176.85 31.32 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 120.998 0.221 . . . . 0.0 113.546 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.51 139.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.459 1.104 . . . . 0.0 109.431 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 40.5 ttt180 -119.65 125.81 49.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.64 0.776 . . . . 0.0 108.991 171.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 37.5 p90 -151.36 162.35 41.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 30.2 ptt180 -100.18 119.26 38.08 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.0 tp -73.79 115.78 13.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.702 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.535 ' HA ' HG21 ' A' ' 86' ' ' THR . 34.2 mt-10 -74.21 101.95 4.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.172 0 C-N-CA 123.611 0.764 . . . . 0.0 111.797 -179.324 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.535 HG21 ' HA ' ' A' ' 78' ' ' GLU . 39.9 p . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.615 0.245 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -101.95 138.82 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.8 m95 -73.89 160.63 31.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.951 0.501 . . . . 0.0 110.777 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.3 t -135.71 108.77 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 108.677 -173.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.9 tp -93.98 94.04 8.23 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -99.48 131.86 45.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -118.74 150.84 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.147 0.579 . . . . 0.0 110.622 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.18 -172.22 14.12 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.195 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.81 121.13 18.43 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.166 0.587 . . . . 0.0 110.106 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.24 124.64 80.6 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.922 0.889 . . . . 0.0 109.332 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.473 ' HD2' HD23 ' A' ' 123' ' ' LEU . 57.8 Cg_endo -68.61 152.58 74.56 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.474 2.116 . . . . 0.0 112.111 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.55 -27.03 63.84 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.524 0.73 . . . . 0.0 111.66 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 96' ' ' PRO . 9.6 t -68.62 -20.02 64.46 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.761 0.425 . . . . 0.0 110.908 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.07 115.33 10.08 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.439 ' O ' HG11 ' A' ' 103' ' ' VAL . 47.8 mtmt -132.15 158.66 74.95 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.487 1.115 . . . . 0.0 108.644 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 11.2 Cg_exo -70.99 141.08 39.42 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.204 1.936 . . . . 0.0 109.985 167.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.72 79.04 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 100' ' ' LYS . 9.9 p -93.25 149.83 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.388 1.094 . . . . 0.0 108.313 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -69.99 139.07 52.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 125' ' ' THR . 16.6 m -133.03 156.4 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.916 0.865 . . . . 0.0 111.017 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.8 mt -121.16 127.89 75.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.738 1.615 . . . . 0.0 106.769 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.6 pt -125.93 145.63 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.26 155.25 46.6 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 109.153 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 165.88 -114.42 0.59 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.02 150.81 20.94 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 117.343 0.571 . . . . 0.0 111.979 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 45.9 tp -127.66 136.11 51.15 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.533 0.733 . . . . 0.0 109.874 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 132.55 37.17 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.64 -19.53 53.43 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.807 2.338 . . . . 0.0 113.728 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.7 -8.28 57.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.792 -0.449 . . . . 0.0 113.768 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -100.68 139.68 36.03 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 117.708 0.754 . . . . 0.0 110.014 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -85.98 -23.14 27.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.994 0.917 . . . . 0.0 111.934 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -99.39 126.47 45.28 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.873 0.844 . . . . 0.0 110.763 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.406 ' HD1' ' HB2' ' A' ' 111' ' ' LEU . 81.2 t80 -75.11 131.02 40.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.762 1.225 . . . . 0.0 108.715 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 60.0 tttm -88.25 108.16 19.17 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.02 113.62 23.84 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.015 0.526 . . . . 0.0 110.111 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.09 -30.51 62.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.468 0.707 . . . . 0.0 109.49 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p -133.4 141.33 47.82 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 109.834 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.473 HD23 ' HD2' ' A' ' 96' ' ' PRO . 62.8 tp -124.8 109.58 13.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.5 ttp -124.86 138.45 54.26 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.445 ' HA ' HG11 ' A' ' 105' ' ' VAL . 65.3 p -89.61 169.01 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.002 0.521 . . . . 0.0 111.231 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 24.9 tptm . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.213 1.005 . . . . 0.0 109.995 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 CA--C 1.563 1.444 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -97.15 118.85 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.336 -0.853 . . . . 0.0 109.521 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -120.1 138.0 53.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.67 140.47 40.82 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.77 134.04 52.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.211 1.005 . . . . 0.0 108.606 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.9 177.38 41.04 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.48 ' HG1' ' HG2' ' A' ' 104' ' ' GLU . 24.0 m -113.4 140.19 48.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.763 0.825 . . . . 0.0 109.074 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.6 132.25 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.764 0.426 . . . . 0.0 110.39 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.67 40.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 122.617 0.367 . . . . 0.0 110.062 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -75.59 -0.33 20.09 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.695 173.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -131.23 120.77 23.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.898 0.879 . . . . 0.0 109.363 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.91 22.91 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.865 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.81 105.73 5.23 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 m -138.59 125.95 21.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.813 0.845 . . . . 0.0 109.944 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtp -96.89 162.19 13.52 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.165 0.586 . . . . 0.0 110.631 -170.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.63 135.12 35.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.013 0.525 . . . . 0.0 111.225 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -73.89 111.84 9.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.554 0.742 . . . . 0.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.95 -53.78 4.88 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.334 0.396 . . . . 0.0 112.347 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.61 129.16 94.14 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 123.856 0.862 . . . . 0.0 110.906 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.31 113.46 1.92 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.435 2.09 . . . . 0.0 110.808 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.41 175.36 35.94 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 121.478 0.488 . . . . 0.0 113.514 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 8.7 p -154.35 131.71 2.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.06 1.344 . . . . 0.0 108.723 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.93 143.4 31.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -156.64 163.32 39.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -98.64 105.99 18.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.85 117.5 23.34 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.6 89.71 1.0 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.471 0.592 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.917 179.448 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 120.534 0.207 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.2 t -104.09 129.35 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.461 0.704 . . . . 0.0 109.657 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.52 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.2 m95 -78.76 100.76 7.25 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.19 110.09 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.359 0.6 . . . . 0.0 109.572 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 tp -93.15 93.75 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.742 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' HE2' ' HA ' ' A' ' 95' ' ' VAL . 47.3 t80 -92.97 111.54 23.2 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.715 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -105.3 116.09 31.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.205 0.602 . . . . 0.0 109.463 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 153.63 -175.24 32.05 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.46 112.76 4.24 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.407 ' HA ' ' HE2' ' A' ' 91' ' ' TYR . 46.2 t -79.82 126.35 80.33 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.423 0.689 . . . . 0.0 109.232 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.6 Cg_endo -57.33 142.88 94.96 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.782 2.322 . . . . 0.0 112.519 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.93 -25.7 67.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.583 0.753 . . . . 0.0 111.441 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.2 p -78.22 -6.65 55.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.503 1.121 . . . . 0.0 112.642 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.48 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 78.9 t80 -69.99 95.94 0.99 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.294 0.638 . . . . 0.0 109.946 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -110.53 157.41 38.36 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.256 1.023 . . . . 0.0 110.018 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.532 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 16.3 Cg_exo -68.46 112.7 2.9 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.302 2.001 . . . . 0.0 110.714 171.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.58 3.31 27.18 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.911 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 125' ' ' THR . 12.8 p -85.63 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 118.07 0.935 . . . . 0.0 110.278 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG2' ' HG1' ' A' ' 58' ' ' THR . 37.6 mt-10 -74.39 110.33 8.59 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 171.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.493 HG12 HG12 ' A' ' 103' ' ' VAL . 29.8 m -104.63 148.05 9.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.952 0.882 . . . . 0.0 110.223 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.55 107.19 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.11 144.42 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 138.89 26.66 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.93 -118.35 0.83 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -172.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.54 141.58 6.63 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 117.907 0.853 . . . . 0.0 112.342 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 tp -87.64 129.17 35.22 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . . . -81.58 132.75 54.23 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.75 -18.78 66.08 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.009 2.473 . . . . 0.0 114.055 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.23 -31.92 6.64 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.679 -0.237 . . . . 0.0 112.76 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 3.2 mp0 -94.45 137.26 33.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.945 0.498 . . . . 0.0 111.313 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.26 -26.69 65.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.992 0.917 . . . . 0.0 110.533 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 58.5 p -84.41 130.04 34.81 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.9 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -77.79 120.43 22.68 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.372 1.069 . . . . 0.0 108.619 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -75.74 94.73 3.31 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.22 109.59 18.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.248 0.619 . . . . 0.0 110.13 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -62.38 -42.36 99.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.931 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.2 p -134.83 162.31 32.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.879 0.871 . . . . 0.0 110.192 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.0 tp -150.58 111.43 4.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.361 1.064 . . . . 0.0 108.895 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 ttp -124.48 116.08 21.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.485 0.314 . . . . 0.0 110.939 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.531 ' HB ' HG22 ' A' ' 103' ' ' VAL . 70.4 p -74.06 150.27 40.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.389 1.076 . . . . 0.0 110.694 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 N--CA 1.47 0.575 0 C-N-CA 122.741 0.417 . . . . 0.0 110.054 177.588 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.6 t -102.65 145.23 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.183 0.993 . . . . 0.0 109.393 -170.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -115.58 123.2 47.85 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.44 147.35 41.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.637 0.732 . . . . 0.0 110.034 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.96 109.06 10.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.913 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.86 -158.31 8.55 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.455 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 50.2 m -117.12 145.71 43.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.388 1.075 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.9 120.43 32.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.079 0.952 . . . . 0.0 109.08 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.9 47.59 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.744 0.652 . . . . 0.0 111.647 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 101' ' ' PRO . . . -70.3 -28.83 65.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.541 0.736 . . . . 0.0 112.111 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -110.59 42.14 1.64 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.54 51.96 0.22 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 tt -133.65 108.42 8.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 m -114.43 119.51 37.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 109.682 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.1 mmt -80.92 143.62 32.52 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 0.0 110.093 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -75.93 131.96 39.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.641 0.376 . . . . 0.0 110.068 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.38 139.48 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.525 0.73 . . . . 0.0 109.93 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.26 19.84 64.55 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.978 0.799 . . . . 0.0 112.9 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.89 129.29 2.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.959 0.904 . . . . 0.0 109.674 -172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.91 121.78 8.43 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.506 2.137 . . . . 0.0 110.668 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.58 -172.96 30.27 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.606 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.09 139.68 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 109.528 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.743 HH21 ' HB ' ' A' ' 117' ' ' THR . 45.9 ttt180 -111.86 139.86 46.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -154.27 152.58 30.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.251 0.62 . . . . 0.0 109.544 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 13.8 ptm180 -94.66 107.24 19.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -73.32 114.26 11.33 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.856 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.73 87.6 6.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 124.129 0.972 . . . . 0.0 109.042 174.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.849 0.357 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.52 135.57 35.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 70.9 m95 -74.7 161.96 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.241 0.616 . . . . 0.0 109.438 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 84.1 t -138.23 115.07 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.1 tp -93.2 98.5 11.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.067 0.854 . . . . 0.0 108.79 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -96.03 125.21 40.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -119.49 117.52 28.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.236 0.614 . . . . 0.0 109.887 172.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.49 -164.52 30.24 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 115.23 9.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.948 0.499 . . . . 0.0 109.694 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.42 130.24 65.99 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.856 0.862 . . . . 0.0 109.474 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.9 Cg_endo -61.46 144.91 98.38 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.38 2.054 . . . . 0.0 112.132 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.83 -27.44 67.55 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.237 1.015 . . . . 0.0 111.446 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 p -78.73 -14.53 59.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.509 1.124 . . . . 0.0 112.139 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.598 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.6 t80 -68.51 119.94 13.78 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -152.37 161.05 30.39 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.275 1.03 . . . . 0.0 108.716 -174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 57.0 Cg_endo -66.73 111.16 2.07 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.032 1.822 . . . . 0.0 110.845 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.63 -11.48 15.92 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.683 -0.509 . . . . 0.0 113.825 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.07 149.18 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 117.714 0.757 . . . . 0.0 110.002 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HB3' ' HZ2' ' A' ' 126' ' ' LYS . 45.2 mt-10 -83.18 140.96 32.27 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.11 168.46 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.063 0.945 . . . . 0.0 111.851 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.403 ' HB ' ' HG2' ' A' ' 124' ' ' MET . 71.5 mt -132.84 122.71 47.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 126.462 1.905 . . . . 0.0 106.202 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.6 139.56 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.689 0.795 . . . . 0.0 109.827 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.42 132.49 56.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.9 -143.09 7.09 Favored Glycine 0 N--CA 1.47 0.946 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.82 136.18 4.58 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 117.685 0.742 . . . . 0.0 112.662 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.2 tp -93.08 134.41 35.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.289 1.035 . . . . 0.0 108.919 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 115' ' ' GLU . . . -88.86 146.59 37.11 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.264 0.626 . . . . 0.0 110.309 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.49 120.25 7.36 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.878 2.385 . . . . 0.0 112.206 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.12 69.14 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.979 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG3' ' HB3' ' A' ' 112' ' ' ALA . 69.3 mm-40 -101.0 151.32 21.92 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.617 0.767 . . . . 0.0 110.13 172.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -106.55 16.45 24.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.925 0.89 . . . . 0.0 109.864 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.743 ' HB ' HH21 ' A' ' 74' ' ' ARG . 12.7 t -134.7 111.77 10.24 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.959 0.885 . . . . 0.0 109.846 -174.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -74.77 109.34 8.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.119 1.367 . . . . 0.0 108.37 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.572 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 9.6 mtmp? -77.79 98.74 5.65 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.29 163.53 26.33 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.629 0.771 . . . . 0.0 111.483 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -125.13 -36.47 2.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.091 1.356 . . . . 0.0 108.071 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -132.32 164.3 26.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.22 1.008 . . . . 0.0 109.778 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -156.71 117.94 3.76 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.488 1.115 . . . . 0.0 108.731 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.403 ' HG2' ' HB ' ' A' ' 106' ' ' ILE . 19.2 ptp -137.38 147.82 45.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -91.55 142.85 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.684 0.394 . . . . 0.0 110.235 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HZ2' ' HB3' ' A' ' 104' ' ' GLU . 49.2 mttp . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 123.073 0.549 . . . . 0.0 110.092 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.4 124.44 49.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -82.72 105.0 13.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.17 132.21 54.37 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -167.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.98 126.52 55.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.86 -178.96 35.3 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -117.18 142.93 46.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.338 0.655 . . . . 0.0 109.726 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.47 125.01 36.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.346 0.658 . . . . 0.0 110.428 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.13 136.29 38.6 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.14 66.64 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.66 0.6 . . . . 0.0 109.744 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.737 ' HB2' HH21 ' A' ' 76' ' ' ARG . 2.6 m-20 -83.78 133.05 34.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.543 177.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.25 78.86 Favored Glycine 0 N--CA 1.468 0.803 0 O-C-N 123.397 0.436 . . . . 0.0 113.217 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tt -76.67 103.79 6.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.6 m -121.05 127.36 51.63 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.778 1.231 . . . . 0.0 109.57 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 91.8 mmm -83.85 145.0 28.88 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.56 125.28 26.23 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.36 104.08 2.6 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.362 1.065 . . . . 0.0 110.552 -170.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.49 73.5 Favored Glycine 0 C--N 1.342 0.895 0 O-C-N 123.749 0.656 . . . . 0.0 112.784 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.7 132.35 13.02 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 123.917 0.887 . . . . 0.0 109.394 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.96 110.69 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.758 2.305 . . . . 0.0 111.051 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 -176.79 30.17 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.841 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.66 135.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 109.579 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.6 ttm180 -112.48 128.11 56.24 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.0 171.85 14.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -171.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.737 HH21 ' HB2' ' A' ' 62' ' ' ASP . 37.9 mtm180 -96.39 130.16 43.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 tp -103.13 117.05 33.69 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.672 0.789 . . . . 0.0 109.234 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -70.62 91.36 0.79 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 170.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.538 0.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.824 -161.336 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 76' ' ' ARG . 28.4 p . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.15 136.42 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.18 127.2 31.73 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 99.3 t -111.94 117.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.429 0.692 . . . . 0.0 109.312 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.38 96.17 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -95.55 123.09 38.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.542 ' HZ1' ' HB2' ' A' ' 92' ' ' LYS . 9.8 mtmp? -115.69 112.6 22.31 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.689 0.796 . . . . 0.0 109.425 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.52 -173.43 34.94 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.96 111.77 5.19 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.264 0.626 . . . . 0.0 110.312 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 110.15 19.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.806 0.691 . . . . 0.0 109.497 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.52 ' HD2' HD23 ' A' ' 123' ' ' LEU . 74.5 Cg_endo -71.5 157.71 55.61 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.34 2.027 . . . . 0.0 112.147 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.55 -12.27 61.51 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.609 0.764 . . . . 0.0 112.242 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -70.15 -22.68 62.96 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.248 0.619 . . . . 0.0 111.485 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -71.56 95.27 1.39 Allowed 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.51 145.77 38.17 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.72 100.54 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.624 2.216 . . . . 0.0 111.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.78 -8.54 7.7 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.222 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.93 148.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 118.352 1.076 . . . . 0.0 110.038 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.88 115.99 19.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 20.7 m -104.67 155.72 6.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 123.847 0.859 . . . . 0.0 111.253 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mt -117.09 107.63 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.47 141.32 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.1 0.56 . . . . 0.0 109.966 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.41 117.85 30.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 120' ' ' ALA . . . -172.09 -149.47 6.69 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 123.49 0.494 . . . . 0.0 112.265 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.16 145.46 10.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 117.165 0.483 . . . . 0.0 112.479 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.9 tp -88.92 105.36 17.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.46 139.31 41.37 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.058 0.543 . . . . 0.0 111.212 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.93 90.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 123.414 2.743 . . . . 0.0 112.62 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.99 -42.57 0.82 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -95.38 130.46 42.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.542 0.737 . . . . 0.0 110.644 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.77 -17.04 60.03 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.864 0.866 . . . . 0.0 110.523 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 t -86.64 133.2 33.72 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.152 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -77.04 109.86 11.21 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -86.12 94.18 9.2 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . . . -84.12 117.35 23.41 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.635 0.774 . . . . 0.0 111.108 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -61.92 -45.41 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.845 0.858 . . . . 0.0 111.035 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m -127.97 136.24 51.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.66 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.52 HD23 ' HD2' ' A' ' 96' ' ' PRO . 33.5 tp -112.99 123.74 51.01 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.6 mtm -132.73 171.01 14.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.226 1.01 . . . . 0.0 108.285 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 35.1 p -130.43 148.92 52.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.771 . . . . 0.0 110.075 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 N--CA 1.476 0.834 0 C-N-CA 123.399 0.68 . . . . 0.0 109.999 173.61 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 43' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.59 162.15 35.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.672 0.789 . . . . 0.0 110.665 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 p -101.26 105.57 40.29 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.74 -176.49 3.2 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.845 2.363 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -63.85 159.03 20.47 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.121 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.36 145.17 48.85 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.142 0.977 . . . . 0.0 111.379 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.659 0.784 . . . . 0.0 111.73 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.29 27.49 1.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.473 0.709 . . . . 0.0 111.156 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -64.24 95.04 0.12 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.625 0.726 . . . . 0.0 109.894 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m -69.06 151.56 46.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.264 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.66 105.54 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -168.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.79 117.82 26.88 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.52 HD22 HD22 ' A' ' 77' ' ' LEU . 3.1 tt -123.62 142.9 50.6 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -121.76 141.25 51.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 0.0 109.302 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.26 -161.35 28.08 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.9 m -127.02 145.08 50.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.434 0.694 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.35 132.3 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.573 0.749 . . . . 0.0 109.972 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.86 156.56 17.41 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.444 0.698 . . . . 0.0 110.964 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.13 30.63 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.482 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -77.31 108.81 10.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.813 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.36 12.21 61.66 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.756 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.24 90.16 1.59 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -116.8 116.66 27.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.734 1.214 . . . . 0.0 109.877 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtt -89.98 161.81 15.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.524 HD22 HD12 ' A' ' 90' ' ' LEU . 79.3 mt -66.94 119.14 11.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.663 0.385 . . . . 0.0 110.681 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.97 98.07 0.27 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.351 1.06 . . . . 0.0 110.724 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.75 22.84 68.44 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.462 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 67' ' ' LEU . . . -143.26 149.14 47.25 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.729 0.812 . . . . 0.0 109.953 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.81 111.52 3.27 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.566 2.178 . . . . 0.0 112.076 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.29 179.33 31.23 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.986 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 11.1 p -149.28 134.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.807 0.843 . . . . 0.0 110.601 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -104.15 138.65 40.33 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.28 163.63 39.88 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -97.98 115.16 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 HD22 ' A' ' 55' ' ' LEU . 21.9 tp -79.66 108.87 13.54 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HG2' HG23 ' A' ' 86' ' ' THR . 58.0 mt-10 -78.01 110.36 12.88 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.298 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.72 129.27 40.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.339 1.056 . . . . 0.0 110.111 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -72.68 -26.83 61.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.565 0.346 . . . . 0.0 111.545 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.65 -49.48 58.74 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.225 0.536 . . . . 0.0 109.97 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -131.47 103.26 6.32 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.1 p -76.07 4.63 8.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.813 0.845 . . . . 0.0 113.132 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 p -102.46 -15.88 16.34 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.433 0.693 . . . . 0.0 109.832 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -77.0 86.63 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 78' ' ' GLU . 35.2 p -107.63 108.02 19.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.468 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.45 129.57 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.41 98.21 8.11 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 107' ' ' ILE . 53.2 t -88.99 130.62 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.625 0.77 . . . . 0.0 109.986 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 HD22 ' A' ' 67' ' ' LEU . 37.0 tp -115.64 114.32 24.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.227 1.011 . . . . 0.0 108.939 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -112.86 128.87 56.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.086 1.354 . . . . 0.0 108.008 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 148.07 29.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.411 0.685 . . . . 0.0 109.433 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.78 -168.16 12.51 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.71 112.2 4.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.243 0.617 . . . . 0.0 110.582 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.11 117.13 68.18 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.029 0.932 . . . . 0.0 108.754 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 29.9 Cg_endo -59.44 151.3 69.62 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.693 2.262 . . . . 0.0 113.173 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -65.74 -25.12 67.14 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.728 0.811 . . . . 0.0 110.393 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.5 p -71.16 -23.87 62.14 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.992 1.317 . . . . 0.0 111.589 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.3 t80 -68.46 106.45 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -133.31 155.76 80.5 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.746 0.819 . . . . 0.0 109.101 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 110.3 2.17 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.523 2.148 . . . . 0.0 111.456 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.93 -11.71 9.37 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.044 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.2 t -81.55 124.41 38.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.456 0.702 . . . . 0.0 109.532 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.77 118.99 14.26 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 m -120.79 154.38 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.606 0.717 . . . . 0.0 111.785 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.55 115.14 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.426 HG23 HG11 ' A' ' 89' ' ' VAL . 37.9 pt -100.91 162.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.504 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 33.5 tt0 -148.67 132.76 17.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.18 -117.54 0.69 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 179.76 146.27 6.79 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 117.453 0.626 . . . . 0.0 112.539 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.98 114.57 27.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.22 134.51 48.82 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 123.593 0.558 . . . . 0.0 110.111 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.7 104.43 0.16 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.871 2.381 . . . . 0.0 111.85 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.07 -29.86 5.42 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.573 ' HG2' ' HE3' ' A' ' 119' ' ' LYS . 11.0 tp10 -91.29 132.64 36.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.4 -5.31 58.91 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.308 0.643 . . . . 0.0 112.284 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.2 p -114.64 137.46 51.87 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.323 0.511 . . . . 0.0 112.031 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.25 111.61 14.39 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.573 ' HE3' ' HG2' ' A' ' 115' ' ' GLU . 93.9 mttt -82.29 93.65 7.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.34 108.32 14.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.73 0.812 . . . . 0.0 110.043 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -19.62 57.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.589 0.755 . . . . 0.0 111.548 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 22.4 p -138.63 157.14 46.7 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.054 0.941 . . . . 0.0 110.107 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 tp -138.6 140.88 39.14 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.984 1.314 . . . . 0.0 108.235 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.8 ttm -136.53 118.77 15.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.348 0.659 . . . . 0.0 109.587 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -100.4 145.11 28.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.748 0.819 . . . . 0.0 110.157 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.61 -53.76 3.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.432 . . . . 0.0 111.122 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 92.3 m -82.11 124.18 78.95 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 122.552 0.341 . . . . 0.0 111.082 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.05 -158.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.998 2.465 . . . . 0.0 112.533 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.94 80.7 2.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.362 0.665 . . . . 0.0 109.911 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.332 1.053 . . . . 0.0 108.788 178.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.6 mtm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.02 50.66 2.22 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.411 ' OG1' ' HB1' ' A' ' 112' ' ' ALA . 80.9 p -74.99 146.66 82.85 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.621 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -43.68 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 124.489 3.46 . . . . 0.0 114.987 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.448 ' OE1' ' HB3' ' A' ' 112' ' ' ALA . 44.2 tt0 -151.81 80.13 1.27 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.66 163.29 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.966 0.412 . . . . 0.0 111.225 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.57 -42.06 65.03 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -22.6 61.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.06 0.144 . . . . 0.0 110.908 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -73.43 88.05 1.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.312 0.645 . . . . 0.0 109.705 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -100.8 121.35 41.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.88 146.13 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -123.33 114.27 19.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.181 0.992 . . . . 0.0 109.043 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tt -114.15 126.15 54.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.93 135.7 39.28 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.76 -174.15 38.47 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -124.12 140.84 52.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.225 1.01 . . . . 0.0 109.002 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.1 123.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.467 ' HB1' ' HG3' ' A' ' 78' ' ' GLU . . . -75.65 149.52 38.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.07 0.548 . . . . 0.0 111.265 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.53 27.35 1.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.822 0.849 . . . . 0.0 110.562 167.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -143.31 128.16 18.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.723 1.209 . . . . 0.0 107.869 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.76 6.76 88.17 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.694 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.87 85.4 2.82 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.3 m -107.45 111.88 24.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.277 1.431 . . . . 0.0 109.847 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtp -91.79 146.64 23.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.55 127.5 32.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.755 0.422 . . . . 0.0 111.677 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.51 118.43 18.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.123 0.969 . . . . 0.0 110.316 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.32 18.71 67.71 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 123.88 0.738 . . . . 0.0 114.068 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.52 12.36 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.579 0.752 . . . . 0.0 109.691 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.54 115.98 4.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.399 2.066 . . . . 0.0 111.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.58 -175.51 31.92 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.841 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.27 130.56 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 124.15 0.98 . . . . 0.0 110.399 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.468 HH12 HG23 ' A' ' 117' ' ' THR . 8.9 tpp180 -92.25 131.84 37.15 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 165.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.92 163.33 37.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.531 0.605 . . . . 0.0 109.611 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.12 106.5 17.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.29 115.77 14.18 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.765 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.576 ' HB3' HG23 ' A' ' 83' ' ' THR . 48.3 mt-10 -73.1 99.35 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.48 101.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.347 1.059 . . . . 0.0 108.65 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -22.9 65.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -167.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.43 -36.54 83.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.242 0.617 . . . . 0.0 111.014 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -121.1 -62.28 1.46 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.337 0.655 . . . . 0.0 110.491 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 78' ' ' GLU . 18.9 m 76.9 -22.07 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.88 1.672 . . . . 0.0 111.613 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 p -64.69 -18.37 64.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.49 1.116 . . . . 0.0 110.846 167.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -126.92 113.54 16.67 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.957 0.903 . . . . 0.0 108.826 172.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 78' ' ' GLU . 71.4 p -110.1 139.16 45.53 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.19 137.76 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -79.89 146.27 32.25 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.75 119.53 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.0 94.16 7.82 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -89.56 125.16 35.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -116.41 110.11 18.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.477 0.711 . . . . 0.0 109.416 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.01 -173.98 35.28 Favored Glycine 0 N--CA 1.469 0.89 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.942 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 108.57 1.96 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.626 0.77 . . . . 0.0 111.763 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -81.67 118.03 70.57 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.401 0.681 . . . . 0.0 109.789 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.21 163.93 29.79 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.59 2.193 . . . . 0.0 112.556 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.72 -22.1 66.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.44 0.696 . . . . 0.0 110.691 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.59 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 18.8 p -82.21 -13.8 56.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.134 0.974 . . . . 0.0 111.833 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.06 107.0 6.84 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 103' ' ' VAL . 47.5 pttt -151.8 150.42 26.13 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.407 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.53 117.77 4.8 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.273 1.982 . . . . 0.0 111.243 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.35 11.64 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.044 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.677 HG23 ' SG ' ' A' ' 127' ' ' CYS . 8.2 p -90.34 145.29 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 117.866 0.833 . . . . 0.0 110.283 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.04 131.63 39.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 151.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.805 0.812 . . . . 0.0 109.65 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.43 119.97 60.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.2 pt -107.94 137.37 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -114.28 145.98 41.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.24 -124.61 1.41 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.98 141.89 6.76 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 117.071 0.435 . . . . 0.0 112.657 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.8 tp -89.33 115.29 26.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.061 0.944 . . . . 0.0 108.592 173.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.448 ' HB3' ' OE1' ' A' ' 47' ' ' GLN . . . -89.55 134.41 32.56 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.56 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.74 90.79 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.954 2.436 . . . . 0.0 111.986 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.73 -45.48 0.65 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 117' ' ' THR . 2.2 mp0 -91.84 116.36 28.84 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.054 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.04 -17.67 63.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.109 0.563 . . . . 0.0 110.617 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 HH12 ' A' ' 74' ' ' ARG . 8.8 t -78.18 134.21 37.67 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -75.46 109.26 8.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -82.5 94.7 7.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.39 126.62 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.333 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.025 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p -138.57 165.03 27.94 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.741 0.816 . . . . 0.0 110.281 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.3 tp -135.19 137.28 42.52 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.698 1.199 . . . . 0.0 109.051 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 ttp -136.84 117.3 13.74 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.5 p -81.74 142.91 32.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.067 0.947 . . . . 0.0 109.887 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.4 mmpt? -71.1 -25.75 62.73 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.388 0.275 . . . . 0.0 111.599 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.677 ' SG ' HG23 ' A' ' 103' ' ' VAL . 21.4 p -85.32 118.43 70.76 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.56 155.8 56.22 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.554 . . . . 0.0 111.756 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.5 mp -53.63 101.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.807 0.843 . . . . 0.0 111.232 -175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 124.737 1.215 . . . . 0.0 110.466 -173.118 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.1 tpp . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.58 93.03 9.08 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -74.94 117.51 63.29 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.885 0.474 . . . . 0.0 111.587 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -94.41 18.28 0.84 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.367 2.711 . . . . 0.0 112.045 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.52 -173.51 2.97 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.234 1.014 . . . . 0.0 111.618 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.69 89.5 0.26 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.033 0.533 . . . . 0.0 110.45 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -151.67 -48.9 0.11 Allowed 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -93.84 -2.05 54.02 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.258 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -70.33 135.71 49.11 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.787 0.835 . . . . 0.0 109.748 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -128.51 125.47 38.45 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.82 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -137.01 118.95 15.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.852 0.861 . . . . 0.0 109.609 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.74 145.71 46.3 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -117.26 142.42 47.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.754 0.822 . . . . 0.0 109.365 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.32 -165.65 36.2 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.295 0.372 . . . . 0.0 112.828 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.2 m -119.28 147.19 44.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.771 0.828 . . . . 0.0 109.565 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.9 126.14 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 110.275 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.65 156.38 16.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.318 0.647 . . . . 0.0 110.064 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.02 59.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.283 0.633 . . . . 0.0 110.98 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.23 110.89 6.99 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.853 0.861 . . . . 0.0 109.466 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.61 16.16 71.61 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.679 0.612 . . . . 0.0 113.337 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.05 105.52 3.36 Favored 'General case' 0 C--N 1.359 1.022 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -143.74 137.56 28.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.573 1.149 . . . . 0.0 108.281 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.03 144.29 29.2 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.51 135.33 52.87 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.469 0.308 . . . . 0.0 110.848 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -65.7 109.89 2.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.97 0.908 . . . . 0.0 111.024 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.45 24.79 67.99 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.719 0.637 . . . . 0.0 113.801 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.5 130.06 10.39 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.534 0.734 . . . . 0.0 109.681 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 117.04 3.72 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.585 2.19 . . . . 0.0 110.499 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.33 176.23 28.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.622 0.576 . . . . 0.0 111.945 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.31 143.83 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.483 0.658 . . . . 0.0 110.489 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -112.44 132.23 55.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -153.86 162.27 41.36 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.832 0.453 . . . . 0.0 110.175 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.513 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 39.6 ttp180 -95.88 111.07 23.15 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 107' ' ' ILE . 22.0 tp -79.13 120.58 23.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.032 0.533 . . . . 0.0 109.93 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.33 95.35 2.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -58.5 136.5 57.54 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.33 1.019 . . . . 0.0 112.079 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -98.74 -28.99 13.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.042 0.937 . . . . 0.0 111.322 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.37 -44.29 91.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.194 0.598 . . . . 0.0 111.749 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -121.45 -38.62 2.75 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.545 0.738 . . . . 0.0 110.717 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m 77.38 -19.23 0.44 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.346 1.458 . . . . 0.0 111.774 -173.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.3 p -81.18 9.28 7.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.161 0.984 . . . . 0.0 112.609 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.602 ' HE3' HG23 ' A' ' 87' ' ' VAL . 38.0 ttpt -147.84 158.11 43.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.971 0.909 . . . . 0.0 108.762 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 20.9 p -126.79 128.78 47.12 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG23 ' HE3' ' A' ' 85' ' ' LYS . 38.2 t -102.61 122.66 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.749 0.82 . . . . 0.0 110.667 -168.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.6 m95 -77.41 106.69 9.33 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.5 t -88.69 109.89 20.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.4 tp -93.18 97.09 10.43 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.379 1.049 . . . . 0.0 108.234 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -102.57 126.09 49.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.183 0.993 . . . . 0.0 109.026 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -111.7 130.57 55.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.354 0.662 . . . . 0.0 109.265 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.95 -166.49 21.39 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 110.84 3.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.546 0.738 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.69 131.89 59.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 109.537 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.02 140.96 58.55 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.802 2.335 . . . . 0.0 112.793 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.03 -24.57 65.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.234 0.54 . . . . 0.0 110.31 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -73.74 -15.06 61.22 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.816 1.246 . . . . 0.0 112.378 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -69.48 134.52 49.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.685 0.794 . . . . 0.0 110.009 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 103' ' ' VAL . 20.0 pttm -168.98 161.01 8.07 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.81 1.244 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.56 107.89 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.904 1.736 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.05 -9.34 8.47 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.811 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 127' ' ' CYS . 10.5 p -84.86 138.43 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 118.11 0.955 . . . . 0.0 109.478 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.91 116.28 19.97 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 125' ' ' THR . 22.2 m -113.33 153.26 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.54 0.686 . . . . 0.0 111.683 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.61 115.77 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.537 HD12 HD21 ' A' ' 77' ' ' LEU . 21.9 pt -100.39 139.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -148.71 142.88 26.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.21 -110.07 0.42 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.09 159.29 31.37 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 117.242 0.521 . . . . 0.0 112.445 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -123.85 143.02 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 0.0 108.813 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.76 147.09 54.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.26 0.624 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.61 72.59 4.34 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.079 2.519 . . . . 0.0 111.633 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.81 69.85 0.1 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.498 ' HG2' ' HE2' ' A' ' 119' ' ' LYS . 10.1 tp10 -172.64 141.05 1.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.789 0.835 . . . . 0.0 110.021 -173.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -86.29 -40.46 15.49 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.604 0.762 . . . . 0.0 109.642 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 69.0 p -83.92 121.32 27.2 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.598 -169.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.05 132.61 36.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.095 0.558 . . . . 0.0 110.114 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HE2' ' HG2' ' A' ' 115' ' ' GLU . 3.2 mptp? -93.23 96.55 10.07 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.24 99.68 9.44 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.932 0.493 . . . . 0.0 111.023 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -57.1 -33.07 66.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.889 0.875 . . . . 0.0 110.619 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p -138.05 141.15 40.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.579 1.152 . . . . 0.0 109.084 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.97 118.91 19.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 ptm -129.81 147.6 51.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.385 0.674 . . . . 0.0 109.502 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.424 HG22 HG13 ' A' ' 105' ' ' VAL . 60.4 p -100.53 152.51 20.32 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.804 0.841 . . . . 0.0 109.957 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.14 -24.22 21.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.479 0.712 . . . . 0.0 110.562 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.519 ' HB2' HG23 ' A' ' 103' ' ' VAL . 58.7 m -106.9 123.06 39.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.306 0.642 . . . . 0.0 110.153 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.08 -174.51 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.828 2.352 . . . . 0.0 112.618 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.92 99.62 0.26 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.314 0.645 . . . . 0.0 110.797 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 124.259 1.024 . . . . 0.0 108.265 179.351 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.14 89.66 1.17 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.268 0.627 . . . . 0.0 109.349 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -109.84 96.19 23.42 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 109.231 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 81.54 2.75 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.448 2.099 . . . . 0.0 111.66 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.77 93.57 2.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.04 148.49 28.58 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.515 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.01 -63.26 1.31 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.523 0.729 . . . . 0.0 109.653 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.94 65.89 2.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.072 0.549 . . . . 0.0 111.762 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -143.25 59.04 1.4 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 162.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.1 m -92.39 141.65 28.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.172 173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.72 136.84 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.342 0.657 . . . . 0.0 109.492 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.69 133.88 52.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.833 0.853 . . . . 0.0 108.995 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.83 139.56 38.21 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -110.42 143.38 40.8 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.403 1.081 . . . . 0.0 108.668 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.94 -173.76 42.78 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 117.876 0.307 . . . . 0.0 112.615 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.6 m -112.3 134.13 54.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.719 0.808 . . . . 0.0 110.057 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.92 122.56 19.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.188 0.995 . . . . 0.0 110.447 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.95 146.94 25.97 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.25 -10.93 58.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.07 116.61 14.9 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.52 1.128 . . . . 0.0 109.995 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.66 9.91 82.75 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 123.682 0.614 . . . . 0.0 113.727 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 4.3 tt -72.61 111.14 7.5 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 p -132.1 130.69 41.55 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.277 1.431 . . . . 0.0 109.137 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 86.9 mmm -85.0 136.48 33.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD13 ' HA3' ' A' ' 72' ' ' GLY . 84.2 mt -63.84 111.52 2.5 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -71.09 110.21 5.63 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 110.57 -167.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.84 22.61 77.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.055 -0.52 . . . . 0.0 113.125 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.5 126.87 7.61 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.36 1.064 . . . . 0.0 108.937 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.68 109.4 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.324 2.016 . . . . 0.0 111.672 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.427 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . 162.46 175.49 33.55 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 123.381 0.425 . . . . 0.0 112.181 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.57 148.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.406 0.682 . . . . 0.0 110.451 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -123.72 137.57 54.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.136 . . . . 0.0 108.256 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.688 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 33.3 p90 -159.88 175.73 12.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.848 0.859 . . . . 0.0 108.893 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 35.1 ptt180 -111.76 135.23 52.64 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 107' ' ' ILE . 24.9 tp -100.83 120.83 40.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.016 0.526 . . . . 0.0 109.939 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HA ' HG22 ' A' ' 86' ' ' THR . 34.3 mt-10 -80.35 97.95 7.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.198 0.599 . . . . 0.0 109.583 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -98.08 149.79 22.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -24.38 18.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.165 0.986 . . . . 0.0 111.285 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.25 -38.07 36.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.532 0.733 . . . . 0.0 110.708 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.83 140.75 36.7 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 t -70.01 81.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.415 1.072 . . . . 0.0 112.19 -167.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 t 60.65 66.32 0.94 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.51 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -158.88 153.76 24.91 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.871 -167.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 78' ' ' GLU . 64.8 p -120.47 134.14 55.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.672 0.789 . . . . 0.0 109.566 175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.55 123.16 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 80.7 m95 -68.1 138.95 56.15 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.96 109.39 28.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.7 tp -93.9 95.77 9.29 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -98.1 124.56 42.68 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.17 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -110.71 143.23 41.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.194 0.998 . . . . 0.0 108.746 170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.63 15.28 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.28 125.05 22.36 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.062 0.545 . . . . 0.0 110.986 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.29 128.88 74.17 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.615 0.766 . . . . 0.0 110.18 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 22.2 Cg_endo -59.47 138.39 83.68 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.642 2.228 . . . . 0.0 111.736 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -68.04 -27.55 66.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.245 0.618 . . . . 0.0 111.808 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 t -71.79 -16.6 62.19 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.922 0.489 . . . . 0.0 111.501 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 84.4 t80 -69.81 137.09 51.54 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 123.105 0.562 . . . . 0.0 109.736 174.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -164.12 156.0 14.39 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.044 0.938 . . . . 0.0 109.282 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.515 ' HG3' HD13 ' A' ' 64' ' ' LEU . 29.3 Cg_exo -61.94 113.1 1.72 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.544 2.163 . . . . 0.0 111.129 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.23 -6.19 28.65 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.892 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.7 p -83.96 150.89 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 118.189 0.995 . . . . 0.0 108.835 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.63 ' HB3' ' HD3' ' A' ' 126' ' ' LYS . 46.9 mt-10 -77.16 145.12 37.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 17.0 m -136.14 154.92 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.224 1.01 . . . . 0.0 111.037 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.491 HD11 ' HE2' ' A' ' 124' ' ' MET . 55.8 mt -107.62 108.15 24.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 166.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 77' ' ' LEU . 43.8 pt -96.73 142.29 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -147.26 139.6 24.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 121' ' ' ARG . . . 163.93 -105.77 0.26 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.25 163.4 37.13 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.5 tp -134.56 131.45 37.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.24 147.13 33.7 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.328 0.651 . . . . 0.0 110.099 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.24 -37.82 80.91 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.266 2.644 . . . . 0.0 112.561 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.86 41.36 2.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.46 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -166.4 142.13 4.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.568 0.747 . . . . 0.0 110.545 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.86 -30.03 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.962 0.905 . . . . 0.0 110.796 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 t -90.21 134.3 34.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.164 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -75.58 127.16 32.47 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 108.549 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -83.97 105.32 14.76 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.39 112.39 19.88 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.438 ' HD2' ' HA2' ' A' ' 109' ' ' GLY . 6.5 ptm180 -68.49 -35.67 77.84 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 p -141.38 148.72 40.08 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.679 1.191 . . . . 0.0 109.094 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.9 tp -127.21 117.53 22.51 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.057 0.943 . . . . 0.0 108.493 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.491 ' HE2' HD11 ' A' ' 106' ' ' ILE . 54.7 ttp -131.45 145.98 52.04 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 82.5 p -91.07 163.36 14.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.166 0.508 . . . . 0.0 110.807 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 9.1 mtpm? -91.97 10.9 26.98 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 109.893 172.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 40.2 t -114.83 144.29 31.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 0.0 109.286 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.41 -173.92 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.566 2.178 . . . . 0.0 112.424 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.05 123.04 19.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.371 0.668 . . . . 0.0 110.516 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 125.047 1.339 . . . . 0.0 111.321 178.024 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 60.6 mtm . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.413 0.149 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.6 18.89 3.66 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.5 0.72 . . . . 0.0 112.522 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 m -66.01 119.21 59.51 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 123.31 0.644 . . . . 0.0 111.347 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.6 92.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.456 2.77 . . . . 0.0 112.665 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -87.68 39.59 0.89 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.024 0.93 . . . . 0.0 110.801 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.538 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 31.5 m-20 -75.15 1.21 13.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.055 0.942 . . . . 0.0 112.357 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -64.73 -38.6 91.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.645 0.778 . . . . 0.0 109.679 169.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.26 -26.03 26.9 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.536 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 48' ' ' ASP . 56.8 m170 -85.3 114.81 22.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.153 0.581 . . . . 0.0 110.676 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.614 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 25.4 p -103.0 109.0 20.38 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.285 1.034 . . . . 0.0 109.658 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 85.7 t -100.34 133.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.777 1.231 . . . . 0.0 108.688 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttt85 -96.59 107.74 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 77' ' ' LEU . 4.2 tt -116.66 141.0 48.77 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -120.75 143.6 48.7 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.946 0.898 . . . . 0.0 109.755 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.57 -162.06 27.51 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 7.6 m -131.31 140.28 49.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.005 0.922 . . . . 0.0 109.565 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.0 131.72 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.215 1.006 . . . . 0.0 111.555 -173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.549 ' HB3' ' HG3' ' A' ' 76' ' ' ARG . . . -94.56 154.39 17.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.226 0.611 . . . . 0.0 110.947 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 -36.66 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.584 0.753 . . . . 0.0 110.758 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -80.58 78.52 7.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.233 0.613 . . . . 0.0 109.881 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.8 0.82 2.48 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.022 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' A' ' 101' ' ' PRO . 5.7 tt -78.37 94.45 4.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 74' ' ' ARG . 86.5 m -103.07 110.63 22.63 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.688 1.195 . . . . 0.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.4 mmt -80.5 117.53 21.31 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.46 123.86 18.17 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 123.637 0.586 . . . . 0.0 111.223 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -71.61 99.89 2.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.983 0.913 . . . . 0.0 110.405 -171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.25 -36.92 2.89 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.563 -0.29 . . . . 0.0 112.995 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.74 131.41 87.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.344 0.657 . . . . 0.0 110.317 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.11 113.03 2.68 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.287 1.991 . . . . 0.0 111.059 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.02 -172.01 29.94 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.798 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.04 133.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.842 0.857 . . . . 0.0 110.179 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 4.8 tpp180 -92.73 141.94 27.91 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.27 174.86 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.581 0.752 . . . . 0.0 109.043 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.549 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.95 117.0 32.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 HD21 HD23 ' A' ' 55' ' ' LEU . 28.9 tp -80.15 109.77 14.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.834 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.461 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 43.2 mt-10 -71.92 100.87 2.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.23 144.0 47.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.972 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -68.16 -17.41 64.34 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.61 -46.2 6.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.542 0.737 . . . . 0.0 110.21 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.53 127.83 43.14 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.792 0.437 . . . . 0.0 111.516 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -117.8 -12.39 10.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.543 0.737 . . . . 0.0 110.503 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 m -61.4 -23.31 65.72 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.397 0.679 . . . . 0.0 110.321 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -138.69 111.7 7.88 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 164.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.3 p -83.49 158.63 21.95 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.38 0.672 . . . . 0.0 109.647 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -99.99 115.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -77.86 130.72 36.99 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.31 117.58 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 123.532 0.733 . . . . 0.0 109.348 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.6 tp -99.86 92.11 5.14 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -86.04 124.22 32.24 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.57 123.1 49.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.307 0.643 . . . . 0.0 109.725 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.72 -174.98 22.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 114.95 8.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.156 0.582 . . . . 0.0 110.189 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.82 133.46 51.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.999 0.92 . . . . 0.0 109.678 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HD2' HD22 ' A' ' 123' ' ' LEU . 55.4 Cg_endo -67.83 150.81 78.84 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.485 2.124 . . . . 0.0 112.139 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.87 -21.61 64.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.88 0.472 . . . . 0.0 110.459 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.8 p -70.46 -19.4 62.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.233 1.013 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -69.55 105.98 2.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.537 0.735 . . . . 0.0 109.462 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' O ' HG11 ' A' ' 103' ' ' VAL . 37.1 mtmm -131.99 156.56 79.96 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.74 1.216 . . . . 0.0 109.853 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HG3' HD11 ' A' ' 64' ' ' LEU . 27.9 Cg_exo -63.02 103.51 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.713 2.275 . . . . 0.0 111.509 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.16 -3.36 18.8 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 119.202 -0.776 . . . . 0.0 113.579 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 100' ' ' LYS . 7.9 p -79.17 139.39 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 118.309 1.054 . . . . 0.0 109.777 174.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.8 mt-10 -71.36 138.87 49.56 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 125' ' ' THR . 35.0 m -135.01 152.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-O 121.707 0.765 . . . . 0.0 110.724 175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.66 109.72 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.6 pt -98.15 152.81 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 31.8 tt0 -152.25 132.54 13.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.6 -147.64 11.56 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.44 133.06 9.05 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 118.392 1.096 . . . . 0.0 114.267 -174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.38 124.75 52.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.905 1.282 . . . . 0.0 108.822 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.4 138.48 41.67 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.58 -33.82 93.16 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.03 2.487 . . . . 0.0 113.175 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.74 -11.36 82.97 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.27 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.06 141.98 34.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.011 0.925 . . . . 0.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -88.48 -33.65 17.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.248 0.619 . . . . 0.0 110.534 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -83.89 129.09 34.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -79.35 121.22 24.86 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.675 ' HZ3' ' HB3' ' A' ' 119' ' ' LYS . 3.4 ttpm? -89.34 97.26 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.93 125.31 28.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.933 0.493 . . . . 0.0 110.591 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -79.58 -38.13 34.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.512 1.125 . . . . 0.0 109.251 172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -133.06 133.81 43.5 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.409 1.084 . . . . 0.0 108.699 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 96' ' ' PRO . 53.9 tp -117.89 108.99 15.99 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.6 ttm -102.82 125.21 49.47 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.536 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.5 p -82.25 123.49 29.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -69.46 -40.47 77.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.289 1.035 . . . . 0.0 108.516 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.5 m -83.02 116.13 62.58 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -85.63 173.71 7.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.951 2.434 . . . . 0.0 115.35 -171.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 21.3 tp -72.29 161.56 30.68 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.414 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.567 1.598 0 CA-C-O 121.155 0.502 . . . . 0.0 110.146 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.71 99.49 7.35 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.722 0.809 . . . . 0.0 109.522 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -73.21 124.18 90.3 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.217 0.607 . . . . 0.0 109.831 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.53 134.59 62.02 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.385 2.057 . . . . 0.0 110.771 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.49 89.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.639 0.776 . . . . 0.0 111.231 -170.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -90.35 114.07 26.08 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.207 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -86.26 -33.1 20.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.976 0.91 . . . . 0.0 109.683 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.12 18.71 0.36 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.592 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -67.83 79.22 0.2 Allowed 'General case' 0 C--N 1.364 1.23 0 CA-C-O 122.328 1.061 . . . . 0.0 111.725 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p -125.46 149.2 48.45 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.44 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.2 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -97.79 108.2 20.87 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD22 HD21 ' A' ' 77' ' ' LEU . 4.0 tt -111.86 125.8 54.41 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -172.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.02 144.88 27.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.536 0.735 . . . . 0.0 109.123 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.79 -160.57 29.77 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.522 -0.371 . . . . 0.0 112.599 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 30.0 m -127.82 140.79 51.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.027 0.931 . . . . 0.0 109.676 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.94 133.27 31.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.36 43.55 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.484 0.49 . . . . 0.0 111.662 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.77 36.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.16 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.97 96.04 7.28 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.855 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.17 73.11 0.65 Allowed Glycine 0 N--CA 1.465 0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.138 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.6 tt -150.41 125.99 10.25 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.3 m -140.24 125.28 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.323 1.049 . . . . 0.0 109.332 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.1 mtp -96.91 162.64 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.136 0.574 . . . . 0.0 109.722 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.454 HD11 ' HA3' ' A' ' 72' ' ' GLY . 84.5 mt -86.48 105.86 17.08 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -63.71 114.88 4.27 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.915 0.886 . . . . 0.0 111.563 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.97 77.09 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.529 0.518 . . . . 0.0 113.624 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.94 142.23 44.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.38 1.072 . . . . 0.0 109.764 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.44 87.76 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' A' ' 67' ' ' LEU . . . 175.39 163.66 28.68 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.613 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 p -157.26 134.84 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.985 0.914 . . . . 0.0 110.115 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -103.89 137.29 42.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.196 0.998 . . . . 0.0 108.311 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 46.3 p90 -158.2 173.07 17.26 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -104.91 122.57 46.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 55' ' ' LEU . 23.5 tp -83.86 116.19 22.63 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.78 118.93 24.76 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 157.06 18.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.342 0.657 . . . . 0.0 112.486 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -35.11 -55.29 0.61 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.726 2.01 . . . . 0.0 113.343 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -129.88 -30.43 2.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.768 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -77.97 95.83 4.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.751 0.42 . . . . 0.0 110.375 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -65.63 -17.96 64.97 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.366 0.666 . . . . 0.0 110.8 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 p -67.39 -46.64 72.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.484 1.114 . . . . 0.0 111.822 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -74.13 84.04 1.82 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.186 0.594 . . . . 0.0 111.366 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 p -103.16 97.65 7.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.3 134.46 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -79.63 144.02 34.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.29 118.36 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.865 0.866 . . . . 0.0 108.746 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.34 93.23 7.14 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -85.37 113.31 21.58 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -111.16 122.94 49.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.45 172.53 18.43 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.88 113.5 1.89 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.251 0.526 . . . . 0.0 110.926 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.86 120.4 81.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.82 146.09 80.16 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.896 2.397 . . . . 0.0 113.713 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.87 -27.5 68.27 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.654 0.782 . . . . 0.0 109.835 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.7 p -78.87 -7.66 58.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.96 1.304 . . . . 0.0 112.278 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.7 t80 -75.66 140.61 42.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.805 0.442 . . . . 0.0 109.817 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.497 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 61.0 pttt -162.07 161.45 21.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.955 0.902 . . . . 0.0 109.709 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.8 100.34 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.102 1.868 . . . . 0.0 111.519 167.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.68 -8.57 8.77 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.131 -0.816 . . . . 0.0 114.25 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 14.5 p -71.46 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 118.54 1.17 . . . . 0.0 111.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 39.7 mt-10 -72.61 125.56 27.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 171.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.426 HG13 HG12 ' A' ' 103' ' ' VAL . 27.9 m -128.16 155.61 39.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.898 0.856 . . . . 0.0 111.753 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 62.4 mt -114.75 107.93 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.479 HG23 HD11 ' A' ' 123' ' ' LEU . 29.6 pt -97.82 155.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.89 138.19 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.0 -127.04 1.35 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.755 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.37 153.0 24.45 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 117.043 0.421 . . . . 0.0 112.456 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 139.9 53.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.474 1.109 . . . . 0.0 108.727 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 136.0 45.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.51 109.69 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.204 . . . . 0.0 113.246 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.61 5.74 53.6 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.077 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.493 ' HG2' ' H ' ' A' ' 117' ' ' THR . 48.7 tt0 -96.53 153.09 18.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.596 0.759 . . . . 0.0 109.738 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.97 0.67 23.89 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.237 1.015 . . . . 0.0 111.213 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.493 ' H ' ' HG2' ' A' ' 115' ' ' GLU . 8.8 t -134.05 119.89 19.52 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.413 0.625 . . . . 0.0 110.453 -173.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -84.69 134.41 34.36 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.622 1.169 . . . . 0.0 110.25 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -95.14 111.31 23.16 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.71 116.68 28.76 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -23.36 44.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.143 0.577 . . . . 0.0 110.886 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -137.71 152.18 48.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.878 0.871 . . . . 0.0 110.045 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 107' ' ' ILE . 23.1 tp -136.92 123.5 20.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.645 1.178 . . . . 0.0 108.233 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.561 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 41.5 ttm -119.87 95.11 4.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.728 0.411 . . . . 0.0 110.282 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.4 p -75.19 137.43 41.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.339 0.656 . . . . 0.0 110.455 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -94.87 -13.48 25.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.906 . . . . 0.0 110.85 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 103' ' ' VAL . 67.2 m -88.6 105.95 11.29 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.077 0.551 . . . . 0.0 110.449 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.18 86.68 1.4 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.089 2.526 . . . . 0.0 111.125 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.08 111.51 2.22 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.368 0.667 . . . . 0.0 109.836 -178.109 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.512 ' HG3' HG21 ' A' ' 45' ' ' THR . 12.0 tpt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 85.23 6.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.632 0.773 . . . . 0.0 109.75 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.512 HG21 ' HG3' ' A' ' 43' ' ' MET . 49.2 p -79.96 123.78 83.44 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.205 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 105.44 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.77 2.313 . . . . 0.0 110.223 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.12 117.71 3.46 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.878 0.871 . . . . 0.0 111.765 -169.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -77.78 119.25 21.02 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.59 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -119.03 -34.83 3.78 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.812 1.245 . . . . 0.0 109.607 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -77.35 -34.9 55.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.73 -169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -88.34 76.22 8.37 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.2 m -72.67 123.28 22.95 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 39.0 t -101.72 143.89 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -138.34 136.23 36.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.512 0.725 . . . . 0.0 109.814 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.24 163.97 21.35 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.6 0.714 . . . . 0.0 110.549 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -138.44 132.29 31.13 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.801 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.33 -161.39 33.85 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 5.0 m -124.14 146.15 48.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.07 127.83 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.933 0.893 . . . . 0.0 110.277 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 140.07 43.8 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.309 0.644 . . . . 0.0 110.13 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.02 55.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.084 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.6 124.13 51.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.575 0.75 . . . . 0.0 109.406 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.17 -0.94 43.91 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.567 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.49 96.12 4.02 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.7 m -118.57 121.07 39.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.435 1.094 . . . . 0.0 109.904 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.508 ' HE1' HG13 ' A' ' 95' ' ' VAL . 23.5 mmt -84.36 136.07 34.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.99 127.95 34.45 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.628 0.58 . . . . 0.0 111.506 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.23 117.25 12.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.678 0.791 . . . . 0.0 110.09 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.83 33.1 84.18 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.456 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.33 136.63 8.77 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 110.102 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.76 109.69 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.332 2.021 . . . . 0.0 110.709 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.76 171.4 33.68 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.466 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -150.62 153.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.65 0.78 . . . . 0.0 110.062 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 47.4 ttp180 -124.66 142.25 51.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -159.45 172.95 16.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.283 0.633 . . . . 0.0 109.316 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.483 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 87.6 mtm-85 -101.58 113.08 25.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.62 111.95 9.25 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 86' ' ' THR . 36.7 mt-10 -72.36 110.44 6.78 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 2.1 m-20 -64.0 146.36 54.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.003 0.521 . . . . 0.0 111.458 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -66.02 -37.41 85.82 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.863 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.64 -55.5 3.75 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.573 0.749 . . . . 0.0 110.229 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 79' ' ' ASP . 94.6 m-20 -75.95 113.16 13.15 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -89.15 -24.59 22.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.306 0.643 . . . . 0.0 111.014 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 m -101.27 -3.35 29.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.942 0.897 . . . . 0.0 111.936 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 9.7 mmpt? -126.74 127.96 45.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.916 0.486 . . . . 0.0 110.796 -176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 76' ' ' ARG . 68.3 p -125.54 132.21 52.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.27 1.028 . . . . 0.0 108.339 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.79 143.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -74.92 142.33 44.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 49.1 t -127.62 108.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.5 tp -93.26 92.97 7.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -91.37 116.59 28.96 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.235 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -108.35 114.3 28.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.93 170.97 23.31 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 113.0 3.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.778 0.431 . . . . 0.0 110.329 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.508 HG13 ' HE1' ' A' ' 66' ' ' MET . 39.5 t -81.67 122.47 80.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 122.955 0.502 . . . . 0.0 110.126 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HD2' HD21 ' A' ' 123' ' ' LEU . 28.4 Cg_endo -60.74 148.49 91.68 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.761 2.307 . . . . 0.0 111.964 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.27 -16.3 61.92 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.417 0.687 . . . . 0.0 110.827 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.3 p -71.6 -23.69 61.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.149 0.98 . . . . 0.0 110.696 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' HA ' HG12 ' A' ' 103' ' ' VAL . 70.4 t80 -71.94 134.75 46.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.831 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -171.36 161.3 5.18 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.8 0.84 . . . . 0.0 109.435 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.1 105.68 0.41 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.276 1.984 . . . . 0.0 111.89 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.78 -10.8 11.17 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.754 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 99' ' ' PHE . 9.6 p -74.55 145.16 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.782 0.791 . . . . 0.0 109.654 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.3 mt-10 -84.32 138.67 32.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.69 155.32 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.036 0.922 . . . . 0.0 111.305 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.6 mt -115.17 108.51 25.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 18.4 pt -100.87 132.6 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.419 0.688 . . . . 0.0 109.859 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -127.97 130.81 49.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.57 -108.01 0.27 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . -177.17 142.63 5.86 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.715 0.757 . . . . 0.0 113.222 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.4 tp -93.87 126.4 39.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.903 0.881 . . . . 0.0 109.112 171.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . . . -83.25 138.33 42.19 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 123.436 0.46 . . . . 0.0 109.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.89 -17.68 60.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.887 2.392 . . . . 0.0 113.726 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.68 -10.67 18.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.504 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 112' ' ' ALA . 28.3 tt0 -117.07 120.98 40.0 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.13 -20.94 63.15 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.562 0.745 . . . . 0.0 112.709 -168.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -88.37 135.62 33.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.42 113.79 14.4 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 26.9 ttmt -85.7 94.57 9.13 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.66 123.05 27.29 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.52 0.728 . . . . 0.0 109.849 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -80.32 -41.22 25.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.255 0.622 . . . . 0.0 109.639 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.7 p -131.53 136.13 47.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.485 1.114 . . . . 0.0 108.843 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.493 HD21 ' HD2' ' A' ' 96' ' ' PRO . 59.6 tp -113.11 133.9 54.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.412 1.085 . . . . 0.0 108.632 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.9 ttp -136.29 103.05 5.17 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.786 0.434 . . . . 0.0 110.106 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.4 p -72.56 140.78 48.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.396 0.678 . . . . 0.0 110.012 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -67.84 -48.19 66.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.594 0.758 . . . . 0.0 110.797 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.1 t -75.45 131.59 77.3 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.4 -165.96 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.841 2.361 . . . . 0.0 112.183 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.2 tp -66.41 99.05 0.53 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.135 0.974 . . . . 0.0 109.865 -173.215 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 107.31 5.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.375 0.67 . . . . 0.0 109.271 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -113.83 84.72 8.78 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.277 1.031 . . . . 0.0 109.847 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -87.61 155.8 7.68 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.035 2.49 . . . . 0.0 112.452 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -91.49 118.07 30.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 109.288 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.43 -3.88 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.831 0.852 . . . . 0.0 111.477 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -58.06 -42.39 85.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.779 1.232 . . . . 0.0 111.343 172.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.34 75.99 4.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.74 -172.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -138.73 64.82 1.47 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.379 1.072 . . . . 0.0 108.62 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.4 m -133.1 137.27 46.27 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.554 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 134.19 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.471 HH21 HD12 ' A' ' 106' ' ' ILE . 55.3 ttt180 -122.26 119.71 31.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.513 0.725 . . . . 0.0 109.219 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.43 161.2 20.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.585 0.754 . . . . 0.0 109.912 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -135.43 136.99 41.8 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.938 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 79' ' ' ASP . . . 176.52 -162.8 31.59 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.028 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 ' HG1' ' HG2' ' A' ' 104' ' ' GLU . 25.8 m -122.31 139.21 54.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.006 0.922 . . . . 0.0 109.749 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.64 130.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.618 1.167 . . . . 0.0 110.631 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.98 139.79 38.14 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.922 0.489 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -72.92 -40.44 65.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.311 0.644 . . . . 0.0 110.092 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.35 115.51 19.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.715 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 42.85 5.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.471 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.496 HD11 ' HG3' ' A' ' 101' ' ' PRO . 6.7 tt -111.85 99.46 8.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -109.79 116.66 32.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.301 1.04 . . . . 0.0 109.711 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.484 ' HG2' HG21 ' A' ' 73' ' ' VAL . 66.5 mtp -89.48 132.6 34.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.467 HD12 ' HA3' ' A' ' 72' ' ' GLY . 76.6 mt -63.39 126.48 27.61 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.658 0.598 . . . . 0.0 111.013 -172.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.63 132.22 33.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.914 0.885 . . . . 0.0 109.762 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.75 68.46 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.472 0.482 . . . . 0.0 113.661 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 138.47 10.15 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.07 0.948 . . . . 0.0 109.149 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 112.73 2.8 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.469 2.113 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 167.25 175.14 37.01 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 121.387 0.437 . . . . 0.0 113.402 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.501 ' HB ' HG21 ' A' ' 95' ' ' VAL . 8.1 p -146.91 161.3 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.949 0.9 . . . . 0.0 109.486 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -137.66 136.01 37.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -152.67 161.66 42.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.174 0.59 . . . . 0.0 109.758 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.62 104.98 17.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 tp -73.52 132.39 42.82 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.22 100.7 6.65 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.424 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -54.03 141.3 28.77 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.097 0.873 . . . . 0.0 111.84 -171.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -52.41 -42.68 64.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.388 1.075 . . . . 0.0 111.245 -171.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.99 -55.39 3.36 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.437 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -94.89 67.35 3.16 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.827 0.822 . . . . 0.0 110.555 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -73.3 -15.24 61.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.892 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 m -64.59 -22.98 67.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.252 1.021 . . . . 0.0 111.25 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -98.85 96.16 7.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.4 p -92.78 104.55 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.66 139.91 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.328 1.051 . . . . 0.0 109.647 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.05 133.1 33.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 168.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.91 120.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -103.81 112.22 25.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -107.98 121.55 45.02 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.857 0.863 . . . . 0.0 108.915 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -103.53 117.72 35.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.654 0.782 . . . . 0.0 109.165 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.47 176.59 17.65 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.0 115.67 5.14 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.665 0.386 . . . . 0.0 110.043 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.501 HG21 ' HB ' ' A' ' 73' ' ' VAL . 43.2 t -80.11 127.45 76.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.454 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.22 138.89 16.66 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.495 2.797 . . . . 0.0 112.769 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.01 -24.13 65.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.39 0.676 . . . . 0.0 111.358 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -75.45 -13.23 60.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.959 0.904 . . . . 0.0 111.883 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -72.72 135.83 45.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.3 pttt -156.6 163.42 25.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.195 0.998 . . . . 0.0 108.741 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 28.9 Cg_exo -64.08 111.86 1.7 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.42 2.08 . . . . 0.0 111.41 168.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.49 0.57 37.43 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.727 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.49 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 7.4 p -77.87 149.55 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.847 0.824 . . . . 0.0 110.067 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HG2' ' HG1' ' A' ' 58' ' ' THR . 42.7 mt-10 -82.41 134.8 35.24 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.6 m -129.89 161.74 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.971 0.908 . . . . 0.0 111.65 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.471 HD12 HH21 ' A' ' 54' ' ' ARG . 62.8 mt -119.11 111.7 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 113.452 -1.704 . . . . 0.0 107.016 168.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.37 142.1 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.451 0.7 . . . . 0.0 109.27 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 8.0 tp10 -139.48 124.99 19.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.59 -106.08 0.23 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.55 143.29 5.16 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 117.787 0.793 . . . . 0.0 112.616 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.2 tp -90.7 116.29 28.45 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.64 126.93 72.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.163 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.66 95.28 0.11 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.845 2.363 . . . . 0.0 111.786 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.56 -41.04 1.27 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.63 135.29 33.57 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.949 0.899 . . . . 0.0 109.985 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.81 -26.86 57.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.132 0.573 . . . . 0.0 110.043 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -84.46 136.04 34.0 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.129 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.6 119.55 21.32 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.27 96.68 10.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.91 115.83 17.04 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.432 0.693 . . . . 0.0 110.044 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -79.45 -41.43 27.58 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.056 0.942 . . . . 0.0 109.631 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 75.0 p -132.28 140.88 48.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.39 1.076 . . . . 0.0 108.18 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.9 tp -127.29 143.38 51.24 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.946 0.499 . . . . 0.0 110.056 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.8 ttp -153.64 148.26 26.26 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 56.9 p -83.11 152.9 25.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -89.16 -34.8 16.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 109.516 175.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.9 p -113.1 118.02 44.92 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.753 0.821 . . . . 0.0 109.472 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -82.56 167.69 14.93 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.657 2.238 . . . . 0.0 112.342 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.69 95.03 3.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.269 0.628 . . . . 0.0 110.01 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.955 0.902 . . . . 0.0 109.82 -174.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.45 96.78 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.739 0.816 . . . . 0.0 111.814 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.9 m -64.39 113.97 12.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.955 0.902 . . . . 0.0 110.912 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -98.27 -152.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.563 2.842 . . . . 0.0 110.49 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 70.4 1.38 3.59 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.226 1.01 . . . . 0.0 112.339 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.2 157.53 26.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.284 0.634 . . . . 0.0 110.539 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -97.37 22.07 9.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.492 0.717 . . . . 0.0 111.381 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.1 11.07 10.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.003 0.521 . . . . 0.0 111.474 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -67.36 -36.51 81.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.422 0.689 . . . . 0.0 110.054 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -69.94 152.79 44.07 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.76 106.02 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.6 ' NH1' HG23 ' A' ' 106' ' ' ILE . 22.5 tpp180 -89.67 127.91 35.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 tt -132.82 130.35 39.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' HB2' ' HD2' ' A' ' 80' ' ' LYS . 42.1 m-85 -108.45 139.0 43.82 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.96 -168.62 36.48 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 143.29 50.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.172 0.589 . . . . 0.0 110.604 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.23 119.59 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB2' HH21 ' A' ' 76' ' ' ARG . . . -69.89 142.85 52.93 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.664 0.602 . . . . 0.0 110.122 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.2 84.42 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.01 117.72 21.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.126 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.64 64.45 1.06 Allowed Glycine 0 C--N 1.339 0.702 0 O-C-N 123.444 0.465 . . . . 0.0 112.199 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tt -133.33 101.82 5.32 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -111.85 116.95 31.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.684 0.793 . . . . 0.0 110.342 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mmm -85.13 145.07 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.438 0.695 . . . . 0.0 109.959 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD13 ' HA3' ' A' ' 72' ' ' GLY . 86.6 mt -85.34 126.53 33.82 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.1 140.54 35.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.38 3.4 89.98 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 123.48 0.487 . . . . 0.0 113.433 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.4 140.3 4.13 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.103 0.961 . . . . 0.0 110.093 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.61 113.37 2.7 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.203 . . . . 0.0 111.734 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . 171.45 173.11 38.16 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.394 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.75 138.15 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.331 1.053 . . . . 0.0 110.223 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 16.3 ttm180 -108.0 137.08 46.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 165.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.04 154.27 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.456 HH21 ' HB2' ' A' ' 60' ' ' ALA . 18.6 ttp180 -92.84 96.88 10.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 HD12 ' A' ' 107' ' ' ILE . 42.0 tp -78.41 138.32 38.44 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.483 0.713 . . . . 0.0 110.225 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.573 ' HG2' HG22 ' A' ' 86' ' ' THR . 31.3 mt-10 -102.96 113.16 26.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 13.9 t70 -58.58 130.32 46.25 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 123.81 0.694 . . . . 0.0 109.631 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 56' ' ' PHE . 21.3 ptmt -62.73 -28.63 70.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.935 0.894 . . . . 0.0 113.187 -169.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -92.77 -33.37 14.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.879 0.472 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 79' ' ' ASP . 8.9 t-20 -139.15 95.58 2.97 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.922 0.392 . . . . 0.0 110.156 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -68.76 -16.86 63.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.482 0.713 . . . . 0.0 111.469 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -55.83 -27.07 49.66 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.755 0.822 . . . . 0.0 111.42 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -98.93 82.57 2.78 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.74 0.816 . . . . 0.0 109.161 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 78' ' ' GLU . 40.9 p -89.96 100.03 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 167.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.5 t -102.85 141.74 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.117 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -79.27 136.63 37.1 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 91.5 t -123.39 118.43 54.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.83 92.28 7.85 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -94.59 116.0 28.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -112.46 144.27 42.19 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.05 -172.31 19.13 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.97 111.38 3.3 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.307 0.643 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.67 123.47 84.03 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.519 0.727 . . . . 0.0 109.09 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.98 145.71 68.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.173 1.915 . . . . 0.0 111.389 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.77 -16.79 64.5 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.591 0.756 . . . . 0.0 111.356 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.3 p -76.45 -19.9 57.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.42 1.088 . . . . 0.0 112.144 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -68.37 126.66 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.223 0.609 . . . . 0.0 109.542 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 103' ' ' VAL . 17.1 ptmt -156.06 165.82 17.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.191 0.596 . . . . 0.0 110.958 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.86 113.01 3.41 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.864 1.709 . . . . 0.0 110.955 170.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.08 -8.01 16.41 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.353 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 105' ' ' VAL . 12.7 p -83.02 142.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 117.425 0.612 . . . . 0.0 111.787 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.84 111.18 9.78 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 103' ' ' VAL . 27.7 m -105.7 153.6 7.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.792 0.805 . . . . 0.0 110.53 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.6 HG23 ' NH1' ' A' ' 54' ' ' ARG . 49.4 mt -122.18 105.59 16.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.415 HD12 HD22 ' A' ' 77' ' ' LEU . 39.2 pt -101.45 154.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.328 0.651 . . . . 0.0 110.246 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.2 tt0 -140.56 123.24 16.23 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 173.56 -121.18 0.84 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.77 166.71 39.9 Favored Glycine 0 C--O 1.241 0.556 0 CA-C-N 117.446 0.623 . . . . 0.0 112.441 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.6 tp -138.3 134.42 34.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.53 129.6 50.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 88.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.922 2.415 . . . . 0.0 111.91 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.65 -36.72 1.42 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -171.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.96 147.95 48.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.762 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.47 -45.02 11.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.728 0.811 . . . . 0.0 111.457 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -109.43 131.87 54.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.12 0.486 . . . . 0.0 111.002 -165.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.75 115.09 16.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.77 96.22 8.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.34 112.07 19.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.902 0.881 . . . . 0.0 110.156 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -60.16 -40.85 91.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.397 1.079 . . . . 0.0 110.399 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 1.7 m -135.41 149.31 49.59 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.885 -167.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.5 tp -137.21 140.33 41.64 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.259 1.024 . . . . 0.0 108.81 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 ttp -152.77 111.97 3.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 109.664 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.481 HG22 HG12 ' A' ' 105' ' ' VAL . 54.3 p -73.21 124.27 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.447 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -81.77 -34.27 30.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.7 m -99.15 91.91 1.53 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.42 141.35 38.53 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.833 1.689 . . . . 0.0 111.813 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.33 91.14 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 170.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.563 1.447 0 C-N-CA 125.167 1.387 . . . . 0.0 109.916 -175.689 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.64 102.37 14.9 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -110.66 97.78 34.36 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.391 0.677 . . . . 0.0 110.508 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.09 54.44 5.23 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.345 2.697 . . . . 0.0 110.857 170.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.45 99.42 12.0 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.629 0.772 . . . . 0.0 110.387 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.41 170.61 14.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.629 1.172 . . . . 0.0 109.398 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.31 19.33 6.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.666 . . . . 0.0 109.561 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.49 -42.11 83.44 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.891 0.876 . . . . 0.0 108.838 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.32 83.87 5.31 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 166.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.3 m -64.15 144.57 57.02 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.369 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -97.97 112.7 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -104.68 116.99 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.89 142.68 36.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -119.1 147.87 43.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.72 -170.3 43.4 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 ' HG1' ' HG2' ' A' ' 104' ' ' GLU . 23.7 m -116.37 140.65 49.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.271 1.028 . . . . 0.0 109.083 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -76.98 126.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.38 0.672 . . . . 0.0 110.238 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.62 150.56 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.394 0.678 . . . . 0.0 111.043 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.66 -31.69 41.49 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.358 0.599 . . . . 0.0 109.671 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.35 100.11 12.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.435 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.55 71.11 0.97 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 tt -144.82 104.59 4.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.1 m -125.17 119.04 27.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.894 1.278 . . . . 0.0 109.233 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.7 mtp -89.9 142.93 27.23 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.88 122.41 17.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 110.478 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.35 123.21 28.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.375 0.67 . . . . 0.0 109.879 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.37 72.21 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 123.607 0.567 . . . . 0.0 112.988 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.23 144.18 16.84 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.049 0.939 . . . . 0.0 109.33 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.88 117.29 4.87 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.262 1.975 . . . . 0.0 110.844 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.48 -175.04 30.5 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.287 174.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.44 132.17 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.319 1.048 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -92.98 131.25 38.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.1 159.63 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.233 0.54 . . . . 0.0 110.885 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -95.59 112.06 23.86 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.289 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.43 117.57 30.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.453 0.701 . . . . 0.0 109.88 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' HB3' ' HG1' ' A' ' 83' ' ' THR . 37.0 mt-10 -103.45 107.9 18.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.241 1.016 . . . . 0.0 109.789 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.54 107.01 1.04 Allowed 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.85 -29.96 5.24 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -168.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -92.26 -48.77 6.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.461 0.704 . . . . 0.0 109.321 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.41 50.23 0.83 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.205 1.002 . . . . 0.0 109.296 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.478 ' HG1' ' HB3' ' A' ' 78' ' ' GLU . 9.3 t -77.6 -6.46 53.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.862 -170.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 m -63.52 -30.84 71.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.457 0.703 . . . . 0.0 110.586 169.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -98.63 83.33 2.97 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.2 p -86.6 111.31 20.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.87 137.15 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.8 m95 -82.63 144.94 29.95 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.4 t -132.38 121.91 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.87 94.01 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -83.38 118.42 23.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -109.1 111.02 22.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.09 174.22 28.51 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.79 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.27 115.04 5.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.967 0.507 . . . . 0.0 110.161 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -81.25 113.95 45.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.063 0.545 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.595 ' HD2' HD22 ' A' ' 123' ' ' LEU . 56.2 Cg_endo -67.28 151.76 80.33 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.443 2.096 . . . . 0.0 111.611 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.01 -16.94 64.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.519 1.127 . . . . 0.0 112.199 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 96' ' ' PRO . 12.2 t -70.55 -24.25 62.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.91 0.884 . . . . 0.0 111.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -68.04 121.6 16.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.752 0.821 . . . . 0.0 109.289 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' O ' HG12 ' A' ' 103' ' ' VAL . 23.6 pttm -165.62 157.54 12.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.431 0.693 . . . . 0.0 110.077 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.22 117.25 3.93 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.178 1.919 . . . . 0.0 111.758 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.49 -17.51 10.32 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.326 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 100' ' ' LYS . 6.0 p -95.06 147.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.863 0.831 . . . . 0.0 110.045 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG2' ' HG1' ' A' ' 58' ' ' THR . 43.6 mt-10 -85.97 130.37 34.56 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 125' ' ' THR . 27.6 m -111.03 155.55 12.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.857 0.837 . . . . 0.0 110.784 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.78 121.07 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.48 129.71 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.155 0.582 . . . . 0.0 110.503 -171.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.37 151.2 25.82 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.19 -119.63 0.89 Allowed Glycine 0 C--O 1.24 0.53 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.4 163.57 29.58 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.731 0.312 . . . . 0.0 112.606 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.0 tp -130.35 118.61 21.51 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 133.81 44.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.74 -24.3 41.05 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.679 2.253 . . . . 0.0 113.046 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.14 -18.1 78.85 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.558 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -108.61 156.61 19.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.141 0.977 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -109.61 26.39 10.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.715 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 5.0 t -133.96 121.22 21.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.353 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.29 130.59 35.61 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 108.945 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.682 ' HB3' ' HZ1' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.78 117.2 31.55 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.699 0.682 . . . . 0.0 109.186 174.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.76 128.69 55.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.94 0.896 . . . . 0.0 109.974 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.438 ' HD3' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -98.82 -8.87 25.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.8 0.44 . . . . 0.0 110.171 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -134.81 152.16 51.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.718 1.207 . . . . 0.0 109.637 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.595 HD22 ' HD2' ' A' ' 96' ' ' PRO . 37.3 tp -150.79 109.88 3.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.126 0.97 . . . . 0.0 108.385 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -135.93 114.03 11.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.648 0.779 . . . . 0.0 109.673 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.465 HG23 HG13 ' A' ' 105' ' ' VAL . 77.3 p -78.12 151.25 33.44 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.46 -40.09 57.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.5 t -101.82 111.39 64.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.983 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.08 153.47 77.58 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.42 2.08 . . . . 0.0 110.621 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 1.8 pt? -62.22 132.7 53.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.893 0.477 . . . . 0.0 110.755 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.866 0.866 . . . . 0.0 110.453 -174.167 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.56 28.1 0.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.053 0.941 . . . . 0.0 109.583 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.8 p 57.91 123.8 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 126.228 1.811 . . . . 0.0 111.906 -169.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.35 151.9 27.9 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.712 2.275 . . . . 0.0 112.409 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -56.87 130.44 45.8 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.84 0.712 . . . . 0.0 110.693 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 51' ' ' HIS . 7.4 p-10 -55.84 137.99 49.11 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.473 1.108 . . . . 0.0 112.531 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -84.33 -62.99 1.42 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.529 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -117.79 -51.94 2.45 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 13.4 t-80 58.08 20.51 7.0 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.531 1.132 . . . . 0.0 111.509 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -75.14 137.97 41.72 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.265 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -105.87 133.09 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -118.97 127.08 53.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.342 0.657 . . . . 0.0 109.505 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.6 mt -125.86 172.37 9.93 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.903 0.881 . . . . 0.0 109.785 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' HB2' ' HD2' ' A' ' 80' ' ' LYS . 51.2 m-85 -135.26 147.89 49.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.776 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -170.74 42.15 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.6 m -121.54 144.34 48.78 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.37 115.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.34 0.656 . . . . 0.0 110.5 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.56 148.16 31.85 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.54 -5.66 46.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.648 0.779 . . . . 0.0 111.231 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.86 129.79 36.18 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.389 1.076 . . . . 0.0 110.05 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.31 15.69 78.85 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.266 0.354 . . . . 0.0 113.889 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.49 89.56 3.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -111.81 124.85 53.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.523 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.1 mmm -80.78 139.7 35.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.7 mt -67.53 133.26 49.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.3 0.5 . . . . 0.0 110.915 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -86.76 118.49 26.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.372 0.669 . . . . 0.0 109.857 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.54 5.0 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.486 0.491 . . . . 0.0 112.282 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.26 139.9 75.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.074 0.55 . . . . 0.0 110.108 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.64 135.79 24.59 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 121.986 1.791 . . . . 0.0 111.929 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.87 -168.58 26.4 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.631 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.18 132.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.381 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 79.3 ttt180 -102.6 138.17 39.86 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 170.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -158.13 168.21 27.71 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.919 0.488 . . . . 0.0 110.492 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 76.5 mtp180 -93.4 124.59 37.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD22 HD11 ' A' ' 107' ' ' ILE . 21.0 tp -105.26 125.76 51.34 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.423 0.689 . . . . 0.0 109.351 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.4 97.43 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -59.67 130.57 47.48 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.101 0.875 . . . . 0.0 111.487 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HD2' ' HB2' ' A' ' 56' ' ' PHE . 15.1 ptmm? -66.27 -31.68 72.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.824 0.85 . . . . 0.0 111.571 -174.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.82 -50.78 11.63 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.342 0.657 . . . . 0.0 109.978 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -128.8 91.96 3.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.899 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 t -78.24 2.86 16.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.087 0.555 . . . . 0.0 111.026 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 m -87.65 16.52 5.54 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.111 0.964 . . . . 0.0 110.858 166.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -153.67 140.04 18.64 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.561 1.144 . . . . 0.0 108.953 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 19.6 p -117.19 127.91 54.58 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.69 134.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -73.77 126.24 29.92 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 86.8 t -107.57 106.25 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 tp -91.54 92.01 8.31 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -83.5 150.21 26.14 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.414 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HB2' ' HZ3' ' A' ' 92' ' ' LYS . 6.7 mtmp? -137.81 122.52 18.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.724 1.21 . . . . 0.0 108.71 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 121.46 -169.01 14.41 Favored Glycine 0 C--O 1.245 0.815 0 C-N-CA 123.464 0.554 . . . . 0.0 111.774 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 116.45 7.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.272 0.629 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.11 127.83 78.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.85 0.86 . . . . 0.0 109.958 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' O ' ' HB3' ' A' ' 99' ' ' PHE . 19.3 Cg_endo -58.41 132.83 50.97 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.036 1.824 . . . . 0.0 110.856 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.82 -26.36 68.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.109 0.564 . . . . 0.0 111.08 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.498 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 30.8 p -72.85 -13.27 61.25 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.118 0.967 . . . . 0.0 112.122 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 96' ' ' PRO . 63.0 t80 -64.32 121.22 13.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.926 0.89 . . . . 0.0 109.055 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -155.04 156.15 30.92 Favored Pre-proline 0 C--O 1.244 0.787 0 C-N-CA 124.002 0.921 . . . . 0.0 109.069 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.08 99.87 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.971 1.781 . . . . 0.0 110.464 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.55 -2.22 6.52 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.985 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -94.35 141.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 118.707 1.253 . . . . 0.0 110.414 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.56 117.38 15.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 125' ' ' THR . 18.0 m -110.25 150.23 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.722 0.773 . . . . 0.0 111.183 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.522 HD13 ' SD ' ' A' ' 124' ' ' MET . 47.6 mt -105.51 111.95 36.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.539 HD11 HD22 ' A' ' 77' ' ' LEU . 28.8 pt -98.27 140.91 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.8 133.1 23.19 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 162.44 -102.7 0.21 Allowed Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.93 147.25 5.25 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 117.482 0.641 . . . . 0.0 112.254 170.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -104.0 149.21 25.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.955 0.902 . . . . 0.0 109.584 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.71 151.41 46.22 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.723 0.809 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.44 -42.66 65.87 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.418 2.745 . . . . 0.0 113.682 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.48 29.55 8.25 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.031 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.15 128.62 40.44 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 0.0 110.266 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 -4.05 53.93 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -133.78 139.18 46.16 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -72.97 119.82 17.74 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 24.8 ttpt -70.26 96.23 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.415 ' HB2' HG11 ' A' ' 89' ' ' VAL . . . -86.39 102.34 13.94 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.348 0.594 . . . . 0.0 109.524 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -62.98 -41.49 99.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.66 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -135.57 143.4 45.64 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.539 -169.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 tp -136.25 125.13 24.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.522 ' SD ' HD13 ' A' ' 106' ' ' ILE . 31.9 ttm -121.47 151.42 40.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.429 HG22 HG13 ' A' ' 105' ' ' VAL . 72.5 p -108.6 145.43 34.9 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -85.82 -34.74 21.0 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.773 0.32 . . . . 0.0 110.297 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 14.4 t -121.79 129.47 25.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.424 0.69 . . . . 0.0 110.04 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.55 -170.19 0.89 Allowed 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.213 2.609 . . . . 0.0 113.892 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' A' ' 98' ' ' THR . 96.3 mt -92.08 102.71 15.25 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.397 0.679 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 123.757 0.823 . . . . 0.0 110.253 176.379 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -56.35 5.59 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -71.79 118.78 69.74 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.51 121.44 9.87 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.028 2.485 . . . . 0.0 111.767 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -89.83 102.71 15.4 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.51 0.724 . . . . 0.0 109.202 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.63 31.2 0.53 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.485 1.114 . . . . 0.0 112.05 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -16.92 61.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.668 0.787 . . . . 0.0 110.94 174.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.4 11.7 8.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.107 0.963 . . . . 0.0 110.899 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -71.72 81.11 0.86 Allowed 'General case' 0 C--N 1.359 1.006 0 CA-C-O 121.469 0.652 . . . . 0.0 109.584 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 p -138.41 159.13 42.86 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.755 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.23 117.33 44.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -116.17 116.53 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -103.18 152.69 21.17 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.883 0.849 . . . . 0.0 109.897 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -128.0 121.4 29.71 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.546 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -171.3 -178.52 41.81 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -173.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -117.76 144.67 45.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.67 121.48 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.709 0.803 . . . . 0.0 110.528 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.6 149.63 40.0 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.074 0.55 . . . . 0.0 111.06 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.88 -32.91 40.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.456 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.53 102.76 14.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 20.68 10.93 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.97 117.62 30.45 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -147.58 137.14 22.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.89 0.876 . . . . 0.0 108.892 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 26.4 mmt -81.29 145.46 30.89 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -72.78 158.6 35.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.866 0.466 . . . . 0.0 112.201 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -115.01 155.96 26.0 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.267 1.027 . . . . 0.0 108.902 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.59 -2.97 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 116.369 -0.378 . . . . 0.0 113.984 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.96 147.96 1.34 Allowed Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.724 1.21 . . . . 0.0 108.625 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.69 148.41 77.7 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.154 1.903 . . . . 0.0 111.421 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.38 -171.8 25.64 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.37 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.9 129.56 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.121 0.968 . . . . 0.0 109.118 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 45.1 ttp180 -95.14 124.72 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.3 156.05 45.9 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -90.37 100.18 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.589 HD22 HD11 ' A' ' 107' ' ' ILE . 12.0 tp -72.54 106.75 4.73 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.417 0.687 . . . . 0.0 109.711 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.53 102.43 11.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.93 148.59 49.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.966 0.906 . . . . 0.0 111.602 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.546 ' HG2' ' HA2' ' A' ' 57' ' ' GLY . 14.1 mmmm -88.61 -27.29 21.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.757 0.823 . . . . 0.0 111.301 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.79 -34.05 60.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.914 0.486 . . . . 0.0 110.257 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -142.43 108.19 5.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.657 1.183 . . . . 0.0 108.972 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -71.53 -22.37 61.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.791 0.436 . . . . 0.0 110.392 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -70.6 -17.62 62.89 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.95 0.9 . . . . 0.0 111.549 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -101.42 92.54 4.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.402 0.681 . . . . 0.0 109.453 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -104.92 102.03 11.58 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.67 148.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.13 0.972 . . . . 0.0 109.096 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -83.46 145.23 29.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 82.7 t -129.96 121.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.18 0.592 . . . . 0.0 109.493 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.3 91.25 7.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.396 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -94.31 115.13 27.31 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -105.58 122.92 47.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.97 -162.63 28.35 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.472 0.482 . . . . 0.0 111.95 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.17 111.91 12.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.696 0.798 . . . . 0.0 110.815 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.66 117.12 66.45 Favored Pre-proline 0 N--CA 1.475 0.776 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.46 161.56 43.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.018 1.812 . . . . 0.0 112.591 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.32 -24.77 62.19 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.083 0.953 . . . . 0.0 110.555 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.8 p -70.79 -21.79 62.44 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.357 1.063 . . . . 0.0 111.642 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.492 ' HA ' HG11 ' A' ' 103' ' ' VAL . 54.0 t80 -71.66 121.56 19.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.606 ' HZ2' HD13 ' A' ' 129' ' ' LEU . 64.6 pttt -145.74 159.81 46.15 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.486 1.115 . . . . 0.0 108.932 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.33 96.8 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.513 2.142 . . . . 0.0 111.887 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.7 1.35 10.83 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.277 -0.735 . . . . 0.0 113.956 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.549 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 8.4 p -75.49 141.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.026 0.913 . . . . 0.0 111.415 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.84 136.26 40.19 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.39 160.86 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.761 0.791 . . . . 0.0 112.598 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.451 HD11 ' HD3' ' A' ' 126' ' ' LYS . 60.7 mt -126.79 107.99 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.46 1.904 . . . . 0.0 105.902 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 77' ' ' LEU . 19.7 pt -111.51 146.68 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.341 0.656 . . . . 0.0 109.422 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -140.66 143.07 34.93 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.99 -122.12 0.99 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.87 140.21 6.64 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 117.409 0.604 . . . . 0.0 112.131 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.92 131.86 53.52 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.772 0.829 . . . . 0.0 109.227 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . . . -84.99 133.51 43.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.69 -31.45 92.04 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.444 2.762 . . . . 0.0 114.093 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.58 80.1 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.648 0.593 . . . . 0.0 113.483 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 36.3 mt-10 -112.85 162.31 15.95 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.837 0.827 . . . . 0.0 113.004 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.17 -43.77 9.16 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.722 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -90.84 129.1 36.92 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.836 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -77.97 123.96 27.43 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.98 0.912 . . . . 0.0 109.268 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.87 100.8 13.45 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.45 105.67 15.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.438 0.695 . . . . 0.0 109.65 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -70.62 -23.94 62.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.918 0.487 . . . . 0.0 110.346 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.8 p -137.23 152.65 50.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.21 1.004 . . . . 0.0 109.489 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -139.37 136.24 34.55 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.419 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 24.3 ttm -136.61 104.8 5.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.031 0.933 . . . . 0.0 108.735 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -70.47 122.75 20.26 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HD3' HD11 ' A' ' 106' ' ' ILE . 56.1 tptt -76.46 -31.4 57.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.932 0.893 . . . . 0.0 109.466 -175.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 43.1 t -85.51 111.95 40.76 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.727 0.811 . . . . 0.0 109.467 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.48 104.31 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.498 2.132 . . . . 0.0 112.125 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.606 HD13 ' HZ2' ' A' ' 100' ' ' LYS . 3.6 mm? -84.11 144.44 29.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.229 0.612 . . . . 0.0 109.488 174.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.99 116.49 22.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.074 0.55 . . . . 0.0 109.823 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 m -77.5 130.51 73.93 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.341 0.656 . . . . 0.0 109.389 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.85 174.54 0.29 Allowed 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.993 3.129 . . . . 0.0 114.284 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -73.0 75.39 1.19 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.1 0.96 . . . . 0.0 110.548 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.809 ' HB2' ' HB2' ' A' ' 51' ' ' HIS . 8.3 m-20 -150.18 123.44 8.93 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.16 -46.41 80.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.209 0.604 . . . . 0.0 110.524 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD22 HG21 ' A' ' 53' ' ' VAL . 84.4 mt -112.15 46.4 1.16 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.679 0.792 . . . . 0.0 110.137 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.809 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 15.4 t60 -59.62 -51.11 71.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.4 p -125.16 150.99 46.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 112.734 -2.03 . . . . 0.0 107.864 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.592 HG21 HD22 ' A' ' 50' ' ' LEU . 48.1 t -101.12 110.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -109.58 114.19 27.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -111.36 138.0 48.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -112.44 145.29 40.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . 173.93 -159.41 28.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 118.19 0.45 . . . . 0.0 112.763 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -131.67 145.68 51.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.92 0.888 . . . . 0.0 110.28 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.72 119.04 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.224 1.01 . . . . 0.0 110.464 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.98 143.41 47.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.765 0.826 . . . . 0.0 110.185 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.62 -41.05 47.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.533 0.733 . . . . 0.0 110.333 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.84 102.64 10.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.086 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 76' ' ' ARG . . . 104.29 42.95 1.81 Allowed Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.795 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.64 125.47 51.82 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -143.67 144.48 31.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.746 1.218 . . . . 0.0 109.668 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 71.9 mmm -81.29 149.46 28.95 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 mt -66.66 150.18 49.43 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.55 104.96 15.0 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.913 0.885 . . . . 0.0 110.334 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.19 33.92 88.53 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.635 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.51 146.86 20.28 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.44 0.696 . . . . 0.0 110.288 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.44 130.83 16.67 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.351 2.034 . . . . 0.0 110.275 170.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.62 -169.19 23.92 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 116.681 -0.236 . . . . 0.0 112.515 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.65 130.59 3.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 34.3 ttm180 -94.61 129.86 41.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.43 162.31 41.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 73.4 mtp180 -95.46 124.44 39.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.5 tp -99.76 116.51 32.01 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 109.517 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -79.38 116.89 19.88 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.412 1.085 . . . . 0.0 108.467 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.75 142.48 51.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.614 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 10.7 mmpt? -64.77 -36.83 85.59 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.431 0.692 . . . . 0.0 112.115 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.88 -39.41 17.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -115.15 90.29 3.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.405 0.682 . . . . 0.0 111.096 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -89.29 9.38 26.19 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.607 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -92.5 4.8 52.81 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.366 0.666 . . . . 0.0 110.957 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.01 134.77 7.76 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.02 0.528 . . . . 0.0 109.612 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 134.09 55.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 108.777 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.69 141.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.81 154.58 41.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 55.9 t -137.3 118.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.47 HD22 ' HE3' ' A' ' 92' ' ' LYS . 59.9 tp -93.01 92.67 7.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 108.77 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -90.91 123.41 34.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HE3' HD22 ' A' ' 90' ' ' LEU . 98.9 mttt -107.53 129.78 54.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 167.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.51 -165.98 26.27 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.452 0.47 . . . . 0.0 112.072 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.01 118.75 13.24 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.581 0.752 . . . . 0.0 111.224 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.15 115.85 63.54 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.013 0.925 . . . . 0.0 109.232 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.87 157.62 47.22 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.061 2.507 . . . . 0.0 114.19 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.49 -27.63 66.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.935 0.894 . . . . 0.0 110.326 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 t -80.58 -14.78 57.91 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CD1' HD22 ' A' ' 123' ' ' LEU . 68.5 t80 -78.14 114.05 16.66 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 154.92 49.43 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.174 0.989 . . . . 0.0 109.121 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.39 102.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.691 2.261 . . . . 0.0 112.414 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.57 -10.19 5.81 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.372 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 105' ' ' VAL . 13.6 p -78.1 136.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 117.662 0.731 . . . . 0.0 110.699 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -76.09 122.57 24.46 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 103' ' ' VAL . 28.0 m -123.83 155.15 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.971 0.891 . . . . 0.0 111.226 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.606 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 61.3 mt -114.34 109.4 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 89' ' ' VAL . 36.1 pt -97.19 153.76 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 38.5 tt0 -145.76 134.93 22.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.69 -114.6 0.59 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.53 166.2 39.42 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.96 123.02 42.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.07 0.948 . . . . 0.0 108.961 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.39 132.35 33.95 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.306 0.642 . . . . 0.0 109.785 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.49 89.34 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.095 2.53 . . . . 0.0 111.611 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.11 -39.65 0.52 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.57 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.95 129.37 35.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.395 0.678 . . . . 0.0 109.197 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.52 -16.29 61.28 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.085 168.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -95.23 126.5 40.59 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 111.871 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -76.48 114.88 15.69 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.013 1.325 . . . . 0.0 109.176 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -74.69 91.42 2.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.08 113.51 25.49 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.861 0.864 . . . . 0.0 110.472 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HG3' ' OG1' ' A' ' 122' ' ' THR . 25.6 ptt180 -74.66 -26.82 60.12 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.903 0.481 . . . . 0.0 110.006 172.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 17.8 m -126.67 145.9 50.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.745 0.818 . . . . 0.0 109.175 -169.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.439 HD22 ' CD1' ' A' ' 99' ' ' PHE . 47.2 tp -137.04 132.95 34.93 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.606 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 38.8 ttm -134.55 96.56 3.6 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.4 p -72.18 121.87 20.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.716 0.806 . . . . 0.0 109.792 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -94.53 1.11 55.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 0.0 111.388 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 46.2 t -95.47 107.65 34.37 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.39 122.31 9.75 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.424 2.082 . . . . 0.0 110.872 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.0 tp -98.4 110.61 23.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.288 0.635 . . . . 0.0 109.716 -174.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.532 0.206 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.76 6.57 2.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 m 55.96 86.65 0.16 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.027 1.331 . . . . 0.0 110.207 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.76 119.52 3.36 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.785 2.99 . . . . 0.0 115.516 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -149.3 37.65 0.77 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.507 1.123 . . . . 0.0 108.021 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.65 141.2 38.67 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.865 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD2' HH12 ' A' ' 121' ' ' ARG . 42.5 mmtm -89.9 -25.69 20.84 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.442 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -67.1 -38.58 85.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.097 0.559 . . . . 0.0 111.507 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -109.06 22.95 15.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 111.383 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.89 139.95 55.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.929 0.492 . . . . 0.0 109.92 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.65 108.26 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -170.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -101.13 109.9 21.85 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.12 136.51 53.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -108.92 131.62 54.85 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.8 -174.26 32.49 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.4 m -128.28 139.4 52.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.144 0.978 . . . . 0.0 108.841 173.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.06 120.13 28.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.918 0.887 . . . . 0.0 108.983 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.29 57.58 Favored 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.694 0.621 . . . . 0.0 110.333 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.67 -18.64 59.57 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.667 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.55 109.19 21.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.975 . . . . 0.0 108.944 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.94 64.85 0.91 Allowed Glycine 0 C--N 1.346 1.096 0 O-C-N 123.146 0.279 . . . . 0.0 112.486 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -136.0 124.49 23.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 84.7 m -147.25 138.79 24.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.479 0.712 . . . . 0.0 110.128 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.421 ' HE1' HG21 ' A' ' 95' ' ' VAL . 80.1 mmm -82.7 153.29 25.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.341 0.657 . . . . 0.0 109.319 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.445 HD12 ' HZ2' ' A' ' 92' ' ' LYS . 63.0 mt -71.96 138.44 48.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.438 0.295 . . . . 0.0 111.008 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.82 112.89 5.81 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.955 0.902 . . . . 0.0 111.669 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.63 30.48 72.32 Favored Glycine 0 C--N 1.347 1.186 0 O-C-N 124.125 0.891 . . . . 0.0 113.349 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.91 138.48 11.9 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.337 0.655 . . . . 0.0 110.213 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 111.0 2.11 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.927 2.418 . . . . 0.0 110.898 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.99 177.43 35.98 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 91' ' ' TYR . 9.2 p -154.35 138.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -106.29 131.57 53.36 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -144.73 154.8 43.11 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -92.5 91.55 7.66 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.68 120.1 22.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.62 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.538 ' HG2' HG23 ' A' ' 86' ' ' THR . 36.5 mt-10 -92.45 105.19 17.41 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 40.9 t0 -59.12 142.28 51.92 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.679 1.192 . . . . 0.0 111.223 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -74.47 -17.05 60.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.144 0.978 . . . . 0.0 111.119 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.35 -55.48 15.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -148.32 134.17 19.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.075 0.95 . . . . 0.0 109.161 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -66.43 -25.38 66.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.29 0.636 . . . . 0.0 111.113 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.93 -29.09 69.99 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.597 0.759 . . . . 0.0 111.227 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 30.8 mmmt -73.91 79.44 1.64 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.506 0.723 . . . . 0.0 110.116 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.538 HG23 ' HG2' ' A' ' 78' ' ' GLU . 18.0 p -94.83 98.57 10.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.0 t -108.4 135.5 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.37 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.6 130.77 34.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.46 116.41 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 tp -91.93 94.26 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.403 ' HD2' HG13 ' A' ' 73' ' ' VAL . 41.1 t80 -92.07 114.16 26.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.174 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HZ2' HD12 ' A' ' 67' ' ' LEU . 4.9 mptp? -91.16 123.13 34.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.13 169.83 12.66 Favored Glycine 0 N--CA 1.467 0.721 0 O-C-N 123.206 0.316 . . . . 0.0 112.653 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 120.18 12.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.235 0.614 . . . . 0.0 110.318 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.421 HG21 ' HE1' ' A' ' 66' ' ' MET . 60.3 t -82.28 124.42 78.33 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.179 0.991 . . . . 0.0 110.251 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HB2' HG21 ' A' ' 98' ' ' THR . 93.9 Cg_endo -75.61 155.46 40.14 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.726 2.284 . . . . 0.0 112.46 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -65.17 -22.37 66.9 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.788 0.835 . . . . 0.0 112.047 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' A' ' 129' ' ' LEU . 6.7 t -74.21 -24.44 59.33 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.511 0.724 . . . . 0.0 111.216 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 103' ' ' VAL . 75.3 t80 -73.32 109.86 7.17 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -141.32 159.76 59.81 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.021 0.929 . . . . 0.0 109.895 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.37 100.11 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.695 2.263 . . . . 0.0 111.574 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.86 -11.28 7.84 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.257 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 99' ' ' PHE . 5.4 p -72.17 146.96 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 117.489 0.644 . . . . 0.0 109.884 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 35.8 mt-10 -81.46 136.42 35.66 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 125' ' ' THR . 19.6 m -128.74 169.58 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 122.152 0.977 . . . . 0.0 111.701 177.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.46 HD12 ' HE3' ' A' ' 124' ' ' MET . 68.9 mt -136.25 107.75 6.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.896 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 118' ' ' PHE . 41.1 pt -98.16 149.51 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.909 0.884 . . . . 0.0 109.471 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 40.7 mt-10 -135.03 139.75 45.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.72 -120.82 0.97 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.2 168.77 41.9 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.808 0.304 . . . . 0.0 112.374 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.29 101.03 7.69 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.49 130.45 58.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.0 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.92 97.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.604 2.869 . . . . 0.0 112.416 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.13 -52.14 0.56 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.87 118.39 24.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.637 0.775 . . . . 0.0 109.886 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.17 -26.56 61.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.378 0.671 . . . . 0.0 109.653 168.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -86.2 141.28 29.43 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.497 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.433 ' CD1' HD13 ' A' ' 107' ' ' ILE . 54.6 t80 -76.5 118.04 18.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 109.702 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.32 97.11 4.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.104 0.962 . . . . 0.0 109.409 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.87 114.2 25.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.049 0.54 . . . . 0.0 110.592 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.44 HH12 ' HD2' ' A' ' 49' ' ' LYS . 12.1 ptm180 -78.57 -34.83 46.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.518 0.727 . . . . 0.0 110.802 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 13.6 p -138.4 146.32 42.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.775 0.83 . . . . 0.0 109.569 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 tp -136.61 111.95 9.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.27 1.028 . . . . 0.0 109.594 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.46 ' HE3' HD12 ' A' ' 106' ' ' ILE . 53.6 ttp -122.47 119.86 32.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 105' ' ' VAL . 45.8 p -72.23 146.78 47.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -67.91 -34.99 77.69 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 175.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.09 107.17 5.57 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.151 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.56 128.41 6.09 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.323 2.015 . . . . 0.0 112.411 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.624 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 32.5 tp -165.44 29.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.44 1.096 . . . . 0.0 108.546 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.152 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.71 -173.98 4.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.905 0.882 . . . . 0.0 111.281 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 t -113.75 89.29 15.6 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.438 0.695 . . . . 0.0 110.069 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 113' ' ' PRO . 2.9 Cg_exo -74.47 115.58 4.35 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.607 2.204 . . . . 0.0 110.881 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.6 -177.1 4.06 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.031 0.532 . . . . 0.0 109.961 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -68.08 127.12 31.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.87 0.468 . . . . 0.0 109.909 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.28 -3.54 33.89 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.793 0.837 . . . . 0.0 111.526 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.98 60.17 4.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.83 0.852 . . . . 0.0 110.091 170.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -145.55 153.16 40.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.461 1.504 . . . . 0.0 108.145 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 p -106.65 121.7 44.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.726 . . . . 0.0 110.195 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.73 118.34 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -91.94 121.59 33.68 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.94 138.81 51.07 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -120.35 154.45 35.04 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 109.882 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.19 -155.56 26.97 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 121.805 -0.236 . . . . 0.0 112.932 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -124.32 145.21 49.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.776 0.83 . . . . 0.0 109.737 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.28 120.51 36.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.64 33.47 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 124.017 0.823 . . . . 0.0 111.003 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.31 -17.78 51.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.413 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.75 127.72 33.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.434 0.693 . . . . 0.0 110.477 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 8.2 84.03 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.431 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD23 ' HE2' ' A' ' 99' ' ' PHE . 4.3 tt -69.55 103.83 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -116.2 113.7 23.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.518 1.127 . . . . 0.0 108.929 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.4 mtp -89.08 136.56 32.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.23 128.59 37.13 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.468 0.48 . . . . 0.0 110.112 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.58 112.34 24.22 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.43 0.692 . . . . 0.0 109.232 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.02 -30.53 9.91 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.023 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.42 141.99 23.64 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.746 0.818 . . . . 0.0 109.57 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.29 6.35 4.42 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.213 2.608 . . . . 0.0 114.112 -175.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.96 -170.66 44.24 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.424 0.452 . . . . 0.0 113.369 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.412 ' HB ' HG21 ' A' ' 95' ' ' VAL . 13.0 p -154.12 154.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.455 0.702 . . . . 0.0 110.73 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -121.78 138.45 54.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.624 1.17 . . . . 0.0 108.015 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -151.1 174.63 12.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -113.37 111.87 22.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.794 0.807 . . . . 0.0 109.83 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.0 tp -77.62 133.66 38.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.007 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 86' ' ' THR . 44.6 mt-10 -84.47 124.22 31.11 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.98 105.63 1.08 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.613 0.57 . . . . 0.0 110.555 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.27 -24.39 46.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -63.23 -32.86 74.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.28 0.632 . . . . 0.0 110.987 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.426 HD21 ' N ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -156.57 97.0 1.7 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.378 0.671 . . . . 0.0 109.644 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -81.3 70.38 8.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 122.629 1.204 . . . . 0.0 111.193 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -147.11 2.32 0.77 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.078 169.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -146.2 159.88 42.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.52 1.128 . . . . 0.0 109.669 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 78' ' ' GLU . 37.6 p -137.75 139.15 39.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.233 1.013 . . . . 0.0 109.042 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.96 133.25 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -83.1 134.97 34.98 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.13 116.29 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.224 0.61 . . . . 0.0 109.485 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.3 tp -93.61 93.97 8.35 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.4 109.99 18.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.183 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.66 109.93 21.81 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 109.518 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.21 37.87 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.11 115.95 27.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 73' ' ' VAL . 97.9 t -80.18 118.69 73.68 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 122.735 0.414 . . . . 0.0 109.884 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.5 162.35 38.24 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.299 1.999 . . . . 0.0 112.439 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.3 -22.55 66.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.926 0.89 . . . . 0.0 111.185 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.602 HG22 ' HG ' ' A' ' 129' ' ' LEU . 67.8 p -67.67 -20.91 65.35 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.617 1.167 . . . . 0.0 112.096 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.401 ' HE2' HD23 ' A' ' 64' ' ' LEU . 75.8 t80 -79.79 136.36 36.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.827 0.851 . . . . 0.0 109.521 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -163.89 162.49 16.45 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.969 0.908 . . . . 0.0 110.599 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.24 101.57 0.35 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.435 2.09 . . . . 0.0 110.517 164.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.21 62.51 0.67 Allowed Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.486 HG13 HG11 ' A' ' 105' ' ' VAL . 11.6 p -137.7 130.53 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -0.615 . . . . 0.0 110.285 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -69.85 132.65 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 165.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 125' ' ' THR . 15.2 m -139.06 159.37 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-O 122.081 0.943 . . . . 0.0 111.174 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.31 106.46 12.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 113.237 -1.801 . . . . 0.0 106.291 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.0 pt -100.87 161.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.254 0.621 . . . . 0.0 110.098 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.89 140.47 20.71 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.19 -108.57 0.27 Allowed Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.26 171.25 41.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.4 tp -128.69 127.71 42.67 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 139.03 43.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.241 0.616 . . . . 0.0 109.913 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HG3' ' HB3' ' A' ' 46' ' ' PRO . 41.2 Cg_endo -65.66 112.12 2.09 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.403 2.069 . . . . 0.0 112.179 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.38 -21.48 19.42 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.83 144.21 26.15 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 110.922 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.62 -34.76 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.811 0.444 . . . . 0.0 110.993 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -82.38 126.29 32.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.109 0.48 . . . . 0.0 110.795 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -77.6 122.54 25.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.846 0.858 . . . . 0.0 108.693 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -91.54 103.83 16.39 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.4 119.57 25.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -68.42 -42.49 78.88 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.272 1.029 . . . . 0.0 109.799 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -134.51 141.73 46.81 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 -170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -125.82 112.39 15.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.702 1.201 . . . . 0.0 108.566 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 ttp -118.55 106.0 12.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 105' ' ' VAL . 77.5 p -71.24 128.06 34.65 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -79.34 -32.53 43.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.811 0.844 . . . . 0.0 109.207 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.6 t -109.27 87.9 5.41 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.455 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 13.5 Cg_exo -67.97 -82.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.065 2.51 . . . . 0.0 113.905 -171.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.602 ' HG ' HG22 ' A' ' 98' ' ' THR . 96.6 mt -138.27 107.63 6.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.298 1.039 . . . . 0.0 109.216 -176.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.164 177.115 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.18 113.36 24.95 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.177 0.591 . . . . 0.0 110.33 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -71.04 127.5 91.56 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.702 0.801 . . . . 0.0 110.452 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.89 97.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.165 2.576 . . . . 0.0 112.481 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -132.85 146.61 51.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.348 1.059 . . . . 0.0 110.501 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.52 94.41 8.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.35 8.71 37.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.297 -173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.46 77.44 1.93 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.603 0.716 . . . . 0.0 109.304 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -79.8 -14.34 58.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.822 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -124.76 143.8 50.59 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.031 1.332 . . . . 0.0 107.705 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 42.2 t -115.48 132.69 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 94.6 mtt180 -100.14 146.22 27.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.342 0.657 . . . . 0.0 110.177 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -133.82 126.6 30.89 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -115.66 108.33 16.25 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.98 -152.11 5.57 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 56.6 m -125.38 146.43 49.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.61 0.764 . . . . 0.0 109.815 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.68 120.04 33.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 124.012 0.925 . . . . 0.0 109.071 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.14 150.98 43.33 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.905 0.753 . . . . 0.0 111.007 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.55 45.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.624 0.769 . . . . 0.0 110.074 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.78 113.91 26.31 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.88 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.56 -1.14 45.92 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.224 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD12 ' HG3' ' A' ' 101' ' ' PRO . 5.4 tt -69.21 108.96 3.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -121.52 128.62 52.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.211 1.005 . . . . 0.0 108.861 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.468 ' HE2' HG11 ' A' ' 95' ' ' VAL . 25.7 mmt -83.06 154.91 24.17 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 172.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -86.3 35.61 0.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 26.42 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 128.078 2.551 . . . . 0.0 114.44 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.72 38.56 3.2 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.174 0.416 . . . . 0.0 113.05 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 133.75 4.38 Favored Pre-proline 0 C--O 1.241 0.618 0 C-N-CA 124.669 1.188 . . . . 0.0 108.694 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.72 115.64 3.51 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.468 2.112 . . . . 0.0 109.901 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.06 -174.4 33.27 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.501 0.5 . . . . 0.0 112.965 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.36 133.77 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.959 0.904 . . . . 0.0 110.057 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 46.2 ttm180 -106.36 124.32 49.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -149.33 160.77 43.12 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -96.45 111.48 23.57 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.86 105.05 10.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.75 121.42 19.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -78.09 147.67 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.176 0.99 . . . . 0.0 110.825 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -108.37 -10.61 15.3 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.408 0.683 . . . . 0.0 111.962 -172.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -83.94 -30.12 26.54 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -145.95 108.8 4.54 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -73.31 -13.75 61.17 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.277 0.631 . . . . 0.0 111.8 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -84.12 -10.13 58.04 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.243 0.617 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HB2' ' HZ3' ' A' ' 85' ' ' LYS . 4.2 ttmp? -109.97 110.92 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 0.0 109.723 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -113.96 127.59 56.03 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 167.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.03 134.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -85.98 138.39 32.02 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 60.2 t -123.08 116.68 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.4 93.87 8.4 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -98.18 122.58 41.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.91 116.17 31.15 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.01 174.65 33.18 Favored Glycine 0 C--O 1.238 0.346 0 O-C-N 123.994 0.808 . . . . 0.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 112.78 4.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.468 HG11 ' HE2' ' A' ' 66' ' ' MET . 97.8 t -81.1 117.01 66.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.413 0.685 . . . . 0.0 109.471 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.01 171.23 18.53 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.182 1.921 . . . . 0.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.16 -22.27 59.49 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -63.54 -32.2 73.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.4 1.08 . . . . 0.0 109.796 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -76.52 120.91 22.38 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 166.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -161.35 155.63 19.25 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.505 0.722 . . . . 0.0 110.173 -174.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HG3' HD12 ' A' ' 64' ' ' LEU . 41.6 Cg_exo -57.98 107.79 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.649 2.232 . . . . 0.0 111.847 172.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.86 -25.14 5.62 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.237 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 p -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 117.44 0.62 . . . . 0.0 110.654 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.5 mt-10 -86.62 129.69 34.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 125' ' ' THR . 34.8 m -119.99 144.94 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.611 0.719 . . . . 0.0 111.068 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.92 107.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.66 143.69 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 25.9 mt-10 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.62 -100.29 0.14 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . 166.15 159.2 11.71 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 170.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.84 127.67 39.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.995 0.918 . . . . 0.0 109.237 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -82.98 135.34 45.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 -28.66 80.96 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.814 2.342 . . . . 0.0 113.377 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.05 -11.26 56.61 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.84 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 42.1 mt-10 -119.14 125.49 49.37 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.562 0.745 . . . . 0.0 110.159 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -61.43 -26.3 67.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.992 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 t -84.67 130.51 34.7 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.23 0.538 . . . . 0.0 111.284 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 10.2 t80 -77.07 116.15 17.47 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -97.51 114.37 26.24 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.28 30.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.165 0.986 . . . . 0.0 110.668 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -75.04 -26.36 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.142 0.577 . . . . 0.0 110.45 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 39.0 p -139.61 155.39 47.48 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.682 1.193 . . . . 0.0 108.836 174.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 tt -137.94 137.11 37.66 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 ttp -133.7 164.97 26.03 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.554 HG21 HG11 ' A' ' 105' ' ' VAL . 40.0 p -109.86 149.36 29.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.113 0.565 . . . . 0.0 109.913 173.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -78.03 -49.47 13.96 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.67 118.59 58.15 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.751 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -85.68 -173.22 1.29 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.685 2.257 . . . . 0.0 112.042 170.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -126.46 -179.96 5.02 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.313 0.645 . . . . 0.0 109.717 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.82 23.55 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.419 0.687 . . . . 0.0 109.833 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.2 m -117.1 89.84 31.56 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.84 94.61 0.54 Allowed 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.067 1.845 . . . . 0.0 110.425 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -69.22 -10.55 58.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.459 0.704 . . . . 0.0 111.776 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.36 77.77 1.01 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -87.43 -6.33 58.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.895 . . . . 0.0 110.466 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.14 77.06 8.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.061 0.945 . . . . 0.0 109.107 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -164.15 142.92 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.0 m -70.59 117.66 12.41 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 122.933 0.493 . . . . 0.0 109.925 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.64 127.78 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -113.84 134.27 54.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.792 0.437 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 163.95 16.93 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.222 1.009 . . . . 0.0 110.244 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -139.37 139.82 37.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.652 1.181 . . . . 0.0 108.368 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.94 30.44 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -123.2 148.68 45.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.588 1.155 . . . . 0.0 109.463 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.47 130.87 35.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.34 37.64 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.564 0.54 . . . . 0.0 110.919 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -70.89 -45.44 64.35 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.437 0.695 . . . . 0.0 109.608 170.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.63 120.58 30.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 52.12 1.93 Allowed Glycine 0 N--CA 1.468 0.782 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.9 tt -135.84 125.76 25.86 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -140.57 142.86 35.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.526 1.13 . . . . 0.0 108.807 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.6 mmt -95.02 147.88 22.93 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.99 123.66 22.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.05 124.88 41.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.351 0.661 . . . . 0.0 109.553 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.92 28.45 70.58 Favored Glycine 0 C--N 1.344 0.989 0 O-C-N 123.726 0.641 . . . . 0.0 111.9 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.33 131.48 2.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.784 1.233 . . . . 0.0 109.007 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 120.77 7.48 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 121.928 1.752 . . . . 0.0 111.771 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -176.85 31.32 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 120.998 0.221 . . . . 0.0 113.546 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.51 139.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.459 1.104 . . . . 0.0 109.431 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 40.5 ttt180 -119.65 125.81 49.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.64 0.776 . . . . 0.0 108.991 171.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 37.5 p90 -151.36 162.35 41.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 30.2 ptt180 -100.18 119.26 38.08 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.0 tp -73.79 115.78 13.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.702 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.535 ' HA ' HG21 ' A' ' 86' ' ' THR . 34.2 mt-10 -74.21 101.95 4.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.65 158.7 1.79 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.611 0.764 . . . . 0.0 111.797 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -49.57 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.4 1.08 . . . . 0.0 112.058 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 66.9 21.78 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.651 1.18 . . . . 0.0 111.956 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -139.39 86.4 2.12 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.118 0.967 . . . . 0.0 109.463 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -82.21 -10.24 59.21 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.754 173.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -81.29 -0.03 39.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.599 0.76 . . . . 0.0 112.249 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -145.99 88.23 1.8 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.535 HG21 ' HA ' ' A' ' 78' ' ' GLU . 39.9 p -98.54 128.26 44.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 110.554 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -101.95 138.82 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.8 m95 -73.89 160.63 31.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.951 0.501 . . . . 0.0 110.777 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.3 t -135.71 108.77 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 108.677 -173.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.9 tp -93.98 94.04 8.23 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -99.48 131.86 45.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -118.74 150.84 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.147 0.579 . . . . 0.0 110.622 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.18 -172.22 14.12 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.195 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.81 121.13 18.43 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.166 0.587 . . . . 0.0 110.106 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.24 124.64 80.6 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.922 0.889 . . . . 0.0 109.332 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.473 ' HD2' HD23 ' A' ' 123' ' ' LEU . 57.8 Cg_endo -68.61 152.58 74.56 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.474 2.116 . . . . 0.0 112.111 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.55 -27.03 63.84 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.524 0.73 . . . . 0.0 111.66 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 96' ' ' PRO . 9.6 t -68.62 -20.02 64.46 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.761 0.425 . . . . 0.0 110.908 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.07 115.33 10.08 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.439 ' O ' HG11 ' A' ' 103' ' ' VAL . 47.8 mtmt -132.15 158.66 74.95 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.487 1.115 . . . . 0.0 108.644 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 11.2 Cg_exo -70.99 141.08 39.42 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.204 1.936 . . . . 0.0 109.985 167.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.72 79.04 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 100' ' ' LYS . 9.9 p -93.25 149.83 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.388 1.094 . . . . 0.0 108.313 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -69.99 139.07 52.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 125' ' ' THR . 16.6 m -133.03 156.4 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.916 0.865 . . . . 0.0 111.017 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.8 mt -121.16 127.89 75.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.738 1.615 . . . . 0.0 106.769 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.6 pt -125.93 145.63 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.26 155.25 46.6 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 109.153 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 165.88 -114.42 0.59 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.02 150.81 20.94 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 117.343 0.571 . . . . 0.0 111.979 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 45.9 tp -127.66 136.11 51.15 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.533 0.733 . . . . 0.0 109.874 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 132.55 37.17 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.64 -19.53 53.43 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.807 2.338 . . . . 0.0 113.728 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.7 -8.28 57.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.792 -0.449 . . . . 0.0 113.768 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -100.68 139.68 36.03 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 117.708 0.754 . . . . 0.0 110.014 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -85.98 -23.14 27.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.994 0.917 . . . . 0.0 111.934 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -99.39 126.47 45.28 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.873 0.844 . . . . 0.0 110.763 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.406 ' HD1' ' HB2' ' A' ' 111' ' ' LEU . 81.2 t80 -75.11 131.02 40.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.762 1.225 . . . . 0.0 108.715 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 60.0 tttm -88.25 108.16 19.17 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.02 113.62 23.84 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.015 0.526 . . . . 0.0 110.111 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.09 -30.51 62.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.468 0.707 . . . . 0.0 109.49 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p -133.4 141.33 47.82 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 109.834 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.473 HD23 ' HD2' ' A' ' 96' ' ' PRO . 62.8 tp -124.8 109.58 13.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.5 ttp -124.86 138.45 54.26 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.445 ' HA ' HG11 ' A' ' 105' ' ' VAL . 65.3 p -89.61 169.01 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.002 0.521 . . . . 0.0 111.231 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 24.9 tptm -62.17 -60.57 3.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.213 1.005 . . . . 0.0 109.995 173.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.9 m -99.84 113.8 65.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.378 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.18 79.45 1.07 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.713 2.275 . . . . 0.0 110.218 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.63 100.45 2.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.884 -172.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 123.959 0.903 . . . . 0.0 108.607 -176.946 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.59 171.95 19.42 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.7 0.8 . . . . 0.0 110.069 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.5 p -73.91 131.76 81.11 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 122.943 0.497 . . . . 0.0 110.012 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -59.25 151.93 63.86 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.022 2.481 . . . . 0.0 113.505 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -68.98 159.73 32.23 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.666 0.786 . . . . 0.0 111.192 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -77.07 161.21 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.195 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -106.76 11.4 30.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.626 0.771 . . . . 0.0 111.312 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -79.8 -34.49 39.56 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -107.17 62.79 0.62 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 t -81.1 -159.23 0.24 Allowed 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.336 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -97.15 118.85 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.336 -0.853 . . . . 0.0 109.521 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -120.1 138.0 53.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.67 140.47 40.82 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.77 134.04 52.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.211 1.005 . . . . 0.0 108.606 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.9 177.38 41.04 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.48 ' HG1' ' HG2' ' A' ' 104' ' ' GLU . 24.0 m -113.4 140.19 48.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.763 0.825 . . . . 0.0 109.074 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.6 132.25 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.764 0.426 . . . . 0.0 110.39 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.67 40.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 122.617 0.367 . . . . 0.0 110.062 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -75.59 -0.33 20.09 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.695 173.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -131.23 120.77 23.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.898 0.879 . . . . 0.0 109.363 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.91 22.91 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.865 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.81 105.73 5.23 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 m -138.59 125.95 21.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.813 0.845 . . . . 0.0 109.944 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtp -96.89 162.19 13.52 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.165 0.586 . . . . 0.0 110.631 -170.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.63 135.12 35.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.013 0.525 . . . . 0.0 111.225 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -73.89 111.84 9.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.554 0.742 . . . . 0.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.95 -53.78 4.88 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.334 0.396 . . . . 0.0 112.347 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.61 129.16 94.14 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 123.856 0.862 . . . . 0.0 110.906 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.31 113.46 1.92 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.435 2.09 . . . . 0.0 110.808 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.41 175.36 35.94 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 121.478 0.488 . . . . 0.0 113.514 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 8.7 p -154.35 131.71 2.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.06 1.344 . . . . 0.0 108.723 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.93 143.4 31.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -156.64 163.32 39.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -98.64 105.99 18.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.85 117.5 23.34 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.6 89.71 1.0 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.38 131.03 47.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.917 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -72.57 -37.91 68.06 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.627 0.579 . . . . 0.0 110.973 -171.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.47 -44.89 70.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 111.115 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.34 89.98 2.43 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 t -77.43 -18.44 57.22 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.923 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -68.35 -18.88 64.59 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.641 0.777 . . . . 0.0 111.556 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -132.18 88.77 2.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.069 0.948 . . . . 0.0 108.919 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.4 p -80.78 151.36 28.83 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.766 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.2 t -104.09 129.35 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.461 0.704 . . . . 0.0 109.657 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.52 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.2 m95 -78.76 100.76 7.25 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.19 110.09 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.359 0.6 . . . . 0.0 109.572 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 tp -93.15 93.75 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.742 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' HE2' ' HA ' ' A' ' 95' ' ' VAL . 47.3 t80 -92.97 111.54 23.2 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.715 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -105.3 116.09 31.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.205 0.602 . . . . 0.0 109.463 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 153.63 -175.24 32.05 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.46 112.76 4.24 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' HA ' ' HE2' ' A' ' 91' ' ' TYR . 46.2 t -79.82 126.35 80.33 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.423 0.689 . . . . 0.0 109.232 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.6 Cg_endo -57.33 142.88 94.96 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.782 2.322 . . . . 0.0 112.519 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.93 -25.7 67.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.583 0.753 . . . . 0.0 111.441 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 33.2 p -78.22 -6.65 55.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.503 1.121 . . . . 0.0 112.642 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.48 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 78.9 t80 -69.99 95.94 0.99 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.294 0.638 . . . . 0.0 109.946 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.615 ' HB3' HD22 ' A' ' 129' ' ' LEU . 48.4 pttt -110.53 157.41 38.36 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.256 1.023 . . . . 0.0 110.018 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.532 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 16.3 Cg_exo -68.46 112.7 2.9 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.302 2.001 . . . . 0.0 110.714 171.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.58 3.31 27.18 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.911 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 125' ' ' THR . 12.8 p -85.63 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 118.07 0.935 . . . . 0.0 110.278 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG2' ' HG1' ' A' ' 58' ' ' THR . 37.6 mt-10 -74.39 110.33 8.59 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 171.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.493 HG12 HG12 ' A' ' 103' ' ' VAL . 29.8 m -104.63 148.05 9.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.952 0.882 . . . . 0.0 110.223 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.55 107.19 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.11 144.42 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 138.89 26.66 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.93 -118.35 0.83 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -172.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.54 141.58 6.63 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 117.907 0.853 . . . . 0.0 112.342 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 tp -87.64 129.17 35.22 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . . . -81.58 132.75 54.23 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.75 -18.78 66.08 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.009 2.473 . . . . 0.0 114.055 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.23 -31.92 6.64 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.679 -0.237 . . . . 0.0 112.76 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 3.2 mp0 -94.45 137.26 33.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.945 0.498 . . . . 0.0 111.313 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.26 -26.69 65.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.992 0.917 . . . . 0.0 110.533 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 58.5 p -84.41 130.04 34.81 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.9 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -77.79 120.43 22.68 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.372 1.069 . . . . 0.0 108.619 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -75.74 94.73 3.31 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.22 109.59 18.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.248 0.619 . . . . 0.0 110.13 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -62.38 -42.36 99.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.931 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.2 p -134.83 162.31 32.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.879 0.871 . . . . 0.0 110.192 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.0 tp -150.58 111.43 4.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.361 1.064 . . . . 0.0 108.895 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 ttp -124.48 116.08 21.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.485 0.314 . . . . 0.0 110.939 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.531 ' HB ' HG22 ' A' ' 103' ' ' VAL . 70.4 p -74.06 150.27 40.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.389 1.076 . . . . 0.0 110.694 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -90.75 -63.84 1.21 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.741 0.417 . . . . 0.0 110.054 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.54 114.27 26.79 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.984 0.513 . . . . 0.0 110.618 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.99 135.27 31.84 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.018 2.479 . . . . 0.0 111.924 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.615 HD22 ' HB3' ' A' ' 100' ' ' LYS . 56.9 tp -102.9 135.44 44.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.884 0.874 . . . . 0.0 109.505 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 124.453 1.101 . . . . 0.0 109.709 -176.591 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 43' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.58 8.64 21.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.484 0.714 . . . . 0.0 110.678 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -66.13 108.43 2.25 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 125.0 1.32 . . . . 0.0 112.114 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -90.79 25.84 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.315 2.676 . . . . 0.0 113.118 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 60.46 33.83 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.283 1.033 . . . . 0.0 111.341 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -74.84 -29.13 60.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.62 0.768 . . . . 0.0 110.317 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt 66.08 12.92 8.82 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.551 1.54 . . . . 0.0 113.55 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -111.55 6.92 20.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.378 0.671 . . . . 0.0 110.311 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -70.3 -50.66 37.15 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.7 m -106.39 116.07 31.3 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 165.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.6 t -102.65 145.23 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.183 0.993 . . . . 0.0 109.393 -170.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -115.58 123.2 47.85 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.44 147.35 41.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.637 0.732 . . . . 0.0 110.034 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.96 109.06 10.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.913 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.86 -158.31 8.55 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.455 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 50.2 m -117.12 145.71 43.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.388 1.075 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.9 120.43 32.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.079 0.952 . . . . 0.0 109.08 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.9 47.59 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.744 0.652 . . . . 0.0 111.647 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 101' ' ' PRO . . . -70.3 -28.83 65.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.541 0.736 . . . . 0.0 112.111 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -110.59 42.14 1.64 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.54 51.96 0.22 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 tt -133.65 108.42 8.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 m -114.43 119.51 37.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 109.682 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.1 mmt -80.92 143.62 32.52 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 0.0 110.093 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -75.93 131.96 39.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.641 0.376 . . . . 0.0 110.068 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.38 139.48 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.525 0.73 . . . . 0.0 109.93 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.26 19.84 64.55 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.978 0.799 . . . . 0.0 112.9 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.89 129.29 2.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.959 0.904 . . . . 0.0 109.674 -172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.91 121.78 8.43 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.506 2.137 . . . . 0.0 110.668 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.58 -172.96 30.27 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.606 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.09 139.68 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 109.528 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.743 HH21 ' HB ' ' A' ' 117' ' ' THR . 45.9 ttt180 -111.86 139.86 46.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -154.27 152.58 30.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.251 0.62 . . . . 0.0 109.544 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 13.8 ptm180 -94.66 107.24 19.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -73.32 114.26 11.33 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.856 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.73 87.6 6.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.65 94.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.129 0.972 . . . . 0.0 109.042 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.594 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 4.1 ttpm? 51.75 58.07 5.86 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.996 0.918 . . . . 0.0 111.127 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 63.93 31.43 13.83 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.372 1.069 . . . . 0.0 113.072 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -83.68 50.1 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.69 . . . . 0.0 110.185 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.3 t -59.49 -21.96 60.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.941 0.897 . . . . 0.0 112.4 -170.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.4 m -85.81 -6.64 59.07 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.1 0.96 . . . . 0.0 112.245 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -156.36 48.2 0.47 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.885 0.874 . . . . 0.0 110.448 -177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p -75.94 136.97 40.05 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.329 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.52 135.57 35.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 70.9 m95 -74.7 161.96 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.241 0.616 . . . . 0.0 109.438 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 84.1 t -138.23 115.07 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.1 tp -93.2 98.5 11.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.067 0.854 . . . . 0.0 108.79 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -96.03 125.21 40.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -119.49 117.52 28.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.236 0.614 . . . . 0.0 109.887 172.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.49 -164.52 30.24 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 115.23 9.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.948 0.499 . . . . 0.0 109.694 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.42 130.24 65.99 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.856 0.862 . . . . 0.0 109.474 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.9 Cg_endo -61.46 144.91 98.38 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.38 2.054 . . . . 0.0 112.132 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.83 -27.44 67.55 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.237 1.015 . . . . 0.0 111.446 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 p -78.73 -14.53 59.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.509 1.124 . . . . 0.0 112.139 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.598 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.6 t80 -68.51 119.94 13.78 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -152.37 161.05 30.39 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.275 1.03 . . . . 0.0 108.716 -174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 57.0 Cg_endo -66.73 111.16 2.07 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.032 1.822 . . . . 0.0 110.845 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.63 -11.48 15.92 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.683 -0.509 . . . . 0.0 113.825 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.07 149.18 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 117.714 0.757 . . . . 0.0 110.002 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HB3' ' HZ2' ' A' ' 126' ' ' LYS . 45.2 mt-10 -83.18 140.96 32.27 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.11 168.46 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.063 0.945 . . . . 0.0 111.851 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.403 ' HB ' ' HG2' ' A' ' 124' ' ' MET . 71.5 mt -132.84 122.71 47.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 126.462 1.905 . . . . 0.0 106.202 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.6 139.56 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.689 0.795 . . . . 0.0 109.827 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.42 132.49 56.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.9 -143.09 7.09 Favored Glycine 0 N--CA 1.47 0.946 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.82 136.18 4.58 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 117.685 0.742 . . . . 0.0 112.662 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.2 tp -93.08 134.41 35.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.289 1.035 . . . . 0.0 108.919 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 115' ' ' GLU . . . -88.86 146.59 37.11 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.264 0.626 . . . . 0.0 110.309 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.49 120.25 7.36 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.878 2.385 . . . . 0.0 112.206 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.12 69.14 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.979 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG3' ' HB3' ' A' ' 112' ' ' ALA . 69.3 mm-40 -101.0 151.32 21.92 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.617 0.767 . . . . 0.0 110.13 172.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -106.55 16.45 24.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.925 0.89 . . . . 0.0 109.864 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.743 ' HB ' HH21 ' A' ' 74' ' ' ARG . 12.7 t -134.7 111.77 10.24 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.959 0.885 . . . . 0.0 109.846 -174.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -74.77 109.34 8.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.119 1.367 . . . . 0.0 108.37 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.572 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 9.6 mtmp? -77.79 98.74 5.65 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.29 163.53 26.33 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.629 0.771 . . . . 0.0 111.483 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -125.13 -36.47 2.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.091 1.356 . . . . 0.0 108.071 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -132.32 164.3 26.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.22 1.008 . . . . 0.0 109.778 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -156.71 117.94 3.76 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.488 1.115 . . . . 0.0 108.731 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.403 ' HG2' ' HB ' ' A' ' 106' ' ' ILE . 19.2 ptp -137.38 147.82 45.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -91.55 142.85 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.684 0.394 . . . . 0.0 110.235 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HZ2' ' HB3' ' A' ' 104' ' ' GLU . 49.2 mttp -68.74 -30.12 68.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.073 0.549 . . . . 0.0 110.092 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 43.8 t -84.46 107.52 11.38 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.858 0.863 . . . . 0.0 109.22 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.43 160.32 44.81 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.984 2.456 . . . . 0.0 111.47 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.88 123.28 18.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 CA--C 1.562 1.404 0 C-N-CA 123.916 0.887 . . . . 0.0 111.187 178.141 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.094 0.473 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.878 1.271 . . . . 0.0 107.883 170.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.4 m -80.52 114.93 51.58 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-N 117.985 0.357 . . . . 0.0 110.876 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.22 117.4 3.8 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.072 1.848 . . . . 0.0 109.99 166.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 71.6 112.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.707 1.203 . . . . 0.0 109.791 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.69 117.37 9.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.934 0.894 . . . . 0.0 108.818 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.08 -15.33 62.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.634 1.174 . . . . 0.0 112.288 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.06 30.9 6.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.6 0.76 . . . . 0.0 110.431 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -121.36 120.51 35.26 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 108.88 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 m -72.53 117.22 13.94 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.4 124.44 49.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -82.72 105.0 13.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.17 132.21 54.37 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -167.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.98 126.52 55.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.86 -178.96 35.3 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -117.18 142.93 46.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.338 0.655 . . . . 0.0 109.726 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.47 125.01 36.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.346 0.658 . . . . 0.0 110.428 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.13 136.29 38.6 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.14 66.64 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.66 0.6 . . . . 0.0 109.744 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.737 ' HB2' HH21 ' A' ' 76' ' ' ARG . 2.6 m-20 -83.78 133.05 34.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.543 177.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.25 78.86 Favored Glycine 0 N--CA 1.468 0.803 0 O-C-N 123.397 0.436 . . . . 0.0 113.217 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tt -76.67 103.79 6.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.6 m -121.05 127.36 51.63 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.778 1.231 . . . . 0.0 109.57 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 91.8 mmm -83.85 145.0 28.88 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.56 125.28 26.23 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.36 104.08 2.6 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.362 1.065 . . . . 0.0 110.552 -170.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.49 73.5 Favored Glycine 0 C--N 1.342 0.895 0 O-C-N 123.749 0.656 . . . . 0.0 112.784 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.7 132.35 13.02 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 123.917 0.887 . . . . 0.0 109.394 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.96 110.69 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.758 2.305 . . . . 0.0 111.051 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 -176.79 30.17 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.841 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.66 135.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 109.579 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.6 ttm180 -112.48 128.11 56.24 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.0 171.85 14.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -171.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.737 HH21 ' HB2' ' A' ' 62' ' ' ASP . 37.9 mtm180 -96.39 130.16 43.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 tp -103.13 117.05 33.69 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.672 0.789 . . . . 0.0 109.234 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -70.62 91.36 0.79 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 170.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.72 91.31 2.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.824 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.663 ' HB3' ' HZ1' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 51.76 81.7 0.07 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.759 1.223 . . . . 0.0 111.618 173.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 74.5 17.2 3.12 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.18 1.392 . . . . 0.0 114.355 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.11 123.97 18.71 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.41 0.55 . . . . 0.0 111.257 173.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -97.8 -28.11 14.01 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.343 1.057 . . . . 0.0 112.224 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.7 t -71.66 -38.84 70.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -92.87 94.77 9.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.527 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 76' ' ' ARG . 28.4 p -111.36 138.07 48.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.551 0.741 . . . . 0.0 109.798 174.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.15 136.42 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.18 127.2 31.73 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 99.3 t -111.94 117.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.429 0.692 . . . . 0.0 109.312 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.38 96.17 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -95.55 123.09 38.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.542 ' HZ1' ' HB2' ' A' ' 92' ' ' LYS . 9.8 mtmp? -115.69 112.6 22.31 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.689 0.796 . . . . 0.0 109.425 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.52 -173.43 34.94 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.96 111.77 5.19 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.264 0.626 . . . . 0.0 110.312 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 110.15 19.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.806 0.691 . . . . 0.0 109.497 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.52 ' HD2' HD23 ' A' ' 123' ' ' LEU . 74.5 Cg_endo -71.5 157.71 55.61 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.34 2.027 . . . . 0.0 112.147 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' HB2' HD22 ' A' ' 129' ' ' LEU . 10.3 m-20 -69.55 -12.27 61.51 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.609 0.764 . . . . 0.0 112.242 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -70.15 -22.68 62.96 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.248 0.619 . . . . 0.0 111.485 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -71.56 95.27 1.39 Allowed 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.51 145.77 38.17 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.72 100.54 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.624 2.216 . . . . 0.0 111.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.78 -8.54 7.7 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.222 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.93 148.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 118.352 1.076 . . . . 0.0 110.038 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.88 115.99 19.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 20.7 m -104.67 155.72 6.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 123.847 0.859 . . . . 0.0 111.253 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mt -117.09 107.63 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.47 141.32 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.1 0.56 . . . . 0.0 109.966 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.41 117.85 30.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 120' ' ' ALA . . . -172.09 -149.47 6.69 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 123.49 0.494 . . . . 0.0 112.265 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.16 145.46 10.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 117.165 0.483 . . . . 0.0 112.479 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.9 tp -88.92 105.36 17.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.46 139.31 41.37 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.058 0.543 . . . . 0.0 111.212 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.93 90.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 123.414 2.743 . . . . 0.0 112.62 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.99 -42.57 0.82 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -95.38 130.46 42.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.542 0.737 . . . . 0.0 110.644 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.77 -17.04 60.03 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.864 0.866 . . . . 0.0 110.523 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 t -86.64 133.2 33.72 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.152 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -77.04 109.86 11.21 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -86.12 94.18 9.2 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . . . -84.12 117.35 23.41 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.635 0.774 . . . . 0.0 111.108 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -61.92 -45.41 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.845 0.858 . . . . 0.0 111.035 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m -127.97 136.24 51.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.66 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.52 HD23 ' HD2' ' A' ' 96' ' ' PRO . 33.5 tp -112.99 123.74 51.01 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.6 mtm -132.73 171.01 14.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.226 1.01 . . . . 0.0 108.285 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 35.1 p -130.43 148.92 52.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.771 . . . . 0.0 110.075 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.77 -33.15 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.399 0.68 . . . . 0.0 109.999 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 50.2 t -117.52 101.12 52.73 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.892 0.877 . . . . 0.0 108.959 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.3 167.58 9.2 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.019 2.48 . . . . 0.0 112.524 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 97' ' ' ASP . 37.6 tp -57.3 101.23 0.06 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.146 0.979 . . . . 0.0 110.676 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.897 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -173.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.66 105.54 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -168.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.79 117.82 26.88 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD22 HD23 ' A' ' 77' ' ' LEU . 3.1 tt -123.62 142.9 50.6 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -121.76 141.25 51.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 0.0 109.302 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.26 -161.35 28.08 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.9 m -127.02 145.08 50.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.434 0.694 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.35 132.3 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.573 0.749 . . . . 0.0 109.972 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.86 156.56 17.41 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.444 0.698 . . . . 0.0 110.964 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.13 30.63 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.482 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -77.31 108.81 10.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.813 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.36 12.21 61.66 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.756 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.24 90.16 1.59 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -116.8 116.66 27.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.734 1.214 . . . . 0.0 109.877 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtt -89.98 161.81 15.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 90' ' ' LEU . 79.3 mt -66.94 119.14 11.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.663 0.385 . . . . 0.0 110.681 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.97 98.07 0.27 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.351 1.06 . . . . 0.0 110.724 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.75 22.84 68.44 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.462 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -143.26 149.14 47.25 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.729 0.812 . . . . 0.0 109.953 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.81 111.52 3.27 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.566 2.178 . . . . 0.0 112.076 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.29 179.33 31.23 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.986 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 11.1 p -149.28 134.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.807 0.843 . . . . 0.0 110.601 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -104.15 138.65 40.33 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.28 163.63 39.88 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -97.98 115.16 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.553 HD23 HD22 ' A' ' 55' ' ' LEU . 21.9 tp -79.66 108.87 13.54 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 86' ' ' THR . 58.0 mt-10 -78.01 110.36 12.88 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.298 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 124.339 1.056 . . . . 0.0 110.111 175.783 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 78' ' ' GLU . 35.2 p . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.45 129.57 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.41 98.21 8.11 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 107' ' ' ILE . 53.2 t -88.99 130.62 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.625 0.77 . . . . 0.0 109.986 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 HD21 ' A' ' 67' ' ' LEU . 37.0 tp -115.64 114.32 24.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.227 1.011 . . . . 0.0 108.939 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -112.86 128.87 56.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.086 1.354 . . . . 0.0 108.008 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 148.07 29.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.411 0.685 . . . . 0.0 109.433 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.78 -168.16 12.51 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.71 112.2 4.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.243 0.617 . . . . 0.0 110.582 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.11 117.13 68.18 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.029 0.932 . . . . 0.0 108.754 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 29.9 Cg_endo -59.44 151.3 69.62 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.693 2.262 . . . . 0.0 113.173 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -65.74 -25.12 67.14 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.728 0.811 . . . . 0.0 110.393 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.5 p -71.16 -23.87 62.14 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.992 1.317 . . . . 0.0 111.589 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.492 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.3 t80 -68.46 106.45 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -133.31 155.76 80.5 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.746 0.819 . . . . 0.0 109.101 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 110.3 2.17 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.523 2.148 . . . . 0.0 111.456 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.93 -11.71 9.37 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.044 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.2 t -81.55 124.41 38.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.456 0.702 . . . . 0.0 109.532 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.77 118.99 14.26 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 m -120.79 154.38 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.606 0.717 . . . . 0.0 111.785 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.55 115.14 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 89' ' ' VAL . 37.9 pt -100.91 162.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 33.5 tt0 -148.67 132.76 17.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.18 -117.54 0.69 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 179.76 146.27 6.79 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 117.453 0.626 . . . . 0.0 112.539 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.98 114.57 27.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.22 134.51 48.82 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 123.593 0.558 . . . . 0.0 110.111 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.7 104.43 0.16 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.871 2.381 . . . . 0.0 111.85 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.07 -29.86 5.42 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HE3' ' A' ' 119' ' ' LYS . 11.0 tp10 -91.29 132.64 36.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.4 -5.31 58.91 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.308 0.643 . . . . 0.0 112.284 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.45 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 40.2 p -114.64 137.46 51.87 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.323 0.511 . . . . 0.0 112.031 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.25 111.61 14.39 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HE3' ' HG2' ' A' ' 115' ' ' GLU . 93.9 mttt -82.29 93.65 7.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.34 108.32 14.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.73 0.812 . . . . 0.0 110.043 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -19.62 57.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.589 0.755 . . . . 0.0 111.548 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 22.4 p -138.63 157.14 46.7 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.054 0.941 . . . . 0.0 110.107 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 tp -138.6 140.88 39.14 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.984 1.314 . . . . 0.0 108.235 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.8 ttm -136.53 118.77 15.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.348 0.659 . . . . 0.0 109.587 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -100.4 145.11 28.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.748 0.819 . . . . 0.0 110.157 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.432 . . . . 0.0 111.122 -177.808 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.239 0.546 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.88 146.13 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -123.33 114.27 19.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.181 0.992 . . . . 0.0 109.043 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tt -114.15 126.15 54.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.93 135.7 39.28 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.76 -174.15 38.47 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -124.12 140.84 52.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.225 1.01 . . . . 0.0 109.002 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.1 123.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . . . -75.65 149.52 38.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.07 0.548 . . . . 0.0 111.265 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.53 27.35 1.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.822 0.849 . . . . 0.0 110.562 167.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -143.31 128.16 18.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.723 1.209 . . . . 0.0 107.869 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.76 6.76 88.17 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.694 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.87 85.4 2.82 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.3 m -107.45 111.88 24.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.277 1.431 . . . . 0.0 109.847 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtp -91.79 146.64 23.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.55 127.5 32.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.755 0.422 . . . . 0.0 111.677 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.51 118.43 18.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.123 0.969 . . . . 0.0 110.316 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.32 18.71 67.71 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 123.88 0.738 . . . . 0.0 114.068 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.52 12.36 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.579 0.752 . . . . 0.0 109.691 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.54 115.98 4.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.399 2.066 . . . . 0.0 111.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.58 -175.51 31.92 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.841 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.27 130.56 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 124.15 0.98 . . . . 0.0 110.399 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.469 HH12 HG21 ' A' ' 117' ' ' THR . 8.9 tpp180 -92.25 131.84 37.15 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 165.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.92 163.33 37.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.531 0.605 . . . . 0.0 109.611 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.12 106.5 17.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.29 115.77 14.18 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.765 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 86' ' ' THR . 48.3 mt-10 -73.1 99.35 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.474 0.765 0 C-N-CA 124.347 1.059 . . . . 0.0 108.65 175.054 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 78' ' ' GLU . 71.4 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.19 137.76 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -79.89 146.27 32.25 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.75 119.53 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.0 94.16 7.82 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -89.56 125.16 35.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -116.41 110.11 18.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.477 0.711 . . . . 0.0 109.416 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.01 -173.98 35.28 Favored Glycine 0 N--CA 1.469 0.89 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.942 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 108.57 1.96 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.626 0.77 . . . . 0.0 111.763 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -81.67 118.03 70.57 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.401 0.681 . . . . 0.0 109.789 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.21 163.93 29.79 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.59 2.193 . . . . 0.0 112.556 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.72 -22.1 66.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.44 0.696 . . . . 0.0 110.691 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 p -82.21 -13.8 56.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.134 0.974 . . . . 0.0 111.833 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.06 107.0 6.84 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.5 pttt -151.8 150.42 26.13 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.407 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.53 117.77 4.8 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.273 1.982 . . . . 0.0 111.243 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.35 11.64 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.044 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 100' ' ' LYS . 8.2 p -90.34 145.29 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 117.866 0.833 . . . . 0.0 110.283 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.04 131.63 39.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 151.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.805 0.812 . . . . 0.0 109.65 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.43 119.97 60.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.2 pt -107.94 137.37 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -114.28 145.98 41.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.24 -124.61 1.41 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.98 141.89 6.76 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 117.071 0.435 . . . . 0.0 112.657 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.8 tp -89.33 115.29 26.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.061 0.944 . . . . 0.0 108.592 173.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . . . -89.55 134.41 32.56 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.56 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' ALA . 21.9 Cg_exo -64.74 90.79 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.954 2.436 . . . . 0.0 111.986 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.73 -45.48 0.65 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 117' ' ' THR . 2.2 mp0 -91.84 116.36 28.84 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.054 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.04 -17.67 63.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.109 0.563 . . . . 0.0 110.617 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.469 HG21 HH12 ' A' ' 74' ' ' ARG . 8.8 t -78.18 134.21 37.67 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -75.46 109.26 8.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -82.5 94.7 7.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.39 126.62 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.333 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.025 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p -138.57 165.03 27.94 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.741 0.816 . . . . 0.0 110.281 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.3 tp -135.19 137.28 42.52 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.698 1.199 . . . . 0.0 109.051 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 ttp -136.84 117.3 13.74 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.5 p -81.74 142.91 32.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.067 0.947 . . . . 0.0 109.887 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.4 mmpt? . . . . . 0 N--CA 1.483 1.215 0 C-N-CA 122.388 0.275 . . . . 0.0 111.599 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.242 0.675 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.82 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -137.01 118.95 15.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.852 0.861 . . . . 0.0 109.609 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.74 145.71 46.3 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -117.26 142.42 47.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.754 0.822 . . . . 0.0 109.365 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.32 -165.65 36.2 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.295 0.372 . . . . 0.0 112.828 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.2 m -119.28 147.19 44.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.771 0.828 . . . . 0.0 109.565 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.9 126.14 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 110.275 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.65 156.38 16.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.318 0.647 . . . . 0.0 110.064 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.02 59.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.283 0.633 . . . . 0.0 110.98 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.23 110.89 6.99 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.853 0.861 . . . . 0.0 109.466 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.61 16.16 71.61 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.679 0.612 . . . . 0.0 113.337 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.05 105.52 3.36 Favored 'General case' 0 C--N 1.359 1.022 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -143.74 137.56 28.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.573 1.149 . . . . 0.0 108.281 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.03 144.29 29.2 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.51 135.33 52.87 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.469 0.308 . . . . 0.0 110.848 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -65.7 109.89 2.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.97 0.908 . . . . 0.0 111.024 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.45 24.79 67.99 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.719 0.637 . . . . 0.0 113.801 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.5 130.06 10.39 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.534 0.734 . . . . 0.0 109.681 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 117.04 3.72 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.585 2.19 . . . . 0.0 110.499 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.33 176.23 28.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.622 0.576 . . . . 0.0 111.945 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.31 143.83 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.483 0.658 . . . . 0.0 110.489 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -112.44 132.23 55.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -153.86 162.27 41.36 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.832 0.453 . . . . 0.0 110.175 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 39.6 ttp180 -95.88 111.07 23.15 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 107' ' ' ILE . 22.0 tp -79.13 120.58 23.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.032 0.533 . . . . 0.0 109.93 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.33 95.35 2.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.484 1.261 0 O-C-N 124.33 1.019 . . . . 0.0 112.079 -175.441 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 20.9 p . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.61 122.66 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.749 0.82 . . . . 0.0 110.667 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.6 m95 -77.41 106.69 9.33 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.5 t -88.69 109.89 20.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.4 tp -93.18 97.09 10.43 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.379 1.049 . . . . 0.0 108.234 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -102.57 126.09 49.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.183 0.993 . . . . 0.0 109.026 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -111.7 130.57 55.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.354 0.662 . . . . 0.0 109.265 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.95 -166.49 21.39 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 110.84 3.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.546 0.738 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.69 131.89 59.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 109.537 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.02 140.96 58.55 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.802 2.335 . . . . 0.0 112.793 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.03 -24.57 65.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.234 0.54 . . . . 0.0 110.31 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -73.74 -15.06 61.22 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.816 1.246 . . . . 0.0 112.378 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -69.48 134.52 49.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.685 0.794 . . . . 0.0 110.009 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 103' ' ' VAL . 20.0 pttm -168.98 161.01 8.07 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.81 1.244 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.56 107.89 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.904 1.736 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.05 -9.34 8.47 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.811 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 100' ' ' LYS . 10.5 p -84.86 138.43 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 118.11 0.955 . . . . 0.0 109.478 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.91 116.28 19.97 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG22 ' A' ' 125' ' ' THR . 22.2 m -113.33 153.26 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.54 0.686 . . . . 0.0 111.683 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.61 115.77 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.49 HD13 HD22 ' A' ' 77' ' ' LEU . 21.9 pt -100.39 139.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -148.71 142.88 26.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.21 -110.07 0.42 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.09 159.29 31.37 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 117.242 0.521 . . . . 0.0 112.445 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -123.85 143.02 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 0.0 108.813 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.76 147.09 54.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.26 0.624 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.61 72.59 4.34 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.079 2.519 . . . . 0.0 111.633 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.81 69.85 0.1 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 119' ' ' LYS . 10.1 tp10 -172.64 141.05 1.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.789 0.835 . . . . 0.0 110.021 -173.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -86.29 -40.46 15.49 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.604 0.762 . . . . 0.0 109.642 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 69.0 p -83.92 121.32 27.2 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.598 -169.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.05 132.61 36.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.095 0.558 . . . . 0.0 110.114 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 115' ' ' GLU . 3.2 mptp? -93.23 96.55 10.07 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.24 99.68 9.44 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.932 0.493 . . . . 0.0 111.023 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -57.1 -33.07 66.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.889 0.875 . . . . 0.0 110.619 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p -138.05 141.15 40.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.579 1.152 . . . . 0.0 109.084 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.97 118.91 19.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 ptm -129.81 147.6 51.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.385 0.674 . . . . 0.0 109.502 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 HG12 ' A' ' 105' ' ' VAL . 60.4 p -100.53 152.51 20.32 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.804 0.841 . . . . 0.0 109.957 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.479 0.712 . . . . 0.0 110.562 176.166 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.72 136.84 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.342 0.657 . . . . 0.0 109.492 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.69 133.88 52.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.833 0.853 . . . . 0.0 108.995 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.83 139.56 38.21 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -110.42 143.38 40.8 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.403 1.081 . . . . 0.0 108.668 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.94 -173.76 42.78 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 117.876 0.307 . . . . 0.0 112.615 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.6 m -112.3 134.13 54.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.719 0.808 . . . . 0.0 110.057 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.92 122.56 19.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.188 0.995 . . . . 0.0 110.447 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.95 146.94 25.97 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.25 -10.93 58.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.07 116.61 14.9 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.52 1.128 . . . . 0.0 109.995 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.66 9.91 82.75 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 123.682 0.614 . . . . 0.0 113.727 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 4.3 tt -72.61 111.14 7.5 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 p -132.1 130.69 41.55 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.277 1.431 . . . . 0.0 109.137 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.423 ' SD ' HG23 ' A' ' 73' ' ' VAL . 86.9 mmm -85.0 136.48 33.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.2 mt -63.84 111.52 2.5 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -71.09 110.21 5.63 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 110.57 -167.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.84 22.61 77.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.055 -0.52 . . . . 0.0 113.125 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.5 126.87 7.61 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.36 1.064 . . . . 0.0 108.937 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.68 109.4 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.324 2.016 . . . . 0.0 111.672 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 162.46 175.49 33.55 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 123.381 0.425 . . . . 0.0 112.181 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.423 HG23 ' SD ' ' A' ' 66' ' ' MET . 10.9 p -145.57 148.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.406 0.682 . . . . 0.0 110.451 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -123.72 137.57 54.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.136 . . . . 0.0 108.256 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.714 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 33.3 p90 -159.88 175.73 12.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.848 0.859 . . . . 0.0 108.893 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 35.1 ptt180 -111.76 135.23 52.64 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.476 HD22 HD13 ' A' ' 107' ' ' ILE . 24.9 tp -100.83 120.83 40.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.016 0.526 . . . . 0.0 109.939 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.35 97.95 7.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.198 0.599 . . . . 0.0 109.583 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.474 0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.164 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.55 123.16 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 80.7 m95 -68.1 138.95 56.15 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.96 109.39 28.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.7 tp -93.9 95.77 9.29 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -98.1 124.56 42.68 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.17 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -110.71 143.23 41.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.194 0.998 . . . . 0.0 108.746 170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.63 15.28 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.28 125.05 22.36 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.062 0.545 . . . . 0.0 110.986 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.29 128.88 74.17 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.615 0.766 . . . . 0.0 110.18 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 22.2 Cg_endo -59.47 138.39 83.68 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.642 2.228 . . . . 0.0 111.736 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -68.04 -27.55 66.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.245 0.618 . . . . 0.0 111.808 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 t -71.79 -16.6 62.19 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.922 0.489 . . . . 0.0 111.501 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 84.4 t80 -69.81 137.09 51.54 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 123.105 0.562 . . . . 0.0 109.736 174.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.431 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.2 pttt -164.12 156.0 14.39 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.044 0.938 . . . . 0.0 109.282 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HG3' HD13 ' A' ' 64' ' ' LEU . 29.3 Cg_exo -61.94 113.1 1.72 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.544 2.163 . . . . 0.0 111.129 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.23 -6.19 28.65 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.892 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 100' ' ' LYS . 8.7 p -83.96 150.89 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 118.189 0.995 . . . . 0.0 108.835 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 126' ' ' LYS . 46.9 mt-10 -77.16 145.12 37.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 17.0 m -136.14 154.92 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.224 1.01 . . . . 0.0 111.037 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.62 108.15 24.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 166.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.476 HD13 HD22 ' A' ' 77' ' ' LEU . 43.8 pt -96.73 142.29 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -147.26 139.6 24.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA2' ' HD2' ' A' ' 121' ' ' ARG . . . 163.93 -105.77 0.26 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -175.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.25 163.4 37.13 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.5 tp -134.56 131.45 37.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.24 147.13 33.7 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.328 0.651 . . . . 0.0 110.099 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.24 -37.82 80.91 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.266 2.644 . . . . 0.0 112.561 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.86 41.36 2.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.46 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -166.4 142.13 4.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.568 0.747 . . . . 0.0 110.545 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.86 -30.03 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.962 0.905 . . . . 0.0 110.796 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 t -90.21 134.3 34.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.164 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -75.58 127.16 32.47 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 108.549 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -83.97 105.32 14.76 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.39 112.39 19.88 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.422 ' HD2' ' HA2' ' A' ' 109' ' ' GLY . 6.5 ptm180 -68.49 -35.67 77.84 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 p -141.38 148.72 40.08 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.679 1.191 . . . . 0.0 109.094 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.9 tp -127.21 117.53 22.51 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.057 0.943 . . . . 0.0 108.493 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.7 ttp -131.45 145.98 52.04 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 82.5 p -91.07 163.36 14.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.166 0.508 . . . . 0.0 110.807 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 9.1 mtpm? . . . . . 0 CA--C 1.547 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 109.893 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.643 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 25.4 p . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 85.7 t -100.34 133.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.777 1.231 . . . . 0.0 108.688 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttt85 -96.59 107.74 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 77' ' ' LEU . 4.2 tt -116.66 141.0 48.77 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -120.75 143.6 48.7 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.946 0.898 . . . . 0.0 109.755 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.57 -162.06 27.51 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 7.6 m -131.31 140.28 49.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.005 0.922 . . . . 0.0 109.565 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.0 131.72 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.215 1.006 . . . . 0.0 111.555 -173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.561 ' HB3' ' HG3' ' A' ' 76' ' ' ARG . . . -94.56 154.39 17.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.226 0.611 . . . . 0.0 110.947 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 -36.66 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.584 0.753 . . . . 0.0 110.758 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -80.58 78.52 7.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.233 0.613 . . . . 0.0 109.881 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.8 0.82 2.48 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.022 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.494 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.7 tt -78.37 94.45 4.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 74' ' ' ARG . 86.5 m -103.07 110.63 22.63 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.688 1.195 . . . . 0.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.4 mmt -80.5 117.53 21.31 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.46 123.86 18.17 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 123.637 0.586 . . . . 0.0 111.223 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -71.61 99.89 2.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.983 0.913 . . . . 0.0 110.405 -171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.25 -36.92 2.89 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.563 -0.29 . . . . 0.0 112.995 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.74 131.41 87.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.344 0.657 . . . . 0.0 110.317 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.11 113.03 2.68 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.287 1.991 . . . . 0.0 111.059 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.02 -172.01 29.94 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.798 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.04 133.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.842 0.857 . . . . 0.0 110.179 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 4.8 tpp180 -92.73 141.94 27.91 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.27 174.86 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.581 0.752 . . . . 0.0 109.043 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.95 117.0 32.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.419 HD23 HD22 ' A' ' 55' ' ' LEU . 28.9 tp -80.15 109.77 14.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.834 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 60' ' ' ALA . 43.2 mt-10 -71.92 100.87 2.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.972 179.373 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.3 p . . . . . 0 C--O 1.244 0.782 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -99.99 115.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -77.86 130.72 36.99 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.31 117.58 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 123.532 0.733 . . . . 0.0 109.348 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.6 tp -99.86 92.11 5.14 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -86.04 124.22 32.24 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.57 123.1 49.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.307 0.643 . . . . 0.0 109.725 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.72 -174.98 22.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 114.95 8.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.156 0.582 . . . . 0.0 110.189 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.82 133.46 51.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.999 0.92 . . . . 0.0 109.678 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 123' ' ' LEU . 55.4 Cg_endo -67.83 150.81 78.84 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.485 2.124 . . . . 0.0 112.139 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.87 -21.61 64.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.88 0.472 . . . . 0.0 110.459 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.8 p -70.46 -19.4 62.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.233 1.013 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -69.55 105.98 2.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.537 0.735 . . . . 0.0 109.462 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 103' ' ' VAL . 37.1 mtmm -131.99 156.56 79.96 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.74 1.216 . . . . 0.0 109.853 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HG3' HD13 ' A' ' 64' ' ' LEU . 27.9 Cg_exo -63.02 103.51 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.713 2.275 . . . . 0.0 111.509 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.16 -3.36 18.8 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 119.202 -0.776 . . . . 0.0 113.579 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 100' ' ' LYS . 7.9 p -79.17 139.39 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 118.309 1.054 . . . . 0.0 109.777 174.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.8 mt-10 -71.36 138.87 49.56 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 125' ' ' THR . 35.0 m -135.01 152.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-O 121.707 0.765 . . . . 0.0 110.724 175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.66 109.72 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.6 pt -98.15 152.81 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 31.8 tt0 -152.25 132.54 13.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.6 -147.64 11.56 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.44 133.06 9.05 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 118.392 1.096 . . . . 0.0 114.267 -174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.38 124.75 52.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.905 1.282 . . . . 0.0 108.822 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.4 138.48 41.67 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.58 -33.82 93.16 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.03 2.487 . . . . 0.0 113.175 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.74 -11.36 82.97 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.27 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.06 141.98 34.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.011 0.925 . . . . 0.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -88.48 -33.65 17.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.248 0.619 . . . . 0.0 110.534 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -83.89 129.09 34.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -79.35 121.22 24.86 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 119' ' ' LYS . 3.4 ttpm? -89.34 97.26 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.93 125.31 28.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.933 0.493 . . . . 0.0 110.591 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -79.58 -38.13 34.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.512 1.125 . . . . 0.0 109.251 172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -133.06 133.81 43.5 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.409 1.084 . . . . 0.0 108.699 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.544 HD23 ' HD2' ' A' ' 96' ' ' PRO . 53.9 tp -117.89 108.99 15.99 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.6 ttm -102.82 125.21 49.47 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.5 p -82.25 123.49 29.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 124.289 1.035 . . . . 0.0 108.516 -175.581 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.24 0.569 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.2 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -97.79 108.2 20.87 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD22 HD23 ' A' ' 77' ' ' LEU . 4.0 tt -111.86 125.8 54.41 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -172.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.02 144.88 27.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.536 0.735 . . . . 0.0 109.123 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.79 -160.57 29.77 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.522 -0.371 . . . . 0.0 112.599 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 30.0 m -127.82 140.79 51.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.027 0.931 . . . . 0.0 109.676 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.94 133.27 31.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.36 43.55 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.484 0.49 . . . . 0.0 111.662 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.77 36.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.16 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.97 96.04 7.28 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.855 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.17 73.11 0.65 Allowed Glycine 0 N--CA 1.465 0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.138 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.6 tt -150.41 125.99 10.25 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.3 m -140.24 125.28 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.323 1.049 . . . . 0.0 109.332 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.1 mtp -96.91 162.64 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.136 0.574 . . . . 0.0 109.722 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.5 mt -86.48 105.86 17.08 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -63.71 114.88 4.27 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.915 0.886 . . . . 0.0 111.563 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.97 77.09 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.529 0.518 . . . . 0.0 113.624 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.94 142.23 44.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.38 1.072 . . . . 0.0 109.764 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.44 87.76 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.474 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 175.39 163.66 28.68 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.613 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 p -157.26 134.84 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.985 0.914 . . . . 0.0 110.115 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -103.89 137.29 42.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.196 0.998 . . . . 0.0 108.311 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 46.3 p90 -158.2 173.07 17.26 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -104.91 122.57 46.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 HD22 ' A' ' 55' ' ' LEU . 23.5 tp -83.86 116.19 22.63 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.78 118.93 24.76 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.485 1.319 0 C-N-CA 123.342 0.657 . . . . 0.0 112.486 -173.547 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.3 134.46 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -79.63 144.02 34.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.29 118.36 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.865 0.866 . . . . 0.0 108.746 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.34 93.23 7.14 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -85.37 113.31 21.58 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -111.16 122.94 49.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.45 172.53 18.43 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.88 113.5 1.89 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.251 0.526 . . . . 0.0 110.926 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.86 120.4 81.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.82 146.09 80.16 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.896 2.397 . . . . 0.0 113.713 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.87 -27.5 68.27 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.654 0.782 . . . . 0.0 109.835 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.7 p -78.87 -7.66 58.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.96 1.304 . . . . 0.0 112.278 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.7 t80 -75.66 140.61 42.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.805 0.442 . . . . 0.0 109.817 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 61.0 pttt -162.07 161.45 21.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.955 0.902 . . . . 0.0 109.709 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.8 100.34 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.102 1.868 . . . . 0.0 111.519 167.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.68 -8.57 8.77 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.131 -0.816 . . . . 0.0 114.25 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.512 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 14.5 p -71.46 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 118.54 1.17 . . . . 0.0 111.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 39.7 mt-10 -72.61 125.56 27.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 171.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 103' ' ' VAL . 27.9 m -128.16 155.61 39.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.898 0.856 . . . . 0.0 111.753 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 62.4 mt -114.75 107.93 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 123' ' ' LEU . 29.6 pt -97.82 155.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.89 138.19 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 121' ' ' ARG . . . 172.0 -127.04 1.35 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.755 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.37 153.0 24.45 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 117.043 0.421 . . . . 0.0 112.456 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 139.9 53.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.474 1.109 . . . . 0.0 108.727 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 136.0 45.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.51 109.69 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.204 . . . . 0.0 113.246 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.61 5.74 53.6 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.077 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.573 ' HG2' ' H ' ' A' ' 117' ' ' THR . 48.7 tt0 -96.53 153.09 18.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.596 0.759 . . . . 0.0 109.738 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.97 0.67 23.89 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.237 1.015 . . . . 0.0 111.213 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.573 ' H ' ' HG2' ' A' ' 115' ' ' GLU . 8.8 t -134.05 119.89 19.52 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.413 0.625 . . . . 0.0 110.453 -173.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -84.69 134.41 34.36 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.622 1.169 . . . . 0.0 110.25 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -95.14 111.31 23.16 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.71 116.68 28.76 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.42 ' HG3' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -79.03 -23.36 44.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.143 0.577 . . . . 0.0 110.886 173.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -137.71 152.18 48.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.878 0.871 . . . . 0.0 110.045 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 107' ' ' ILE . 23.1 tp -136.92 123.5 20.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.645 1.178 . . . . 0.0 108.233 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 41.5 ttm -119.87 95.11 4.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.728 0.411 . . . . 0.0 110.282 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.4 p -75.19 137.43 41.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.339 0.656 . . . . 0.0 110.455 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.906 . . . . 0.0 110.85 -173.585 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.72 143.89 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -138.34 136.23 36.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.512 0.725 . . . . 0.0 109.814 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.24 163.97 21.35 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.6 0.714 . . . . 0.0 110.549 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -138.44 132.29 31.13 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.801 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.33 -161.39 33.85 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 5.0 m -124.14 146.15 48.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.07 127.83 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.933 0.893 . . . . 0.0 110.277 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 140.07 43.8 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.309 0.644 . . . . 0.0 110.13 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.02 55.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.084 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.6 124.13 51.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.575 0.75 . . . . 0.0 109.406 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.17 -0.94 43.91 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.567 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.49 96.12 4.02 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.7 m -118.57 121.07 39.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.435 1.094 . . . . 0.0 109.904 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.5 mmt -84.36 136.07 34.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.99 127.95 34.45 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.628 0.58 . . . . 0.0 111.506 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.23 117.25 12.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.678 0.791 . . . . 0.0 110.09 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.83 33.1 84.18 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.456 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.33 136.63 8.77 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 110.102 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.76 109.69 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.332 2.021 . . . . 0.0 110.709 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.76 171.4 33.68 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.466 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -150.62 153.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.65 0.78 . . . . 0.0 110.062 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 47.4 ttp180 -124.66 142.25 51.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -159.45 172.95 16.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.283 0.633 . . . . 0.0 109.316 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 87.6 mtm-85 -101.58 113.08 25.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.62 111.95 9.25 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 86' ' ' THR . 36.7 mt-10 -72.36 110.44 6.78 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 123.003 0.521 . . . . 0.0 111.458 -175.645 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 78' ' ' GLU . 68.3 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.79 143.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -74.92 142.33 44.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 49.1 t -127.62 108.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.5 tp -93.26 92.97 7.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -91.37 116.59 28.96 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.235 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -108.35 114.3 28.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.93 170.97 23.31 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 113.0 3.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.778 0.431 . . . . 0.0 110.329 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.5 t -81.67 122.47 80.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 122.955 0.502 . . . . 0.0 110.126 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HD2' HD23 ' A' ' 123' ' ' LEU . 28.4 Cg_endo -60.74 148.49 91.68 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.761 2.307 . . . . 0.0 111.964 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.27 -16.3 61.92 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.417 0.687 . . . . 0.0 110.827 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.3 p -71.6 -23.69 61.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.149 0.98 . . . . 0.0 110.696 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' HA ' HG11 ' A' ' 103' ' ' VAL . 70.4 t80 -71.94 134.75 46.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.831 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -171.36 161.3 5.18 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.8 0.84 . . . . 0.0 109.435 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.1 105.68 0.41 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.276 1.984 . . . . 0.0 111.89 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.78 -10.8 11.17 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.754 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 99' ' ' PHE . 9.6 p -74.55 145.16 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.782 0.791 . . . . 0.0 109.654 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.3 mt-10 -84.32 138.67 32.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.69 155.32 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.036 0.922 . . . . 0.0 111.305 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.6 mt -115.17 108.51 25.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 18.4 pt -100.87 132.6 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.419 0.688 . . . . 0.0 109.859 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -127.97 130.81 49.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.57 -108.01 0.27 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.17 142.63 5.86 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.715 0.757 . . . . 0.0 113.222 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.4 tp -93.87 126.4 39.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.903 0.881 . . . . 0.0 109.112 171.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . . . -83.25 138.33 42.19 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 123.436 0.46 . . . . 0.0 109.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.89 -17.68 60.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.887 2.392 . . . . 0.0 113.726 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.68 -10.67 18.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.504 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 28.3 tt0 -117.07 120.98 40.0 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.13 -20.94 63.15 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.562 0.745 . . . . 0.0 112.709 -168.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -88.37 135.62 33.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.42 113.79 14.4 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 26.9 ttmt -85.7 94.57 9.13 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.66 123.05 27.29 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.52 0.728 . . . . 0.0 109.849 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -80.32 -41.22 25.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.255 0.622 . . . . 0.0 109.639 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.7 p -131.53 136.13 47.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.485 1.114 . . . . 0.0 108.843 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 96' ' ' PRO . 59.6 tp -113.11 133.9 54.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.412 1.085 . . . . 0.0 108.632 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.9 ttp -136.29 103.05 5.17 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.786 0.434 . . . . 0.0 110.106 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.4 p -72.56 140.78 48.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.396 0.678 . . . . 0.0 110.012 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 123.594 0.758 . . . . 0.0 110.797 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 134.19 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.489 HH21 HD13 ' A' ' 106' ' ' ILE . 55.3 ttt180 -122.26 119.71 31.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.513 0.725 . . . . 0.0 109.219 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.43 161.2 20.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.585 0.754 . . . . 0.0 109.912 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -135.43 136.99 41.8 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.938 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 79' ' ' ASP . . . 176.52 -162.8 31.59 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.028 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -122.31 139.21 54.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.006 0.922 . . . . 0.0 109.749 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.64 130.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.618 1.167 . . . . 0.0 110.631 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.98 139.79 38.14 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.922 0.489 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -72.92 -40.44 65.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.311 0.644 . . . . 0.0 110.092 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.35 115.51 19.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.715 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 42.85 5.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.471 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 101' ' ' PRO . 6.7 tt -111.85 99.46 8.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -109.79 116.66 32.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.301 1.04 . . . . 0.0 109.711 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.51 ' HG2' HG23 ' A' ' 73' ' ' VAL . 66.5 mtp -89.48 132.6 34.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.495 HD12 ' HA3' ' A' ' 72' ' ' GLY . 76.6 mt -63.39 126.48 27.61 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.658 0.598 . . . . 0.0 111.013 -172.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.63 132.22 33.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.914 0.885 . . . . 0.0 109.762 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.75 68.46 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.472 0.482 . . . . 0.0 113.661 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 138.47 10.15 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.07 0.948 . . . . 0.0 109.149 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 112.73 2.8 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.469 2.113 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 167.25 175.14 37.01 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 121.387 0.437 . . . . 0.0 113.402 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 95' ' ' VAL . 8.1 p -146.91 161.3 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.949 0.9 . . . . 0.0 109.486 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -137.66 136.01 37.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -152.67 161.66 42.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.174 0.59 . . . . 0.0 109.758 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.62 104.98 17.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 tp -73.52 132.39 42.82 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.22 100.7 6.65 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 O-C-N 124.097 0.873 . . . . 0.0 111.84 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.66 139.91 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.328 1.051 . . . . 0.0 109.647 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.05 133.1 33.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 168.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.91 120.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -103.81 112.22 25.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -107.98 121.55 45.02 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.857 0.863 . . . . 0.0 108.915 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -103.53 117.72 35.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.654 0.782 . . . . 0.0 109.165 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.47 176.59 17.65 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.0 115.67 5.14 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.665 0.386 . . . . 0.0 110.043 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 73' ' ' VAL . 43.2 t -80.11 127.45 76.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.454 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD2' HD23 ' A' ' 123' ' ' LEU . 93.2 Cg_exo -47.22 138.89 16.66 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.495 2.797 . . . . 0.0 112.769 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.01 -24.13 65.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.39 0.676 . . . . 0.0 111.358 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -75.45 -13.23 60.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.959 0.904 . . . . 0.0 111.883 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -72.72 135.83 45.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.3 pttt -156.6 163.42 25.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.195 0.998 . . . . 0.0 108.741 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 28.9 Cg_exo -64.08 111.86 1.7 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.42 2.08 . . . . 0.0 111.41 168.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.49 0.57 37.43 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.727 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 7.4 p -77.87 149.55 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.847 0.824 . . . . 0.0 110.067 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.41 134.8 35.24 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 103' ' ' VAL . 18.6 m -129.89 161.74 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.971 0.908 . . . . 0.0 111.65 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.489 HD13 HH21 ' A' ' 54' ' ' ARG . 62.8 mt -119.11 111.7 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 113.452 -1.704 . . . . 0.0 107.016 168.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 118' ' ' PHE . 29.4 pt -100.37 142.1 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.451 0.7 . . . . 0.0 109.27 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 8.0 tp10 -139.48 124.99 19.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.59 -106.08 0.23 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.55 143.29 5.16 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 117.787 0.793 . . . . 0.0 112.616 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.2 tp -90.7 116.29 28.45 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.64 126.93 72.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.163 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.66 95.28 0.11 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.845 2.363 . . . . 0.0 111.786 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.56 -41.04 1.27 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.63 135.29 33.57 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.949 0.899 . . . . 0.0 109.985 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.81 -26.86 57.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.132 0.573 . . . . 0.0 110.043 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -84.46 136.04 34.0 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.129 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 107' ' ' ILE . 36.6 t80 -77.6 119.55 21.32 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.27 96.68 10.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.91 115.83 17.04 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.432 0.693 . . . . 0.0 110.044 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -79.45 -41.43 27.58 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.056 0.942 . . . . 0.0 109.631 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 75.0 p -132.28 140.88 48.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.39 1.076 . . . . 0.0 108.18 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.405 HD23 ' HD2' ' A' ' 96' ' ' PRO . 46.9 tp -127.29 143.38 51.24 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.946 0.499 . . . . 0.0 110.056 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.8 ttp -153.64 148.26 26.26 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 56.9 p -83.11 152.9 25.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 109.516 175.969 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.76 106.02 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.613 ' NH1' HG22 ' A' ' 106' ' ' ILE . 22.5 tpp180 -89.67 127.91 35.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 tt -132.82 130.35 39.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.45 139.0 43.82 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.96 -168.62 36.48 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 143.29 50.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.172 0.589 . . . . 0.0 110.604 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.23 119.59 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' HH21 ' A' ' 76' ' ' ARG . . . -69.89 142.85 52.93 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.664 0.602 . . . . 0.0 110.122 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.2 84.42 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.01 117.72 21.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.126 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.64 64.45 1.06 Allowed Glycine 0 C--N 1.339 0.702 0 O-C-N 123.444 0.465 . . . . 0.0 112.199 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tt -133.33 101.82 5.32 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -111.85 116.95 31.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.684 0.793 . . . . 0.0 110.342 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mmm -85.13 145.07 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.438 0.695 . . . . 0.0 109.959 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.475 HD12 ' HA3' ' A' ' 72' ' ' GLY . 86.6 mt -85.34 126.53 33.82 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.1 140.54 35.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.38 3.4 89.98 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 123.48 0.487 . . . . 0.0 113.433 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.4 140.3 4.13 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.103 0.961 . . . . 0.0 110.093 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.61 113.37 2.7 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.203 . . . . 0.0 111.734 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 171.45 173.11 38.16 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.394 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.75 138.15 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.331 1.053 . . . . 0.0 110.223 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 16.3 ttm180 -108.0 137.08 46.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 165.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.04 154.27 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.482 HH21 ' HB1' ' A' ' 60' ' ' ALA . 18.6 ttp180 -92.84 96.88 10.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 tp -78.41 138.32 38.44 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.483 0.713 . . . . 0.0 110.225 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.607 ' HG2' HG22 ' A' ' 86' ' ' THR . 31.3 mt-10 -102.96 113.16 26.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 N--CA 1.482 1.167 0 O-C-N 123.81 0.694 . . . . 0.0 109.631 178.087 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.607 HG22 ' HG2' ' A' ' 78' ' ' GLU . 40.9 p . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.5 t -102.85 141.74 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.117 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -79.27 136.63 37.1 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 91.5 t -123.39 118.43 54.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.83 92.28 7.85 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -94.59 116.0 28.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -112.46 144.27 42.19 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.05 -172.31 19.13 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.97 111.38 3.3 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.307 0.643 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.67 123.47 84.03 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.519 0.727 . . . . 0.0 109.09 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.98 145.71 68.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.173 1.915 . . . . 0.0 111.389 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.77 -16.79 64.5 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.591 0.756 . . . . 0.0 111.356 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.3 p -76.45 -19.9 57.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.42 1.088 . . . . 0.0 112.144 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -68.37 126.66 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.223 0.609 . . . . 0.0 109.542 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 103' ' ' VAL . 17.1 ptmt -156.06 165.82 17.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.191 0.596 . . . . 0.0 110.958 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.86 113.01 3.41 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.864 1.709 . . . . 0.0 110.955 170.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.08 -8.01 16.41 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.353 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 105' ' ' VAL . 12.7 p -83.02 142.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 117.425 0.612 . . . . 0.0 111.787 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.84 111.18 9.78 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 103' ' ' VAL . 27.7 m -105.7 153.6 7.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.792 0.805 . . . . 0.0 110.53 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.613 HG22 ' NH1' ' A' ' 54' ' ' ARG . 49.4 mt -122.18 105.59 16.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.2 pt -101.45 154.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.328 0.651 . . . . 0.0 110.246 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.2 tt0 -140.56 123.24 16.23 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 173.56 -121.18 0.84 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.77 166.71 39.9 Favored Glycine 0 C--O 1.241 0.556 0 CA-C-N 117.446 0.623 . . . . 0.0 112.441 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.6 tp -138.3 134.42 34.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.53 129.6 50.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 88.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.922 2.415 . . . . 0.0 111.91 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.65 -36.72 1.42 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -171.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.96 147.95 48.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.762 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.47 -45.02 11.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.728 0.811 . . . . 0.0 111.457 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -109.43 131.87 54.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.12 0.486 . . . . 0.0 111.002 -165.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.75 115.09 16.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.77 96.22 8.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.34 112.07 19.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.902 0.881 . . . . 0.0 110.156 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -60.16 -40.85 91.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.397 1.079 . . . . 0.0 110.399 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 1.7 m -135.41 149.31 49.59 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.885 -167.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.5 tp -137.21 140.33 41.64 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.259 1.024 . . . . 0.0 108.81 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 ttp -152.77 111.97 3.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 109.664 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 105' ' ' VAL . 54.3 p -73.21 124.27 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -97.97 112.7 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -104.68 116.99 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.89 142.68 36.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -119.1 147.87 43.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.72 -170.3 43.4 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.7 m -116.37 140.65 49.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.271 1.028 . . . . 0.0 109.083 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -76.98 126.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.38 0.672 . . . . 0.0 110.238 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.62 150.56 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.394 0.678 . . . . 0.0 111.043 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.66 -31.69 41.49 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.358 0.599 . . . . 0.0 109.671 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.35 100.11 12.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.435 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.55 71.11 0.97 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 tt -144.82 104.59 4.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.1 m -125.17 119.04 27.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.894 1.278 . . . . 0.0 109.233 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.7 mtp -89.9 142.93 27.23 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.88 122.41 17.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 110.478 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.35 123.21 28.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.375 0.67 . . . . 0.0 109.879 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.37 72.21 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 123.607 0.567 . . . . 0.0 112.988 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.23 144.18 16.84 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.049 0.939 . . . . 0.0 109.33 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.88 117.29 4.87 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.262 1.975 . . . . 0.0 110.844 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.48 -175.04 30.5 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.287 174.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.44 132.17 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.319 1.048 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -92.98 131.25 38.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.1 159.63 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.233 0.54 . . . . 0.0 110.885 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -95.59 112.06 23.86 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.289 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.43 117.57 30.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.453 0.701 . . . . 0.0 109.88 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.45 107.9 18.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.241 1.016 . . . . 0.0 109.789 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.21 -1.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.737 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.87 137.15 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.63 144.94 29.95 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.4 t -132.38 121.91 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.87 94.01 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -83.38 118.42 23.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -109.1 111.02 22.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.09 174.22 28.51 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.79 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.27 115.04 5.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.967 0.507 . . . . 0.0 110.161 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -81.25 113.95 45.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.063 0.545 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 123' ' ' LEU . 56.2 Cg_endo -67.28 151.76 80.33 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.443 2.096 . . . . 0.0 111.611 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.01 -16.94 64.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.519 1.127 . . . . 0.0 112.199 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 96' ' ' PRO . 12.2 t -70.55 -24.25 62.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.91 0.884 . . . . 0.0 111.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -68.04 121.6 16.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.752 0.821 . . . . 0.0 109.289 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 103' ' ' VAL . 23.6 pttm -165.62 157.54 12.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.431 0.693 . . . . 0.0 110.077 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.22 117.25 3.93 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.178 1.919 . . . . 0.0 111.758 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.49 -17.51 10.32 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.326 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 100' ' ' LYS . 6.0 p -95.06 147.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.863 0.831 . . . . 0.0 110.045 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -85.97 130.37 34.56 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 HG22 ' A' ' 125' ' ' THR . 27.6 m -111.03 155.55 12.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.857 0.837 . . . . 0.0 110.784 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.78 121.07 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.48 129.71 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.155 0.582 . . . . 0.0 110.503 -171.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.37 151.2 25.82 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.19 -119.63 0.89 Allowed Glycine 0 C--O 1.24 0.53 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.4 163.57 29.58 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.731 0.312 . . . . 0.0 112.606 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.0 tp -130.35 118.61 21.51 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 133.81 44.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.74 -24.3 41.05 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.679 2.253 . . . . 0.0 113.046 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.14 -18.1 78.85 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.558 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -108.61 156.61 19.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.141 0.977 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -109.61 26.39 10.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.715 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -133.96 121.22 21.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.353 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.29 130.59 35.61 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 108.945 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.78 117.2 31.55 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.699 0.682 . . . . 0.0 109.186 174.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.76 128.69 55.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.94 0.896 . . . . 0.0 109.974 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -98.82 -8.87 25.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.8 0.44 . . . . 0.0 110.171 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -134.81 152.16 51.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.718 1.207 . . . . 0.0 109.637 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 96' ' ' PRO . 37.3 tp -150.79 109.88 3.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.126 0.97 . . . . 0.0 108.385 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -135.93 114.03 11.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.648 0.779 . . . . 0.0 109.673 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.455 HG22 HG12 ' A' ' 105' ' ' VAL . 77.3 p -78.12 151.25 33.44 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.532 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 120.709 0.29 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -105.87 133.09 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -118.97 127.08 53.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.342 0.657 . . . . 0.0 109.505 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.6 mt -125.86 172.37 9.93 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.903 0.881 . . . . 0.0 109.785 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.26 147.89 49.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.776 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -170.74 42.15 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.6 m -121.54 144.34 48.78 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.37 115.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.34 0.656 . . . . 0.0 110.5 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.56 148.16 31.85 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.54 -5.66 46.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.648 0.779 . . . . 0.0 111.231 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.86 129.79 36.18 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.389 1.076 . . . . 0.0 110.05 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.31 15.69 78.85 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.266 0.354 . . . . 0.0 113.889 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.49 89.56 3.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -111.81 124.85 53.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.523 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.1 mmm -80.78 139.7 35.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.7 mt -67.53 133.26 49.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.3 0.5 . . . . 0.0 110.915 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -86.76 118.49 26.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.372 0.669 . . . . 0.0 109.857 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.54 5.0 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.486 0.491 . . . . 0.0 112.282 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.26 139.9 75.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.074 0.55 . . . . 0.0 110.108 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.64 135.79 24.59 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 121.986 1.791 . . . . 0.0 111.929 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.87 -168.58 26.4 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.631 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.18 132.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.381 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 79.3 ttt180 -102.6 138.17 39.86 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 170.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -158.13 168.21 27.71 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.919 0.488 . . . . 0.0 110.492 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -93.4 124.59 37.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 107' ' ' ILE . 21.0 tp -105.26 125.76 51.34 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.423 0.689 . . . . 0.0 109.351 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.4 97.43 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t0 . . . . . 0 N--CA 1.476 0.866 0 O-C-N 124.101 0.875 . . . . 0.0 111.487 -173.368 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 19.6 p . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.69 134.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -73.77 126.24 29.92 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 86.8 t -107.57 106.25 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 tp -91.54 92.01 8.31 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -83.5 150.21 26.14 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.414 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 92' ' ' LYS . 6.7 mtmp? -137.81 122.52 18.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.724 1.21 . . . . 0.0 108.71 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 121.46 -169.01 14.41 Favored Glycine 0 C--O 1.245 0.815 0 C-N-CA 123.464 0.554 . . . . 0.0 111.774 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 116.45 7.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.272 0.629 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.11 127.83 78.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.85 0.86 . . . . 0.0 109.958 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' PHE . 19.3 Cg_endo -58.41 132.83 50.97 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.036 1.824 . . . . 0.0 110.856 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.82 -26.36 68.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.109 0.564 . . . . 0.0 111.08 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 p -72.85 -13.27 61.25 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.118 0.967 . . . . 0.0 112.122 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' PRO . 63.0 t80 -64.32 121.22 13.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.926 0.89 . . . . 0.0 109.055 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -155.04 156.15 30.92 Favored Pre-proline 0 C--O 1.244 0.787 0 C-N-CA 124.002 0.921 . . . . 0.0 109.069 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.08 99.87 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.971 1.781 . . . . 0.0 110.464 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.55 -2.22 6.52 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.985 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -94.35 141.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 118.707 1.253 . . . . 0.0 110.414 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.56 117.38 15.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 125' ' ' THR . 18.0 m -110.25 150.23 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.722 0.773 . . . . 0.0 111.183 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.53 HD12 ' SD ' ' A' ' 124' ' ' MET . 47.6 mt -105.51 111.95 36.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.552 HD13 HD22 ' A' ' 77' ' ' LEU . 28.8 pt -98.27 140.91 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.8 133.1 23.19 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 162.44 -102.7 0.21 Allowed Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.93 147.25 5.25 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 117.482 0.641 . . . . 0.0 112.254 170.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -104.0 149.21 25.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.955 0.902 . . . . 0.0 109.584 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.71 151.41 46.22 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.723 0.809 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.44 -42.66 65.87 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.418 2.745 . . . . 0.0 113.682 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.48 29.55 8.25 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.031 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.15 128.62 40.44 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 0.0 110.266 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 -4.05 53.93 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -133.78 139.18 46.16 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -72.97 119.82 17.74 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 24.8 ttpt -70.26 96.23 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 89' ' ' VAL . . . -86.39 102.34 13.94 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.348 0.594 . . . . 0.0 109.524 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -62.98 -41.49 99.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.66 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -135.57 143.4 45.64 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.539 -169.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 tp -136.25 125.13 24.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' HD12 ' A' ' 106' ' ' ILE . 31.9 ttm -121.47 151.42 40.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 HG12 ' A' ' 105' ' ' VAL . 72.5 p -108.6 145.43 34.9 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.773 0.32 . . . . 0.0 110.297 178.739 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.238 0.473 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.23 117.33 44.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -116.17 116.53 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -103.18 152.69 21.17 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.883 0.849 . . . . 0.0 109.897 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -128.0 121.4 29.71 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.3 -178.52 41.81 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -117.76 144.67 45.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.67 121.48 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.709 0.803 . . . . 0.0 110.528 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.6 149.63 40.0 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.074 0.55 . . . . 0.0 111.06 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.88 -32.91 40.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.456 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.53 102.76 14.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 20.68 10.93 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.97 117.62 30.45 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -147.58 137.14 22.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.89 0.876 . . . . 0.0 108.892 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 26.4 mmt -81.29 145.46 30.89 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -72.78 158.6 35.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.866 0.466 . . . . 0.0 112.201 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -115.01 155.96 26.0 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.267 1.027 . . . . 0.0 108.902 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.59 -2.97 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 116.369 -0.378 . . . . 0.0 113.984 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.96 147.96 1.34 Allowed Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.724 1.21 . . . . 0.0 108.625 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.69 148.41 77.7 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.154 1.903 . . . . 0.0 111.421 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.38 -171.8 25.64 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.37 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.9 129.56 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.121 0.968 . . . . 0.0 109.118 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 45.1 ttp180 -95.14 124.72 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.3 156.05 45.9 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -90.37 100.18 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 107' ' ' ILE . 12.0 tp -72.54 106.75 4.73 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.417 0.687 . . . . 0.0 109.711 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.53 102.43 11.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.966 0.906 . . . . 0.0 111.602 -174.378 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.67 148.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.13 0.972 . . . . 0.0 109.096 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -83.46 145.23 29.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 82.7 t -129.96 121.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.18 0.592 . . . . 0.0 109.493 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.3 91.25 7.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.396 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -94.31 115.13 27.31 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -105.58 122.92 47.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.97 -162.63 28.35 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.472 0.482 . . . . 0.0 111.95 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.17 111.91 12.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.696 0.798 . . . . 0.0 110.815 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.66 117.12 66.45 Favored Pre-proline 0 N--CA 1.475 0.776 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.46 161.56 43.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.018 1.812 . . . . 0.0 112.591 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.32 -24.77 62.19 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.083 0.953 . . . . 0.0 110.555 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.8 p -70.79 -21.79 62.44 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.357 1.063 . . . . 0.0 111.642 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.504 ' HA ' HG11 ' A' ' 103' ' ' VAL . 54.0 t80 -71.66 121.56 19.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.568 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.6 pttt -145.74 159.81 46.15 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.486 1.115 . . . . 0.0 108.932 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.33 96.8 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.513 2.142 . . . . 0.0 111.887 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.7 1.35 10.83 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.277 -0.735 . . . . 0.0 113.956 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 8.4 p -75.49 141.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.026 0.913 . . . . 0.0 111.415 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.84 136.26 40.19 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.39 160.86 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.761 0.791 . . . . 0.0 112.598 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.441 HD11 ' HD3' ' A' ' 126' ' ' LYS . 60.7 mt -126.79 107.99 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.46 1.904 . . . . 0.0 105.902 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 77' ' ' LEU . 19.7 pt -111.51 146.68 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.341 0.656 . . . . 0.0 109.422 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -140.66 143.07 34.93 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.99 -122.12 0.99 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.87 140.21 6.64 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 117.409 0.604 . . . . 0.0 112.131 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.92 131.86 53.52 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.772 0.829 . . . . 0.0 109.227 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -84.99 133.51 43.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.69 -31.45 92.04 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.444 2.762 . . . . 0.0 114.093 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.58 80.1 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.648 0.593 . . . . 0.0 113.483 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 36.3 mt-10 -112.85 162.31 15.95 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.837 0.827 . . . . 0.0 113.004 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.17 -43.77 9.16 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.722 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -90.84 129.1 36.92 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.836 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -77.97 123.96 27.43 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.98 0.912 . . . . 0.0 109.268 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.87 100.8 13.45 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.45 105.67 15.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.438 0.695 . . . . 0.0 109.65 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -70.62 -23.94 62.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.918 0.487 . . . . 0.0 110.346 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.8 p -137.23 152.65 50.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.21 1.004 . . . . 0.0 109.489 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -139.37 136.24 34.55 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 24.3 ttm -136.61 104.8 5.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.031 0.933 . . . . 0.0 108.735 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -70.47 122.75 20.26 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HD3' HD11 ' A' ' 106' ' ' ILE . 56.1 tptt . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 123.932 0.893 . . . . 0.0 109.466 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.12 110.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -109.58 114.19 27.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -111.36 138.0 48.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -112.44 145.29 40.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.93 -159.41 28.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 118.19 0.45 . . . . 0.0 112.763 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -131.67 145.68 51.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.92 0.888 . . . . 0.0 110.28 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.72 119.04 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.224 1.01 . . . . 0.0 110.464 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.98 143.41 47.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.765 0.826 . . . . 0.0 110.185 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.62 -41.05 47.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.533 0.733 . . . . 0.0 110.333 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.84 102.64 10.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.086 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 76' ' ' ARG . . . 104.29 42.95 1.81 Allowed Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.795 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.64 125.47 51.82 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -143.67 144.48 31.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.746 1.218 . . . . 0.0 109.668 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 71.9 mmm -81.29 149.46 28.95 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 mt -66.66 150.18 49.43 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.55 104.96 15.0 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.913 0.885 . . . . 0.0 110.334 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.19 33.92 88.53 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.635 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.51 146.86 20.28 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.44 0.696 . . . . 0.0 110.288 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.44 130.83 16.67 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.351 2.034 . . . . 0.0 110.275 170.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.62 -169.19 23.92 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 116.681 -0.236 . . . . 0.0 112.515 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.65 130.59 3.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 34.3 ttm180 -94.61 129.86 41.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.43 162.31 41.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.422 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 73.4 mtp180 -95.46 124.44 39.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.5 tp -99.76 116.51 32.01 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 109.517 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -79.38 116.89 19.88 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.412 1.085 . . . . 0.0 108.467 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.585 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.6 p . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.69 141.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.81 154.58 41.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 55.9 t -137.3 118.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 92' ' ' LYS . 59.9 tp -93.01 92.67 7.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 108.77 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -90.91 123.41 34.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 90' ' ' LEU . 98.9 mttt -107.53 129.78 54.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 167.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.51 -165.98 26.27 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.452 0.47 . . . . 0.0 112.072 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.01 118.75 13.24 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.581 0.752 . . . . 0.0 111.224 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.15 115.85 63.54 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.013 0.925 . . . . 0.0 109.232 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.87 157.62 47.22 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.061 2.507 . . . . 0.0 114.19 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.49 -27.63 66.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.935 0.894 . . . . 0.0 110.326 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 t -80.58 -14.78 57.91 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 123' ' ' LEU . 68.5 t80 -78.14 114.05 16.66 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -146.48 154.92 49.43 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.174 0.989 . . . . 0.0 109.121 177.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.39 102.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.691 2.261 . . . . 0.0 112.414 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.57 -10.19 5.81 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.372 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 99' ' ' PHE . 13.6 p -78.1 136.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 117.662 0.731 . . . . 0.0 110.699 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -76.09 122.57 24.46 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.83 155.15 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.971 0.891 . . . . 0.0 111.226 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 61.3 mt -114.34 109.4 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.1 pt -97.19 153.76 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 38.5 tt0 -145.76 134.93 22.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.69 -114.6 0.59 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.53 166.2 39.42 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.96 123.02 42.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.07 0.948 . . . . 0.0 108.961 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.39 132.35 33.95 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.306 0.642 . . . . 0.0 109.785 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.49 89.34 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.095 2.53 . . . . 0.0 111.611 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.11 -39.65 0.52 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.57 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.95 129.37 35.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.395 0.678 . . . . 0.0 109.197 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.52 -16.29 61.28 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.085 168.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -95.23 126.5 40.59 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 111.871 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -76.48 114.88 15.69 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.013 1.325 . . . . 0.0 109.176 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -74.69 91.42 2.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.08 113.51 25.49 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.861 0.864 . . . . 0.0 110.472 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.441 ' HG3' ' OG1' ' A' ' 122' ' ' THR . 25.6 ptt180 -74.66 -26.82 60.12 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.903 0.481 . . . . 0.0 110.006 172.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 17.8 m -126.67 145.9 50.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.745 0.818 . . . . 0.0 109.175 -169.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 99' ' ' PHE . 47.2 tp -137.04 132.95 34.93 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.615 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 38.8 ttm -134.55 96.56 3.6 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.4 p -72.18 121.87 20.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.716 0.806 . . . . 0.0 109.792 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 0.0 111.388 -173.443 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.65 108.26 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -170.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -101.13 109.9 21.85 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.12 136.51 53.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -108.92 131.62 54.85 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.8 -174.26 32.49 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.4 m -128.28 139.4 52.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.144 0.978 . . . . 0.0 108.841 173.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.06 120.13 28.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.918 0.887 . . . . 0.0 108.983 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.29 57.58 Favored 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.694 0.621 . . . . 0.0 110.333 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.67 -18.64 59.57 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.667 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.55 109.19 21.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.975 . . . . 0.0 108.944 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.94 64.85 0.91 Allowed Glycine 0 C--N 1.346 1.096 0 O-C-N 123.146 0.279 . . . . 0.0 112.486 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -136.0 124.49 23.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 84.7 m -147.25 138.79 24.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.479 0.712 . . . . 0.0 110.128 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 80.1 mmm -82.7 153.29 25.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.341 0.657 . . . . 0.0 109.319 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.96 138.44 48.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.438 0.295 . . . . 0.0 111.008 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.82 112.89 5.81 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.955 0.902 . . . . 0.0 111.669 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.63 30.48 72.32 Favored Glycine 0 C--N 1.347 1.186 0 O-C-N 124.125 0.891 . . . . 0.0 113.349 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.91 138.48 11.9 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.337 0.655 . . . . 0.0 110.213 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 111.0 2.11 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.927 2.418 . . . . 0.0 110.898 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.99 177.43 35.98 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -154.35 138.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -106.29 131.57 53.36 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -144.73 154.8 43.11 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -92.5 91.55 7.66 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.68 120.1 22.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.62 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 86' ' ' THR . 36.5 mt-10 -92.45 105.19 17.41 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.9 t0 . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 124.679 1.192 . . . . 0.0 111.223 -174.706 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 78' ' ' GLU . 18.0 p . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.0 t -108.4 135.5 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.37 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.6 130.77 34.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.46 116.41 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 tp -91.93 94.26 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -92.07 114.16 26.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.174 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.16 123.13 34.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.13 169.83 12.66 Favored Glycine 0 N--CA 1.467 0.721 0 O-C-N 123.206 0.316 . . . . 0.0 112.653 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 120.18 12.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.235 0.614 . . . . 0.0 110.318 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.28 124.42 78.33 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.179 0.991 . . . . 0.0 110.251 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.5 ' HB2' HG22 ' A' ' 98' ' ' THR . 93.9 Cg_endo -75.61 155.46 40.14 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.726 2.284 . . . . 0.0 112.46 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -65.17 -22.37 66.9 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.788 0.835 . . . . 0.0 112.047 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 96' ' ' PRO . 6.7 t -74.21 -24.44 59.33 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.511 0.724 . . . . 0.0 111.216 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.514 ' HA ' HG11 ' A' ' 103' ' ' VAL . 75.3 t80 -73.32 109.86 7.17 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -141.32 159.76 59.81 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.021 0.929 . . . . 0.0 109.895 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.37 100.11 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.695 2.263 . . . . 0.0 111.574 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.86 -11.28 7.84 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.257 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 99' ' ' PHE . 5.4 p -72.17 146.96 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 117.489 0.644 . . . . 0.0 109.884 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 35.8 mt-10 -81.46 136.42 35.66 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.616 HG12 HG22 ' A' ' 125' ' ' THR . 19.6 m -128.74 169.58 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 122.152 0.977 . . . . 0.0 111.701 177.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -136.25 107.75 6.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.896 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 118' ' ' PHE . 41.1 pt -98.16 149.51 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.909 0.884 . . . . 0.0 109.471 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 40.7 mt-10 -135.03 139.75 45.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.72 -120.82 0.97 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.2 168.77 41.9 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.808 0.304 . . . . 0.0 112.374 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.29 101.03 7.69 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.49 130.45 58.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.0 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.92 97.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.604 2.869 . . . . 0.0 112.416 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.13 -52.14 0.56 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.87 118.39 24.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.637 0.775 . . . . 0.0 109.886 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.17 -26.56 61.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.378 0.671 . . . . 0.0 109.653 168.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -86.2 141.28 29.43 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.497 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.446 ' CD1' HD12 ' A' ' 107' ' ' ILE . 54.6 t80 -76.5 118.04 18.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 109.702 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.32 97.11 4.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.104 0.962 . . . . 0.0 109.409 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.87 114.2 25.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.049 0.54 . . . . 0.0 110.592 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.57 -34.83 46.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.518 0.727 . . . . 0.0 110.802 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 13.6 p -138.4 146.32 42.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.775 0.83 . . . . 0.0 109.569 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 tp -136.61 111.95 9.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.27 1.028 . . . . 0.0 109.594 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -122.47 119.86 32.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 105' ' ' VAL . 45.8 p -72.23 146.78 47.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.809 0.337 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.73 118.34 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -91.94 121.59 33.68 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.94 138.81 51.07 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -120.35 154.45 35.04 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 109.882 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.19 -155.56 26.97 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 121.805 -0.236 . . . . 0.0 112.932 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -124.32 145.21 49.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.776 0.83 . . . . 0.0 109.737 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.28 120.51 36.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.64 33.47 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 124.017 0.823 . . . . 0.0 111.003 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.31 -17.78 51.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.413 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.75 127.72 33.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.434 0.693 . . . . 0.0 110.477 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 8.2 84.03 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.431 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HE2' ' A' ' 99' ' ' PHE . 4.3 tt -69.55 103.83 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -116.2 113.7 23.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.518 1.127 . . . . 0.0 108.929 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.4 mtp -89.08 136.56 32.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.23 128.59 37.13 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.468 0.48 . . . . 0.0 110.112 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.58 112.34 24.22 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.43 0.692 . . . . 0.0 109.232 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.02 -30.53 9.91 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.023 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.42 141.99 23.64 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.746 0.818 . . . . 0.0 109.57 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.29 6.35 4.42 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.213 2.608 . . . . 0.0 114.112 -175.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.96 -170.66 44.24 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.424 0.452 . . . . 0.0 113.369 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 95' ' ' VAL . 13.0 p -154.12 154.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.455 0.702 . . . . 0.0 110.73 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -121.78 138.45 54.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.624 1.17 . . . . 0.0 108.015 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -151.1 174.63 12.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -113.37 111.87 22.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.794 0.807 . . . . 0.0 109.83 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.0 tp -77.62 133.66 38.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.007 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 86' ' ' THR . 44.6 mt-10 -84.47 124.22 31.11 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.613 0.57 . . . . 0.0 110.555 174.362 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 78' ' ' GLU . 37.6 p . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.96 133.25 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -83.1 134.97 34.98 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.13 116.29 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.224 0.61 . . . . 0.0 109.485 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.3 tp -93.61 93.97 8.35 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.4 109.99 18.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.183 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.66 109.93 21.81 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 109.518 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.21 37.87 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.11 115.95 27.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.427 HG21 ' HB ' ' A' ' 73' ' ' VAL . 97.9 t -80.18 118.69 73.68 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 122.735 0.414 . . . . 0.0 109.884 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.5 162.35 38.24 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.299 1.999 . . . . 0.0 112.439 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.3 -22.55 66.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.926 0.89 . . . . 0.0 111.185 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 p -67.67 -20.91 65.35 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.617 1.167 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.409 ' HE2' HD21 ' A' ' 64' ' ' LEU . 75.8 t80 -79.79 136.36 36.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.827 0.851 . . . . 0.0 109.521 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -163.89 162.49 16.45 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.969 0.908 . . . . 0.0 110.599 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.24 101.57 0.35 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.435 2.09 . . . . 0.0 110.517 164.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.21 62.51 0.67 Allowed Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HG13 ' A' ' 105' ' ' VAL . 11.6 p -137.7 130.53 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -0.615 . . . . 0.0 110.285 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -69.85 132.65 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 165.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG12 HG22 ' A' ' 125' ' ' THR . 15.2 m -139.06 159.37 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-O 122.081 0.943 . . . . 0.0 111.174 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.31 106.46 12.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 113.237 -1.801 . . . . 0.0 106.291 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.0 pt -100.87 161.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.254 0.621 . . . . 0.0 110.098 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.89 140.47 20.71 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.19 -108.57 0.27 Allowed Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.26 171.25 41.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.4 tp -128.69 127.71 42.67 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 139.03 43.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.241 0.616 . . . . 0.0 109.913 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.66 112.12 2.09 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.403 2.069 . . . . 0.0 112.179 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.38 -21.48 19.42 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.83 144.21 26.15 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 110.922 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.62 -34.76 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.811 0.444 . . . . 0.0 110.993 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -82.38 126.29 32.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.109 0.48 . . . . 0.0 110.795 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -77.6 122.54 25.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.846 0.858 . . . . 0.0 108.693 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -91.54 103.83 16.39 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.4 119.57 25.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -68.42 -42.49 78.88 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.272 1.029 . . . . 0.0 109.799 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -134.51 141.73 46.81 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 -170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -125.82 112.39 15.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.702 1.201 . . . . 0.0 108.566 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 ttp -118.55 106.0 12.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.498 HG22 HG12 ' A' ' 105' ' ' VAL . 77.5 p -71.24 128.06 34.65 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 123.811 0.844 . . . . 0.0 109.207 -177.475 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 42.2 t -115.48 132.69 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 94.6 mtt180 -100.14 146.22 27.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.342 0.657 . . . . 0.0 110.177 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD23 ' A' ' 77' ' ' LEU . 1.5 tt -133.82 126.6 30.89 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -115.66 108.33 16.25 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.98 -152.11 5.57 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 56.6 m -125.38 146.43 49.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.61 0.764 . . . . 0.0 109.815 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.68 120.04 33.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 124.012 0.925 . . . . 0.0 109.071 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.14 150.98 43.33 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.905 0.753 . . . . 0.0 111.007 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.55 45.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.624 0.769 . . . . 0.0 110.074 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.78 113.91 26.31 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.88 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.56 -1.14 45.92 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.224 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.4 tt -69.21 108.96 3.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -121.52 128.62 52.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.211 1.005 . . . . 0.0 108.861 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.7 mmt -83.06 154.91 24.17 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -86.3 35.61 0.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 26.42 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 128.078 2.551 . . . . 0.0 114.44 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.72 38.56 3.2 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.174 0.416 . . . . 0.0 113.05 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 133.75 4.38 Favored Pre-proline 0 C--O 1.241 0.618 0 C-N-CA 124.669 1.188 . . . . 0.0 108.694 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.72 115.64 3.51 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.468 2.112 . . . . 0.0 109.901 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.06 -174.4 33.27 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.501 0.5 . . . . 0.0 112.965 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.36 133.77 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.959 0.904 . . . . 0.0 110.057 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 46.2 ttm180 -106.36 124.32 49.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -149.33 160.77 43.12 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -96.45 111.48 23.57 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.439 HD23 HD22 ' A' ' 55' ' ' LEU . 19.7 tp -79.86 105.05 10.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.75 121.42 19.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.6 t70 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 124.176 0.99 . . . . 0.0 110.825 -177.896 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 C--O 1.239 0.533 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.03 134.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -85.98 138.39 32.02 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 60.2 t -123.08 116.68 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.4 93.87 8.4 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -98.18 122.58 41.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.91 116.17 31.15 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.01 174.65 33.18 Favored Glycine 0 C--O 1.238 0.346 0 O-C-N 123.994 0.808 . . . . 0.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 112.78 4.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.1 117.01 66.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.413 0.685 . . . . 0.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.01 171.23 18.53 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.182 1.921 . . . . 0.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.16 -22.27 59.49 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -63.54 -32.2 73.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.4 1.08 . . . . 0.0 109.796 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -76.52 120.91 22.38 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 166.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.35 155.63 19.25 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.505 0.722 . . . . 0.0 110.173 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 64' ' ' LEU . 41.6 Cg_exo -57.98 107.79 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.649 2.232 . . . . 0.0 111.847 172.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.86 -25.14 5.62 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.237 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 p -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 117.44 0.62 . . . . 0.0 110.654 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.5 mt-10 -86.62 129.69 34.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 125' ' ' THR . 34.8 m -119.99 144.94 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.611 0.719 . . . . 0.0 111.068 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.92 107.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.66 143.69 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 25.9 mt-10 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.62 -100.29 0.14 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . 166.15 159.2 11.71 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 170.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.84 127.67 39.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.995 0.918 . . . . 0.0 109.237 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -82.98 135.34 45.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 -28.66 80.96 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.814 2.342 . . . . 0.0 113.377 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.05 -11.26 56.61 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.84 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 42.1 mt-10 -119.14 125.49 49.37 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.562 0.745 . . . . 0.0 110.159 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -61.43 -26.3 67.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.992 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 t -84.67 130.51 34.7 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.23 0.538 . . . . 0.0 111.284 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 10.2 t80 -77.07 116.15 17.47 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -97.51 114.37 26.24 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.28 30.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.165 0.986 . . . . 0.0 110.668 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -75.04 -26.36 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.142 0.577 . . . . 0.0 110.45 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 39.0 p -139.61 155.39 47.48 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.682 1.193 . . . . 0.0 108.836 174.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 tt -137.94 137.11 37.66 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 ttp -133.7 164.97 26.03 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 105' ' ' VAL . 40.0 p -109.86 149.36 29.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.113 0.565 . . . . 0.0 109.913 173.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.21 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.004 0.43 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.64 127.78 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -113.84 134.27 54.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.792 0.437 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 163.95 16.93 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.222 1.009 . . . . 0.0 110.244 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -139.37 139.82 37.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.652 1.181 . . . . 0.0 108.368 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.94 30.44 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -123.2 148.68 45.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.588 1.155 . . . . 0.0 109.463 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.47 130.87 35.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.34 37.64 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.564 0.54 . . . . 0.0 110.919 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -70.89 -45.44 64.35 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.437 0.695 . . . . 0.0 109.608 170.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.63 120.58 30.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 52.12 1.93 Allowed Glycine 0 N--CA 1.468 0.782 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.9 tt -135.84 125.76 25.86 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -140.57 142.86 35.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.526 1.13 . . . . 0.0 108.807 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.6 mmt -95.02 147.88 22.93 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.99 123.66 22.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.05 124.88 41.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.351 0.661 . . . . 0.0 109.553 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.92 28.45 70.58 Favored Glycine 0 C--N 1.344 0.989 0 O-C-N 123.726 0.641 . . . . 0.0 111.9 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.33 131.48 2.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.784 1.233 . . . . 0.0 109.007 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 120.77 7.48 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 121.928 1.752 . . . . 0.0 111.771 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -176.85 31.32 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 120.998 0.221 . . . . 0.0 113.546 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.51 139.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.459 1.104 . . . . 0.0 109.431 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 40.5 ttt180 -119.65 125.81 49.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.64 0.776 . . . . 0.0 108.991 171.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.442 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 37.5 p90 -151.36 162.35 41.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 30.2 ptt180 -100.18 119.26 38.08 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 107' ' ' ILE . 41.0 tp -73.79 115.78 13.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.702 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.527 ' HA ' HG22 ' A' ' 86' ' ' THR . 34.2 mt-10 -74.21 101.95 4.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.172 0 C-N-CA 123.611 0.764 . . . . 0.0 111.797 -179.324 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 78' ' ' GLU . 39.9 p . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.615 0.245 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -101.95 138.82 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.8 m95 -73.89 160.63 31.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.951 0.501 . . . . 0.0 110.777 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.3 t -135.71 108.77 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 108.677 -173.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.9 tp -93.98 94.04 8.23 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -99.48 131.86 45.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -118.74 150.84 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.147 0.579 . . . . 0.0 110.622 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.18 -172.22 14.12 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.195 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.81 121.13 18.43 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.166 0.587 . . . . 0.0 110.106 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.24 124.64 80.6 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.922 0.889 . . . . 0.0 109.332 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 123' ' ' LEU . 57.8 Cg_endo -68.61 152.58 74.56 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.474 2.116 . . . . 0.0 112.111 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.55 -27.03 63.84 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.524 0.73 . . . . 0.0 111.66 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 96' ' ' PRO . 9.6 t -68.62 -20.02 64.46 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.761 0.425 . . . . 0.0 110.908 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.07 115.33 10.08 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.8 mtmt -132.15 158.66 74.95 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.487 1.115 . . . . 0.0 108.644 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 11.2 Cg_exo -70.99 141.08 39.42 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.204 1.936 . . . . 0.0 109.985 167.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.72 79.04 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 100' ' ' LYS . 9.9 p -93.25 149.83 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.388 1.094 . . . . 0.0 108.313 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -69.99 139.07 52.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 125' ' ' THR . 16.6 m -133.03 156.4 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.916 0.865 . . . . 0.0 111.017 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.8 mt -121.16 127.89 75.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.738 1.615 . . . . 0.0 106.769 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 77' ' ' LEU . 17.6 pt -125.93 145.63 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.26 155.25 46.6 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 109.153 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 165.88 -114.42 0.59 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.02 150.81 20.94 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 117.343 0.571 . . . . 0.0 111.979 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 45.9 tp -127.66 136.11 51.15 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.533 0.733 . . . . 0.0 109.874 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 132.55 37.17 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.64 -19.53 53.43 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.807 2.338 . . . . 0.0 113.728 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.7 -8.28 57.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.792 -0.449 . . . . 0.0 113.768 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -100.68 139.68 36.03 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 117.708 0.754 . . . . 0.0 110.014 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -85.98 -23.14 27.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.994 0.917 . . . . 0.0 111.934 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -99.39 126.47 45.28 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.873 0.844 . . . . 0.0 110.763 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 111' ' ' LEU . 81.2 t80 -75.11 131.02 40.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.762 1.225 . . . . 0.0 108.715 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 60.0 tttm -88.25 108.16 19.17 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.02 113.62 23.84 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.015 0.526 . . . . 0.0 110.111 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.09 -30.51 62.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.468 0.707 . . . . 0.0 109.49 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p -133.4 141.33 47.82 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 109.834 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 96' ' ' PRO . 62.8 tp -124.8 109.58 13.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.5 ttp -124.86 138.45 54.26 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' HG12 ' A' ' 105' ' ' VAL . 65.3 p -89.61 169.01 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.002 0.521 . . . . 0.0 111.231 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 24.9 tptm . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.213 1.005 . . . . 0.0 109.995 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 CA--C 1.563 1.444 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -97.15 118.85 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.336 -0.853 . . . . 0.0 109.521 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -120.1 138.0 53.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.67 140.47 40.82 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.77 134.04 52.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.211 1.005 . . . . 0.0 108.606 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.9 177.38 41.04 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -113.4 140.19 48.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.763 0.825 . . . . 0.0 109.074 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 102' ' ' GLY . 59.6 t -74.6 132.25 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.764 0.426 . . . . 0.0 110.39 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.67 40.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 122.617 0.367 . . . . 0.0 110.062 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -75.59 -0.33 20.09 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.695 173.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -131.23 120.77 23.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.898 0.879 . . . . 0.0 109.363 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.91 22.91 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.865 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.81 105.73 5.23 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 m -138.59 125.95 21.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.813 0.845 . . . . 0.0 109.944 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtp -96.89 162.19 13.52 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.165 0.586 . . . . 0.0 110.631 -170.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.63 135.12 35.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.013 0.525 . . . . 0.0 111.225 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -73.89 111.84 9.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.554 0.742 . . . . 0.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.95 -53.78 4.88 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.334 0.396 . . . . 0.0 112.347 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.61 129.16 94.14 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 123.856 0.862 . . . . 0.0 110.906 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.31 113.46 1.92 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.435 2.09 . . . . 0.0 110.808 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.41 175.36 35.94 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 121.478 0.488 . . . . 0.0 113.514 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 8.7 p -154.35 131.71 2.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.06 1.344 . . . . 0.0 108.723 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.93 143.4 31.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -156.64 163.32 39.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -98.64 105.99 18.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.85 117.5 23.34 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.6 89.71 1.0 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.471 0.592 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.917 179.448 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 120.534 0.207 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.2 t -104.09 129.35 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.461 0.704 . . . . 0.0 109.657 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.2 m95 -78.76 100.76 7.25 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.19 110.09 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.359 0.6 . . . . 0.0 109.572 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 tp -93.15 93.75 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.742 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' HE2' ' HA ' ' A' ' 95' ' ' VAL . 47.3 t80 -92.97 111.54 23.2 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.715 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -105.3 116.09 31.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.205 0.602 . . . . 0.0 109.463 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 153.63 -175.24 32.05 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.46 112.76 4.24 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' TYR . 46.2 t -79.82 126.35 80.33 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.423 0.689 . . . . 0.0 109.232 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.6 Cg_endo -57.33 142.88 94.96 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.782 2.322 . . . . 0.0 112.519 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.93 -25.7 67.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.583 0.753 . . . . 0.0 111.441 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.2 p -78.22 -6.65 55.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.503 1.121 . . . . 0.0 112.642 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 78.9 t80 -69.99 95.94 0.99 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.294 0.638 . . . . 0.0 109.946 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.4 pttt -110.53 157.41 38.36 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.256 1.023 . . . . 0.0 110.018 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.536 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 16.3 Cg_exo -68.46 112.7 2.9 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.302 2.001 . . . . 0.0 110.714 171.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 59' ' ' VAL . . . 111.58 3.31 27.18 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.911 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 125' ' ' THR . 12.8 p -85.63 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 118.07 0.935 . . . . 0.0 110.278 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.39 110.33 8.59 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.5 HG13 HG13 ' A' ' 103' ' ' VAL . 29.8 m -104.63 148.05 9.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.952 0.882 . . . . 0.0 110.223 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.55 107.19 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.11 144.42 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 138.89 26.66 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.93 -118.35 0.83 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -172.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.54 141.58 6.63 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 117.907 0.853 . . . . 0.0 112.342 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 tp -87.64 129.17 35.22 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -81.58 132.75 54.23 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.75 -18.78 66.08 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.009 2.473 . . . . 0.0 114.055 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.23 -31.92 6.64 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.679 -0.237 . . . . 0.0 112.76 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 3.2 mp0 -94.45 137.26 33.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.945 0.498 . . . . 0.0 111.313 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.26 -26.69 65.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.992 0.917 . . . . 0.0 110.533 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 58.5 p -84.41 130.04 34.81 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.9 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -77.79 120.43 22.68 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.372 1.069 . . . . 0.0 108.619 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -75.74 94.73 3.31 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.22 109.59 18.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.248 0.619 . . . . 0.0 110.13 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -62.38 -42.36 99.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.931 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.2 p -134.83 162.31 32.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.879 0.871 . . . . 0.0 110.192 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.0 tp -150.58 111.43 4.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.361 1.064 . . . . 0.0 108.895 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 ttp -124.48 116.08 21.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.485 0.314 . . . . 0.0 110.939 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 103' ' ' VAL . 70.4 p -74.06 150.27 40.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.389 1.076 . . . . 0.0 110.694 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 N--CA 1.47 0.575 0 C-N-CA 122.741 0.417 . . . . 0.0 110.054 177.588 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.6 t -102.65 145.23 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.183 0.993 . . . . 0.0 109.393 -170.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -115.58 123.2 47.85 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.44 147.35 41.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.637 0.732 . . . . 0.0 110.034 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.96 109.06 10.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.913 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.86 -158.31 8.55 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.455 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 50.2 m -117.12 145.71 43.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.388 1.075 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.9 120.43 32.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.079 0.952 . . . . 0.0 109.08 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.9 47.59 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.744 0.652 . . . . 0.0 111.647 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 101' ' ' PRO . . . -70.3 -28.83 65.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.541 0.736 . . . . 0.0 112.111 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -110.59 42.14 1.64 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.54 51.96 0.22 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 tt -133.65 108.42 8.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 m -114.43 119.51 37.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 109.682 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.1 mmt -80.92 143.62 32.52 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 0.0 110.093 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -75.93 131.96 39.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.641 0.376 . . . . 0.0 110.068 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.38 139.48 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.525 0.73 . . . . 0.0 109.93 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.26 19.84 64.55 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.978 0.799 . . . . 0.0 112.9 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.89 129.29 2.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.959 0.904 . . . . 0.0 109.674 -172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.91 121.78 8.43 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.506 2.137 . . . . 0.0 110.668 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.58 -172.96 30.27 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.606 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.09 139.68 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 109.528 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.749 HH21 ' HB ' ' A' ' 117' ' ' THR . 45.9 ttt180 -111.86 139.86 46.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -154.27 152.58 30.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.251 0.62 . . . . 0.0 109.544 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 13.8 ptm180 -94.66 107.24 19.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -73.32 114.26 11.33 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.856 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.73 87.6 6.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 124.129 0.972 . . . . 0.0 109.042 174.978 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.849 0.357 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.52 135.57 35.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 70.9 m95 -74.7 161.96 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.241 0.616 . . . . 0.0 109.438 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 84.1 t -138.23 115.07 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.1 tp -93.2 98.5 11.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.067 0.854 . . . . 0.0 108.79 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -96.03 125.21 40.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -119.49 117.52 28.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.236 0.614 . . . . 0.0 109.887 172.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.49 -164.52 30.24 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 115.23 9.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.948 0.499 . . . . 0.0 109.694 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.42 130.24 65.99 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.856 0.862 . . . . 0.0 109.474 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.605 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.9 Cg_endo -61.46 144.91 98.38 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.38 2.054 . . . . 0.0 112.132 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.83 -27.44 67.55 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.237 1.015 . . . . 0.0 111.446 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 p -78.73 -14.53 59.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.509 1.124 . . . . 0.0 112.139 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.6 t80 -68.51 119.94 13.78 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -152.37 161.05 30.39 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.275 1.03 . . . . 0.0 108.716 -174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 57.0 Cg_endo -66.73 111.16 2.07 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.032 1.822 . . . . 0.0 110.845 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.63 -11.48 15.92 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.683 -0.509 . . . . 0.0 113.825 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.07 149.18 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 117.714 0.757 . . . . 0.0 110.002 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.2 mt-10 -83.18 140.96 32.27 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.11 168.46 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.063 0.945 . . . . 0.0 111.851 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.415 ' HB ' ' HG2' ' A' ' 124' ' ' MET . 71.5 mt -132.84 122.71 47.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 126.462 1.905 . . . . 0.0 106.202 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.6 139.56 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.689 0.795 . . . . 0.0 109.827 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.42 132.49 56.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.9 -143.09 7.09 Favored Glycine 0 N--CA 1.47 0.946 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.82 136.18 4.58 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 117.685 0.742 . . . . 0.0 112.662 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.2 tp -93.08 134.41 35.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.289 1.035 . . . . 0.0 108.919 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 115' ' ' GLU . . . -88.86 146.59 37.11 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.264 0.626 . . . . 0.0 110.309 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.49 120.25 7.36 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.878 2.385 . . . . 0.0 112.206 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.12 69.14 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.979 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 112' ' ' ALA . 69.3 mm-40 -101.0 151.32 21.92 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.617 0.767 . . . . 0.0 110.13 172.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -106.55 16.45 24.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.925 0.89 . . . . 0.0 109.864 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.749 ' HB ' HH21 ' A' ' 74' ' ' ARG . 12.7 t -134.7 111.77 10.24 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.959 0.885 . . . . 0.0 109.846 -174.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -74.77 109.34 8.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.119 1.367 . . . . 0.0 108.37 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -77.79 98.74 5.65 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.29 163.53 26.33 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.629 0.771 . . . . 0.0 111.483 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -125.13 -36.47 2.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.091 1.356 . . . . 0.0 108.071 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -132.32 164.3 26.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.22 1.008 . . . . 0.0 109.778 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -156.71 117.94 3.76 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.488 1.115 . . . . 0.0 108.731 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 106' ' ' ILE . 19.2 ptp -137.38 147.82 45.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -91.55 142.85 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.684 0.394 . . . . 0.0 110.235 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 mttp . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 123.073 0.549 . . . . 0.0 110.092 177.055 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.4 124.44 49.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -82.72 105.0 13.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.17 132.21 54.37 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -167.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.98 126.52 55.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.86 -178.96 35.3 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -117.18 142.93 46.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.338 0.655 . . . . 0.0 109.726 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.47 125.01 36.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.346 0.658 . . . . 0.0 110.428 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.13 136.29 38.6 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.14 66.64 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.66 0.6 . . . . 0.0 109.744 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.754 ' HB2' HH21 ' A' ' 76' ' ' ARG . 2.6 m-20 -83.78 133.05 34.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.543 177.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.25 78.86 Favored Glycine 0 N--CA 1.468 0.803 0 O-C-N 123.397 0.436 . . . . 0.0 113.217 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tt -76.67 103.79 6.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.6 m -121.05 127.36 51.63 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.778 1.231 . . . . 0.0 109.57 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 91.8 mmm -83.85 145.0 28.88 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.56 125.28 26.23 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.36 104.08 2.6 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.362 1.065 . . . . 0.0 110.552 -170.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.49 73.5 Favored Glycine 0 C--N 1.342 0.895 0 O-C-N 123.749 0.656 . . . . 0.0 112.784 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.7 132.35 13.02 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 123.917 0.887 . . . . 0.0 109.394 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.96 110.69 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.758 2.305 . . . . 0.0 111.051 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 -176.79 30.17 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.841 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.66 135.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 109.579 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.6 ttm180 -112.48 128.11 56.24 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.0 171.85 14.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -171.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.754 HH21 ' HB2' ' A' ' 62' ' ' ASP . 37.9 mtm180 -96.39 130.16 43.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 tp -103.13 117.05 33.69 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.672 0.789 . . . . 0.0 109.234 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -70.62 91.36 0.79 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 170.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.538 0.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.824 -161.336 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.15 136.42 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.18 127.2 31.73 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 99.3 t -111.94 117.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.429 0.692 . . . . 0.0 109.312 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.38 96.17 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -95.55 123.09 38.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -115.69 112.6 22.31 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.689 0.796 . . . . 0.0 109.425 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.52 -173.43 34.94 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.96 111.77 5.19 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.264 0.626 . . . . 0.0 110.312 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 110.15 19.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.806 0.691 . . . . 0.0 109.497 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 123' ' ' LEU . 74.5 Cg_endo -71.5 157.71 55.61 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.34 2.027 . . . . 0.0 112.147 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.55 -12.27 61.51 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.609 0.764 . . . . 0.0 112.242 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -70.15 -22.68 62.96 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.248 0.619 . . . . 0.0 111.485 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -71.56 95.27 1.39 Allowed 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.51 145.77 38.17 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.72 100.54 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.624 2.216 . . . . 0.0 111.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.78 -8.54 7.7 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.222 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.93 148.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 118.352 1.076 . . . . 0.0 110.038 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.88 115.99 19.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 20.7 m -104.67 155.72 6.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 123.847 0.859 . . . . 0.0 111.253 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mt -117.09 107.63 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.47 141.32 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.1 0.56 . . . . 0.0 109.966 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.41 117.85 30.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 120' ' ' ALA . . . -172.09 -149.47 6.69 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 123.49 0.494 . . . . 0.0 112.265 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.16 145.46 10.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 117.165 0.483 . . . . 0.0 112.479 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.9 tp -88.92 105.36 17.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.46 139.31 41.37 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.058 0.543 . . . . 0.0 111.212 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.93 90.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 123.414 2.743 . . . . 0.0 112.62 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.99 -42.57 0.82 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -95.38 130.46 42.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.542 0.737 . . . . 0.0 110.644 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.77 -17.04 60.03 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.864 0.866 . . . . 0.0 110.523 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 t -86.64 133.2 33.72 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.152 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -77.04 109.86 11.21 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -86.12 94.18 9.2 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . . . -84.12 117.35 23.41 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.635 0.774 . . . . 0.0 111.108 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -61.92 -45.41 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.845 0.858 . . . . 0.0 111.035 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m -127.97 136.24 51.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.66 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 96' ' ' PRO . 33.5 tp -112.99 123.74 51.01 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.6 mtm -132.73 171.01 14.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.226 1.01 . . . . 0.0 108.285 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 35.1 p -130.43 148.92 52.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.771 . . . . 0.0 110.075 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 N--CA 1.476 0.834 0 C-N-CA 123.399 0.68 . . . . 0.0 109.999 173.61 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.447 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.59 162.15 35.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.672 0.789 . . . . 0.0 110.665 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 p -101.26 105.57 40.29 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.74 -176.49 3.2 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.845 2.363 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -63.85 159.03 20.47 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.121 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.36 145.17 48.85 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.142 0.977 . . . . 0.0 111.379 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.659 0.784 . . . . 0.0 111.73 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.29 27.49 1.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.473 0.709 . . . . 0.0 111.156 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -64.24 95.04 0.12 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.625 0.726 . . . . 0.0 109.894 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m -69.06 151.56 46.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.264 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.66 105.54 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -168.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.79 117.82 26.88 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD22 HD23 ' A' ' 77' ' ' LEU . 3.1 tt -123.62 142.9 50.6 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -121.76 141.25 51.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 0.0 109.302 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.26 -161.35 28.08 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.9 m -127.02 145.08 50.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.434 0.694 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.35 132.3 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.573 0.749 . . . . 0.0 109.972 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.86 156.56 17.41 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.444 0.698 . . . . 0.0 110.964 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.13 30.63 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.482 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -77.31 108.81 10.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.813 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.36 12.21 61.66 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.756 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.24 90.16 1.59 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -116.8 116.66 27.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.734 1.214 . . . . 0.0 109.877 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtt -89.98 161.81 15.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 90' ' ' LEU . 79.3 mt -66.94 119.14 11.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.663 0.385 . . . . 0.0 110.681 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.97 98.07 0.27 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.351 1.06 . . . . 0.0 110.724 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.75 22.84 68.44 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.462 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -143.26 149.14 47.25 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.729 0.812 . . . . 0.0 109.953 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.81 111.52 3.27 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.566 2.178 . . . . 0.0 112.076 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.29 179.33 31.23 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.986 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 11.1 p -149.28 134.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.807 0.843 . . . . 0.0 110.601 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -104.15 138.65 40.33 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.28 163.63 39.88 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -97.98 115.16 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.553 HD23 HD22 ' A' ' 55' ' ' LEU . 21.9 tp -79.66 108.87 13.54 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 86' ' ' THR . 58.0 mt-10 -78.01 110.36 12.88 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.298 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.72 129.27 40.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.339 1.056 . . . . 0.0 110.111 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -72.68 -26.83 61.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.565 0.346 . . . . 0.0 111.545 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.65 -49.48 58.74 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.225 0.536 . . . . 0.0 109.97 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -131.47 103.26 6.32 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.1 p -76.07 4.63 8.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.813 0.845 . . . . 0.0 113.132 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 p -102.46 -15.88 16.34 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.433 0.693 . . . . 0.0 109.832 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -77.0 86.63 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 78' ' ' GLU . 35.2 p -107.63 108.02 19.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.468 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.45 129.57 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.41 98.21 8.11 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 107' ' ' ILE . 53.2 t -88.99 130.62 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.625 0.77 . . . . 0.0 109.986 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 HD21 ' A' ' 67' ' ' LEU . 37.0 tp -115.64 114.32 24.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.227 1.011 . . . . 0.0 108.939 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -112.86 128.87 56.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.086 1.354 . . . . 0.0 108.008 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 148.07 29.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.411 0.685 . . . . 0.0 109.433 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.78 -168.16 12.51 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.71 112.2 4.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.243 0.617 . . . . 0.0 110.582 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.11 117.13 68.18 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.029 0.932 . . . . 0.0 108.754 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 29.9 Cg_endo -59.44 151.3 69.62 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.693 2.262 . . . . 0.0 113.173 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -65.74 -25.12 67.14 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.728 0.811 . . . . 0.0 110.393 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.5 p -71.16 -23.87 62.14 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.992 1.317 . . . . 0.0 111.589 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.492 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.3 t80 -68.46 106.45 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -133.31 155.76 80.5 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.746 0.819 . . . . 0.0 109.101 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 110.3 2.17 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.523 2.148 . . . . 0.0 111.456 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.93 -11.71 9.37 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.044 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.2 t -81.55 124.41 38.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.456 0.702 . . . . 0.0 109.532 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.77 118.99 14.26 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 m -120.79 154.38 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.606 0.717 . . . . 0.0 111.785 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.55 115.14 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 89' ' ' VAL . 37.9 pt -100.91 162.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 33.5 tt0 -148.67 132.76 17.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.18 -117.54 0.69 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 179.76 146.27 6.79 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 117.453 0.626 . . . . 0.0 112.539 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.98 114.57 27.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.22 134.51 48.82 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 123.593 0.558 . . . . 0.0 110.111 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.7 104.43 0.16 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.871 2.381 . . . . 0.0 111.85 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.07 -29.86 5.42 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HE3' ' A' ' 119' ' ' LYS . 11.0 tp10 -91.29 132.64 36.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.4 -5.31 58.91 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.308 0.643 . . . . 0.0 112.284 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.45 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 40.2 p -114.64 137.46 51.87 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.323 0.511 . . . . 0.0 112.031 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.25 111.61 14.39 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HE3' ' HG2' ' A' ' 115' ' ' GLU . 93.9 mttt -82.29 93.65 7.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.34 108.32 14.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.73 0.812 . . . . 0.0 110.043 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -19.62 57.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.589 0.755 . . . . 0.0 111.548 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 22.4 p -138.63 157.14 46.7 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.054 0.941 . . . . 0.0 110.107 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 tp -138.6 140.88 39.14 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.984 1.314 . . . . 0.0 108.235 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.8 ttm -136.53 118.77 15.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.348 0.659 . . . . 0.0 109.587 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -100.4 145.11 28.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.748 0.819 . . . . 0.0 110.157 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.61 -53.76 3.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.432 . . . . 0.0 111.122 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 92.3 m -82.11 124.18 78.95 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 122.552 0.341 . . . . 0.0 111.082 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.05 -158.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.998 2.465 . . . . 0.0 112.533 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.94 80.7 2.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.362 0.665 . . . . 0.0 109.911 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.332 1.053 . . . . 0.0 108.788 178.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.6 mtm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.02 50.66 2.22 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 ' OG1' ' HB1' ' A' ' 112' ' ' ALA . 80.9 p -74.99 146.66 82.85 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.621 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -43.68 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 124.489 3.46 . . . . 0.0 114.987 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' HB2' ' A' ' 112' ' ' ALA . 44.2 tt0 -151.81 80.13 1.27 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.66 163.29 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.966 0.412 . . . . 0.0 111.225 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.57 -42.06 65.03 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -22.6 61.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.06 0.144 . . . . 0.0 110.908 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -73.43 88.05 1.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.312 0.645 . . . . 0.0 109.705 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -100.8 121.35 41.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.88 146.13 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -123.33 114.27 19.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.181 0.992 . . . . 0.0 109.043 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tt -114.15 126.15 54.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.93 135.7 39.28 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.76 -174.15 38.47 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -124.12 140.84 52.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.225 1.01 . . . . 0.0 109.002 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.1 123.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . . . -75.65 149.52 38.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.07 0.548 . . . . 0.0 111.265 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.53 27.35 1.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.822 0.849 . . . . 0.0 110.562 167.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -143.31 128.16 18.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.723 1.209 . . . . 0.0 107.869 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.76 6.76 88.17 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.694 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.87 85.4 2.82 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.3 m -107.45 111.88 24.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.277 1.431 . . . . 0.0 109.847 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtp -91.79 146.64 23.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.55 127.5 32.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.755 0.422 . . . . 0.0 111.677 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.51 118.43 18.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.123 0.969 . . . . 0.0 110.316 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.32 18.71 67.71 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 123.88 0.738 . . . . 0.0 114.068 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.52 12.36 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.579 0.752 . . . . 0.0 109.691 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.54 115.98 4.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.399 2.066 . . . . 0.0 111.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.58 -175.51 31.92 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.841 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.27 130.56 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 124.15 0.98 . . . . 0.0 110.399 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.469 HH12 HG21 ' A' ' 117' ' ' THR . 8.9 tpp180 -92.25 131.84 37.15 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 165.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.92 163.33 37.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.531 0.605 . . . . 0.0 109.611 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.12 106.5 17.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.29 115.77 14.18 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.765 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' A' ' 83' ' ' THR . 48.3 mt-10 -73.1 99.35 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.48 101.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.347 1.059 . . . . 0.0 108.65 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -61.13 -22.9 65.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -167.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' N ' ' HD2' ' A' ' 80' ' ' LYS . 29.9 t70 -66.43 -36.54 83.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.242 0.617 . . . . 0.0 111.014 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -121.1 -62.28 1.46 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.337 0.655 . . . . 0.0 110.491 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 78' ' ' GLU . 18.9 m 76.9 -22.07 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.88 1.672 . . . . 0.0 111.613 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 p -64.69 -18.37 64.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.49 1.116 . . . . 0.0 110.846 167.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -126.92 113.54 16.67 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.957 0.903 . . . . 0.0 108.826 172.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 78' ' ' GLU . 71.4 p -110.1 139.16 45.53 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.19 137.76 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -79.89 146.27 32.25 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.75 119.53 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.0 94.16 7.82 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -89.56 125.16 35.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -116.41 110.11 18.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.477 0.711 . . . . 0.0 109.416 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.01 -173.98 35.28 Favored Glycine 0 N--CA 1.469 0.89 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.942 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 108.57 1.96 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.626 0.77 . . . . 0.0 111.763 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -81.67 118.03 70.57 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.401 0.681 . . . . 0.0 109.789 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.21 163.93 29.79 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.59 2.193 . . . . 0.0 112.556 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.72 -22.1 66.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.44 0.696 . . . . 0.0 110.691 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.599 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 18.8 p -82.21 -13.8 56.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.134 0.974 . . . . 0.0 111.833 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.06 107.0 6.84 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.5 pttt -151.8 150.42 26.13 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.407 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.53 117.77 4.8 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.273 1.982 . . . . 0.0 111.243 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.35 11.64 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.044 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.682 HG21 ' SG ' ' A' ' 127' ' ' CYS . 8.2 p -90.34 145.29 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 117.866 0.833 . . . . 0.0 110.283 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.04 131.63 39.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 151.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.805 0.812 . . . . 0.0 109.65 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.43 119.97 60.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.2 pt -107.94 137.37 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -114.28 145.98 41.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.24 -124.61 1.41 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.98 141.89 6.76 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 117.071 0.435 . . . . 0.0 112.657 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.8 tp -89.33 115.29 26.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.061 0.944 . . . . 0.0 108.592 173.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . . . -89.55 134.41 32.56 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.56 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' ALA . 21.9 Cg_exo -64.74 90.79 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.954 2.436 . . . . 0.0 111.986 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.73 -45.48 0.65 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 117' ' ' THR . 2.2 mp0 -91.84 116.36 28.84 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.054 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.04 -17.67 63.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.109 0.563 . . . . 0.0 110.617 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.469 HG21 HH12 ' A' ' 74' ' ' ARG . 8.8 t -78.18 134.21 37.67 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -75.46 109.26 8.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -82.5 94.7 7.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.39 126.62 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.333 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.025 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p -138.57 165.03 27.94 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.741 0.816 . . . . 0.0 110.281 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.3 tp -135.19 137.28 42.52 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.698 1.199 . . . . 0.0 109.051 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 ttp -136.84 117.3 13.74 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.5 p -81.74 142.91 32.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.067 0.947 . . . . 0.0 109.887 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.4 mmpt? -71.1 -25.75 62.73 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.388 0.275 . . . . 0.0 111.599 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.682 ' SG ' HG21 ' A' ' 103' ' ' VAL . 21.4 p -85.32 118.43 70.76 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.56 155.8 56.22 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.554 . . . . 0.0 111.756 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.5 mp -53.63 101.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.807 0.843 . . . . 0.0 111.232 -175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 124.737 1.215 . . . . 0.0 110.466 -173.118 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.1 tpp . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.58 93.03 9.08 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -74.94 117.51 63.29 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.885 0.474 . . . . 0.0 111.587 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -94.41 18.28 0.84 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.367 2.711 . . . . 0.0 112.045 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.52 -173.51 2.97 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.234 1.014 . . . . 0.0 111.618 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.69 89.5 0.26 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.033 0.533 . . . . 0.0 110.45 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.474 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -151.67 -48.9 0.11 Allowed 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.7 pt? -93.84 -2.05 54.02 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.258 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -70.33 135.71 49.11 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.787 0.835 . . . . 0.0 109.748 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -128.51 125.47 38.45 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.82 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -137.01 118.95 15.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.852 0.861 . . . . 0.0 109.609 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.74 145.71 46.3 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -117.26 142.42 47.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.754 0.822 . . . . 0.0 109.365 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.32 -165.65 36.2 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.295 0.372 . . . . 0.0 112.828 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.2 m -119.28 147.19 44.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.771 0.828 . . . . 0.0 109.565 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.9 126.14 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 110.275 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.65 156.38 16.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.318 0.647 . . . . 0.0 110.064 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.02 59.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.283 0.633 . . . . 0.0 110.98 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.23 110.89 6.99 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.853 0.861 . . . . 0.0 109.466 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.61 16.16 71.61 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.679 0.612 . . . . 0.0 113.337 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.05 105.52 3.36 Favored 'General case' 0 C--N 1.359 1.022 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -143.74 137.56 28.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.573 1.149 . . . . 0.0 108.281 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.03 144.29 29.2 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.51 135.33 52.87 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.469 0.308 . . . . 0.0 110.848 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -65.7 109.89 2.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.97 0.908 . . . . 0.0 111.024 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.45 24.79 67.99 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.719 0.637 . . . . 0.0 113.801 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.5 130.06 10.39 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.534 0.734 . . . . 0.0 109.681 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 117.04 3.72 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.585 2.19 . . . . 0.0 110.499 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.33 176.23 28.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.622 0.576 . . . . 0.0 111.945 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.31 143.83 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.483 0.658 . . . . 0.0 110.489 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -112.44 132.23 55.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -153.86 162.27 41.36 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.832 0.453 . . . . 0.0 110.175 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 39.6 ttp180 -95.88 111.07 23.15 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 107' ' ' ILE . 22.0 tp -79.13 120.58 23.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.032 0.533 . . . . 0.0 109.93 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.33 95.35 2.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -58.5 136.5 57.54 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.33 1.019 . . . . 0.0 112.079 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -98.74 -28.99 13.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.042 0.937 . . . . 0.0 111.322 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.37 -44.29 91.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.194 0.598 . . . . 0.0 111.749 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -121.45 -38.62 2.75 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.545 0.738 . . . . 0.0 110.717 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m 77.38 -19.23 0.44 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.346 1.458 . . . . 0.0 111.774 -173.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.3 p -81.18 9.28 7.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.161 0.984 . . . . 0.0 112.609 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.619 ' HE3' HG22 ' A' ' 87' ' ' VAL . 38.0 ttpt -147.84 158.11 43.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.971 0.909 . . . . 0.0 108.762 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 20.9 p -126.79 128.78 47.12 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG22 ' HE3' ' A' ' 85' ' ' LYS . 38.2 t -102.61 122.66 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.749 0.82 . . . . 0.0 110.667 -168.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.6 m95 -77.41 106.69 9.33 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.5 t -88.69 109.89 20.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.4 tp -93.18 97.09 10.43 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.379 1.049 . . . . 0.0 108.234 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -102.57 126.09 49.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.183 0.993 . . . . 0.0 109.026 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -111.7 130.57 55.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.354 0.662 . . . . 0.0 109.265 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.95 -166.49 21.39 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 110.84 3.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.546 0.738 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.69 131.89 59.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 109.537 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.02 140.96 58.55 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.802 2.335 . . . . 0.0 112.793 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.03 -24.57 65.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.234 0.54 . . . . 0.0 110.31 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -73.74 -15.06 61.22 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.816 1.246 . . . . 0.0 112.378 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -69.48 134.52 49.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.685 0.794 . . . . 0.0 110.009 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 103' ' ' VAL . 20.0 pttm -168.98 161.01 8.07 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.81 1.244 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.56 107.89 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.904 1.736 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.05 -9.34 8.47 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.811 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 127' ' ' CYS . 10.5 p -84.86 138.43 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 118.11 0.955 . . . . 0.0 109.478 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.91 116.28 19.97 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG22 ' A' ' 125' ' ' THR . 22.2 m -113.33 153.26 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.54 0.686 . . . . 0.0 111.683 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.61 115.77 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.49 HD13 HD22 ' A' ' 77' ' ' LEU . 21.9 pt -100.39 139.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -148.71 142.88 26.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.21 -110.07 0.42 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.09 159.29 31.37 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 117.242 0.521 . . . . 0.0 112.445 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -123.85 143.02 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 0.0 108.813 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.76 147.09 54.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.26 0.624 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.61 72.59 4.34 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.079 2.519 . . . . 0.0 111.633 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.81 69.85 0.1 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 119' ' ' LYS . 10.1 tp10 -172.64 141.05 1.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.789 0.835 . . . . 0.0 110.021 -173.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -86.29 -40.46 15.49 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.604 0.762 . . . . 0.0 109.642 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 69.0 p -83.92 121.32 27.2 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.598 -169.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.05 132.61 36.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.095 0.558 . . . . 0.0 110.114 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 115' ' ' GLU . 3.2 mptp? -93.23 96.55 10.07 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.24 99.68 9.44 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.932 0.493 . . . . 0.0 111.023 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -57.1 -33.07 66.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.889 0.875 . . . . 0.0 110.619 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p -138.05 141.15 40.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.579 1.152 . . . . 0.0 109.084 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.97 118.91 19.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 ptm -129.81 147.6 51.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.385 0.674 . . . . 0.0 109.502 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 HG12 ' A' ' 105' ' ' VAL . 60.4 p -100.53 152.51 20.32 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.804 0.841 . . . . 0.0 109.957 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.14 -24.22 21.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.479 0.712 . . . . 0.0 110.562 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.528 ' HB2' HG23 ' A' ' 103' ' ' VAL . 58.7 m -106.9 123.06 39.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.306 0.642 . . . . 0.0 110.153 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.08 -174.51 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.828 2.352 . . . . 0.0 112.618 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.92 99.62 0.26 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.314 0.645 . . . . 0.0 110.797 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 124.259 1.024 . . . . 0.0 108.265 179.351 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.14 89.66 1.17 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.268 0.627 . . . . 0.0 109.349 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -109.84 96.19 23.42 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 109.231 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 81.54 2.75 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.448 2.099 . . . . 0.0 111.66 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.77 93.57 2.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.04 148.49 28.58 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.515 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.01 -63.26 1.31 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.523 0.729 . . . . 0.0 109.653 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.94 65.89 2.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.072 0.549 . . . . 0.0 111.762 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -143.25 59.04 1.4 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 162.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.1 m -92.39 141.65 28.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.172 173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.72 136.84 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.342 0.657 . . . . 0.0 109.492 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.69 133.88 52.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.833 0.853 . . . . 0.0 108.995 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.83 139.56 38.21 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -110.42 143.38 40.8 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.403 1.081 . . . . 0.0 108.668 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.94 -173.76 42.78 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 117.876 0.307 . . . . 0.0 112.615 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.6 m -112.3 134.13 54.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.719 0.808 . . . . 0.0 110.057 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.92 122.56 19.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.188 0.995 . . . . 0.0 110.447 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.95 146.94 25.97 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.25 -10.93 58.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.07 116.61 14.9 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.52 1.128 . . . . 0.0 109.995 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.66 9.91 82.75 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 123.682 0.614 . . . . 0.0 113.727 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 4.3 tt -72.61 111.14 7.5 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 p -132.1 130.69 41.55 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.277 1.431 . . . . 0.0 109.137 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.423 ' SD ' HG23 ' A' ' 73' ' ' VAL . 86.9 mmm -85.0 136.48 33.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.2 mt -63.84 111.52 2.5 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -71.09 110.21 5.63 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 110.57 -167.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.84 22.61 77.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.055 -0.52 . . . . 0.0 113.125 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.5 126.87 7.61 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.36 1.064 . . . . 0.0 108.937 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.68 109.4 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.324 2.016 . . . . 0.0 111.672 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 162.46 175.49 33.55 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 123.381 0.425 . . . . 0.0 112.181 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.423 HG23 ' SD ' ' A' ' 66' ' ' MET . 10.9 p -145.57 148.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.406 0.682 . . . . 0.0 110.451 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -123.72 137.57 54.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.136 . . . . 0.0 108.256 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.714 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 33.3 p90 -159.88 175.73 12.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.848 0.859 . . . . 0.0 108.893 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 35.1 ptt180 -111.76 135.23 52.64 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.476 HD22 HD13 ' A' ' 107' ' ' ILE . 24.9 tp -100.83 120.83 40.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.016 0.526 . . . . 0.0 109.939 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.35 97.95 7.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.198 0.599 . . . . 0.0 109.583 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -98.08 149.79 22.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -24.38 18.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.165 0.986 . . . . 0.0 111.285 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.25 -38.07 36.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.532 0.733 . . . . 0.0 110.708 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -79.83 140.75 36.7 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 t -70.01 81.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.415 1.072 . . . . 0.0 112.19 -167.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 t 60.65 66.32 0.94 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.51 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -158.88 153.76 24.91 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.871 -167.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.8 p -120.47 134.14 55.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.672 0.789 . . . . 0.0 109.566 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.55 123.16 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 80.7 m95 -68.1 138.95 56.15 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.96 109.39 28.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.7 tp -93.9 95.77 9.29 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -98.1 124.56 42.68 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.17 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -110.71 143.23 41.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.194 0.998 . . . . 0.0 108.746 170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.63 15.28 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.28 125.05 22.36 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.062 0.545 . . . . 0.0 110.986 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.29 128.88 74.17 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.615 0.766 . . . . 0.0 110.18 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 22.2 Cg_endo -59.47 138.39 83.68 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.642 2.228 . . . . 0.0 111.736 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -68.04 -27.55 66.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.245 0.618 . . . . 0.0 111.808 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 t -71.79 -16.6 62.19 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.922 0.489 . . . . 0.0 111.501 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 84.4 t80 -69.81 137.09 51.54 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 123.105 0.562 . . . . 0.0 109.736 174.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.431 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.2 pttt -164.12 156.0 14.39 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.044 0.938 . . . . 0.0 109.282 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HG3' HD13 ' A' ' 64' ' ' LEU . 29.3 Cg_exo -61.94 113.1 1.72 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.544 2.163 . . . . 0.0 111.129 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.23 -6.19 28.65 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.892 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 100' ' ' LYS . 8.7 p -83.96 150.89 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 118.189 0.995 . . . . 0.0 108.835 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 126' ' ' LYS . 46.9 mt-10 -77.16 145.12 37.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 17.0 m -136.14 154.92 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.224 1.01 . . . . 0.0 111.037 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.62 108.15 24.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 166.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.476 HD13 HD22 ' A' ' 77' ' ' LEU . 43.8 pt -96.73 142.29 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -147.26 139.6 24.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA2' ' HD2' ' A' ' 121' ' ' ARG . . . 163.93 -105.77 0.26 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -175.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.25 163.4 37.13 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.5 tp -134.56 131.45 37.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.24 147.13 33.7 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.328 0.651 . . . . 0.0 110.099 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.24 -37.82 80.91 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.266 2.644 . . . . 0.0 112.561 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.86 41.36 2.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.46 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -166.4 142.13 4.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.568 0.747 . . . . 0.0 110.545 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.86 -30.03 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.962 0.905 . . . . 0.0 110.796 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 t -90.21 134.3 34.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.164 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -75.58 127.16 32.47 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 108.549 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -83.97 105.32 14.76 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.39 112.39 19.88 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.422 ' HD2' ' HA2' ' A' ' 109' ' ' GLY . 6.5 ptm180 -68.49 -35.67 77.84 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 p -141.38 148.72 40.08 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.679 1.191 . . . . 0.0 109.094 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.9 tp -127.21 117.53 22.51 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.057 0.943 . . . . 0.0 108.493 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.7 ttp -131.45 145.98 52.04 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 82.5 p -91.07 163.36 14.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.166 0.508 . . . . 0.0 110.807 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 9.1 mtpm? -91.97 10.9 26.98 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 109.893 172.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 40.2 t -114.83 144.29 31.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 0.0 109.286 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.41 -173.92 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.566 2.178 . . . . 0.0 112.424 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.05 123.04 19.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.371 0.668 . . . . 0.0 110.516 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 125.047 1.339 . . . . 0.0 111.321 178.024 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 60.6 mtm . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.413 0.149 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.6 18.89 3.66 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.5 0.72 . . . . 0.0 112.522 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 m -66.01 119.21 59.51 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 123.31 0.644 . . . . 0.0 111.347 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.6 92.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.456 2.77 . . . . 0.0 112.665 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -87.68 39.59 0.89 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.024 0.93 . . . . 0.0 110.801 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 31.5 m-20 -75.15 1.21 13.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.055 0.942 . . . . 0.0 112.357 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -64.73 -38.6 91.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.645 0.778 . . . . 0.0 109.679 169.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.26 -26.03 26.9 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.536 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 48' ' ' ASP . 56.8 m170 -85.3 114.81 22.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.153 0.581 . . . . 0.0 110.676 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.643 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 25.4 p -103.0 109.0 20.38 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.285 1.034 . . . . 0.0 109.658 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 85.7 t -100.34 133.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.777 1.231 . . . . 0.0 108.688 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttt85 -96.59 107.74 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 77' ' ' LEU . 4.2 tt -116.66 141.0 48.77 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -120.75 143.6 48.7 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.946 0.898 . . . . 0.0 109.755 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.57 -162.06 27.51 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 7.6 m -131.31 140.28 49.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.005 0.922 . . . . 0.0 109.565 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.0 131.72 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.215 1.006 . . . . 0.0 111.555 -173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.561 ' HB3' ' HG3' ' A' ' 76' ' ' ARG . . . -94.56 154.39 17.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.226 0.611 . . . . 0.0 110.947 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 -36.66 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.584 0.753 . . . . 0.0 110.758 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -80.58 78.52 7.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.233 0.613 . . . . 0.0 109.881 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.8 0.82 2.48 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.022 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.494 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.7 tt -78.37 94.45 4.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 74' ' ' ARG . 86.5 m -103.07 110.63 22.63 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.688 1.195 . . . . 0.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.4 mmt -80.5 117.53 21.31 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.46 123.86 18.17 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 123.637 0.586 . . . . 0.0 111.223 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -71.61 99.89 2.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.983 0.913 . . . . 0.0 110.405 -171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.25 -36.92 2.89 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.563 -0.29 . . . . 0.0 112.995 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.74 131.41 87.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.344 0.657 . . . . 0.0 110.317 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.11 113.03 2.68 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.287 1.991 . . . . 0.0 111.059 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.02 -172.01 29.94 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.798 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.04 133.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.842 0.857 . . . . 0.0 110.179 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 4.8 tpp180 -92.73 141.94 27.91 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.27 174.86 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.581 0.752 . . . . 0.0 109.043 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.95 117.0 32.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.419 HD23 HD22 ' A' ' 55' ' ' LEU . 28.9 tp -80.15 109.77 14.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.834 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 60' ' ' ALA . 43.2 mt-10 -71.92 100.87 2.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.23 144.0 47.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.972 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -68.16 -17.41 64.34 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.61 -46.2 6.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.542 0.737 . . . . 0.0 110.21 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.53 127.83 43.14 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.792 0.437 . . . . 0.0 111.516 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -117.8 -12.39 10.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.543 0.737 . . . . 0.0 110.503 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 m -61.4 -23.31 65.72 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.397 0.679 . . . . 0.0 110.321 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -138.69 111.7 7.88 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 164.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.3 p -83.49 158.63 21.95 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.38 0.672 . . . . 0.0 109.647 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -99.99 115.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -77.86 130.72 36.99 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.31 117.58 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 123.532 0.733 . . . . 0.0 109.348 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.6 tp -99.86 92.11 5.14 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -86.04 124.22 32.24 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.57 123.1 49.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.307 0.643 . . . . 0.0 109.725 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.72 -174.98 22.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 114.95 8.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.156 0.582 . . . . 0.0 110.189 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.82 133.46 51.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.999 0.92 . . . . 0.0 109.678 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 123' ' ' LEU . 55.4 Cg_endo -67.83 150.81 78.84 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.485 2.124 . . . . 0.0 112.139 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.87 -21.61 64.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.88 0.472 . . . . 0.0 110.459 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.8 p -70.46 -19.4 62.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.233 1.013 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -69.55 105.98 2.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.537 0.735 . . . . 0.0 109.462 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 103' ' ' VAL . 37.1 mtmm -131.99 156.56 79.96 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.74 1.216 . . . . 0.0 109.853 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HG3' HD13 ' A' ' 64' ' ' LEU . 27.9 Cg_exo -63.02 103.51 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.713 2.275 . . . . 0.0 111.509 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.16 -3.36 18.8 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 119.202 -0.776 . . . . 0.0 113.579 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 100' ' ' LYS . 7.9 p -79.17 139.39 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 118.309 1.054 . . . . 0.0 109.777 174.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.8 mt-10 -71.36 138.87 49.56 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 125' ' ' THR . 35.0 m -135.01 152.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-O 121.707 0.765 . . . . 0.0 110.724 175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.66 109.72 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.6 pt -98.15 152.81 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 31.8 tt0 -152.25 132.54 13.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.6 -147.64 11.56 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.44 133.06 9.05 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 118.392 1.096 . . . . 0.0 114.267 -174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.38 124.75 52.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.905 1.282 . . . . 0.0 108.822 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.4 138.48 41.67 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.58 -33.82 93.16 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.03 2.487 . . . . 0.0 113.175 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.74 -11.36 82.97 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.27 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.06 141.98 34.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.011 0.925 . . . . 0.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -88.48 -33.65 17.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.248 0.619 . . . . 0.0 110.534 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -83.89 129.09 34.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -79.35 121.22 24.86 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 119' ' ' LYS . 3.4 ttpm? -89.34 97.26 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.93 125.31 28.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.933 0.493 . . . . 0.0 110.591 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -79.58 -38.13 34.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.512 1.125 . . . . 0.0 109.251 172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -133.06 133.81 43.5 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.409 1.084 . . . . 0.0 108.699 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.544 HD23 ' HD2' ' A' ' 96' ' ' PRO . 53.9 tp -117.89 108.99 15.99 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.6 ttm -102.82 125.21 49.47 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.5 p -82.25 123.49 29.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -69.46 -40.47 77.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.289 1.035 . . . . 0.0 108.516 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.5 m -83.02 116.13 62.58 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -85.63 173.71 7.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.951 2.434 . . . . 0.0 115.35 -171.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 21.3 tp -72.29 161.56 30.68 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.414 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.567 1.598 0 CA-C-O 121.155 0.502 . . . . 0.0 110.146 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.71 99.49 7.35 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.722 0.809 . . . . 0.0 109.522 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -73.21 124.18 90.3 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.217 0.607 . . . . 0.0 109.831 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.53 134.59 62.02 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.385 2.057 . . . . 0.0 110.771 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.49 89.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.639 0.776 . . . . 0.0 111.231 -170.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -90.35 114.07 26.08 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.207 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -86.26 -33.1 20.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.976 0.91 . . . . 0.0 109.683 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.12 18.71 0.36 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.592 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -67.83 79.22 0.2 Allowed 'General case' 0 C--N 1.364 1.23 0 CA-C-O 122.328 1.061 . . . . 0.0 111.725 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p -125.46 149.2 48.45 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.44 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.2 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -97.79 108.2 20.87 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD22 HD23 ' A' ' 77' ' ' LEU . 4.0 tt -111.86 125.8 54.41 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -172.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.02 144.88 27.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.536 0.735 . . . . 0.0 109.123 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.79 -160.57 29.77 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.522 -0.371 . . . . 0.0 112.599 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 30.0 m -127.82 140.79 51.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.027 0.931 . . . . 0.0 109.676 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.94 133.27 31.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.36 43.55 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.484 0.49 . . . . 0.0 111.662 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.77 36.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.16 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.97 96.04 7.28 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.855 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.17 73.11 0.65 Allowed Glycine 0 N--CA 1.465 0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.138 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.6 tt -150.41 125.99 10.25 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.3 m -140.24 125.28 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.323 1.049 . . . . 0.0 109.332 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.1 mtp -96.91 162.64 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.136 0.574 . . . . 0.0 109.722 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.5 mt -86.48 105.86 17.08 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -63.71 114.88 4.27 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.915 0.886 . . . . 0.0 111.563 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.97 77.09 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.529 0.518 . . . . 0.0 113.624 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.94 142.23 44.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.38 1.072 . . . . 0.0 109.764 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.44 87.76 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.474 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 175.39 163.66 28.68 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.613 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 p -157.26 134.84 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.985 0.914 . . . . 0.0 110.115 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -103.89 137.29 42.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.196 0.998 . . . . 0.0 108.311 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 46.3 p90 -158.2 173.07 17.26 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -104.91 122.57 46.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 HD22 ' A' ' 55' ' ' LEU . 23.5 tp -83.86 116.19 22.63 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.78 118.93 24.76 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 157.06 18.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.342 0.657 . . . . 0.0 112.486 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -35.11 -55.29 0.61 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.726 2.01 . . . . 0.0 113.343 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -129.88 -30.43 2.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.768 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -77.97 95.83 4.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.751 0.42 . . . . 0.0 110.375 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -65.63 -17.96 64.97 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.366 0.666 . . . . 0.0 110.8 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 p -67.39 -46.64 72.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.484 1.114 . . . . 0.0 111.822 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -74.13 84.04 1.82 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.186 0.594 . . . . 0.0 111.366 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 p -103.16 97.65 7.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.3 134.46 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -79.63 144.02 34.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.29 118.36 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.865 0.866 . . . . 0.0 108.746 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.34 93.23 7.14 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -85.37 113.31 21.58 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -111.16 122.94 49.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.45 172.53 18.43 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.88 113.5 1.89 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.251 0.526 . . . . 0.0 110.926 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.86 120.4 81.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.82 146.09 80.16 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.896 2.397 . . . . 0.0 113.713 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.87 -27.5 68.27 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.654 0.782 . . . . 0.0 109.835 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.7 p -78.87 -7.66 58.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.96 1.304 . . . . 0.0 112.278 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.7 t80 -75.66 140.61 42.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.805 0.442 . . . . 0.0 109.817 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 61.0 pttt -162.07 161.45 21.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.955 0.902 . . . . 0.0 109.709 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.8 100.34 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.102 1.868 . . . . 0.0 111.519 167.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.68 -8.57 8.77 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.131 -0.816 . . . . 0.0 114.25 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.512 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 14.5 p -71.46 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 118.54 1.17 . . . . 0.0 111.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 39.7 mt-10 -72.61 125.56 27.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 171.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 103' ' ' VAL . 27.9 m -128.16 155.61 39.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.898 0.856 . . . . 0.0 111.753 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 62.4 mt -114.75 107.93 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 123' ' ' LEU . 29.6 pt -97.82 155.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.89 138.19 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 121' ' ' ARG . . . 172.0 -127.04 1.35 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.755 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.37 153.0 24.45 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 117.043 0.421 . . . . 0.0 112.456 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 139.9 53.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.474 1.109 . . . . 0.0 108.727 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 136.0 45.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.51 109.69 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.204 . . . . 0.0 113.246 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.61 5.74 53.6 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.077 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.573 ' HG2' ' H ' ' A' ' 117' ' ' THR . 48.7 tt0 -96.53 153.09 18.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.596 0.759 . . . . 0.0 109.738 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.97 0.67 23.89 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.237 1.015 . . . . 0.0 111.213 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.573 ' H ' ' HG2' ' A' ' 115' ' ' GLU . 8.8 t -134.05 119.89 19.52 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.413 0.625 . . . . 0.0 110.453 -173.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -84.69 134.41 34.36 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.622 1.169 . . . . 0.0 110.25 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -95.14 111.31 23.16 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.71 116.68 28.76 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.42 ' HG3' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -79.03 -23.36 44.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.143 0.577 . . . . 0.0 110.886 173.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -137.71 152.18 48.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.878 0.871 . . . . 0.0 110.045 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 107' ' ' ILE . 23.1 tp -136.92 123.5 20.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.645 1.178 . . . . 0.0 108.233 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 41.5 ttm -119.87 95.11 4.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.728 0.411 . . . . 0.0 110.282 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.4 p -75.19 137.43 41.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.339 0.656 . . . . 0.0 110.455 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -94.87 -13.48 25.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.906 . . . . 0.0 110.85 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.475 ' SG ' HG23 ' A' ' 103' ' ' VAL . 67.2 m -88.6 105.95 11.29 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.077 0.551 . . . . 0.0 110.449 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.18 86.68 1.4 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.089 2.526 . . . . 0.0 111.125 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.08 111.51 2.22 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.368 0.667 . . . . 0.0 109.836 -178.109 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.537 ' HG3' HG23 ' A' ' 45' ' ' THR . 12.0 tpt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 85.23 6.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.632 0.773 . . . . 0.0 109.75 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 43' ' ' MET . 49.2 p -79.96 123.78 83.44 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.205 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 105.44 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.77 2.313 . . . . 0.0 110.223 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.12 117.71 3.46 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.878 0.871 . . . . 0.0 111.765 -169.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -77.78 119.25 21.02 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.59 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -119.03 -34.83 3.78 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.812 1.245 . . . . 0.0 109.607 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -77.35 -34.9 55.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.73 -169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -88.34 76.22 8.37 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.2 m -72.67 123.28 22.95 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.72 143.89 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -138.34 136.23 36.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.512 0.725 . . . . 0.0 109.814 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.24 163.97 21.35 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.6 0.714 . . . . 0.0 110.549 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -138.44 132.29 31.13 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.801 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.33 -161.39 33.85 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 5.0 m -124.14 146.15 48.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.07 127.83 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.933 0.893 . . . . 0.0 110.277 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 140.07 43.8 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.309 0.644 . . . . 0.0 110.13 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.02 55.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.084 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.6 124.13 51.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.575 0.75 . . . . 0.0 109.406 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.17 -0.94 43.91 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.567 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.49 96.12 4.02 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.7 m -118.57 121.07 39.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.435 1.094 . . . . 0.0 109.904 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.5 mmt -84.36 136.07 34.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.99 127.95 34.45 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.628 0.58 . . . . 0.0 111.506 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.23 117.25 12.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.678 0.791 . . . . 0.0 110.09 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.83 33.1 84.18 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.456 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.33 136.63 8.77 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 110.102 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.76 109.69 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.332 2.021 . . . . 0.0 110.709 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.76 171.4 33.68 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.466 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -150.62 153.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.65 0.78 . . . . 0.0 110.062 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 47.4 ttp180 -124.66 142.25 51.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -159.45 172.95 16.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.283 0.633 . . . . 0.0 109.316 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 87.6 mtm-85 -101.58 113.08 25.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.62 111.95 9.25 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 86' ' ' THR . 36.7 mt-10 -72.36 110.44 6.78 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 2.1 m-20 -64.0 146.36 54.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.003 0.521 . . . . 0.0 111.458 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -66.02 -37.41 85.82 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.863 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.64 -55.5 3.75 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.573 0.749 . . . . 0.0 110.229 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 79' ' ' ASP . 94.6 m-20 -75.95 113.16 13.15 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -89.15 -24.59 22.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.306 0.643 . . . . 0.0 111.014 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 m -101.27 -3.35 29.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.942 0.897 . . . . 0.0 111.936 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 9.7 mmpt? -126.74 127.96 45.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.916 0.486 . . . . 0.0 110.796 -176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 78' ' ' GLU . 68.3 p -125.54 132.21 52.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.27 1.028 . . . . 0.0 108.339 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.79 143.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -74.92 142.33 44.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 49.1 t -127.62 108.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.5 tp -93.26 92.97 7.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -91.37 116.59 28.96 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.235 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -108.35 114.3 28.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.93 170.97 23.31 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 113.0 3.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.778 0.431 . . . . 0.0 110.329 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.5 t -81.67 122.47 80.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 122.955 0.502 . . . . 0.0 110.126 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HD2' HD23 ' A' ' 123' ' ' LEU . 28.4 Cg_endo -60.74 148.49 91.68 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.761 2.307 . . . . 0.0 111.964 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.27 -16.3 61.92 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.417 0.687 . . . . 0.0 110.827 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.3 p -71.6 -23.69 61.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.149 0.98 . . . . 0.0 110.696 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' HA ' HG11 ' A' ' 103' ' ' VAL . 70.4 t80 -71.94 134.75 46.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.831 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -171.36 161.3 5.18 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.8 0.84 . . . . 0.0 109.435 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.1 105.68 0.41 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.276 1.984 . . . . 0.0 111.89 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.78 -10.8 11.17 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.754 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 99' ' ' PHE . 9.6 p -74.55 145.16 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.782 0.791 . . . . 0.0 109.654 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.3 mt-10 -84.32 138.67 32.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.69 155.32 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.036 0.922 . . . . 0.0 111.305 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.6 mt -115.17 108.51 25.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 18.4 pt -100.87 132.6 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.419 0.688 . . . . 0.0 109.859 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -127.97 130.81 49.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.57 -108.01 0.27 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.17 142.63 5.86 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.715 0.757 . . . . 0.0 113.222 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.4 tp -93.87 126.4 39.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.903 0.881 . . . . 0.0 109.112 171.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . . . -83.25 138.33 42.19 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 123.436 0.46 . . . . 0.0 109.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.89 -17.68 60.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.887 2.392 . . . . 0.0 113.726 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.68 -10.67 18.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.504 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 28.3 tt0 -117.07 120.98 40.0 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.13 -20.94 63.15 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.562 0.745 . . . . 0.0 112.709 -168.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -88.37 135.62 33.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.42 113.79 14.4 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 26.9 ttmt -85.7 94.57 9.13 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.66 123.05 27.29 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.52 0.728 . . . . 0.0 109.849 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -80.32 -41.22 25.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.255 0.622 . . . . 0.0 109.639 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.7 p -131.53 136.13 47.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.485 1.114 . . . . 0.0 108.843 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 96' ' ' PRO . 59.6 tp -113.11 133.9 54.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.412 1.085 . . . . 0.0 108.632 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.9 ttp -136.29 103.05 5.17 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.786 0.434 . . . . 0.0 110.106 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.4 p -72.56 140.78 48.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.396 0.678 . . . . 0.0 110.012 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -67.84 -48.19 66.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.594 0.758 . . . . 0.0 110.797 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.1 t -75.45 131.59 77.3 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.4 -165.96 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.841 2.361 . . . . 0.0 112.183 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.2 tp -66.41 99.05 0.53 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.135 0.974 . . . . 0.0 109.865 -173.215 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 107.31 5.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.375 0.67 . . . . 0.0 109.271 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -113.83 84.72 8.78 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.277 1.031 . . . . 0.0 109.847 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -87.61 155.8 7.68 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.035 2.49 . . . . 0.0 112.452 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -91.49 118.07 30.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 109.288 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.43 -3.88 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.831 0.852 . . . . 0.0 111.477 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -58.06 -42.39 85.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.779 1.232 . . . . 0.0 111.343 172.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.34 75.99 4.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.74 -172.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -138.73 64.82 1.47 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.379 1.072 . . . . 0.0 108.62 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.4 m -133.1 137.27 46.27 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.554 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 134.19 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.489 HH21 HD13 ' A' ' 106' ' ' ILE . 55.3 ttt180 -122.26 119.71 31.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.513 0.725 . . . . 0.0 109.219 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.43 161.2 20.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.585 0.754 . . . . 0.0 109.912 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -135.43 136.99 41.8 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.938 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 79' ' ' ASP . . . 176.52 -162.8 31.59 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.028 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -122.31 139.21 54.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.006 0.922 . . . . 0.0 109.749 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.64 130.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.618 1.167 . . . . 0.0 110.631 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.98 139.79 38.14 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.922 0.489 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -72.92 -40.44 65.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.311 0.644 . . . . 0.0 110.092 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.35 115.51 19.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.715 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 42.85 5.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.471 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 101' ' ' PRO . 6.7 tt -111.85 99.46 8.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -109.79 116.66 32.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.301 1.04 . . . . 0.0 109.711 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.51 ' HG2' HG23 ' A' ' 73' ' ' VAL . 66.5 mtp -89.48 132.6 34.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.495 HD12 ' HA3' ' A' ' 72' ' ' GLY . 76.6 mt -63.39 126.48 27.61 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.658 0.598 . . . . 0.0 111.013 -172.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.63 132.22 33.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.914 0.885 . . . . 0.0 109.762 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.75 68.46 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.472 0.482 . . . . 0.0 113.661 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 138.47 10.15 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.07 0.948 . . . . 0.0 109.149 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 112.73 2.8 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.469 2.113 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 167.25 175.14 37.01 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 121.387 0.437 . . . . 0.0 113.402 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 95' ' ' VAL . 8.1 p -146.91 161.3 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.949 0.9 . . . . 0.0 109.486 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -137.66 136.01 37.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -152.67 161.66 42.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.174 0.59 . . . . 0.0 109.758 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.62 104.98 17.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 tp -73.52 132.39 42.82 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.22 100.7 6.65 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -54.03 141.3 28.77 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.097 0.873 . . . . 0.0 111.84 -171.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' H ' ' HA2' ' A' ' 57' ' ' GLY . 62.3 tttm -52.41 -42.68 64.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.388 1.075 . . . . 0.0 111.245 -171.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.99 -55.39 3.36 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.437 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -94.89 67.35 3.16 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.827 0.822 . . . . 0.0 110.555 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -73.3 -15.24 61.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.892 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 m -64.59 -22.98 67.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.252 1.021 . . . . 0.0 111.25 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -98.85 96.16 7.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.4 p -92.78 104.55 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.66 139.91 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.328 1.051 . . . . 0.0 109.647 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.05 133.1 33.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 168.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.91 120.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -103.81 112.22 25.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -107.98 121.55 45.02 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.857 0.863 . . . . 0.0 108.915 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -103.53 117.72 35.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.654 0.782 . . . . 0.0 109.165 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.47 176.59 17.65 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.0 115.67 5.14 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.665 0.386 . . . . 0.0 110.043 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 73' ' ' VAL . 43.2 t -80.11 127.45 76.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.454 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD2' HD23 ' A' ' 123' ' ' LEU . 93.2 Cg_exo -47.22 138.89 16.66 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.495 2.797 . . . . 0.0 112.769 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.01 -24.13 65.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.39 0.676 . . . . 0.0 111.358 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -75.45 -13.23 60.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.959 0.904 . . . . 0.0 111.883 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -72.72 135.83 45.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.3 pttt -156.6 163.42 25.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.195 0.998 . . . . 0.0 108.741 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 28.9 Cg_exo -64.08 111.86 1.7 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.42 2.08 . . . . 0.0 111.41 168.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.49 0.57 37.43 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.727 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 7.4 p -77.87 149.55 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.847 0.824 . . . . 0.0 110.067 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.41 134.8 35.24 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 103' ' ' VAL . 18.6 m -129.89 161.74 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.971 0.908 . . . . 0.0 111.65 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.489 HD13 HH21 ' A' ' 54' ' ' ARG . 62.8 mt -119.11 111.7 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 113.452 -1.704 . . . . 0.0 107.016 168.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 118' ' ' PHE . 29.4 pt -100.37 142.1 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.451 0.7 . . . . 0.0 109.27 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 8.0 tp10 -139.48 124.99 19.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.59 -106.08 0.23 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.55 143.29 5.16 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 117.787 0.793 . . . . 0.0 112.616 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.2 tp -90.7 116.29 28.45 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.64 126.93 72.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.163 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.66 95.28 0.11 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.845 2.363 . . . . 0.0 111.786 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.56 -41.04 1.27 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.63 135.29 33.57 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.949 0.899 . . . . 0.0 109.985 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.81 -26.86 57.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.132 0.573 . . . . 0.0 110.043 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -84.46 136.04 34.0 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.129 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 107' ' ' ILE . 36.6 t80 -77.6 119.55 21.32 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.27 96.68 10.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.91 115.83 17.04 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.432 0.693 . . . . 0.0 110.044 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -79.45 -41.43 27.58 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.056 0.942 . . . . 0.0 109.631 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 75.0 p -132.28 140.88 48.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.39 1.076 . . . . 0.0 108.18 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.405 HD23 ' HD2' ' A' ' 96' ' ' PRO . 46.9 tp -127.29 143.38 51.24 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.946 0.499 . . . . 0.0 110.056 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.8 ttp -153.64 148.26 26.26 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 56.9 p -83.11 152.9 25.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -89.16 -34.8 16.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 109.516 175.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.9 p -113.1 118.02 44.92 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.753 0.821 . . . . 0.0 109.472 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -82.56 167.69 14.93 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.657 2.238 . . . . 0.0 112.342 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.69 95.03 3.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.269 0.628 . . . . 0.0 110.01 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.955 0.902 . . . . 0.0 109.82 -174.973 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.45 96.78 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.739 0.816 . . . . 0.0 111.814 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.9 m -64.39 113.97 12.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.955 0.902 . . . . 0.0 110.912 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -98.27 -152.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.563 2.842 . . . . 0.0 110.49 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 70.4 1.38 3.59 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.226 1.01 . . . . 0.0 112.339 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.2 157.53 26.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.284 0.634 . . . . 0.0 110.539 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -97.37 22.07 9.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.492 0.717 . . . . 0.0 111.381 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.1 11.07 10.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.003 0.521 . . . . 0.0 111.474 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -67.36 -36.51 81.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.422 0.689 . . . . 0.0 110.054 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -69.94 152.79 44.07 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.76 106.02 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.613 ' NH1' HG22 ' A' ' 106' ' ' ILE . 22.5 tpp180 -89.67 127.91 35.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 tt -132.82 130.35 39.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.628 ' HB2' ' HD2' ' A' ' 80' ' ' LYS . 42.1 m-85 -108.45 139.0 43.82 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.96 -168.62 36.48 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 143.29 50.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.172 0.589 . . . . 0.0 110.604 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.23 119.59 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' HH21 ' A' ' 76' ' ' ARG . . . -69.89 142.85 52.93 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.664 0.602 . . . . 0.0 110.122 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.2 84.42 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.01 117.72 21.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.126 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.64 64.45 1.06 Allowed Glycine 0 C--N 1.339 0.702 0 O-C-N 123.444 0.465 . . . . 0.0 112.199 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tt -133.33 101.82 5.32 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -111.85 116.95 31.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.684 0.793 . . . . 0.0 110.342 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mmm -85.13 145.07 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.438 0.695 . . . . 0.0 109.959 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.475 HD12 ' HA3' ' A' ' 72' ' ' GLY . 86.6 mt -85.34 126.53 33.82 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.1 140.54 35.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.38 3.4 89.98 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 123.48 0.487 . . . . 0.0 113.433 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.4 140.3 4.13 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.103 0.961 . . . . 0.0 110.093 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.61 113.37 2.7 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.203 . . . . 0.0 111.734 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 171.45 173.11 38.16 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.394 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.75 138.15 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.331 1.053 . . . . 0.0 110.223 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 16.3 ttm180 -108.0 137.08 46.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 165.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.04 154.27 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.482 HH21 ' HB1' ' A' ' 60' ' ' ALA . 18.6 ttp180 -92.84 96.88 10.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 tp -78.41 138.32 38.44 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.483 0.713 . . . . 0.0 110.225 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.607 ' HG2' HG22 ' A' ' 86' ' ' THR . 31.3 mt-10 -102.96 113.16 26.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 13.9 t70 -58.58 130.32 46.25 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 123.81 0.694 . . . . 0.0 109.631 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.628 ' HD2' ' HB2' ' A' ' 56' ' ' PHE . 21.3 ptmt -62.73 -28.63 70.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.935 0.894 . . . . 0.0 113.187 -169.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -92.77 -33.37 14.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.879 0.472 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' ASP . 8.9 t-20 -139.15 95.58 2.97 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.922 0.392 . . . . 0.0 110.156 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -68.76 -16.86 63.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.482 0.713 . . . . 0.0 111.469 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -55.83 -27.07 49.66 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.755 0.822 . . . . 0.0 111.42 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -98.93 82.57 2.78 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.74 0.816 . . . . 0.0 109.161 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.607 HG22 ' HG2' ' A' ' 78' ' ' GLU . 40.9 p -89.96 100.03 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 167.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.5 t -102.85 141.74 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.117 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -79.27 136.63 37.1 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 91.5 t -123.39 118.43 54.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.83 92.28 7.85 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -94.59 116.0 28.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -112.46 144.27 42.19 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.05 -172.31 19.13 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.97 111.38 3.3 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.307 0.643 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.67 123.47 84.03 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.519 0.727 . . . . 0.0 109.09 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.98 145.71 68.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.173 1.915 . . . . 0.0 111.389 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.77 -16.79 64.5 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.591 0.756 . . . . 0.0 111.356 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.3 p -76.45 -19.9 57.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.42 1.088 . . . . 0.0 112.144 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -68.37 126.66 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.223 0.609 . . . . 0.0 109.542 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 103' ' ' VAL . 17.1 ptmt -156.06 165.82 17.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.191 0.596 . . . . 0.0 110.958 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.86 113.01 3.41 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.864 1.709 . . . . 0.0 110.955 170.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.08 -8.01 16.41 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.353 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 105' ' ' VAL . 12.7 p -83.02 142.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 117.425 0.612 . . . . 0.0 111.787 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.84 111.18 9.78 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 103' ' ' VAL . 27.7 m -105.7 153.6 7.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.792 0.805 . . . . 0.0 110.53 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.613 HG22 ' NH1' ' A' ' 54' ' ' ARG . 49.4 mt -122.18 105.59 16.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.2 pt -101.45 154.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.328 0.651 . . . . 0.0 110.246 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.2 tt0 -140.56 123.24 16.23 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 173.56 -121.18 0.84 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.77 166.71 39.9 Favored Glycine 0 C--O 1.241 0.556 0 CA-C-N 117.446 0.623 . . . . 0.0 112.441 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.6 tp -138.3 134.42 34.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.53 129.6 50.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 88.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.922 2.415 . . . . 0.0 111.91 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.65 -36.72 1.42 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -171.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.96 147.95 48.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.762 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.47 -45.02 11.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.728 0.811 . . . . 0.0 111.457 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -109.43 131.87 54.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.12 0.486 . . . . 0.0 111.002 -165.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.75 115.09 16.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.77 96.22 8.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.34 112.07 19.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.902 0.881 . . . . 0.0 110.156 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -60.16 -40.85 91.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.397 1.079 . . . . 0.0 110.399 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 1.7 m -135.41 149.31 49.59 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.885 -167.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.5 tp -137.21 140.33 41.64 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.259 1.024 . . . . 0.0 108.81 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 ttp -152.77 111.97 3.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 109.664 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 105' ' ' VAL . 54.3 p -73.21 124.27 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -81.77 -34.27 30.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.165 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.7 m -99.15 91.91 1.53 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.42 141.35 38.53 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.833 1.689 . . . . 0.0 111.813 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.33 91.14 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 170.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.563 1.447 0 C-N-CA 125.167 1.387 . . . . 0.0 109.916 -175.689 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.64 102.37 14.9 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -110.66 97.78 34.36 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.391 0.677 . . . . 0.0 110.508 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.09 54.44 5.23 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.345 2.697 . . . . 0.0 110.857 170.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.45 99.42 12.0 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.629 0.772 . . . . 0.0 110.387 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.41 170.61 14.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.629 1.172 . . . . 0.0 109.398 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.31 19.33 6.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.666 . . . . 0.0 109.561 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.49 -42.11 83.44 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.891 0.876 . . . . 0.0 108.838 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.32 83.87 5.31 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 166.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.3 m -64.15 144.57 57.02 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.369 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -97.97 112.7 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -104.68 116.99 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.89 142.68 36.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -119.1 147.87 43.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.72 -170.3 43.4 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.7 m -116.37 140.65 49.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.271 1.028 . . . . 0.0 109.083 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -76.98 126.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.38 0.672 . . . . 0.0 110.238 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.62 150.56 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.394 0.678 . . . . 0.0 111.043 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.66 -31.69 41.49 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.358 0.599 . . . . 0.0 109.671 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.35 100.11 12.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.435 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.55 71.11 0.97 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 tt -144.82 104.59 4.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.1 m -125.17 119.04 27.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.894 1.278 . . . . 0.0 109.233 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.7 mtp -89.9 142.93 27.23 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.88 122.41 17.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 110.478 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.35 123.21 28.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.375 0.67 . . . . 0.0 109.879 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.37 72.21 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 123.607 0.567 . . . . 0.0 112.988 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.23 144.18 16.84 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.049 0.939 . . . . 0.0 109.33 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.88 117.29 4.87 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.262 1.975 . . . . 0.0 110.844 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.48 -175.04 30.5 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.287 174.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.44 132.17 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.319 1.048 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -92.98 131.25 38.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.1 159.63 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.233 0.54 . . . . 0.0 110.885 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -95.59 112.06 23.86 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.289 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.43 117.57 30.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.453 0.701 . . . . 0.0 109.88 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.45 107.9 18.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.241 1.016 . . . . 0.0 109.789 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.54 107.01 1.04 Allowed 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -48.85 -29.96 5.24 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -168.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -92.26 -48.77 6.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.461 0.704 . . . . 0.0 109.321 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.41 50.23 0.83 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.205 1.002 . . . . 0.0 109.296 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -77.6 -6.46 53.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.862 -170.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 m -63.52 -30.84 71.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.457 0.703 . . . . 0.0 110.586 169.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -98.63 83.33 2.97 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.2 p -86.6 111.31 20.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.87 137.15 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.63 144.94 29.95 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.4 t -132.38 121.91 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.87 94.01 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -83.38 118.42 23.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -109.1 111.02 22.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.09 174.22 28.51 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.79 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.27 115.04 5.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.967 0.507 . . . . 0.0 110.161 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -81.25 113.95 45.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.063 0.545 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 123' ' ' LEU . 56.2 Cg_endo -67.28 151.76 80.33 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.443 2.096 . . . . 0.0 111.611 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.01 -16.94 64.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.519 1.127 . . . . 0.0 112.199 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 96' ' ' PRO . 12.2 t -70.55 -24.25 62.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.91 0.884 . . . . 0.0 111.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -68.04 121.6 16.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.752 0.821 . . . . 0.0 109.289 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 103' ' ' VAL . 23.6 pttm -165.62 157.54 12.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.431 0.693 . . . . 0.0 110.077 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.22 117.25 3.93 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.178 1.919 . . . . 0.0 111.758 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.49 -17.51 10.32 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.326 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 100' ' ' LYS . 6.0 p -95.06 147.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.863 0.831 . . . . 0.0 110.045 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -85.97 130.37 34.56 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 HG22 ' A' ' 125' ' ' THR . 27.6 m -111.03 155.55 12.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.857 0.837 . . . . 0.0 110.784 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.78 121.07 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.48 129.71 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.155 0.582 . . . . 0.0 110.503 -171.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.37 151.2 25.82 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.19 -119.63 0.89 Allowed Glycine 0 C--O 1.24 0.53 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.4 163.57 29.58 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.731 0.312 . . . . 0.0 112.606 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.0 tp -130.35 118.61 21.51 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 133.81 44.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.74 -24.3 41.05 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.679 2.253 . . . . 0.0 113.046 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.14 -18.1 78.85 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.558 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -108.61 156.61 19.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.141 0.977 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -109.61 26.39 10.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.715 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -133.96 121.22 21.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.353 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.29 130.59 35.61 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 108.945 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.78 117.2 31.55 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.699 0.682 . . . . 0.0 109.186 174.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.76 128.69 55.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.94 0.896 . . . . 0.0 109.974 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -98.82 -8.87 25.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.8 0.44 . . . . 0.0 110.171 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -134.81 152.16 51.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.718 1.207 . . . . 0.0 109.637 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 96' ' ' PRO . 37.3 tp -150.79 109.88 3.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.126 0.97 . . . . 0.0 108.385 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -135.93 114.03 11.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.648 0.779 . . . . 0.0 109.673 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.455 HG22 HG12 ' A' ' 105' ' ' VAL . 77.3 p -78.12 151.25 33.44 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.46 -40.09 57.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.5 t -101.82 111.39 64.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.983 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.08 153.47 77.58 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.42 2.08 . . . . 0.0 110.621 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.435 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 1.8 pt? -62.22 132.7 53.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.893 0.477 . . . . 0.0 110.755 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.866 0.866 . . . . 0.0 110.453 -174.167 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.56 28.1 0.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.053 0.941 . . . . 0.0 109.583 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.8 p 57.91 123.8 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 126.228 1.811 . . . . 0.0 111.906 -169.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.35 151.9 27.9 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.712 2.275 . . . . 0.0 112.409 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -56.87 130.44 45.8 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.84 0.712 . . . . 0.0 110.693 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.668 ' HB2' ' HB2' ' A' ' 51' ' ' HIS . 7.4 p-10 -55.84 137.99 49.11 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.473 1.108 . . . . 0.0 112.531 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -84.33 -62.99 1.42 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.529 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -117.79 -51.94 2.45 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 13.4 t-80 58.08 20.51 7.0 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.531 1.132 . . . . 0.0 111.509 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -75.14 137.97 41.72 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.265 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -105.87 133.09 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -118.97 127.08 53.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.342 0.657 . . . . 0.0 109.505 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.6 mt -125.86 172.37 9.93 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.903 0.881 . . . . 0.0 109.785 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.424 ' HB2' ' HD2' ' A' ' 80' ' ' LYS . 51.2 m-85 -135.26 147.89 49.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.776 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -170.74 42.15 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.6 m -121.54 144.34 48.78 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.37 115.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.34 0.656 . . . . 0.0 110.5 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.56 148.16 31.85 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.54 -5.66 46.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.648 0.779 . . . . 0.0 111.231 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.86 129.79 36.18 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.389 1.076 . . . . 0.0 110.05 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.31 15.69 78.85 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.266 0.354 . . . . 0.0 113.889 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.49 89.56 3.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -111.81 124.85 53.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.523 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.1 mmm -80.78 139.7 35.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.7 mt -67.53 133.26 49.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.3 0.5 . . . . 0.0 110.915 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -86.76 118.49 26.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.372 0.669 . . . . 0.0 109.857 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.54 5.0 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.486 0.491 . . . . 0.0 112.282 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.26 139.9 75.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.074 0.55 . . . . 0.0 110.108 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.64 135.79 24.59 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 121.986 1.791 . . . . 0.0 111.929 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.87 -168.58 26.4 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.631 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.18 132.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.381 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 79.3 ttt180 -102.6 138.17 39.86 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 170.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -158.13 168.21 27.71 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.919 0.488 . . . . 0.0 110.492 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -93.4 124.59 37.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 107' ' ' ILE . 21.0 tp -105.26 125.76 51.34 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.423 0.689 . . . . 0.0 109.351 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.4 97.43 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -59.67 130.57 47.48 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.101 0.875 . . . . 0.0 111.487 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.424 ' HD2' ' HB2' ' A' ' 56' ' ' PHE . 15.1 ptmm? -66.27 -31.68 72.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.824 0.85 . . . . 0.0 111.571 -174.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.82 -50.78 11.63 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.342 0.657 . . . . 0.0 109.978 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -128.8 91.96 3.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.899 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 t -78.24 2.86 16.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.087 0.555 . . . . 0.0 111.026 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 m -87.65 16.52 5.54 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.111 0.964 . . . . 0.0 110.858 166.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -153.67 140.04 18.64 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.561 1.144 . . . . 0.0 108.953 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 19.6 p -117.19 127.91 54.58 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.69 134.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -73.77 126.24 29.92 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 86.8 t -107.57 106.25 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 tp -91.54 92.01 8.31 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -83.5 150.21 26.14 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.414 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 92' ' ' LYS . 6.7 mtmp? -137.81 122.52 18.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.724 1.21 . . . . 0.0 108.71 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 121.46 -169.01 14.41 Favored Glycine 0 C--O 1.245 0.815 0 C-N-CA 123.464 0.554 . . . . 0.0 111.774 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 116.45 7.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.272 0.629 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.11 127.83 78.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.85 0.86 . . . . 0.0 109.958 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' PHE . 19.3 Cg_endo -58.41 132.83 50.97 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.036 1.824 . . . . 0.0 110.856 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.82 -26.36 68.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.109 0.564 . . . . 0.0 111.08 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.473 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 30.8 p -72.85 -13.27 61.25 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.118 0.967 . . . . 0.0 112.122 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' PRO . 63.0 t80 -64.32 121.22 13.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.926 0.89 . . . . 0.0 109.055 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -155.04 156.15 30.92 Favored Pre-proline 0 C--O 1.244 0.787 0 C-N-CA 124.002 0.921 . . . . 0.0 109.069 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.08 99.87 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.971 1.781 . . . . 0.0 110.464 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.55 -2.22 6.52 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.985 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -94.35 141.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 118.707 1.253 . . . . 0.0 110.414 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.56 117.38 15.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 125' ' ' THR . 18.0 m -110.25 150.23 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.722 0.773 . . . . 0.0 111.183 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.53 HD12 ' SD ' ' A' ' 124' ' ' MET . 47.6 mt -105.51 111.95 36.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.552 HD13 HD22 ' A' ' 77' ' ' LEU . 28.8 pt -98.27 140.91 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.8 133.1 23.19 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 162.44 -102.7 0.21 Allowed Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.93 147.25 5.25 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 117.482 0.641 . . . . 0.0 112.254 170.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -104.0 149.21 25.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.955 0.902 . . . . 0.0 109.584 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.71 151.41 46.22 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.723 0.809 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.44 -42.66 65.87 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.418 2.745 . . . . 0.0 113.682 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.48 29.55 8.25 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.031 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.15 128.62 40.44 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 0.0 110.266 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 -4.05 53.93 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -133.78 139.18 46.16 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -72.97 119.82 17.74 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 24.8 ttpt -70.26 96.23 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 89' ' ' VAL . . . -86.39 102.34 13.94 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.348 0.594 . . . . 0.0 109.524 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -62.98 -41.49 99.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.66 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -135.57 143.4 45.64 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.539 -169.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 tp -136.25 125.13 24.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' HD12 ' A' ' 106' ' ' ILE . 31.9 ttm -121.47 151.42 40.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 HG12 ' A' ' 105' ' ' VAL . 72.5 p -108.6 145.43 34.9 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -85.82 -34.74 21.0 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.773 0.32 . . . . 0.0 110.297 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 14.4 t -121.79 129.47 25.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.424 0.69 . . . . 0.0 110.04 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.55 -170.19 0.89 Allowed 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.213 2.609 . . . . 0.0 113.892 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 98' ' ' THR . 96.3 mt -92.08 102.71 15.25 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.397 0.679 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 123.757 0.823 . . . . 0.0 110.253 176.379 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -56.35 5.59 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -71.79 118.78 69.74 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.51 121.44 9.87 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.028 2.485 . . . . 0.0 111.767 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -89.83 102.71 15.4 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.51 0.724 . . . . 0.0 109.202 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.63 31.2 0.53 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.485 1.114 . . . . 0.0 112.05 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -16.92 61.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.668 0.787 . . . . 0.0 110.94 174.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.4 11.7 8.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.107 0.963 . . . . 0.0 110.899 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -71.72 81.11 0.86 Allowed 'General case' 0 C--N 1.359 1.006 0 CA-C-O 121.469 0.652 . . . . 0.0 109.584 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 p -138.41 159.13 42.86 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.755 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.23 117.33 44.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -116.17 116.53 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -103.18 152.69 21.17 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.883 0.849 . . . . 0.0 109.897 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -128.0 121.4 29.71 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.545 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -171.3 -178.52 41.81 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -173.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -117.76 144.67 45.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.67 121.48 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.709 0.803 . . . . 0.0 110.528 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.6 149.63 40.0 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.074 0.55 . . . . 0.0 111.06 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.88 -32.91 40.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.456 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.53 102.76 14.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 20.68 10.93 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.97 117.62 30.45 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -147.58 137.14 22.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.89 0.876 . . . . 0.0 108.892 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 26.4 mmt -81.29 145.46 30.89 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -72.78 158.6 35.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.866 0.466 . . . . 0.0 112.201 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -115.01 155.96 26.0 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.267 1.027 . . . . 0.0 108.902 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.59 -2.97 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 116.369 -0.378 . . . . 0.0 113.984 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.96 147.96 1.34 Allowed Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.724 1.21 . . . . 0.0 108.625 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.69 148.41 77.7 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.154 1.903 . . . . 0.0 111.421 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.38 -171.8 25.64 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.37 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.9 129.56 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.121 0.968 . . . . 0.0 109.118 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 45.1 ttp180 -95.14 124.72 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.3 156.05 45.9 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -90.37 100.18 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 107' ' ' ILE . 12.0 tp -72.54 106.75 4.73 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.417 0.687 . . . . 0.0 109.711 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.53 102.43 11.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.93 148.59 49.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.966 0.906 . . . . 0.0 111.602 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.545 ' HG2' ' HA2' ' A' ' 57' ' ' GLY . 14.1 mmmm -88.61 -27.29 21.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.757 0.823 . . . . 0.0 111.301 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.79 -34.05 60.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.914 0.486 . . . . 0.0 110.257 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -142.43 108.19 5.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.657 1.183 . . . . 0.0 108.972 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -71.53 -22.37 61.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.791 0.436 . . . . 0.0 110.392 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -70.6 -17.62 62.89 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.95 0.9 . . . . 0.0 111.549 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -101.42 92.54 4.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.402 0.681 . . . . 0.0 109.453 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -104.92 102.03 11.58 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.67 148.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.13 0.972 . . . . 0.0 109.096 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -83.46 145.23 29.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 82.7 t -129.96 121.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.18 0.592 . . . . 0.0 109.493 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.3 91.25 7.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.396 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -94.31 115.13 27.31 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -105.58 122.92 47.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.97 -162.63 28.35 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.472 0.482 . . . . 0.0 111.95 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.17 111.91 12.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.696 0.798 . . . . 0.0 110.815 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.66 117.12 66.45 Favored Pre-proline 0 N--CA 1.475 0.776 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.46 161.56 43.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.018 1.812 . . . . 0.0 112.591 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.32 -24.77 62.19 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.083 0.953 . . . . 0.0 110.555 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.8 p -70.79 -21.79 62.44 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.357 1.063 . . . . 0.0 111.642 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' HA ' HG11 ' A' ' 103' ' ' VAL . 54.0 t80 -71.66 121.56 19.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.568 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.6 pttt -145.74 159.81 46.15 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.486 1.115 . . . . 0.0 108.932 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.33 96.8 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.513 2.142 . . . . 0.0 111.887 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.7 1.35 10.83 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.277 -0.735 . . . . 0.0 113.956 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 8.4 p -75.49 141.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.026 0.913 . . . . 0.0 111.415 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.84 136.26 40.19 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.39 160.86 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.761 0.791 . . . . 0.0 112.598 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.441 HD11 ' HD3' ' A' ' 126' ' ' LYS . 60.7 mt -126.79 107.99 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.46 1.904 . . . . 0.0 105.902 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 77' ' ' LEU . 19.7 pt -111.51 146.68 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.341 0.656 . . . . 0.0 109.422 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -140.66 143.07 34.93 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.99 -122.12 0.99 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.87 140.21 6.64 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 117.409 0.604 . . . . 0.0 112.131 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.92 131.86 53.52 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.772 0.829 . . . . 0.0 109.227 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -84.99 133.51 43.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.69 -31.45 92.04 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.444 2.762 . . . . 0.0 114.093 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.58 80.1 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.648 0.593 . . . . 0.0 113.483 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 36.3 mt-10 -112.85 162.31 15.95 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.837 0.827 . . . . 0.0 113.004 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.17 -43.77 9.16 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.722 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -90.84 129.1 36.92 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.836 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -77.97 123.96 27.43 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.98 0.912 . . . . 0.0 109.268 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.87 100.8 13.45 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.45 105.67 15.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.438 0.695 . . . . 0.0 109.65 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -70.62 -23.94 62.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.918 0.487 . . . . 0.0 110.346 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.8 p -137.23 152.65 50.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.21 1.004 . . . . 0.0 109.489 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -139.37 136.24 34.55 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 24.3 ttm -136.61 104.8 5.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.031 0.933 . . . . 0.0 108.735 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -70.47 122.75 20.26 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HD3' HD11 ' A' ' 106' ' ' ILE . 56.1 tptt -76.46 -31.4 57.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.932 0.893 . . . . 0.0 109.466 -175.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 43.1 t -85.51 111.95 40.76 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.727 0.811 . . . . 0.0 109.467 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.48 104.31 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.498 2.132 . . . . 0.0 112.125 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.11 144.44 29.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.229 0.612 . . . . 0.0 109.488 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.99 116.49 22.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.074 0.55 . . . . 0.0 109.823 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 m -77.5 130.51 73.93 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.341 0.656 . . . . 0.0 109.389 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.85 174.54 0.29 Allowed 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.993 3.129 . . . . 0.0 114.284 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -73.0 75.39 1.19 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.1 0.96 . . . . 0.0 110.548 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.817 ' HB2' ' HB2' ' A' ' 51' ' ' HIS . 8.3 m-20 -150.18 123.44 8.93 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.16 -46.41 80.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.209 0.604 . . . . 0.0 110.524 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.604 HD22 HG22 ' A' ' 53' ' ' VAL . 84.4 mt -112.15 46.4 1.16 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.679 0.792 . . . . 0.0 110.137 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 15.4 t60 -59.62 -51.11 71.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.4 p -125.16 150.99 46.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 112.734 -2.03 . . . . 0.0 107.864 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG22 HD22 ' A' ' 50' ' ' LEU . 48.1 t -101.12 110.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -109.58 114.19 27.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -111.36 138.0 48.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -112.44 145.29 40.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . 173.93 -159.41 28.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 118.19 0.45 . . . . 0.0 112.763 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -131.67 145.68 51.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.92 0.888 . . . . 0.0 110.28 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.72 119.04 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.224 1.01 . . . . 0.0 110.464 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.98 143.41 47.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.765 0.826 . . . . 0.0 110.185 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.62 -41.05 47.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.533 0.733 . . . . 0.0 110.333 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.84 102.64 10.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.086 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 76' ' ' ARG . . . 104.29 42.95 1.81 Allowed Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.795 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.64 125.47 51.82 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -143.67 144.48 31.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.746 1.218 . . . . 0.0 109.668 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 71.9 mmm -81.29 149.46 28.95 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 mt -66.66 150.18 49.43 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.55 104.96 15.0 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.913 0.885 . . . . 0.0 110.334 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.19 33.92 88.53 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.635 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.51 146.86 20.28 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.44 0.696 . . . . 0.0 110.288 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.44 130.83 16.67 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.351 2.034 . . . . 0.0 110.275 170.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.62 -169.19 23.92 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 116.681 -0.236 . . . . 0.0 112.515 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.65 130.59 3.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 34.3 ttm180 -94.61 129.86 41.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.43 162.31 41.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.422 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 73.4 mtp180 -95.46 124.44 39.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.5 tp -99.76 116.51 32.01 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 109.517 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -79.38 116.89 19.88 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.412 1.085 . . . . 0.0 108.467 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.75 142.48 51.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 10.7 mmpt? -64.77 -36.83 85.59 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.431 0.692 . . . . 0.0 112.115 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.88 -39.41 17.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -115.15 90.29 3.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.405 0.682 . . . . 0.0 111.096 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -89.29 9.38 26.19 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.607 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -92.5 4.8 52.81 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.366 0.666 . . . . 0.0 110.957 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.01 134.77 7.76 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.02 0.528 . . . . 0.0 109.612 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 134.09 55.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 108.777 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.69 141.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.81 154.58 41.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 55.9 t -137.3 118.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 92' ' ' LYS . 59.9 tp -93.01 92.67 7.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 108.77 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -90.91 123.41 34.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 90' ' ' LEU . 98.9 mttt -107.53 129.78 54.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 167.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.51 -165.98 26.27 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.452 0.47 . . . . 0.0 112.072 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.01 118.75 13.24 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.581 0.752 . . . . 0.0 111.224 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.15 115.85 63.54 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.013 0.925 . . . . 0.0 109.232 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.87 157.62 47.22 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.061 2.507 . . . . 0.0 114.19 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.49 -27.63 66.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.935 0.894 . . . . 0.0 110.326 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 t -80.58 -14.78 57.91 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 123' ' ' LEU . 68.5 t80 -78.14 114.05 16.66 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -146.48 154.92 49.43 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.174 0.989 . . . . 0.0 109.121 177.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.39 102.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.691 2.261 . . . . 0.0 112.414 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.57 -10.19 5.81 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.372 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 99' ' ' PHE . 13.6 p -78.1 136.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 117.662 0.731 . . . . 0.0 110.699 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -76.09 122.57 24.46 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.83 155.15 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.971 0.891 . . . . 0.0 111.226 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 61.3 mt -114.34 109.4 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.1 pt -97.19 153.76 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 38.5 tt0 -145.76 134.93 22.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.69 -114.6 0.59 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.53 166.2 39.42 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.96 123.02 42.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.07 0.948 . . . . 0.0 108.961 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.39 132.35 33.95 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.306 0.642 . . . . 0.0 109.785 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.49 89.34 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.095 2.53 . . . . 0.0 111.611 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.11 -39.65 0.52 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.57 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.95 129.37 35.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.395 0.678 . . . . 0.0 109.197 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.52 -16.29 61.28 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.085 168.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -95.23 126.5 40.59 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 111.871 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -76.48 114.88 15.69 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.013 1.325 . . . . 0.0 109.176 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -74.69 91.42 2.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.08 113.51 25.49 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.861 0.864 . . . . 0.0 110.472 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.441 ' HG3' ' OG1' ' A' ' 122' ' ' THR . 25.6 ptt180 -74.66 -26.82 60.12 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.903 0.481 . . . . 0.0 110.006 172.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 17.8 m -126.67 145.9 50.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.745 0.818 . . . . 0.0 109.175 -169.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 99' ' ' PHE . 47.2 tp -137.04 132.95 34.93 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.615 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 38.8 ttm -134.55 96.56 3.6 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.4 p -72.18 121.87 20.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.716 0.806 . . . . 0.0 109.792 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -94.53 1.11 55.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 0.0 111.388 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 46.2 t -95.47 107.65 34.37 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.39 122.31 9.75 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.424 2.082 . . . . 0.0 110.872 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.0 tp -98.4 110.61 23.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.288 0.635 . . . . 0.0 109.716 -174.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.532 0.206 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.76 6.57 2.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 m 55.96 86.65 0.16 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.027 1.331 . . . . 0.0 110.207 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.76 119.52 3.36 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.785 2.99 . . . . 0.0 115.516 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -149.3 37.65 0.77 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.507 1.123 . . . . 0.0 108.021 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.65 141.2 38.67 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.865 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HD2' HH12 ' A' ' 121' ' ' ARG . 42.5 mmtm -89.9 -25.69 20.84 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.442 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -67.1 -38.58 85.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.097 0.559 . . . . 0.0 111.507 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -109.06 22.95 15.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 111.383 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.89 139.95 55.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.929 0.492 . . . . 0.0 109.92 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.65 108.26 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -170.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -101.13 109.9 21.85 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.12 136.51 53.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -108.92 131.62 54.85 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.8 -174.26 32.49 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.4 m -128.28 139.4 52.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.144 0.978 . . . . 0.0 108.841 173.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.06 120.13 28.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.918 0.887 . . . . 0.0 108.983 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.29 57.58 Favored 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.694 0.621 . . . . 0.0 110.333 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.67 -18.64 59.57 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.667 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.55 109.19 21.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.975 . . . . 0.0 108.944 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.94 64.85 0.91 Allowed Glycine 0 C--N 1.346 1.096 0 O-C-N 123.146 0.279 . . . . 0.0 112.486 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -136.0 124.49 23.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 84.7 m -147.25 138.79 24.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.479 0.712 . . . . 0.0 110.128 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 80.1 mmm -82.7 153.29 25.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.341 0.657 . . . . 0.0 109.319 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.96 138.44 48.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.438 0.295 . . . . 0.0 111.008 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.82 112.89 5.81 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.955 0.902 . . . . 0.0 111.669 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.63 30.48 72.32 Favored Glycine 0 C--N 1.347 1.186 0 O-C-N 124.125 0.891 . . . . 0.0 113.349 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.91 138.48 11.9 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.337 0.655 . . . . 0.0 110.213 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 111.0 2.11 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.927 2.418 . . . . 0.0 110.898 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.99 177.43 35.98 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -154.35 138.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -106.29 131.57 53.36 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -144.73 154.8 43.11 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -92.5 91.55 7.66 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.68 120.1 22.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.62 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 86' ' ' THR . 36.5 mt-10 -92.45 105.19 17.41 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 40.9 t0 -59.12 142.28 51.92 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.679 1.192 . . . . 0.0 111.223 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -74.47 -17.05 60.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.144 0.978 . . . . 0.0 111.119 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.35 -55.48 15.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -148.32 134.17 19.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.075 0.95 . . . . 0.0 109.161 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -66.43 -25.38 66.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.29 0.636 . . . . 0.0 111.113 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.93 -29.09 69.99 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.597 0.759 . . . . 0.0 111.227 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 30.8 mmmt -73.91 79.44 1.64 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.506 0.723 . . . . 0.0 110.116 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 78' ' ' GLU . 18.0 p -94.83 98.57 10.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.0 t -108.4 135.5 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.37 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.6 130.77 34.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.46 116.41 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 tp -91.93 94.26 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -92.07 114.16 26.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.174 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.16 123.13 34.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.13 169.83 12.66 Favored Glycine 0 N--CA 1.467 0.721 0 O-C-N 123.206 0.316 . . . . 0.0 112.653 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 120.18 12.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.235 0.614 . . . . 0.0 110.318 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.28 124.42 78.33 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.179 0.991 . . . . 0.0 110.251 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.5 ' HB2' HG22 ' A' ' 98' ' ' THR . 93.9 Cg_endo -75.61 155.46 40.14 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.726 2.284 . . . . 0.0 112.46 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -65.17 -22.37 66.9 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.788 0.835 . . . . 0.0 112.047 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 129' ' ' LEU . 6.7 t -74.21 -24.44 59.33 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.511 0.724 . . . . 0.0 111.216 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.514 ' HA ' HG11 ' A' ' 103' ' ' VAL . 75.3 t80 -73.32 109.86 7.17 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -141.32 159.76 59.81 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.021 0.929 . . . . 0.0 109.895 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.37 100.11 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.695 2.263 . . . . 0.0 111.574 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.86 -11.28 7.84 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.257 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 99' ' ' PHE . 5.4 p -72.17 146.96 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 117.489 0.644 . . . . 0.0 109.884 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 35.8 mt-10 -81.46 136.42 35.66 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.616 HG12 HG22 ' A' ' 125' ' ' THR . 19.6 m -128.74 169.58 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 122.152 0.977 . . . . 0.0 111.701 177.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -136.25 107.75 6.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.896 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 118' ' ' PHE . 41.1 pt -98.16 149.51 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.909 0.884 . . . . 0.0 109.471 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 40.7 mt-10 -135.03 139.75 45.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.72 -120.82 0.97 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.2 168.77 41.9 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.808 0.304 . . . . 0.0 112.374 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.29 101.03 7.69 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.49 130.45 58.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.0 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.92 97.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.604 2.869 . . . . 0.0 112.416 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.13 -52.14 0.56 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.87 118.39 24.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.637 0.775 . . . . 0.0 109.886 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.17 -26.56 61.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.378 0.671 . . . . 0.0 109.653 168.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -86.2 141.28 29.43 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.497 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.446 ' CD1' HD12 ' A' ' 107' ' ' ILE . 54.6 t80 -76.5 118.04 18.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 109.702 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.32 97.11 4.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.104 0.962 . . . . 0.0 109.409 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.87 114.2 25.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.049 0.54 . . . . 0.0 110.592 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.465 HH12 ' HD2' ' A' ' 49' ' ' LYS . 12.1 ptm180 -78.57 -34.83 46.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.518 0.727 . . . . 0.0 110.802 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 13.6 p -138.4 146.32 42.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.775 0.83 . . . . 0.0 109.569 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 tp -136.61 111.95 9.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.27 1.028 . . . . 0.0 109.594 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -122.47 119.86 32.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 105' ' ' VAL . 45.8 p -72.23 146.78 47.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -67.91 -34.99 77.69 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 175.011 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.09 107.17 5.57 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.151 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.56 128.41 6.09 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.323 2.015 . . . . 0.0 112.411 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 32.5 tp -165.44 29.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.44 1.096 . . . . 0.0 108.546 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.152 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.71 -173.98 4.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.905 0.882 . . . . 0.0 111.281 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 t -113.75 89.29 15.6 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.438 0.695 . . . . 0.0 110.069 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HB3' ' HG3' ' A' ' 113' ' ' PRO . 2.9 Cg_exo -74.47 115.58 4.35 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.607 2.204 . . . . 0.0 110.881 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -76.6 -177.1 4.06 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.031 0.532 . . . . 0.0 109.961 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -68.08 127.12 31.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.87 0.468 . . . . 0.0 109.909 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.28 -3.54 33.89 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.793 0.837 . . . . 0.0 111.526 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.98 60.17 4.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.83 0.852 . . . . 0.0 110.091 170.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -145.55 153.16 40.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.461 1.504 . . . . 0.0 108.145 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 p -106.65 121.7 44.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.726 . . . . 0.0 110.195 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.73 118.34 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -91.94 121.59 33.68 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.94 138.81 51.07 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -120.35 154.45 35.04 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 109.882 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.19 -155.56 26.97 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 121.805 -0.236 . . . . 0.0 112.932 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -124.32 145.21 49.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.776 0.83 . . . . 0.0 109.737 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.28 120.51 36.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.64 33.47 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 124.017 0.823 . . . . 0.0 111.003 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.31 -17.78 51.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.413 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.75 127.72 33.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.434 0.693 . . . . 0.0 110.477 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 8.2 84.03 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.431 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HE2' ' A' ' 99' ' ' PHE . 4.3 tt -69.55 103.83 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -116.2 113.7 23.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.518 1.127 . . . . 0.0 108.929 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.4 mtp -89.08 136.56 32.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.23 128.59 37.13 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.468 0.48 . . . . 0.0 110.112 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.58 112.34 24.22 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.43 0.692 . . . . 0.0 109.232 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.02 -30.53 9.91 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.023 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.42 141.99 23.64 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.746 0.818 . . . . 0.0 109.57 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.29 6.35 4.42 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.213 2.608 . . . . 0.0 114.112 -175.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.96 -170.66 44.24 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.424 0.452 . . . . 0.0 113.369 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 95' ' ' VAL . 13.0 p -154.12 154.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.455 0.702 . . . . 0.0 110.73 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -121.78 138.45 54.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.624 1.17 . . . . 0.0 108.015 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -151.1 174.63 12.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -113.37 111.87 22.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.794 0.807 . . . . 0.0 109.83 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.0 tp -77.62 133.66 38.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.007 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 86' ' ' THR . 44.6 mt-10 -84.47 124.22 31.11 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.98 105.63 1.08 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.613 0.57 . . . . 0.0 110.555 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.27 -24.39 46.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -63.23 -32.86 74.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.28 0.632 . . . . 0.0 110.987 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -156.57 97.0 1.7 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.378 0.671 . . . . 0.0 109.644 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -81.3 70.38 8.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 122.629 1.204 . . . . 0.0 111.193 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -147.11 2.32 0.77 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.078 169.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -146.2 159.88 42.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.52 1.128 . . . . 0.0 109.669 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 78' ' ' GLU . 37.6 p -137.75 139.15 39.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.233 1.013 . . . . 0.0 109.042 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.96 133.25 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -83.1 134.97 34.98 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.13 116.29 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.224 0.61 . . . . 0.0 109.485 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.3 tp -93.61 93.97 8.35 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.4 109.99 18.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.183 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.66 109.93 21.81 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 109.518 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.21 37.87 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.11 115.95 27.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG21 ' HB ' ' A' ' 73' ' ' VAL . 97.9 t -80.18 118.69 73.68 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 122.735 0.414 . . . . 0.0 109.884 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.5 162.35 38.24 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.299 1.999 . . . . 0.0 112.439 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.3 -22.55 66.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.926 0.89 . . . . 0.0 111.185 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.599 HG22 ' HG ' ' A' ' 129' ' ' LEU . 67.8 p -67.67 -20.91 65.35 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.617 1.167 . . . . 0.0 112.096 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.409 ' HE2' HD21 ' A' ' 64' ' ' LEU . 75.8 t80 -79.79 136.36 36.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.827 0.851 . . . . 0.0 109.521 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -163.89 162.49 16.45 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.969 0.908 . . . . 0.0 110.599 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.24 101.57 0.35 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.435 2.09 . . . . 0.0 110.517 164.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.21 62.51 0.67 Allowed Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HG13 ' A' ' 105' ' ' VAL . 11.6 p -137.7 130.53 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -0.615 . . . . 0.0 110.285 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -69.85 132.65 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 165.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG12 HG22 ' A' ' 125' ' ' THR . 15.2 m -139.06 159.37 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-O 122.081 0.943 . . . . 0.0 111.174 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.31 106.46 12.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 113.237 -1.801 . . . . 0.0 106.291 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.0 pt -100.87 161.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.254 0.621 . . . . 0.0 110.098 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.89 140.47 20.71 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.19 -108.57 0.27 Allowed Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.26 171.25 41.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.4 tp -128.69 127.71 42.67 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 139.03 43.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.241 0.616 . . . . 0.0 109.913 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.506 ' HG3' ' HB3' ' A' ' 46' ' ' PRO . 41.2 Cg_endo -65.66 112.12 2.09 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.403 2.069 . . . . 0.0 112.179 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.38 -21.48 19.42 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.83 144.21 26.15 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 110.922 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.62 -34.76 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.811 0.444 . . . . 0.0 110.993 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -82.38 126.29 32.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.109 0.48 . . . . 0.0 110.795 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -77.6 122.54 25.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.846 0.858 . . . . 0.0 108.693 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -91.54 103.83 16.39 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.4 119.57 25.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -68.42 -42.49 78.88 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.272 1.029 . . . . 0.0 109.799 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -134.51 141.73 46.81 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 -170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -125.82 112.39 15.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.702 1.201 . . . . 0.0 108.566 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 ttp -118.55 106.0 12.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.498 HG22 HG12 ' A' ' 105' ' ' VAL . 77.5 p -71.24 128.06 34.65 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -79.34 -32.53 43.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.811 0.844 . . . . 0.0 109.207 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.6 t -109.27 87.9 5.41 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.502 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 13.5 Cg_exo -67.97 -82.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.065 2.51 . . . . 0.0 113.905 -171.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.599 ' HG ' HG22 ' A' ' 98' ' ' THR . 96.6 mt -138.27 107.63 6.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.298 1.039 . . . . 0.0 109.216 -176.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.164 177.115 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.18 113.36 24.95 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.177 0.591 . . . . 0.0 110.33 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -71.04 127.5 91.56 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.702 0.801 . . . . 0.0 110.452 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.89 97.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.165 2.576 . . . . 0.0 112.481 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -132.85 146.61 51.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.348 1.059 . . . . 0.0 110.501 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.52 94.41 8.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.35 8.71 37.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.297 -173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.46 77.44 1.93 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.603 0.716 . . . . 0.0 109.304 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -79.8 -14.34 58.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.822 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -124.76 143.8 50.59 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.031 1.332 . . . . 0.0 107.705 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 42.2 t -115.48 132.69 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 94.6 mtt180 -100.14 146.22 27.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.342 0.657 . . . . 0.0 110.177 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD23 ' A' ' 77' ' ' LEU . 1.5 tt -133.82 126.6 30.89 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -115.66 108.33 16.25 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.98 -152.11 5.57 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 56.6 m -125.38 146.43 49.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.61 0.764 . . . . 0.0 109.815 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.68 120.04 33.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 124.012 0.925 . . . . 0.0 109.071 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.14 150.98 43.33 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.905 0.753 . . . . 0.0 111.007 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.55 45.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.624 0.769 . . . . 0.0 110.074 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.78 113.91 26.31 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.88 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.56 -1.14 45.92 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.224 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.4 tt -69.21 108.96 3.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -121.52 128.62 52.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.211 1.005 . . . . 0.0 108.861 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.7 mmt -83.06 154.91 24.17 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -86.3 35.61 0.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 26.42 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 128.078 2.551 . . . . 0.0 114.44 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.72 38.56 3.2 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.174 0.416 . . . . 0.0 113.05 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 133.75 4.38 Favored Pre-proline 0 C--O 1.241 0.618 0 C-N-CA 124.669 1.188 . . . . 0.0 108.694 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.72 115.64 3.51 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.468 2.112 . . . . 0.0 109.901 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.06 -174.4 33.27 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.501 0.5 . . . . 0.0 112.965 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.36 133.77 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.959 0.904 . . . . 0.0 110.057 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 46.2 ttm180 -106.36 124.32 49.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -149.33 160.77 43.12 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -96.45 111.48 23.57 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.439 HD23 HD22 ' A' ' 55' ' ' LEU . 19.7 tp -79.86 105.05 10.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.75 121.42 19.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -78.09 147.67 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.176 0.99 . . . . 0.0 110.825 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -108.37 -10.61 15.3 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.408 0.683 . . . . 0.0 111.962 -172.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -83.94 -30.12 26.54 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -145.95 108.8 4.54 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -73.31 -13.75 61.17 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.277 0.631 . . . . 0.0 111.8 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -84.12 -10.13 58.04 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.243 0.617 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -109.97 110.92 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 0.0 109.723 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -113.96 127.59 56.03 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 167.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.03 134.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -85.98 138.39 32.02 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 60.2 t -123.08 116.68 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.4 93.87 8.4 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -98.18 122.58 41.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.91 116.17 31.15 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.01 174.65 33.18 Favored Glycine 0 C--O 1.238 0.346 0 O-C-N 123.994 0.808 . . . . 0.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 112.78 4.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.1 117.01 66.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.413 0.685 . . . . 0.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.01 171.23 18.53 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.182 1.921 . . . . 0.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.16 -22.27 59.49 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -63.54 -32.2 73.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.4 1.08 . . . . 0.0 109.796 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -76.52 120.91 22.38 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 166.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.35 155.63 19.25 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.505 0.722 . . . . 0.0 110.173 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 64' ' ' LEU . 41.6 Cg_exo -57.98 107.79 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.649 2.232 . . . . 0.0 111.847 172.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.86 -25.14 5.62 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.237 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 p -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 117.44 0.62 . . . . 0.0 110.654 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.5 mt-10 -86.62 129.69 34.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 125' ' ' THR . 34.8 m -119.99 144.94 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.611 0.719 . . . . 0.0 111.068 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.92 107.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.66 143.69 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 25.9 mt-10 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.62 -100.29 0.14 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . 166.15 159.2 11.71 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 170.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.84 127.67 39.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.995 0.918 . . . . 0.0 109.237 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -82.98 135.34 45.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 -28.66 80.96 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.814 2.342 . . . . 0.0 113.377 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.05 -11.26 56.61 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.84 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 42.1 mt-10 -119.14 125.49 49.37 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.562 0.745 . . . . 0.0 110.159 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -61.43 -26.3 67.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.992 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 t -84.67 130.51 34.7 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.23 0.538 . . . . 0.0 111.284 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 10.2 t80 -77.07 116.15 17.47 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -97.51 114.37 26.24 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.28 30.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.165 0.986 . . . . 0.0 110.668 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -75.04 -26.36 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.142 0.577 . . . . 0.0 110.45 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 39.0 p -139.61 155.39 47.48 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.682 1.193 . . . . 0.0 108.836 174.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 tt -137.94 137.11 37.66 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 ttp -133.7 164.97 26.03 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 105' ' ' VAL . 40.0 p -109.86 149.36 29.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.113 0.565 . . . . 0.0 109.913 173.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -78.03 -49.47 13.96 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.67 118.59 58.15 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.751 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -85.68 -173.22 1.29 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.685 2.257 . . . . 0.0 112.042 170.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -126.46 -179.96 5.02 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.313 0.645 . . . . 0.0 109.717 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.82 23.55 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.419 0.687 . . . . 0.0 109.833 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.2 m -117.1 89.84 31.56 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.84 94.61 0.54 Allowed 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.067 1.845 . . . . 0.0 110.425 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -69.22 -10.55 58.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.459 0.704 . . . . 0.0 111.776 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.36 77.77 1.01 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -87.43 -6.33 58.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.895 . . . . 0.0 110.466 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.14 77.06 8.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.061 0.945 . . . . 0.0 109.107 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -164.15 142.92 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.0 m -70.59 117.66 12.41 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 122.933 0.493 . . . . 0.0 109.925 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.64 127.78 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -113.84 134.27 54.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.792 0.437 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 163.95 16.93 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.222 1.009 . . . . 0.0 110.244 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -139.37 139.82 37.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.652 1.181 . . . . 0.0 108.368 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.94 30.44 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -123.2 148.68 45.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.588 1.155 . . . . 0.0 109.463 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.47 130.87 35.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.34 37.64 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.564 0.54 . . . . 0.0 110.919 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -70.89 -45.44 64.35 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.437 0.695 . . . . 0.0 109.608 170.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.63 120.58 30.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 52.12 1.93 Allowed Glycine 0 N--CA 1.468 0.782 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.9 tt -135.84 125.76 25.86 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -140.57 142.86 35.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.526 1.13 . . . . 0.0 108.807 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.6 mmt -95.02 147.88 22.93 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.99 123.66 22.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.05 124.88 41.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.351 0.661 . . . . 0.0 109.553 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.92 28.45 70.58 Favored Glycine 0 C--N 1.344 0.989 0 O-C-N 123.726 0.641 . . . . 0.0 111.9 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.33 131.48 2.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.784 1.233 . . . . 0.0 109.007 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 120.77 7.48 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 121.928 1.752 . . . . 0.0 111.771 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -176.85 31.32 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 120.998 0.221 . . . . 0.0 113.546 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.51 139.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.459 1.104 . . . . 0.0 109.431 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 40.5 ttt180 -119.65 125.81 49.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.64 0.776 . . . . 0.0 108.991 171.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.442 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 37.5 p90 -151.36 162.35 41.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 30.2 ptt180 -100.18 119.26 38.08 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 107' ' ' ILE . 41.0 tp -73.79 115.78 13.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.702 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.527 ' HA ' HG22 ' A' ' 86' ' ' THR . 34.2 mt-10 -74.21 101.95 4.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.65 158.7 1.79 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.611 0.764 . . . . 0.0 111.797 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -49.57 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.4 1.08 . . . . 0.0 112.058 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 66.9 21.78 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.651 1.18 . . . . 0.0 111.956 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -139.39 86.4 2.12 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.118 0.967 . . . . 0.0 109.463 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -82.21 -10.24 59.21 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.754 173.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -81.29 -0.03 39.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.599 0.76 . . . . 0.0 112.249 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -145.99 88.23 1.8 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 78' ' ' GLU . 39.9 p -98.54 128.26 44.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 110.554 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -101.95 138.82 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.8 m95 -73.89 160.63 31.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.951 0.501 . . . . 0.0 110.777 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.3 t -135.71 108.77 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 108.677 -173.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.9 tp -93.98 94.04 8.23 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -99.48 131.86 45.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -118.74 150.84 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.147 0.579 . . . . 0.0 110.622 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.18 -172.22 14.12 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.195 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.81 121.13 18.43 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.166 0.587 . . . . 0.0 110.106 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.24 124.64 80.6 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.922 0.889 . . . . 0.0 109.332 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 123' ' ' LEU . 57.8 Cg_endo -68.61 152.58 74.56 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.474 2.116 . . . . 0.0 112.111 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.55 -27.03 63.84 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.524 0.73 . . . . 0.0 111.66 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 96' ' ' PRO . 9.6 t -68.62 -20.02 64.46 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.761 0.425 . . . . 0.0 110.908 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.07 115.33 10.08 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.8 mtmt -132.15 158.66 74.95 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.487 1.115 . . . . 0.0 108.644 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 11.2 Cg_exo -70.99 141.08 39.42 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.204 1.936 . . . . 0.0 109.985 167.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.72 79.04 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 100' ' ' LYS . 9.9 p -93.25 149.83 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.388 1.094 . . . . 0.0 108.313 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -69.99 139.07 52.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 125' ' ' THR . 16.6 m -133.03 156.4 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.916 0.865 . . . . 0.0 111.017 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.8 mt -121.16 127.89 75.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.738 1.615 . . . . 0.0 106.769 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 77' ' ' LEU . 17.6 pt -125.93 145.63 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.26 155.25 46.6 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 109.153 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 165.88 -114.42 0.59 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.02 150.81 20.94 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 117.343 0.571 . . . . 0.0 111.979 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 45.9 tp -127.66 136.11 51.15 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.533 0.733 . . . . 0.0 109.874 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 132.55 37.17 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.64 -19.53 53.43 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.807 2.338 . . . . 0.0 113.728 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.7 -8.28 57.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.792 -0.449 . . . . 0.0 113.768 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -100.68 139.68 36.03 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 117.708 0.754 . . . . 0.0 110.014 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -85.98 -23.14 27.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.994 0.917 . . . . 0.0 111.934 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -99.39 126.47 45.28 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.873 0.844 . . . . 0.0 110.763 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 111' ' ' LEU . 81.2 t80 -75.11 131.02 40.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.762 1.225 . . . . 0.0 108.715 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 60.0 tttm -88.25 108.16 19.17 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.02 113.62 23.84 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.015 0.526 . . . . 0.0 110.111 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.09 -30.51 62.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.468 0.707 . . . . 0.0 109.49 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p -133.4 141.33 47.82 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 109.834 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 96' ' ' PRO . 62.8 tp -124.8 109.58 13.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.5 ttp -124.86 138.45 54.26 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' HG12 ' A' ' 105' ' ' VAL . 65.3 p -89.61 169.01 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.002 0.521 . . . . 0.0 111.231 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 24.9 tptm -62.17 -60.57 3.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.213 1.005 . . . . 0.0 109.995 173.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.9 m -99.84 113.8 65.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.378 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.18 79.45 1.07 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.713 2.275 . . . . 0.0 110.218 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.63 100.45 2.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.884 -172.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 123.959 0.903 . . . . 0.0 108.607 -176.946 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.59 171.95 19.42 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.7 0.8 . . . . 0.0 110.069 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.5 p -73.91 131.76 81.11 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 122.943 0.497 . . . . 0.0 110.012 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -59.25 151.93 63.86 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.022 2.481 . . . . 0.0 113.505 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -68.98 159.73 32.23 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.666 0.786 . . . . 0.0 111.192 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -77.07 161.21 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.195 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -106.76 11.4 30.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.626 0.771 . . . . 0.0 111.312 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -79.8 -34.49 39.56 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -107.17 62.79 0.62 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 t -81.1 -159.23 0.24 Allowed 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.336 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -97.15 118.85 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.336 -0.853 . . . . 0.0 109.521 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -120.1 138.0 53.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.67 140.47 40.82 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.77 134.04 52.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.211 1.005 . . . . 0.0 108.606 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.9 177.38 41.04 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -113.4 140.19 48.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.763 0.825 . . . . 0.0 109.074 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 102' ' ' GLY . 59.6 t -74.6 132.25 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.764 0.426 . . . . 0.0 110.39 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.67 40.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 122.617 0.367 . . . . 0.0 110.062 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -75.59 -0.33 20.09 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.695 173.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -131.23 120.77 23.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.898 0.879 . . . . 0.0 109.363 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.91 22.91 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.865 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.81 105.73 5.23 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 m -138.59 125.95 21.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.813 0.845 . . . . 0.0 109.944 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtp -96.89 162.19 13.52 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.165 0.586 . . . . 0.0 110.631 -170.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.63 135.12 35.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.013 0.525 . . . . 0.0 111.225 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -73.89 111.84 9.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.554 0.742 . . . . 0.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.95 -53.78 4.88 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.334 0.396 . . . . 0.0 112.347 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.61 129.16 94.14 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 123.856 0.862 . . . . 0.0 110.906 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.31 113.46 1.92 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.435 2.09 . . . . 0.0 110.808 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.41 175.36 35.94 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 121.478 0.488 . . . . 0.0 113.514 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 8.7 p -154.35 131.71 2.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.06 1.344 . . . . 0.0 108.723 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.93 143.4 31.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -156.64 163.32 39.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -98.64 105.99 18.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.85 117.5 23.34 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.6 89.71 1.0 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.38 131.03 47.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.917 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -72.57 -37.91 68.06 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.627 0.579 . . . . 0.0 110.973 -171.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.47 -44.89 70.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 111.115 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.34 89.98 2.43 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 t -77.43 -18.44 57.22 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.923 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -68.35 -18.88 64.59 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.641 0.777 . . . . 0.0 111.556 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -132.18 88.77 2.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.069 0.948 . . . . 0.0 108.919 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.4 p -80.78 151.36 28.83 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.766 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.2 t -104.09 129.35 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.461 0.704 . . . . 0.0 109.657 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.2 m95 -78.76 100.76 7.25 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.19 110.09 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.359 0.6 . . . . 0.0 109.572 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 tp -93.15 93.75 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.742 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' HE2' ' HA ' ' A' ' 95' ' ' VAL . 47.3 t80 -92.97 111.54 23.2 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.715 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -105.3 116.09 31.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.205 0.602 . . . . 0.0 109.463 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 153.63 -175.24 32.05 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.46 112.76 4.24 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' TYR . 46.2 t -79.82 126.35 80.33 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.423 0.689 . . . . 0.0 109.232 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.6 Cg_endo -57.33 142.88 94.96 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.782 2.322 . . . . 0.0 112.519 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.93 -25.7 67.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.583 0.753 . . . . 0.0 111.441 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 33.2 p -78.22 -6.65 55.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.503 1.121 . . . . 0.0 112.642 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 78.9 t80 -69.99 95.94 0.99 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.294 0.638 . . . . 0.0 109.946 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.601 ' HB3' HD22 ' A' ' 129' ' ' LEU . 48.4 pttt -110.53 157.41 38.36 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.256 1.023 . . . . 0.0 110.018 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.536 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 16.3 Cg_exo -68.46 112.7 2.9 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.302 2.001 . . . . 0.0 110.714 171.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 59' ' ' VAL . . . 111.58 3.31 27.18 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.911 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 125' ' ' THR . 12.8 p -85.63 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 118.07 0.935 . . . . 0.0 110.278 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.39 110.33 8.59 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.5 HG13 HG13 ' A' ' 103' ' ' VAL . 29.8 m -104.63 148.05 9.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.952 0.882 . . . . 0.0 110.223 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.55 107.19 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.11 144.42 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 138.89 26.66 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.93 -118.35 0.83 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -172.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.54 141.58 6.63 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 117.907 0.853 . . . . 0.0 112.342 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 tp -87.64 129.17 35.22 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -81.58 132.75 54.23 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.75 -18.78 66.08 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.009 2.473 . . . . 0.0 114.055 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.23 -31.92 6.64 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.679 -0.237 . . . . 0.0 112.76 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 3.2 mp0 -94.45 137.26 33.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.945 0.498 . . . . 0.0 111.313 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.26 -26.69 65.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.992 0.917 . . . . 0.0 110.533 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 58.5 p -84.41 130.04 34.81 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.9 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -77.79 120.43 22.68 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.372 1.069 . . . . 0.0 108.619 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -75.74 94.73 3.31 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.22 109.59 18.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.248 0.619 . . . . 0.0 110.13 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -62.38 -42.36 99.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.931 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.2 p -134.83 162.31 32.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.879 0.871 . . . . 0.0 110.192 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.0 tp -150.58 111.43 4.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.361 1.064 . . . . 0.0 108.895 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 ttp -124.48 116.08 21.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.485 0.314 . . . . 0.0 110.939 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 103' ' ' VAL . 70.4 p -74.06 150.27 40.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.389 1.076 . . . . 0.0 110.694 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -90.75 -63.84 1.21 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.741 0.417 . . . . 0.0 110.054 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.54 114.27 26.79 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.984 0.513 . . . . 0.0 110.618 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.99 135.27 31.84 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.018 2.479 . . . . 0.0 111.924 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 100' ' ' LYS . 56.9 tp -102.9 135.44 44.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.884 0.874 . . . . 0.0 109.505 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 124.453 1.101 . . . . 0.0 109.709 -176.591 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.429 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.58 8.64 21.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.484 0.714 . . . . 0.0 110.678 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -66.13 108.43 2.25 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 125.0 1.32 . . . . 0.0 112.114 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -90.79 25.84 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.315 2.676 . . . . 0.0 113.118 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 60.46 33.83 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.283 1.033 . . . . 0.0 111.341 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -74.84 -29.13 60.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.62 0.768 . . . . 0.0 110.317 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt 66.08 12.92 8.82 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.551 1.54 . . . . 0.0 113.55 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -111.55 6.92 20.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.378 0.671 . . . . 0.0 110.311 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -70.3 -50.66 37.15 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.7 m -106.39 116.07 31.3 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 165.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.6 t -102.65 145.23 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.183 0.993 . . . . 0.0 109.393 -170.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -115.58 123.2 47.85 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.44 147.35 41.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.637 0.732 . . . . 0.0 110.034 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.96 109.06 10.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.913 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.86 -158.31 8.55 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.455 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 50.2 m -117.12 145.71 43.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.388 1.075 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.9 120.43 32.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.079 0.952 . . . . 0.0 109.08 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.9 47.59 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.744 0.652 . . . . 0.0 111.647 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 101' ' ' PRO . . . -70.3 -28.83 65.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.541 0.736 . . . . 0.0 112.111 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -110.59 42.14 1.64 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.54 51.96 0.22 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 tt -133.65 108.42 8.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 m -114.43 119.51 37.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 109.682 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.1 mmt -80.92 143.62 32.52 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 0.0 110.093 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -75.93 131.96 39.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.641 0.376 . . . . 0.0 110.068 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.38 139.48 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.525 0.73 . . . . 0.0 109.93 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.26 19.84 64.55 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.978 0.799 . . . . 0.0 112.9 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.89 129.29 2.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.959 0.904 . . . . 0.0 109.674 -172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.91 121.78 8.43 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.506 2.137 . . . . 0.0 110.668 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.58 -172.96 30.27 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.606 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.09 139.68 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 109.528 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.749 HH21 ' HB ' ' A' ' 117' ' ' THR . 45.9 ttt180 -111.86 139.86 46.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -154.27 152.58 30.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.251 0.62 . . . . 0.0 109.544 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 13.8 ptm180 -94.66 107.24 19.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -73.32 114.26 11.33 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.856 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.73 87.6 6.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.65 94.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.129 0.972 . . . . 0.0 109.042 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 80' ' ' LYS . 4.1 ttpm? 51.75 58.07 5.86 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.996 0.918 . . . . 0.0 111.127 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 63.93 31.43 13.83 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.372 1.069 . . . . 0.0 113.072 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -83.68 50.1 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.69 . . . . 0.0 110.185 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.3 t -59.49 -21.96 60.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.941 0.897 . . . . 0.0 112.4 -170.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.4 m -85.81 -6.64 59.07 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.1 0.96 . . . . 0.0 112.245 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -156.36 48.2 0.47 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.885 0.874 . . . . 0.0 110.448 -177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p -75.94 136.97 40.05 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.329 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.52 135.57 35.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 70.9 m95 -74.7 161.96 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.241 0.616 . . . . 0.0 109.438 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 84.1 t -138.23 115.07 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.1 tp -93.2 98.5 11.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.067 0.854 . . . . 0.0 108.79 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -96.03 125.21 40.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -119.49 117.52 28.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.236 0.614 . . . . 0.0 109.887 172.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.49 -164.52 30.24 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 115.23 9.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.948 0.499 . . . . 0.0 109.694 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.42 130.24 65.99 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.856 0.862 . . . . 0.0 109.474 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.605 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.9 Cg_endo -61.46 144.91 98.38 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.38 2.054 . . . . 0.0 112.132 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.83 -27.44 67.55 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.237 1.015 . . . . 0.0 111.446 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 p -78.73 -14.53 59.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.509 1.124 . . . . 0.0 112.139 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.6 t80 -68.51 119.94 13.78 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -152.37 161.05 30.39 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.275 1.03 . . . . 0.0 108.716 -174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 57.0 Cg_endo -66.73 111.16 2.07 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.032 1.822 . . . . 0.0 110.845 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.63 -11.48 15.92 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.683 -0.509 . . . . 0.0 113.825 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.07 149.18 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 117.714 0.757 . . . . 0.0 110.002 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.2 mt-10 -83.18 140.96 32.27 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.11 168.46 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.063 0.945 . . . . 0.0 111.851 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.415 ' HB ' ' HG2' ' A' ' 124' ' ' MET . 71.5 mt -132.84 122.71 47.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 126.462 1.905 . . . . 0.0 106.202 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.6 139.56 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.689 0.795 . . . . 0.0 109.827 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.42 132.49 56.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.9 -143.09 7.09 Favored Glycine 0 N--CA 1.47 0.946 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.82 136.18 4.58 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 117.685 0.742 . . . . 0.0 112.662 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.2 tp -93.08 134.41 35.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.289 1.035 . . . . 0.0 108.919 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 115' ' ' GLU . . . -88.86 146.59 37.11 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.264 0.626 . . . . 0.0 110.309 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.49 120.25 7.36 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.878 2.385 . . . . 0.0 112.206 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.12 69.14 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.979 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 112' ' ' ALA . 69.3 mm-40 -101.0 151.32 21.92 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.617 0.767 . . . . 0.0 110.13 172.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -106.55 16.45 24.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.925 0.89 . . . . 0.0 109.864 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.749 ' HB ' HH21 ' A' ' 74' ' ' ARG . 12.7 t -134.7 111.77 10.24 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.959 0.885 . . . . 0.0 109.846 -174.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -74.77 109.34 8.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.119 1.367 . . . . 0.0 108.37 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -77.79 98.74 5.65 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.29 163.53 26.33 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.629 0.771 . . . . 0.0 111.483 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -125.13 -36.47 2.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.091 1.356 . . . . 0.0 108.071 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -132.32 164.3 26.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.22 1.008 . . . . 0.0 109.778 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -156.71 117.94 3.76 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.488 1.115 . . . . 0.0 108.731 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 106' ' ' ILE . 19.2 ptp -137.38 147.82 45.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -91.55 142.85 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.684 0.394 . . . . 0.0 110.235 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -68.74 -30.12 68.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.073 0.549 . . . . 0.0 110.092 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 43.8 t -84.46 107.52 11.38 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.858 0.863 . . . . 0.0 109.22 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.43 160.32 44.81 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.984 2.456 . . . . 0.0 111.47 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.88 123.28 18.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 CA--C 1.562 1.404 0 C-N-CA 123.916 0.887 . . . . 0.0 111.187 178.141 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.094 0.473 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.878 1.271 . . . . 0.0 107.883 170.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.4 m -80.52 114.93 51.58 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-N 117.985 0.357 . . . . 0.0 110.876 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.22 117.4 3.8 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.072 1.848 . . . . 0.0 109.99 166.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 71.6 112.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.707 1.203 . . . . 0.0 109.791 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.69 117.37 9.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.934 0.894 . . . . 0.0 108.818 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.08 -15.33 62.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.634 1.174 . . . . 0.0 112.288 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.06 30.9 6.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.6 0.76 . . . . 0.0 110.431 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -121.36 120.51 35.26 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 108.88 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 m -72.53 117.22 13.94 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.4 124.44 49.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -82.72 105.0 13.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.17 132.21 54.37 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -167.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.98 126.52 55.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.86 -178.96 35.3 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -117.18 142.93 46.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.338 0.655 . . . . 0.0 109.726 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.47 125.01 36.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.346 0.658 . . . . 0.0 110.428 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.13 136.29 38.6 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.14 66.64 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.66 0.6 . . . . 0.0 109.744 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.754 ' HB2' HH21 ' A' ' 76' ' ' ARG . 2.6 m-20 -83.78 133.05 34.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.543 177.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.25 78.86 Favored Glycine 0 N--CA 1.468 0.803 0 O-C-N 123.397 0.436 . . . . 0.0 113.217 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tt -76.67 103.79 6.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.6 m -121.05 127.36 51.63 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.778 1.231 . . . . 0.0 109.57 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 91.8 mmm -83.85 145.0 28.88 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.56 125.28 26.23 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.36 104.08 2.6 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.362 1.065 . . . . 0.0 110.552 -170.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.49 73.5 Favored Glycine 0 C--N 1.342 0.895 0 O-C-N 123.749 0.656 . . . . 0.0 112.784 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.7 132.35 13.02 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 123.917 0.887 . . . . 0.0 109.394 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.96 110.69 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.758 2.305 . . . . 0.0 111.051 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 -176.79 30.17 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.841 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.66 135.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 109.579 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.6 ttm180 -112.48 128.11 56.24 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.0 171.85 14.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -171.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.754 HH21 ' HB2' ' A' ' 62' ' ' ASP . 37.9 mtm180 -96.39 130.16 43.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 tp -103.13 117.05 33.69 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.672 0.789 . . . . 0.0 109.234 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -70.62 91.36 0.79 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 170.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.72 91.31 2.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.824 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 51.76 81.7 0.07 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.759 1.223 . . . . 0.0 111.618 173.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 74.5 17.2 3.12 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.18 1.392 . . . . 0.0 114.355 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.11 123.97 18.71 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.41 0.55 . . . . 0.0 111.257 173.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 86' ' ' THR . 14.4 t -97.8 -28.11 14.01 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.343 1.057 . . . . 0.0 112.224 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.7 t -71.66 -38.84 70.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -92.87 94.77 9.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.527 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 83' ' ' THR . 28.4 p -111.36 138.07 48.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.551 0.741 . . . . 0.0 109.798 174.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.15 136.42 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.18 127.2 31.73 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 99.3 t -111.94 117.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.429 0.692 . . . . 0.0 109.312 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.38 96.17 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -95.55 123.09 38.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -115.69 112.6 22.31 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.689 0.796 . . . . 0.0 109.425 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.52 -173.43 34.94 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.96 111.77 5.19 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.264 0.626 . . . . 0.0 110.312 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 110.15 19.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.806 0.691 . . . . 0.0 109.497 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 123' ' ' LEU . 74.5 Cg_endo -71.5 157.71 55.61 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.34 2.027 . . . . 0.0 112.147 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' HD22 ' A' ' 129' ' ' LEU . 10.3 m-20 -69.55 -12.27 61.51 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.609 0.764 . . . . 0.0 112.242 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -70.15 -22.68 62.96 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.248 0.619 . . . . 0.0 111.485 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -71.56 95.27 1.39 Allowed 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.51 145.77 38.17 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.72 100.54 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.624 2.216 . . . . 0.0 111.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.78 -8.54 7.7 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.222 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.93 148.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 118.352 1.076 . . . . 0.0 110.038 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.88 115.99 19.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 20.7 m -104.67 155.72 6.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 123.847 0.859 . . . . 0.0 111.253 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mt -117.09 107.63 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.47 141.32 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.1 0.56 . . . . 0.0 109.966 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.41 117.85 30.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 120' ' ' ALA . . . -172.09 -149.47 6.69 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 123.49 0.494 . . . . 0.0 112.265 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.16 145.46 10.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 117.165 0.483 . . . . 0.0 112.479 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.9 tp -88.92 105.36 17.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.46 139.31 41.37 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.058 0.543 . . . . 0.0 111.212 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.93 90.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 123.414 2.743 . . . . 0.0 112.62 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.99 -42.57 0.82 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -95.38 130.46 42.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.542 0.737 . . . . 0.0 110.644 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.77 -17.04 60.03 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.864 0.866 . . . . 0.0 110.523 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 t -86.64 133.2 33.72 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.152 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -77.04 109.86 11.21 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -86.12 94.18 9.2 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . . . -84.12 117.35 23.41 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.635 0.774 . . . . 0.0 111.108 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -61.92 -45.41 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.845 0.858 . . . . 0.0 111.035 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m -127.97 136.24 51.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.66 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 96' ' ' PRO . 33.5 tp -112.99 123.74 51.01 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.6 mtm -132.73 171.01 14.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.226 1.01 . . . . 0.0 108.285 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 35.1 p -130.43 148.92 52.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.771 . . . . 0.0 110.075 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.77 -33.15 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.399 0.68 . . . . 0.0 109.999 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 50.2 t -117.52 101.12 52.73 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.892 0.877 . . . . 0.0 108.959 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.3 167.58 9.2 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.019 2.48 . . . . 0.0 112.524 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 97' ' ' ASP . 37.6 tp -57.3 101.23 0.06 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.146 0.979 . . . . 0.0 110.676 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.897 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -173.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.545 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.66 105.54 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -168.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.79 117.82 26.88 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD22 HD23 ' A' ' 77' ' ' LEU . 3.1 tt -123.62 142.9 50.6 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -121.76 141.25 51.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 0.0 109.302 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.26 -161.35 28.08 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.9 m -127.02 145.08 50.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.434 0.694 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.35 132.3 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.573 0.749 . . . . 0.0 109.972 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.86 156.56 17.41 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.444 0.698 . . . . 0.0 110.964 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.13 30.63 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.482 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -77.31 108.81 10.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.813 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.36 12.21 61.66 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.756 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.24 90.16 1.59 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -116.8 116.66 27.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.734 1.214 . . . . 0.0 109.877 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtt -89.98 161.81 15.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 90' ' ' LEU . 79.3 mt -66.94 119.14 11.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.663 0.385 . . . . 0.0 110.681 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.97 98.07 0.27 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.351 1.06 . . . . 0.0 110.724 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.75 22.84 68.44 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.462 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -143.26 149.14 47.25 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.729 0.812 . . . . 0.0 109.953 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.81 111.52 3.27 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.566 2.178 . . . . 0.0 112.076 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.29 179.33 31.23 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.986 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 11.1 p -149.28 134.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.807 0.843 . . . . 0.0 110.601 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -104.15 138.65 40.33 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.28 163.63 39.88 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -97.98 115.16 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.553 HD23 HD22 ' A' ' 55' ' ' LEU . 21.9 tp -79.66 108.87 13.54 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 86' ' ' THR . 58.0 mt-10 -78.01 110.36 12.88 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.298 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 124.339 1.056 . . . . 0.0 110.111 175.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 78' ' ' GLU . 35.2 p . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.45 129.57 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.41 98.21 8.11 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 107' ' ' ILE . 53.2 t -88.99 130.62 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.625 0.77 . . . . 0.0 109.986 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 HD21 ' A' ' 67' ' ' LEU . 37.0 tp -115.64 114.32 24.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.227 1.011 . . . . 0.0 108.939 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -112.86 128.87 56.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.086 1.354 . . . . 0.0 108.008 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 148.07 29.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.411 0.685 . . . . 0.0 109.433 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.78 -168.16 12.51 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.71 112.2 4.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.243 0.617 . . . . 0.0 110.582 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.11 117.13 68.18 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.029 0.932 . . . . 0.0 108.754 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 29.9 Cg_endo -59.44 151.3 69.62 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.693 2.262 . . . . 0.0 113.173 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -65.74 -25.12 67.14 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.728 0.811 . . . . 0.0 110.393 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.5 p -71.16 -23.87 62.14 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.992 1.317 . . . . 0.0 111.589 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.492 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.3 t80 -68.46 106.45 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -133.31 155.76 80.5 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.746 0.819 . . . . 0.0 109.101 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 110.3 2.17 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.523 2.148 . . . . 0.0 111.456 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.93 -11.71 9.37 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.044 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.2 t -81.55 124.41 38.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.456 0.702 . . . . 0.0 109.532 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.77 118.99 14.26 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 m -120.79 154.38 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.606 0.717 . . . . 0.0 111.785 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.55 115.14 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 89' ' ' VAL . 37.9 pt -100.91 162.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 33.5 tt0 -148.67 132.76 17.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.18 -117.54 0.69 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 179.76 146.27 6.79 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 117.453 0.626 . . . . 0.0 112.539 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.98 114.57 27.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.22 134.51 48.82 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 123.593 0.558 . . . . 0.0 110.111 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.7 104.43 0.16 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.871 2.381 . . . . 0.0 111.85 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.07 -29.86 5.42 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HE3' ' A' ' 119' ' ' LYS . 11.0 tp10 -91.29 132.64 36.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.4 -5.31 58.91 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.308 0.643 . . . . 0.0 112.284 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.45 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 40.2 p -114.64 137.46 51.87 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.323 0.511 . . . . 0.0 112.031 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.25 111.61 14.39 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HE3' ' HG2' ' A' ' 115' ' ' GLU . 93.9 mttt -82.29 93.65 7.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.34 108.32 14.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.73 0.812 . . . . 0.0 110.043 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -19.62 57.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.589 0.755 . . . . 0.0 111.548 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 22.4 p -138.63 157.14 46.7 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.054 0.941 . . . . 0.0 110.107 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 tp -138.6 140.88 39.14 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.984 1.314 . . . . 0.0 108.235 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.8 ttm -136.53 118.77 15.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.348 0.659 . . . . 0.0 109.587 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -100.4 145.11 28.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.748 0.819 . . . . 0.0 110.157 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.432 . . . . 0.0 111.122 -177.808 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.239 0.546 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.88 146.13 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -123.33 114.27 19.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.181 0.992 . . . . 0.0 109.043 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tt -114.15 126.15 54.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.93 135.7 39.28 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.76 -174.15 38.47 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -124.12 140.84 52.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.225 1.01 . . . . 0.0 109.002 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.1 123.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . . . -75.65 149.52 38.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.07 0.548 . . . . 0.0 111.265 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.53 27.35 1.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.822 0.849 . . . . 0.0 110.562 167.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -143.31 128.16 18.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.723 1.209 . . . . 0.0 107.869 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.76 6.76 88.17 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.694 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.87 85.4 2.82 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.3 m -107.45 111.88 24.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.277 1.431 . . . . 0.0 109.847 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtp -91.79 146.64 23.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.55 127.5 32.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.755 0.422 . . . . 0.0 111.677 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.51 118.43 18.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.123 0.969 . . . . 0.0 110.316 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.32 18.71 67.71 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 123.88 0.738 . . . . 0.0 114.068 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.52 12.36 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.579 0.752 . . . . 0.0 109.691 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.54 115.98 4.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.399 2.066 . . . . 0.0 111.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.58 -175.51 31.92 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.841 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.27 130.56 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 124.15 0.98 . . . . 0.0 110.399 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.469 HH12 HG21 ' A' ' 117' ' ' THR . 8.9 tpp180 -92.25 131.84 37.15 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 165.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.92 163.33 37.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.531 0.605 . . . . 0.0 109.611 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.12 106.5 17.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.29 115.77 14.18 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.765 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 86' ' ' THR . 48.3 mt-10 -73.1 99.35 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.474 0.765 0 C-N-CA 124.347 1.059 . . . . 0.0 108.65 175.054 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 78' ' ' GLU . 71.4 p . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.19 137.76 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -79.89 146.27 32.25 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.75 119.53 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.0 94.16 7.82 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -89.56 125.16 35.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -116.41 110.11 18.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.477 0.711 . . . . 0.0 109.416 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.01 -173.98 35.28 Favored Glycine 0 N--CA 1.469 0.89 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.942 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 108.57 1.96 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.626 0.77 . . . . 0.0 111.763 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -81.67 118.03 70.57 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.401 0.681 . . . . 0.0 109.789 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.21 163.93 29.79 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.59 2.193 . . . . 0.0 112.556 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.72 -22.1 66.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.44 0.696 . . . . 0.0 110.691 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.8 p -82.21 -13.8 56.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.134 0.974 . . . . 0.0 111.833 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.06 107.0 6.84 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.5 pttt -151.8 150.42 26.13 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.407 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.53 117.77 4.8 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.273 1.982 . . . . 0.0 111.243 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.35 11.64 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.044 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 100' ' ' LYS . 8.2 p -90.34 145.29 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 117.866 0.833 . . . . 0.0 110.283 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.04 131.63 39.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 151.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.805 0.812 . . . . 0.0 109.65 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.43 119.97 60.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.2 pt -107.94 137.37 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -114.28 145.98 41.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.24 -124.61 1.41 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.98 141.89 6.76 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 117.071 0.435 . . . . 0.0 112.657 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.8 tp -89.33 115.29 26.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.061 0.944 . . . . 0.0 108.592 173.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . . . -89.55 134.41 32.56 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.56 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' ALA . 21.9 Cg_exo -64.74 90.79 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.954 2.436 . . . . 0.0 111.986 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.73 -45.48 0.65 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 117' ' ' THR . 2.2 mp0 -91.84 116.36 28.84 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.054 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.04 -17.67 63.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.109 0.563 . . . . 0.0 110.617 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.469 HG21 HH12 ' A' ' 74' ' ' ARG . 8.8 t -78.18 134.21 37.67 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -75.46 109.26 8.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -82.5 94.7 7.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.39 126.62 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.333 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.025 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p -138.57 165.03 27.94 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.741 0.816 . . . . 0.0 110.281 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.3 tp -135.19 137.28 42.52 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.698 1.199 . . . . 0.0 109.051 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 ttp -136.84 117.3 13.74 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.5 p -81.74 142.91 32.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.067 0.947 . . . . 0.0 109.887 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.4 mmpt? . . . . . 0 N--CA 1.483 1.215 0 C-N-CA 122.388 0.275 . . . . 0.0 111.599 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.242 0.675 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.82 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -137.01 118.95 15.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.852 0.861 . . . . 0.0 109.609 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.74 145.71 46.3 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -117.26 142.42 47.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.754 0.822 . . . . 0.0 109.365 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.32 -165.65 36.2 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.295 0.372 . . . . 0.0 112.828 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.2 m -119.28 147.19 44.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.771 0.828 . . . . 0.0 109.565 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.9 126.14 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 110.275 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.65 156.38 16.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.318 0.647 . . . . 0.0 110.064 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.02 59.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.283 0.633 . . . . 0.0 110.98 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.23 110.89 6.99 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.853 0.861 . . . . 0.0 109.466 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.61 16.16 71.61 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.679 0.612 . . . . 0.0 113.337 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.05 105.52 3.36 Favored 'General case' 0 C--N 1.359 1.022 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -143.74 137.56 28.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.573 1.149 . . . . 0.0 108.281 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.03 144.29 29.2 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.51 135.33 52.87 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.469 0.308 . . . . 0.0 110.848 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -65.7 109.89 2.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.97 0.908 . . . . 0.0 111.024 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.45 24.79 67.99 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.719 0.637 . . . . 0.0 113.801 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.5 130.06 10.39 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.534 0.734 . . . . 0.0 109.681 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 117.04 3.72 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.585 2.19 . . . . 0.0 110.499 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.33 176.23 28.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.622 0.576 . . . . 0.0 111.945 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.31 143.83 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.483 0.658 . . . . 0.0 110.489 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -112.44 132.23 55.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -153.86 162.27 41.36 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.832 0.453 . . . . 0.0 110.175 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 39.6 ttp180 -95.88 111.07 23.15 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 107' ' ' ILE . 22.0 tp -79.13 120.58 23.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.032 0.533 . . . . 0.0 109.93 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.33 95.35 2.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.484 1.261 0 O-C-N 124.33 1.019 . . . . 0.0 112.079 -175.441 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 20.9 p . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.61 122.66 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.749 0.82 . . . . 0.0 110.667 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.6 m95 -77.41 106.69 9.33 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.5 t -88.69 109.89 20.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.4 tp -93.18 97.09 10.43 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.379 1.049 . . . . 0.0 108.234 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -102.57 126.09 49.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.183 0.993 . . . . 0.0 109.026 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -111.7 130.57 55.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.354 0.662 . . . . 0.0 109.265 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.95 -166.49 21.39 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 110.84 3.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.546 0.738 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.69 131.89 59.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 109.537 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.02 140.96 58.55 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.802 2.335 . . . . 0.0 112.793 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.03 -24.57 65.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.234 0.54 . . . . 0.0 110.31 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -73.74 -15.06 61.22 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.816 1.246 . . . . 0.0 112.378 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -69.48 134.52 49.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.685 0.794 . . . . 0.0 110.009 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 103' ' ' VAL . 20.0 pttm -168.98 161.01 8.07 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.81 1.244 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.56 107.89 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.904 1.736 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.05 -9.34 8.47 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.811 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 100' ' ' LYS . 10.5 p -84.86 138.43 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 118.11 0.955 . . . . 0.0 109.478 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.91 116.28 19.97 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG22 ' A' ' 125' ' ' THR . 22.2 m -113.33 153.26 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.54 0.686 . . . . 0.0 111.683 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.61 115.77 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.49 HD13 HD22 ' A' ' 77' ' ' LEU . 21.9 pt -100.39 139.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -148.71 142.88 26.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.21 -110.07 0.42 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.09 159.29 31.37 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 117.242 0.521 . . . . 0.0 112.445 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -123.85 143.02 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 0.0 108.813 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.76 147.09 54.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.26 0.624 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.61 72.59 4.34 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.079 2.519 . . . . 0.0 111.633 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.81 69.85 0.1 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 119' ' ' LYS . 10.1 tp10 -172.64 141.05 1.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.789 0.835 . . . . 0.0 110.021 -173.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -86.29 -40.46 15.49 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.604 0.762 . . . . 0.0 109.642 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 69.0 p -83.92 121.32 27.2 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.598 -169.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.05 132.61 36.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.095 0.558 . . . . 0.0 110.114 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 115' ' ' GLU . 3.2 mptp? -93.23 96.55 10.07 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.24 99.68 9.44 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.932 0.493 . . . . 0.0 111.023 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -57.1 -33.07 66.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.889 0.875 . . . . 0.0 110.619 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p -138.05 141.15 40.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.579 1.152 . . . . 0.0 109.084 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.97 118.91 19.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 ptm -129.81 147.6 51.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.385 0.674 . . . . 0.0 109.502 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 HG12 ' A' ' 105' ' ' VAL . 60.4 p -100.53 152.51 20.32 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.804 0.841 . . . . 0.0 109.957 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.479 0.712 . . . . 0.0 110.562 176.166 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.72 136.84 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.342 0.657 . . . . 0.0 109.492 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.69 133.88 52.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.833 0.853 . . . . 0.0 108.995 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.83 139.56 38.21 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -110.42 143.38 40.8 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.403 1.081 . . . . 0.0 108.668 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.94 -173.76 42.78 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 117.876 0.307 . . . . 0.0 112.615 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.6 m -112.3 134.13 54.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.719 0.808 . . . . 0.0 110.057 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.92 122.56 19.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.188 0.995 . . . . 0.0 110.447 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.95 146.94 25.97 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.25 -10.93 58.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.07 116.61 14.9 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.52 1.128 . . . . 0.0 109.995 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.66 9.91 82.75 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 123.682 0.614 . . . . 0.0 113.727 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 4.3 tt -72.61 111.14 7.5 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 p -132.1 130.69 41.55 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.277 1.431 . . . . 0.0 109.137 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.423 ' SD ' HG23 ' A' ' 73' ' ' VAL . 86.9 mmm -85.0 136.48 33.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.2 mt -63.84 111.52 2.5 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -71.09 110.21 5.63 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 110.57 -167.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.84 22.61 77.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.055 -0.52 . . . . 0.0 113.125 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.5 126.87 7.61 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.36 1.064 . . . . 0.0 108.937 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.68 109.4 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.324 2.016 . . . . 0.0 111.672 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 162.46 175.49 33.55 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 123.381 0.425 . . . . 0.0 112.181 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.423 HG23 ' SD ' ' A' ' 66' ' ' MET . 10.9 p -145.57 148.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.406 0.682 . . . . 0.0 110.451 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -123.72 137.57 54.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.136 . . . . 0.0 108.256 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.714 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 33.3 p90 -159.88 175.73 12.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.848 0.859 . . . . 0.0 108.893 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 35.1 ptt180 -111.76 135.23 52.64 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.476 HD22 HD13 ' A' ' 107' ' ' ILE . 24.9 tp -100.83 120.83 40.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.016 0.526 . . . . 0.0 109.939 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.35 97.95 7.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.198 0.599 . . . . 0.0 109.583 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.474 0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.164 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.55 123.16 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 80.7 m95 -68.1 138.95 56.15 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.96 109.39 28.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.7 tp -93.9 95.77 9.29 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -98.1 124.56 42.68 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.17 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -110.71 143.23 41.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.194 0.998 . . . . 0.0 108.746 170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.63 15.28 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.28 125.05 22.36 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.062 0.545 . . . . 0.0 110.986 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.29 128.88 74.17 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.615 0.766 . . . . 0.0 110.18 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 22.2 Cg_endo -59.47 138.39 83.68 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.642 2.228 . . . . 0.0 111.736 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -68.04 -27.55 66.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.245 0.618 . . . . 0.0 111.808 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 t -71.79 -16.6 62.19 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.922 0.489 . . . . 0.0 111.501 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 84.4 t80 -69.81 137.09 51.54 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 123.105 0.562 . . . . 0.0 109.736 174.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.431 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.2 pttt -164.12 156.0 14.39 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.044 0.938 . . . . 0.0 109.282 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HG3' HD13 ' A' ' 64' ' ' LEU . 29.3 Cg_exo -61.94 113.1 1.72 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.544 2.163 . . . . 0.0 111.129 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.23 -6.19 28.65 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.892 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 100' ' ' LYS . 8.7 p -83.96 150.89 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 118.189 0.995 . . . . 0.0 108.835 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 126' ' ' LYS . 46.9 mt-10 -77.16 145.12 37.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 17.0 m -136.14 154.92 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.224 1.01 . . . . 0.0 111.037 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.62 108.15 24.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 166.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.476 HD13 HD22 ' A' ' 77' ' ' LEU . 43.8 pt -96.73 142.29 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -147.26 139.6 24.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA2' ' HD2' ' A' ' 121' ' ' ARG . . . 163.93 -105.77 0.26 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -175.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.25 163.4 37.13 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.5 tp -134.56 131.45 37.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.24 147.13 33.7 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.328 0.651 . . . . 0.0 110.099 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.24 -37.82 80.91 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.266 2.644 . . . . 0.0 112.561 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.86 41.36 2.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.46 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -166.4 142.13 4.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.568 0.747 . . . . 0.0 110.545 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.86 -30.03 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.962 0.905 . . . . 0.0 110.796 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 t -90.21 134.3 34.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.164 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -75.58 127.16 32.47 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 108.549 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -83.97 105.32 14.76 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.39 112.39 19.88 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.422 ' HD2' ' HA2' ' A' ' 109' ' ' GLY . 6.5 ptm180 -68.49 -35.67 77.84 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 p -141.38 148.72 40.08 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.679 1.191 . . . . 0.0 109.094 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.9 tp -127.21 117.53 22.51 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.057 0.943 . . . . 0.0 108.493 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.7 ttp -131.45 145.98 52.04 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 82.5 p -91.07 163.36 14.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.166 0.508 . . . . 0.0 110.807 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 9.1 mtpm? . . . . . 0 CA--C 1.547 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 109.893 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.643 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 25.4 p . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 85.7 t -100.34 133.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.777 1.231 . . . . 0.0 108.688 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttt85 -96.59 107.74 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 77' ' ' LEU . 4.2 tt -116.66 141.0 48.77 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -120.75 143.6 48.7 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.946 0.898 . . . . 0.0 109.755 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.57 -162.06 27.51 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 7.6 m -131.31 140.28 49.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.005 0.922 . . . . 0.0 109.565 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.0 131.72 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.215 1.006 . . . . 0.0 111.555 -173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.561 ' HB3' ' HG3' ' A' ' 76' ' ' ARG . . . -94.56 154.39 17.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.226 0.611 . . . . 0.0 110.947 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 -36.66 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.584 0.753 . . . . 0.0 110.758 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -80.58 78.52 7.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.233 0.613 . . . . 0.0 109.881 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.8 0.82 2.48 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.022 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.494 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.7 tt -78.37 94.45 4.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 74' ' ' ARG . 86.5 m -103.07 110.63 22.63 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.688 1.195 . . . . 0.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.4 mmt -80.5 117.53 21.31 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.46 123.86 18.17 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 123.637 0.586 . . . . 0.0 111.223 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -71.61 99.89 2.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.983 0.913 . . . . 0.0 110.405 -171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.25 -36.92 2.89 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.563 -0.29 . . . . 0.0 112.995 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.74 131.41 87.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.344 0.657 . . . . 0.0 110.317 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.11 113.03 2.68 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.287 1.991 . . . . 0.0 111.059 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.02 -172.01 29.94 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.798 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.04 133.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.842 0.857 . . . . 0.0 110.179 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 4.8 tpp180 -92.73 141.94 27.91 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.27 174.86 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.581 0.752 . . . . 0.0 109.043 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.95 117.0 32.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.419 HD23 HD22 ' A' ' 55' ' ' LEU . 28.9 tp -80.15 109.77 14.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.834 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 60' ' ' ALA . 43.2 mt-10 -71.92 100.87 2.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.972 179.373 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.3 p . . . . . 0 C--O 1.244 0.782 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -99.99 115.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -77.86 130.72 36.99 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.31 117.58 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 123.532 0.733 . . . . 0.0 109.348 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.6 tp -99.86 92.11 5.14 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -86.04 124.22 32.24 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.57 123.1 49.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.307 0.643 . . . . 0.0 109.725 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.72 -174.98 22.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 114.95 8.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.156 0.582 . . . . 0.0 110.189 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.82 133.46 51.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.999 0.92 . . . . 0.0 109.678 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 123' ' ' LEU . 55.4 Cg_endo -67.83 150.81 78.84 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.485 2.124 . . . . 0.0 112.139 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.87 -21.61 64.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.88 0.472 . . . . 0.0 110.459 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.8 p -70.46 -19.4 62.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.233 1.013 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -69.55 105.98 2.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.537 0.735 . . . . 0.0 109.462 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 103' ' ' VAL . 37.1 mtmm -131.99 156.56 79.96 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.74 1.216 . . . . 0.0 109.853 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HG3' HD13 ' A' ' 64' ' ' LEU . 27.9 Cg_exo -63.02 103.51 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.713 2.275 . . . . 0.0 111.509 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.16 -3.36 18.8 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 119.202 -0.776 . . . . 0.0 113.579 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 100' ' ' LYS . 7.9 p -79.17 139.39 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 118.309 1.054 . . . . 0.0 109.777 174.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.8 mt-10 -71.36 138.87 49.56 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 125' ' ' THR . 35.0 m -135.01 152.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-O 121.707 0.765 . . . . 0.0 110.724 175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.66 109.72 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.6 pt -98.15 152.81 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 31.8 tt0 -152.25 132.54 13.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.6 -147.64 11.56 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.44 133.06 9.05 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 118.392 1.096 . . . . 0.0 114.267 -174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.38 124.75 52.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.905 1.282 . . . . 0.0 108.822 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.4 138.48 41.67 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.58 -33.82 93.16 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.03 2.487 . . . . 0.0 113.175 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.74 -11.36 82.97 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.27 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.06 141.98 34.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.011 0.925 . . . . 0.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -88.48 -33.65 17.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.248 0.619 . . . . 0.0 110.534 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -83.89 129.09 34.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -79.35 121.22 24.86 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.502 ' HB3' ' NZ ' ' A' ' 119' ' ' LYS . 3.4 ttpm? -89.34 97.26 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.93 125.31 28.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.933 0.493 . . . . 0.0 110.591 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -79.58 -38.13 34.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.512 1.125 . . . . 0.0 109.251 172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -133.06 133.81 43.5 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.409 1.084 . . . . 0.0 108.699 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.544 HD23 ' HD2' ' A' ' 96' ' ' PRO . 53.9 tp -117.89 108.99 15.99 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.6 ttm -102.82 125.21 49.47 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.5 p -82.25 123.49 29.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 124.289 1.035 . . . . 0.0 108.516 -175.581 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.24 0.569 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.2 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -97.79 108.2 20.87 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD22 HD23 ' A' ' 77' ' ' LEU . 4.0 tt -111.86 125.8 54.41 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -172.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.02 144.88 27.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.536 0.735 . . . . 0.0 109.123 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.79 -160.57 29.77 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.522 -0.371 . . . . 0.0 112.599 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 30.0 m -127.82 140.79 51.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.027 0.931 . . . . 0.0 109.676 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.94 133.27 31.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.36 43.55 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.484 0.49 . . . . 0.0 111.662 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.77 36.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.16 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.97 96.04 7.28 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.855 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.17 73.11 0.65 Allowed Glycine 0 N--CA 1.465 0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.138 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.6 tt -150.41 125.99 10.25 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.3 m -140.24 125.28 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.323 1.049 . . . . 0.0 109.332 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.1 mtp -96.91 162.64 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.136 0.574 . . . . 0.0 109.722 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.5 mt -86.48 105.86 17.08 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -63.71 114.88 4.27 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.915 0.886 . . . . 0.0 111.563 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.97 77.09 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.529 0.518 . . . . 0.0 113.624 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.94 142.23 44.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.38 1.072 . . . . 0.0 109.764 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.44 87.76 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.474 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 175.39 163.66 28.68 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.613 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 p -157.26 134.84 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.985 0.914 . . . . 0.0 110.115 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -103.89 137.29 42.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.196 0.998 . . . . 0.0 108.311 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 46.3 p90 -158.2 173.07 17.26 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -104.91 122.57 46.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 HD22 ' A' ' 55' ' ' LEU . 23.5 tp -83.86 116.19 22.63 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.78 118.93 24.76 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.485 1.319 0 C-N-CA 123.342 0.657 . . . . 0.0 112.486 -173.547 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.3 134.46 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -79.63 144.02 34.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.29 118.36 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.865 0.866 . . . . 0.0 108.746 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.34 93.23 7.14 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -85.37 113.31 21.58 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -111.16 122.94 49.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.45 172.53 18.43 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.88 113.5 1.89 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.251 0.526 . . . . 0.0 110.926 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.86 120.4 81.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.82 146.09 80.16 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.896 2.397 . . . . 0.0 113.713 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.87 -27.5 68.27 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.654 0.782 . . . . 0.0 109.835 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.7 p -78.87 -7.66 58.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.96 1.304 . . . . 0.0 112.278 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.7 t80 -75.66 140.61 42.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.805 0.442 . . . . 0.0 109.817 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 61.0 pttt -162.07 161.45 21.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.955 0.902 . . . . 0.0 109.709 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.8 100.34 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.102 1.868 . . . . 0.0 111.519 167.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.68 -8.57 8.77 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.131 -0.816 . . . . 0.0 114.25 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.512 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 14.5 p -71.46 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 118.54 1.17 . . . . 0.0 111.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 39.7 mt-10 -72.61 125.56 27.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 171.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 103' ' ' VAL . 27.9 m -128.16 155.61 39.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.898 0.856 . . . . 0.0 111.753 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 62.4 mt -114.75 107.93 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 123' ' ' LEU . 29.6 pt -97.82 155.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.89 138.19 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 121' ' ' ARG . . . 172.0 -127.04 1.35 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.755 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.37 153.0 24.45 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 117.043 0.421 . . . . 0.0 112.456 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 139.9 53.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.474 1.109 . . . . 0.0 108.727 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 136.0 45.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.51 109.69 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.204 . . . . 0.0 113.246 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.61 5.74 53.6 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.077 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.573 ' HG2' ' H ' ' A' ' 117' ' ' THR . 48.7 tt0 -96.53 153.09 18.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.596 0.759 . . . . 0.0 109.738 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.97 0.67 23.89 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.237 1.015 . . . . 0.0 111.213 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.573 ' H ' ' HG2' ' A' ' 115' ' ' GLU . 8.8 t -134.05 119.89 19.52 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.413 0.625 . . . . 0.0 110.453 -173.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -84.69 134.41 34.36 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.622 1.169 . . . . 0.0 110.25 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -95.14 111.31 23.16 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.71 116.68 28.76 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.42 ' HG3' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -79.03 -23.36 44.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.143 0.577 . . . . 0.0 110.886 173.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -137.71 152.18 48.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.878 0.871 . . . . 0.0 110.045 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 107' ' ' ILE . 23.1 tp -136.92 123.5 20.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.645 1.178 . . . . 0.0 108.233 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 41.5 ttm -119.87 95.11 4.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.728 0.411 . . . . 0.0 110.282 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.4 p -75.19 137.43 41.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.339 0.656 . . . . 0.0 110.455 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.906 . . . . 0.0 110.85 -173.585 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.72 143.89 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -138.34 136.23 36.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.512 0.725 . . . . 0.0 109.814 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.24 163.97 21.35 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.6 0.714 . . . . 0.0 110.549 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -138.44 132.29 31.13 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.801 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.33 -161.39 33.85 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 5.0 m -124.14 146.15 48.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.07 127.83 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.933 0.893 . . . . 0.0 110.277 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 140.07 43.8 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.309 0.644 . . . . 0.0 110.13 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.02 55.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.084 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.6 124.13 51.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.575 0.75 . . . . 0.0 109.406 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.17 -0.94 43.91 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.567 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.49 96.12 4.02 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.7 m -118.57 121.07 39.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.435 1.094 . . . . 0.0 109.904 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.5 mmt -84.36 136.07 34.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.99 127.95 34.45 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.628 0.58 . . . . 0.0 111.506 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.23 117.25 12.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.678 0.791 . . . . 0.0 110.09 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.83 33.1 84.18 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.456 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.33 136.63 8.77 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 110.102 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.76 109.69 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.332 2.021 . . . . 0.0 110.709 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.76 171.4 33.68 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.466 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -150.62 153.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.65 0.78 . . . . 0.0 110.062 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 47.4 ttp180 -124.66 142.25 51.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -159.45 172.95 16.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.283 0.633 . . . . 0.0 109.316 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 87.6 mtm-85 -101.58 113.08 25.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.62 111.95 9.25 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 86' ' ' THR . 36.7 mt-10 -72.36 110.44 6.78 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 123.003 0.521 . . . . 0.0 111.458 -175.645 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 78' ' ' GLU . 68.3 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.79 143.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -74.92 142.33 44.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 49.1 t -127.62 108.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.5 tp -93.26 92.97 7.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -91.37 116.59 28.96 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.235 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -108.35 114.3 28.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.93 170.97 23.31 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 113.0 3.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.778 0.431 . . . . 0.0 110.329 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.5 t -81.67 122.47 80.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 122.955 0.502 . . . . 0.0 110.126 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HD2' HD23 ' A' ' 123' ' ' LEU . 28.4 Cg_endo -60.74 148.49 91.68 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.761 2.307 . . . . 0.0 111.964 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.27 -16.3 61.92 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.417 0.687 . . . . 0.0 110.827 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.3 p -71.6 -23.69 61.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.149 0.98 . . . . 0.0 110.696 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' HA ' HG11 ' A' ' 103' ' ' VAL . 70.4 t80 -71.94 134.75 46.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.831 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -171.36 161.3 5.18 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.8 0.84 . . . . 0.0 109.435 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.1 105.68 0.41 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.276 1.984 . . . . 0.0 111.89 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.78 -10.8 11.17 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.754 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 99' ' ' PHE . 9.6 p -74.55 145.16 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.782 0.791 . . . . 0.0 109.654 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.3 mt-10 -84.32 138.67 32.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.69 155.32 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.036 0.922 . . . . 0.0 111.305 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.6 mt -115.17 108.51 25.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 18.4 pt -100.87 132.6 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.419 0.688 . . . . 0.0 109.859 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -127.97 130.81 49.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.57 -108.01 0.27 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.17 142.63 5.86 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.715 0.757 . . . . 0.0 113.222 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.4 tp -93.87 126.4 39.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.903 0.881 . . . . 0.0 109.112 171.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . . . -83.25 138.33 42.19 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 123.436 0.46 . . . . 0.0 109.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.89 -17.68 60.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.887 2.392 . . . . 0.0 113.726 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.68 -10.67 18.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.504 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 28.3 tt0 -117.07 120.98 40.0 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.13 -20.94 63.15 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.562 0.745 . . . . 0.0 112.709 -168.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -88.37 135.62 33.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.42 113.79 14.4 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 26.9 ttmt -85.7 94.57 9.13 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.66 123.05 27.29 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.52 0.728 . . . . 0.0 109.849 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -80.32 -41.22 25.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.255 0.622 . . . . 0.0 109.639 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.7 p -131.53 136.13 47.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.485 1.114 . . . . 0.0 108.843 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 96' ' ' PRO . 59.6 tp -113.11 133.9 54.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.412 1.085 . . . . 0.0 108.632 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.9 ttp -136.29 103.05 5.17 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.786 0.434 . . . . 0.0 110.106 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.4 p -72.56 140.78 48.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.396 0.678 . . . . 0.0 110.012 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 123.594 0.758 . . . . 0.0 110.797 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 134.19 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.489 HH21 HD13 ' A' ' 106' ' ' ILE . 55.3 ttt180 -122.26 119.71 31.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.513 0.725 . . . . 0.0 109.219 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.43 161.2 20.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.585 0.754 . . . . 0.0 109.912 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -135.43 136.99 41.8 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.938 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 79' ' ' ASP . . . 176.52 -162.8 31.59 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.028 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -122.31 139.21 54.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.006 0.922 . . . . 0.0 109.749 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.64 130.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.618 1.167 . . . . 0.0 110.631 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.98 139.79 38.14 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.922 0.489 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -72.92 -40.44 65.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.311 0.644 . . . . 0.0 110.092 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.35 115.51 19.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.715 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 42.85 5.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.471 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 101' ' ' PRO . 6.7 tt -111.85 99.46 8.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -109.79 116.66 32.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.301 1.04 . . . . 0.0 109.711 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.51 ' HG2' HG23 ' A' ' 73' ' ' VAL . 66.5 mtp -89.48 132.6 34.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.495 HD12 ' HA3' ' A' ' 72' ' ' GLY . 76.6 mt -63.39 126.48 27.61 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.658 0.598 . . . . 0.0 111.013 -172.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.63 132.22 33.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.914 0.885 . . . . 0.0 109.762 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.75 68.46 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.472 0.482 . . . . 0.0 113.661 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 138.47 10.15 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.07 0.948 . . . . 0.0 109.149 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 112.73 2.8 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.469 2.113 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 167.25 175.14 37.01 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 121.387 0.437 . . . . 0.0 113.402 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 95' ' ' VAL . 8.1 p -146.91 161.3 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.949 0.9 . . . . 0.0 109.486 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -137.66 136.01 37.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -152.67 161.66 42.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.174 0.59 . . . . 0.0 109.758 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.62 104.98 17.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 tp -73.52 132.39 42.82 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.22 100.7 6.65 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 O-C-N 124.097 0.873 . . . . 0.0 111.84 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.66 139.91 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.328 1.051 . . . . 0.0 109.647 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.05 133.1 33.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 168.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.91 120.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -103.81 112.22 25.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -107.98 121.55 45.02 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.857 0.863 . . . . 0.0 108.915 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -103.53 117.72 35.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.654 0.782 . . . . 0.0 109.165 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.47 176.59 17.65 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.0 115.67 5.14 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.665 0.386 . . . . 0.0 110.043 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 73' ' ' VAL . 43.2 t -80.11 127.45 76.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.454 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD2' HD23 ' A' ' 123' ' ' LEU . 93.2 Cg_exo -47.22 138.89 16.66 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.495 2.797 . . . . 0.0 112.769 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.01 -24.13 65.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.39 0.676 . . . . 0.0 111.358 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -75.45 -13.23 60.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.959 0.904 . . . . 0.0 111.883 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -72.72 135.83 45.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.3 pttt -156.6 163.42 25.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.195 0.998 . . . . 0.0 108.741 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 28.9 Cg_exo -64.08 111.86 1.7 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.42 2.08 . . . . 0.0 111.41 168.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.49 0.57 37.43 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.727 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 7.4 p -77.87 149.55 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.847 0.824 . . . . 0.0 110.067 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.41 134.8 35.24 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 103' ' ' VAL . 18.6 m -129.89 161.74 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.971 0.908 . . . . 0.0 111.65 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.489 HD13 HH21 ' A' ' 54' ' ' ARG . 62.8 mt -119.11 111.7 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 113.452 -1.704 . . . . 0.0 107.016 168.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 118' ' ' PHE . 29.4 pt -100.37 142.1 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.451 0.7 . . . . 0.0 109.27 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 8.0 tp10 -139.48 124.99 19.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.59 -106.08 0.23 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.55 143.29 5.16 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 117.787 0.793 . . . . 0.0 112.616 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.2 tp -90.7 116.29 28.45 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.64 126.93 72.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.163 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.66 95.28 0.11 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.845 2.363 . . . . 0.0 111.786 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.56 -41.04 1.27 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.63 135.29 33.57 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.949 0.899 . . . . 0.0 109.985 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.81 -26.86 57.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.132 0.573 . . . . 0.0 110.043 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -84.46 136.04 34.0 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.129 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 107' ' ' ILE . 36.6 t80 -77.6 119.55 21.32 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.27 96.68 10.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.91 115.83 17.04 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.432 0.693 . . . . 0.0 110.044 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -79.45 -41.43 27.58 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.056 0.942 . . . . 0.0 109.631 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 75.0 p -132.28 140.88 48.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.39 1.076 . . . . 0.0 108.18 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.405 HD23 ' HD2' ' A' ' 96' ' ' PRO . 46.9 tp -127.29 143.38 51.24 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.946 0.499 . . . . 0.0 110.056 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.8 ttp -153.64 148.26 26.26 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 56.9 p -83.11 152.9 25.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 109.516 175.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.76 106.02 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.613 ' NH1' HG22 ' A' ' 106' ' ' ILE . 22.5 tpp180 -89.67 127.91 35.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 tt -132.82 130.35 39.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.45 139.0 43.82 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.96 -168.62 36.48 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 143.29 50.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.172 0.589 . . . . 0.0 110.604 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.23 119.59 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' HH21 ' A' ' 76' ' ' ARG . . . -69.89 142.85 52.93 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.664 0.602 . . . . 0.0 110.122 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.2 84.42 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.01 117.72 21.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.126 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.64 64.45 1.06 Allowed Glycine 0 C--N 1.339 0.702 0 O-C-N 123.444 0.465 . . . . 0.0 112.199 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tt -133.33 101.82 5.32 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -111.85 116.95 31.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.684 0.793 . . . . 0.0 110.342 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mmm -85.13 145.07 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.438 0.695 . . . . 0.0 109.959 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.475 HD12 ' HA3' ' A' ' 72' ' ' GLY . 86.6 mt -85.34 126.53 33.82 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.1 140.54 35.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.38 3.4 89.98 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 123.48 0.487 . . . . 0.0 113.433 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.4 140.3 4.13 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.103 0.961 . . . . 0.0 110.093 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.61 113.37 2.7 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.203 . . . . 0.0 111.734 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 171.45 173.11 38.16 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.394 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.75 138.15 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.331 1.053 . . . . 0.0 110.223 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 16.3 ttm180 -108.0 137.08 46.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 165.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.04 154.27 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.482 HH21 ' HB1' ' A' ' 60' ' ' ALA . 18.6 ttp180 -92.84 96.88 10.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 tp -78.41 138.32 38.44 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.483 0.713 . . . . 0.0 110.225 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.607 ' HG2' HG22 ' A' ' 86' ' ' THR . 31.3 mt-10 -102.96 113.16 26.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 N--CA 1.482 1.167 0 O-C-N 123.81 0.694 . . . . 0.0 109.631 178.087 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.607 HG22 ' HG2' ' A' ' 78' ' ' GLU . 40.9 p . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.5 t -102.85 141.74 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.117 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -79.27 136.63 37.1 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 91.5 t -123.39 118.43 54.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.83 92.28 7.85 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -94.59 116.0 28.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -112.46 144.27 42.19 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.05 -172.31 19.13 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.97 111.38 3.3 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.307 0.643 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.67 123.47 84.03 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.519 0.727 . . . . 0.0 109.09 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.98 145.71 68.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.173 1.915 . . . . 0.0 111.389 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.77 -16.79 64.5 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.591 0.756 . . . . 0.0 111.356 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.3 p -76.45 -19.9 57.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.42 1.088 . . . . 0.0 112.144 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -68.37 126.66 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.223 0.609 . . . . 0.0 109.542 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 103' ' ' VAL . 17.1 ptmt -156.06 165.82 17.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.191 0.596 . . . . 0.0 110.958 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.86 113.01 3.41 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.864 1.709 . . . . 0.0 110.955 170.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.08 -8.01 16.41 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.353 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 105' ' ' VAL . 12.7 p -83.02 142.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 117.425 0.612 . . . . 0.0 111.787 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.84 111.18 9.78 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 103' ' ' VAL . 27.7 m -105.7 153.6 7.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.792 0.805 . . . . 0.0 110.53 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.613 HG22 ' NH1' ' A' ' 54' ' ' ARG . 49.4 mt -122.18 105.59 16.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.2 pt -101.45 154.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.328 0.651 . . . . 0.0 110.246 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.2 tt0 -140.56 123.24 16.23 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 173.56 -121.18 0.84 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.77 166.71 39.9 Favored Glycine 0 C--O 1.241 0.556 0 CA-C-N 117.446 0.623 . . . . 0.0 112.441 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.6 tp -138.3 134.42 34.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.53 129.6 50.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 88.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.922 2.415 . . . . 0.0 111.91 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.65 -36.72 1.42 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -171.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.96 147.95 48.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.762 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.47 -45.02 11.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.728 0.811 . . . . 0.0 111.457 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -109.43 131.87 54.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.12 0.486 . . . . 0.0 111.002 -165.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.75 115.09 16.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.77 96.22 8.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.34 112.07 19.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.902 0.881 . . . . 0.0 110.156 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -60.16 -40.85 91.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.397 1.079 . . . . 0.0 110.399 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 1.7 m -135.41 149.31 49.59 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.885 -167.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.5 tp -137.21 140.33 41.64 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.259 1.024 . . . . 0.0 108.81 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 ttp -152.77 111.97 3.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 109.664 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 105' ' ' VAL . 54.3 p -73.21 124.27 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -97.97 112.7 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -104.68 116.99 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.89 142.68 36.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -119.1 147.87 43.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.72 -170.3 43.4 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.7 m -116.37 140.65 49.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.271 1.028 . . . . 0.0 109.083 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -76.98 126.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.38 0.672 . . . . 0.0 110.238 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.62 150.56 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.394 0.678 . . . . 0.0 111.043 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.66 -31.69 41.49 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.358 0.599 . . . . 0.0 109.671 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.35 100.11 12.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.435 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.55 71.11 0.97 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 tt -144.82 104.59 4.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.1 m -125.17 119.04 27.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.894 1.278 . . . . 0.0 109.233 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.7 mtp -89.9 142.93 27.23 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.88 122.41 17.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 110.478 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.35 123.21 28.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.375 0.67 . . . . 0.0 109.879 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.37 72.21 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 123.607 0.567 . . . . 0.0 112.988 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.23 144.18 16.84 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.049 0.939 . . . . 0.0 109.33 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.88 117.29 4.87 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.262 1.975 . . . . 0.0 110.844 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.48 -175.04 30.5 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.287 174.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.44 132.17 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.319 1.048 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -92.98 131.25 38.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.1 159.63 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.233 0.54 . . . . 0.0 110.885 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -95.59 112.06 23.86 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.289 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.43 117.57 30.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.453 0.701 . . . . 0.0 109.88 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.45 107.9 18.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.241 1.016 . . . . 0.0 109.789 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.21 -1.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.737 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.87 137.15 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.63 144.94 29.95 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.4 t -132.38 121.91 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.87 94.01 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -83.38 118.42 23.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -109.1 111.02 22.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.09 174.22 28.51 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.79 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.27 115.04 5.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.967 0.507 . . . . 0.0 110.161 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -81.25 113.95 45.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.063 0.545 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 123' ' ' LEU . 56.2 Cg_endo -67.28 151.76 80.33 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.443 2.096 . . . . 0.0 111.611 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.01 -16.94 64.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.519 1.127 . . . . 0.0 112.199 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 96' ' ' PRO . 12.2 t -70.55 -24.25 62.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.91 0.884 . . . . 0.0 111.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -68.04 121.6 16.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.752 0.821 . . . . 0.0 109.289 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 103' ' ' VAL . 23.6 pttm -165.62 157.54 12.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.431 0.693 . . . . 0.0 110.077 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.22 117.25 3.93 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.178 1.919 . . . . 0.0 111.758 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.49 -17.51 10.32 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.326 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 100' ' ' LYS . 6.0 p -95.06 147.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.863 0.831 . . . . 0.0 110.045 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -85.97 130.37 34.56 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 HG22 ' A' ' 125' ' ' THR . 27.6 m -111.03 155.55 12.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.857 0.837 . . . . 0.0 110.784 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.78 121.07 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.48 129.71 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.155 0.582 . . . . 0.0 110.503 -171.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.37 151.2 25.82 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.19 -119.63 0.89 Allowed Glycine 0 C--O 1.24 0.53 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.4 163.57 29.58 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.731 0.312 . . . . 0.0 112.606 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.0 tp -130.35 118.61 21.51 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 133.81 44.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.74 -24.3 41.05 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.679 2.253 . . . . 0.0 113.046 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.14 -18.1 78.85 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.558 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -108.61 156.61 19.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.141 0.977 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -109.61 26.39 10.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.715 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -133.96 121.22 21.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.353 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.29 130.59 35.61 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 108.945 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.78 117.2 31.55 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.699 0.682 . . . . 0.0 109.186 174.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.76 128.69 55.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.94 0.896 . . . . 0.0 109.974 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.534 ' HD3' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -98.82 -8.87 25.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.8 0.44 . . . . 0.0 110.171 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -134.81 152.16 51.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.718 1.207 . . . . 0.0 109.637 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 96' ' ' PRO . 37.3 tp -150.79 109.88 3.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.126 0.97 . . . . 0.0 108.385 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -135.93 114.03 11.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.648 0.779 . . . . 0.0 109.673 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.455 HG22 HG12 ' A' ' 105' ' ' VAL . 77.3 p -78.12 151.25 33.44 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.532 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 120.709 0.29 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -105.87 133.09 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -118.97 127.08 53.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.342 0.657 . . . . 0.0 109.505 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.6 mt -125.86 172.37 9.93 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.903 0.881 . . . . 0.0 109.785 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.26 147.89 49.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.776 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -170.74 42.15 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.6 m -121.54 144.34 48.78 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.37 115.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.34 0.656 . . . . 0.0 110.5 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.56 148.16 31.85 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.54 -5.66 46.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.648 0.779 . . . . 0.0 111.231 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.86 129.79 36.18 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.389 1.076 . . . . 0.0 110.05 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.31 15.69 78.85 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.266 0.354 . . . . 0.0 113.889 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.49 89.56 3.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -111.81 124.85 53.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.523 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.1 mmm -80.78 139.7 35.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.7 mt -67.53 133.26 49.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.3 0.5 . . . . 0.0 110.915 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -86.76 118.49 26.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.372 0.669 . . . . 0.0 109.857 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.54 5.0 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.486 0.491 . . . . 0.0 112.282 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.26 139.9 75.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.074 0.55 . . . . 0.0 110.108 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.64 135.79 24.59 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 121.986 1.791 . . . . 0.0 111.929 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.87 -168.58 26.4 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.631 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.18 132.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.381 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 79.3 ttt180 -102.6 138.17 39.86 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 170.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -158.13 168.21 27.71 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.919 0.488 . . . . 0.0 110.492 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -93.4 124.59 37.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 107' ' ' ILE . 21.0 tp -105.26 125.76 51.34 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.423 0.689 . . . . 0.0 109.351 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.4 97.43 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t0 . . . . . 0 N--CA 1.476 0.866 0 O-C-N 124.101 0.875 . . . . 0.0 111.487 -173.368 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 19.6 p . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.69 134.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -73.77 126.24 29.92 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 86.8 t -107.57 106.25 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 tp -91.54 92.01 8.31 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -83.5 150.21 26.14 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.414 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 92' ' ' LYS . 6.7 mtmp? -137.81 122.52 18.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.724 1.21 . . . . 0.0 108.71 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 121.46 -169.01 14.41 Favored Glycine 0 C--O 1.245 0.815 0 C-N-CA 123.464 0.554 . . . . 0.0 111.774 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 116.45 7.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.272 0.629 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.11 127.83 78.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.85 0.86 . . . . 0.0 109.958 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' PHE . 19.3 Cg_endo -58.41 132.83 50.97 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.036 1.824 . . . . 0.0 110.856 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.82 -26.36 68.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.109 0.564 . . . . 0.0 111.08 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 p -72.85 -13.27 61.25 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.118 0.967 . . . . 0.0 112.122 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' PRO . 63.0 t80 -64.32 121.22 13.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.926 0.89 . . . . 0.0 109.055 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -155.04 156.15 30.92 Favored Pre-proline 0 C--O 1.244 0.787 0 C-N-CA 124.002 0.921 . . . . 0.0 109.069 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.08 99.87 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.971 1.781 . . . . 0.0 110.464 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.55 -2.22 6.52 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.985 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -94.35 141.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 118.707 1.253 . . . . 0.0 110.414 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.56 117.38 15.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 125' ' ' THR . 18.0 m -110.25 150.23 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.722 0.773 . . . . 0.0 111.183 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.53 HD12 ' SD ' ' A' ' 124' ' ' MET . 47.6 mt -105.51 111.95 36.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.552 HD13 HD22 ' A' ' 77' ' ' LEU . 28.8 pt -98.27 140.91 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.8 133.1 23.19 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 162.44 -102.7 0.21 Allowed Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.93 147.25 5.25 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 117.482 0.641 . . . . 0.0 112.254 170.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -104.0 149.21 25.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.955 0.902 . . . . 0.0 109.584 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.71 151.41 46.22 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.723 0.809 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.44 -42.66 65.87 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.418 2.745 . . . . 0.0 113.682 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.48 29.55 8.25 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.031 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.15 128.62 40.44 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 0.0 110.266 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 -4.05 53.93 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -133.78 139.18 46.16 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -72.97 119.82 17.74 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 24.8 ttpt -70.26 96.23 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 89' ' ' VAL . . . -86.39 102.34 13.94 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.348 0.594 . . . . 0.0 109.524 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -62.98 -41.49 99.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.66 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -135.57 143.4 45.64 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.539 -169.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 tp -136.25 125.13 24.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' HD12 ' A' ' 106' ' ' ILE . 31.9 ttm -121.47 151.42 40.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 HG12 ' A' ' 105' ' ' VAL . 72.5 p -108.6 145.43 34.9 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.773 0.32 . . . . 0.0 110.297 178.739 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.238 0.473 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.23 117.33 44.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -116.17 116.53 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -103.18 152.69 21.17 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.883 0.849 . . . . 0.0 109.897 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -128.0 121.4 29.71 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.3 -178.52 41.81 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -117.76 144.67 45.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.67 121.48 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.709 0.803 . . . . 0.0 110.528 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.6 149.63 40.0 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.074 0.55 . . . . 0.0 111.06 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.88 -32.91 40.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.456 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.53 102.76 14.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 20.68 10.93 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.97 117.62 30.45 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -147.58 137.14 22.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.89 0.876 . . . . 0.0 108.892 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 26.4 mmt -81.29 145.46 30.89 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -72.78 158.6 35.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.866 0.466 . . . . 0.0 112.201 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -115.01 155.96 26.0 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.267 1.027 . . . . 0.0 108.902 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.59 -2.97 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 116.369 -0.378 . . . . 0.0 113.984 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.96 147.96 1.34 Allowed Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.724 1.21 . . . . 0.0 108.625 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.69 148.41 77.7 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.154 1.903 . . . . 0.0 111.421 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.38 -171.8 25.64 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.37 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.9 129.56 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.121 0.968 . . . . 0.0 109.118 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 45.1 ttp180 -95.14 124.72 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.3 156.05 45.9 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -90.37 100.18 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 107' ' ' ILE . 12.0 tp -72.54 106.75 4.73 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.417 0.687 . . . . 0.0 109.711 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.53 102.43 11.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.966 0.906 . . . . 0.0 111.602 -174.378 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.67 148.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.13 0.972 . . . . 0.0 109.096 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -83.46 145.23 29.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 82.7 t -129.96 121.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.18 0.592 . . . . 0.0 109.493 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.3 91.25 7.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.396 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -94.31 115.13 27.31 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -105.58 122.92 47.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.97 -162.63 28.35 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.472 0.482 . . . . 0.0 111.95 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.17 111.91 12.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.696 0.798 . . . . 0.0 110.815 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.66 117.12 66.45 Favored Pre-proline 0 N--CA 1.475 0.776 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.46 161.56 43.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.018 1.812 . . . . 0.0 112.591 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.32 -24.77 62.19 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.083 0.953 . . . . 0.0 110.555 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.8 p -70.79 -21.79 62.44 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.357 1.063 . . . . 0.0 111.642 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.504 ' HA ' HG11 ' A' ' 103' ' ' VAL . 54.0 t80 -71.66 121.56 19.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.568 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.6 pttt -145.74 159.81 46.15 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.486 1.115 . . . . 0.0 108.932 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.33 96.8 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.513 2.142 . . . . 0.0 111.887 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.7 1.35 10.83 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.277 -0.735 . . . . 0.0 113.956 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 8.4 p -75.49 141.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.026 0.913 . . . . 0.0 111.415 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.84 136.26 40.19 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.39 160.86 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.761 0.791 . . . . 0.0 112.598 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.441 HD11 ' HD3' ' A' ' 126' ' ' LYS . 60.7 mt -126.79 107.99 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.46 1.904 . . . . 0.0 105.902 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 77' ' ' LEU . 19.7 pt -111.51 146.68 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.341 0.656 . . . . 0.0 109.422 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -140.66 143.07 34.93 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.99 -122.12 0.99 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.87 140.21 6.64 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 117.409 0.604 . . . . 0.0 112.131 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.92 131.86 53.52 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.772 0.829 . . . . 0.0 109.227 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -84.99 133.51 43.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.69 -31.45 92.04 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.444 2.762 . . . . 0.0 114.093 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.58 80.1 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.648 0.593 . . . . 0.0 113.483 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 36.3 mt-10 -112.85 162.31 15.95 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.837 0.827 . . . . 0.0 113.004 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.17 -43.77 9.16 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.722 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -90.84 129.1 36.92 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.836 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -77.97 123.96 27.43 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.98 0.912 . . . . 0.0 109.268 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.87 100.8 13.45 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.45 105.67 15.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.438 0.695 . . . . 0.0 109.65 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -70.62 -23.94 62.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.918 0.487 . . . . 0.0 110.346 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.8 p -137.23 152.65 50.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.21 1.004 . . . . 0.0 109.489 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -139.37 136.24 34.55 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 24.3 ttm -136.61 104.8 5.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.031 0.933 . . . . 0.0 108.735 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -70.47 122.75 20.26 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HD3' HD11 ' A' ' 106' ' ' ILE . 56.1 tptt . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 123.932 0.893 . . . . 0.0 109.466 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.12 110.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -109.58 114.19 27.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -111.36 138.0 48.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -112.44 145.29 40.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.93 -159.41 28.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 118.19 0.45 . . . . 0.0 112.763 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -131.67 145.68 51.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.92 0.888 . . . . 0.0 110.28 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.72 119.04 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.224 1.01 . . . . 0.0 110.464 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.98 143.41 47.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.765 0.826 . . . . 0.0 110.185 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.62 -41.05 47.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.533 0.733 . . . . 0.0 110.333 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.84 102.64 10.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.086 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 76' ' ' ARG . . . 104.29 42.95 1.81 Allowed Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.795 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.64 125.47 51.82 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -143.67 144.48 31.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.746 1.218 . . . . 0.0 109.668 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 71.9 mmm -81.29 149.46 28.95 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 mt -66.66 150.18 49.43 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.55 104.96 15.0 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.913 0.885 . . . . 0.0 110.334 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.19 33.92 88.53 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.635 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.51 146.86 20.28 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.44 0.696 . . . . 0.0 110.288 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.44 130.83 16.67 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.351 2.034 . . . . 0.0 110.275 170.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.62 -169.19 23.92 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 116.681 -0.236 . . . . 0.0 112.515 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.65 130.59 3.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 34.3 ttm180 -94.61 129.86 41.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.43 162.31 41.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.422 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 73.4 mtp180 -95.46 124.44 39.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.5 tp -99.76 116.51 32.01 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 109.517 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -79.38 116.89 19.88 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.412 1.085 . . . . 0.0 108.467 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.585 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.6 p . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.69 141.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.81 154.58 41.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 55.9 t -137.3 118.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 92' ' ' LYS . 59.9 tp -93.01 92.67 7.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 108.77 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -90.91 123.41 34.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 90' ' ' LEU . 98.9 mttt -107.53 129.78 54.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 167.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.51 -165.98 26.27 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.452 0.47 . . . . 0.0 112.072 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.01 118.75 13.24 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.581 0.752 . . . . 0.0 111.224 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.15 115.85 63.54 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.013 0.925 . . . . 0.0 109.232 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.87 157.62 47.22 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.061 2.507 . . . . 0.0 114.19 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.49 -27.63 66.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.935 0.894 . . . . 0.0 110.326 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 t -80.58 -14.78 57.91 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 123' ' ' LEU . 68.5 t80 -78.14 114.05 16.66 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -146.48 154.92 49.43 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.174 0.989 . . . . 0.0 109.121 177.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.39 102.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.691 2.261 . . . . 0.0 112.414 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.57 -10.19 5.81 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.372 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 99' ' ' PHE . 13.6 p -78.1 136.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 117.662 0.731 . . . . 0.0 110.699 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -76.09 122.57 24.46 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.83 155.15 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.971 0.891 . . . . 0.0 111.226 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 61.3 mt -114.34 109.4 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.1 pt -97.19 153.76 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 38.5 tt0 -145.76 134.93 22.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.69 -114.6 0.59 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.53 166.2 39.42 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.96 123.02 42.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.07 0.948 . . . . 0.0 108.961 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.39 132.35 33.95 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.306 0.642 . . . . 0.0 109.785 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.49 89.34 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.095 2.53 . . . . 0.0 111.611 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.11 -39.65 0.52 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.57 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.95 129.37 35.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.395 0.678 . . . . 0.0 109.197 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.52 -16.29 61.28 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.085 168.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -95.23 126.5 40.59 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 111.871 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -76.48 114.88 15.69 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.013 1.325 . . . . 0.0 109.176 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -74.69 91.42 2.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.08 113.51 25.49 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.861 0.864 . . . . 0.0 110.472 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.441 ' HG3' ' OG1' ' A' ' 122' ' ' THR . 25.6 ptt180 -74.66 -26.82 60.12 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.903 0.481 . . . . 0.0 110.006 172.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 17.8 m -126.67 145.9 50.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.745 0.818 . . . . 0.0 109.175 -169.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 99' ' ' PHE . 47.2 tp -137.04 132.95 34.93 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.615 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 38.8 ttm -134.55 96.56 3.6 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.4 p -72.18 121.87 20.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.716 0.806 . . . . 0.0 109.792 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 0.0 111.388 -173.443 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.65 108.26 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -170.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -101.13 109.9 21.85 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.12 136.51 53.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -108.92 131.62 54.85 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.8 -174.26 32.49 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.4 m -128.28 139.4 52.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.144 0.978 . . . . 0.0 108.841 173.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.06 120.13 28.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.918 0.887 . . . . 0.0 108.983 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.29 57.58 Favored 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.694 0.621 . . . . 0.0 110.333 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.67 -18.64 59.57 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.667 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.55 109.19 21.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.975 . . . . 0.0 108.944 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.94 64.85 0.91 Allowed Glycine 0 C--N 1.346 1.096 0 O-C-N 123.146 0.279 . . . . 0.0 112.486 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -136.0 124.49 23.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 84.7 m -147.25 138.79 24.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.479 0.712 . . . . 0.0 110.128 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 80.1 mmm -82.7 153.29 25.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.341 0.657 . . . . 0.0 109.319 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.96 138.44 48.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.438 0.295 . . . . 0.0 111.008 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.82 112.89 5.81 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.955 0.902 . . . . 0.0 111.669 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.63 30.48 72.32 Favored Glycine 0 C--N 1.347 1.186 0 O-C-N 124.125 0.891 . . . . 0.0 113.349 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.91 138.48 11.9 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.337 0.655 . . . . 0.0 110.213 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 111.0 2.11 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.927 2.418 . . . . 0.0 110.898 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.99 177.43 35.98 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -154.35 138.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -106.29 131.57 53.36 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -144.73 154.8 43.11 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -92.5 91.55 7.66 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.68 120.1 22.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.62 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 86' ' ' THR . 36.5 mt-10 -92.45 105.19 17.41 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.9 t0 . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 124.679 1.192 . . . . 0.0 111.223 -174.706 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 78' ' ' GLU . 18.0 p . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.0 t -108.4 135.5 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.37 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.6 130.77 34.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.46 116.41 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 tp -91.93 94.26 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -92.07 114.16 26.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.174 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.16 123.13 34.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.13 169.83 12.66 Favored Glycine 0 N--CA 1.467 0.721 0 O-C-N 123.206 0.316 . . . . 0.0 112.653 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 120.18 12.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.235 0.614 . . . . 0.0 110.318 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.28 124.42 78.33 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.179 0.991 . . . . 0.0 110.251 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.5 ' HB2' HG22 ' A' ' 98' ' ' THR . 93.9 Cg_endo -75.61 155.46 40.14 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.726 2.284 . . . . 0.0 112.46 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -65.17 -22.37 66.9 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.788 0.835 . . . . 0.0 112.047 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 96' ' ' PRO . 6.7 t -74.21 -24.44 59.33 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.511 0.724 . . . . 0.0 111.216 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.514 ' HA ' HG11 ' A' ' 103' ' ' VAL . 75.3 t80 -73.32 109.86 7.17 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -141.32 159.76 59.81 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.021 0.929 . . . . 0.0 109.895 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.37 100.11 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.695 2.263 . . . . 0.0 111.574 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.86 -11.28 7.84 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.257 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 99' ' ' PHE . 5.4 p -72.17 146.96 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 117.489 0.644 . . . . 0.0 109.884 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 35.8 mt-10 -81.46 136.42 35.66 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.616 HG12 HG22 ' A' ' 125' ' ' THR . 19.6 m -128.74 169.58 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 122.152 0.977 . . . . 0.0 111.701 177.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -136.25 107.75 6.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.896 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 118' ' ' PHE . 41.1 pt -98.16 149.51 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.909 0.884 . . . . 0.0 109.471 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 40.7 mt-10 -135.03 139.75 45.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.72 -120.82 0.97 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.2 168.77 41.9 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.808 0.304 . . . . 0.0 112.374 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.29 101.03 7.69 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.49 130.45 58.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.0 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.92 97.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.604 2.869 . . . . 0.0 112.416 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.13 -52.14 0.56 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.87 118.39 24.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.637 0.775 . . . . 0.0 109.886 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.17 -26.56 61.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.378 0.671 . . . . 0.0 109.653 168.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -86.2 141.28 29.43 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.497 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.446 ' CD1' HD12 ' A' ' 107' ' ' ILE . 54.6 t80 -76.5 118.04 18.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 109.702 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.32 97.11 4.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.104 0.962 . . . . 0.0 109.409 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.87 114.2 25.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.049 0.54 . . . . 0.0 110.592 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.57 -34.83 46.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.518 0.727 . . . . 0.0 110.802 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 13.6 p -138.4 146.32 42.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.775 0.83 . . . . 0.0 109.569 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 tp -136.61 111.95 9.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.27 1.028 . . . . 0.0 109.594 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -122.47 119.86 32.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 105' ' ' VAL . 45.8 p -72.23 146.78 47.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.809 0.337 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.73 118.34 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -91.94 121.59 33.68 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.94 138.81 51.07 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -120.35 154.45 35.04 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 109.882 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.19 -155.56 26.97 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 121.805 -0.236 . . . . 0.0 112.932 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -124.32 145.21 49.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.776 0.83 . . . . 0.0 109.737 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.28 120.51 36.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.64 33.47 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 124.017 0.823 . . . . 0.0 111.003 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.31 -17.78 51.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.413 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.75 127.72 33.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.434 0.693 . . . . 0.0 110.477 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 8.2 84.03 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.431 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HE2' ' A' ' 99' ' ' PHE . 4.3 tt -69.55 103.83 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -116.2 113.7 23.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.518 1.127 . . . . 0.0 108.929 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.4 mtp -89.08 136.56 32.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.23 128.59 37.13 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.468 0.48 . . . . 0.0 110.112 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.58 112.34 24.22 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.43 0.692 . . . . 0.0 109.232 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.02 -30.53 9.91 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.023 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.42 141.99 23.64 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.746 0.818 . . . . 0.0 109.57 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.29 6.35 4.42 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.213 2.608 . . . . 0.0 114.112 -175.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.96 -170.66 44.24 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.424 0.452 . . . . 0.0 113.369 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 95' ' ' VAL . 13.0 p -154.12 154.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.455 0.702 . . . . 0.0 110.73 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -121.78 138.45 54.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.624 1.17 . . . . 0.0 108.015 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -151.1 174.63 12.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -113.37 111.87 22.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.794 0.807 . . . . 0.0 109.83 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.0 tp -77.62 133.66 38.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.007 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 86' ' ' THR . 44.6 mt-10 -84.47 124.22 31.11 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.613 0.57 . . . . 0.0 110.555 174.362 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 78' ' ' GLU . 37.6 p . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.96 133.25 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -83.1 134.97 34.98 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.13 116.29 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.224 0.61 . . . . 0.0 109.485 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.3 tp -93.61 93.97 8.35 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.4 109.99 18.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.183 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.66 109.93 21.81 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 109.518 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.21 37.87 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.11 115.95 27.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.427 HG21 ' HB ' ' A' ' 73' ' ' VAL . 97.9 t -80.18 118.69 73.68 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 122.735 0.414 . . . . 0.0 109.884 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.5 162.35 38.24 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.299 1.999 . . . . 0.0 112.439 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.3 -22.55 66.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.926 0.89 . . . . 0.0 111.185 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 67.8 p -67.67 -20.91 65.35 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.617 1.167 . . . . 0.0 112.096 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.409 ' HE2' HD21 ' A' ' 64' ' ' LEU . 75.8 t80 -79.79 136.36 36.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.827 0.851 . . . . 0.0 109.521 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -163.89 162.49 16.45 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.969 0.908 . . . . 0.0 110.599 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.24 101.57 0.35 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.435 2.09 . . . . 0.0 110.517 164.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.21 62.51 0.67 Allowed Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HG13 ' A' ' 105' ' ' VAL . 11.6 p -137.7 130.53 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -0.615 . . . . 0.0 110.285 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -69.85 132.65 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 165.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG12 HG22 ' A' ' 125' ' ' THR . 15.2 m -139.06 159.37 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-O 122.081 0.943 . . . . 0.0 111.174 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.31 106.46 12.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 113.237 -1.801 . . . . 0.0 106.291 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.0 pt -100.87 161.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.254 0.621 . . . . 0.0 110.098 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.89 140.47 20.71 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.19 -108.57 0.27 Allowed Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.26 171.25 41.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.4 tp -128.69 127.71 42.67 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 139.03 43.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.241 0.616 . . . . 0.0 109.913 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.66 112.12 2.09 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.403 2.069 . . . . 0.0 112.179 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.38 -21.48 19.42 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.83 144.21 26.15 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 110.922 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.62 -34.76 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.811 0.444 . . . . 0.0 110.993 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -82.38 126.29 32.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.109 0.48 . . . . 0.0 110.795 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -77.6 122.54 25.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.846 0.858 . . . . 0.0 108.693 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -91.54 103.83 16.39 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.4 119.57 25.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -68.42 -42.49 78.88 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.272 1.029 . . . . 0.0 109.799 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -134.51 141.73 46.81 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 -170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -125.82 112.39 15.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.702 1.201 . . . . 0.0 108.566 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 ttp -118.55 106.0 12.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.498 HG22 HG12 ' A' ' 105' ' ' VAL . 77.5 p -71.24 128.06 34.65 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 123.811 0.844 . . . . 0.0 109.207 -177.475 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 42.2 t -115.48 132.69 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 94.6 mtt180 -100.14 146.22 27.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.342 0.657 . . . . 0.0 110.177 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD23 ' A' ' 77' ' ' LEU . 1.5 tt -133.82 126.6 30.89 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -115.66 108.33 16.25 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.98 -152.11 5.57 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 56.6 m -125.38 146.43 49.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.61 0.764 . . . . 0.0 109.815 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.68 120.04 33.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 124.012 0.925 . . . . 0.0 109.071 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.14 150.98 43.33 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.905 0.753 . . . . 0.0 111.007 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.55 45.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.624 0.769 . . . . 0.0 110.074 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.78 113.91 26.31 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.88 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.56 -1.14 45.92 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.224 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.4 tt -69.21 108.96 3.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -121.52 128.62 52.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.211 1.005 . . . . 0.0 108.861 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.7 mmt -83.06 154.91 24.17 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -86.3 35.61 0.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 26.42 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 128.078 2.551 . . . . 0.0 114.44 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.72 38.56 3.2 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.174 0.416 . . . . 0.0 113.05 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 133.75 4.38 Favored Pre-proline 0 C--O 1.241 0.618 0 C-N-CA 124.669 1.188 . . . . 0.0 108.694 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.72 115.64 3.51 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.468 2.112 . . . . 0.0 109.901 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.06 -174.4 33.27 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.501 0.5 . . . . 0.0 112.965 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.36 133.77 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.959 0.904 . . . . 0.0 110.057 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 46.2 ttm180 -106.36 124.32 49.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -149.33 160.77 43.12 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -96.45 111.48 23.57 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.439 HD23 HD22 ' A' ' 55' ' ' LEU . 19.7 tp -79.86 105.05 10.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.75 121.42 19.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.6 t70 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 124.176 0.99 . . . . 0.0 110.825 -177.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 C--O 1.239 0.533 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.03 134.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -85.98 138.39 32.02 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 60.2 t -123.08 116.68 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.4 93.87 8.4 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -98.18 122.58 41.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.91 116.17 31.15 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.01 174.65 33.18 Favored Glycine 0 C--O 1.238 0.346 0 O-C-N 123.994 0.808 . . . . 0.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 112.78 4.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.1 117.01 66.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.413 0.685 . . . . 0.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.01 171.23 18.53 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.182 1.921 . . . . 0.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.16 -22.27 59.49 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -63.54 -32.2 73.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.4 1.08 . . . . 0.0 109.796 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -76.52 120.91 22.38 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 166.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.35 155.63 19.25 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.505 0.722 . . . . 0.0 110.173 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 64' ' ' LEU . 41.6 Cg_exo -57.98 107.79 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.649 2.232 . . . . 0.0 111.847 172.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.86 -25.14 5.62 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.237 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 p -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 117.44 0.62 . . . . 0.0 110.654 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.5 mt-10 -86.62 129.69 34.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 125' ' ' THR . 34.8 m -119.99 144.94 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.611 0.719 . . . . 0.0 111.068 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.92 107.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.66 143.69 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 25.9 mt-10 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.62 -100.29 0.14 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . 166.15 159.2 11.71 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 170.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.84 127.67 39.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.995 0.918 . . . . 0.0 109.237 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -82.98 135.34 45.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 -28.66 80.96 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.814 2.342 . . . . 0.0 113.377 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.05 -11.26 56.61 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.84 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 42.1 mt-10 -119.14 125.49 49.37 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.562 0.745 . . . . 0.0 110.159 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -61.43 -26.3 67.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.992 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 t -84.67 130.51 34.7 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.23 0.538 . . . . 0.0 111.284 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 10.2 t80 -77.07 116.15 17.47 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -97.51 114.37 26.24 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.28 30.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.165 0.986 . . . . 0.0 110.668 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -75.04 -26.36 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.142 0.577 . . . . 0.0 110.45 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 39.0 p -139.61 155.39 47.48 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.682 1.193 . . . . 0.0 108.836 174.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 tt -137.94 137.11 37.66 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 ttp -133.7 164.97 26.03 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 105' ' ' VAL . 40.0 p -109.86 149.36 29.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.113 0.565 . . . . 0.0 109.913 173.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.21 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.004 0.43 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.64 127.78 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -113.84 134.27 54.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.792 0.437 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 163.95 16.93 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.222 1.009 . . . . 0.0 110.244 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -139.37 139.82 37.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.652 1.181 . . . . 0.0 108.368 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.94 30.44 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -123.2 148.68 45.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.588 1.155 . . . . 0.0 109.463 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.47 130.87 35.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.34 37.64 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.564 0.54 . . . . 0.0 110.919 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -70.89 -45.44 64.35 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.437 0.695 . . . . 0.0 109.608 170.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.63 120.58 30.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 52.12 1.93 Allowed Glycine 0 N--CA 1.468 0.782 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.9 tt -135.84 125.76 25.86 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -140.57 142.86 35.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.526 1.13 . . . . 0.0 108.807 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.6 mmt -95.02 147.88 22.93 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.99 123.66 22.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.05 124.88 41.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.351 0.661 . . . . 0.0 109.553 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.92 28.45 70.58 Favored Glycine 0 C--N 1.344 0.989 0 O-C-N 123.726 0.641 . . . . 0.0 111.9 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.33 131.48 2.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.784 1.233 . . . . 0.0 109.007 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 120.77 7.48 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 121.928 1.752 . . . . 0.0 111.771 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -176.85 31.32 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 120.998 0.221 . . . . 0.0 113.546 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.51 139.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.459 1.104 . . . . 0.0 109.431 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 40.5 ttt180 -119.65 125.81 49.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.64 0.776 . . . . 0.0 108.991 171.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.442 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 37.5 p90 -151.36 162.35 41.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 30.2 ptt180 -100.18 119.26 38.08 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 107' ' ' ILE . 41.0 tp -73.79 115.78 13.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.702 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.527 ' HA ' HG22 ' A' ' 86' ' ' THR . 34.2 mt-10 -74.21 101.95 4.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.172 0 C-N-CA 123.611 0.764 . . . . 0.0 111.797 -179.324 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 78' ' ' GLU . 39.9 p . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.615 0.245 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -101.95 138.82 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.8 m95 -73.89 160.63 31.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.951 0.501 . . . . 0.0 110.777 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.3 t -135.71 108.77 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 108.677 -173.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.9 tp -93.98 94.04 8.23 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -99.48 131.86 45.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -118.74 150.84 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.147 0.579 . . . . 0.0 110.622 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.18 -172.22 14.12 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.195 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.81 121.13 18.43 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.166 0.587 . . . . 0.0 110.106 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.24 124.64 80.6 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.922 0.889 . . . . 0.0 109.332 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 123' ' ' LEU . 57.8 Cg_endo -68.61 152.58 74.56 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.474 2.116 . . . . 0.0 112.111 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.55 -27.03 63.84 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.524 0.73 . . . . 0.0 111.66 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 96' ' ' PRO . 9.6 t -68.62 -20.02 64.46 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.761 0.425 . . . . 0.0 110.908 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.07 115.33 10.08 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.8 mtmt -132.15 158.66 74.95 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.487 1.115 . . . . 0.0 108.644 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 11.2 Cg_exo -70.99 141.08 39.42 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.204 1.936 . . . . 0.0 109.985 167.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.72 79.04 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 100' ' ' LYS . 9.9 p -93.25 149.83 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.388 1.094 . . . . 0.0 108.313 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -69.99 139.07 52.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 125' ' ' THR . 16.6 m -133.03 156.4 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.916 0.865 . . . . 0.0 111.017 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.8 mt -121.16 127.89 75.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.738 1.615 . . . . 0.0 106.769 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 77' ' ' LEU . 17.6 pt -125.93 145.63 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.26 155.25 46.6 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 109.153 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 165.88 -114.42 0.59 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.02 150.81 20.94 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 117.343 0.571 . . . . 0.0 111.979 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 45.9 tp -127.66 136.11 51.15 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.533 0.733 . . . . 0.0 109.874 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 132.55 37.17 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.64 -19.53 53.43 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.807 2.338 . . . . 0.0 113.728 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.7 -8.28 57.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.792 -0.449 . . . . 0.0 113.768 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -100.68 139.68 36.03 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 117.708 0.754 . . . . 0.0 110.014 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -85.98 -23.14 27.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.994 0.917 . . . . 0.0 111.934 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -99.39 126.47 45.28 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.873 0.844 . . . . 0.0 110.763 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 111' ' ' LEU . 81.2 t80 -75.11 131.02 40.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.762 1.225 . . . . 0.0 108.715 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 60.0 tttm -88.25 108.16 19.17 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.02 113.62 23.84 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.015 0.526 . . . . 0.0 110.111 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.09 -30.51 62.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.468 0.707 . . . . 0.0 109.49 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p -133.4 141.33 47.82 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 109.834 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 96' ' ' PRO . 62.8 tp -124.8 109.58 13.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.5 ttp -124.86 138.45 54.26 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' HG12 ' A' ' 105' ' ' VAL . 65.3 p -89.61 169.01 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.002 0.521 . . . . 0.0 111.231 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 24.9 tptm . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.213 1.005 . . . . 0.0 109.995 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 CA--C 1.563 1.444 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -97.15 118.85 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.336 -0.853 . . . . 0.0 109.521 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -120.1 138.0 53.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.67 140.47 40.82 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.77 134.04 52.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.211 1.005 . . . . 0.0 108.606 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.9 177.38 41.04 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -113.4 140.19 48.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.763 0.825 . . . . 0.0 109.074 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 102' ' ' GLY . 59.6 t -74.6 132.25 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.764 0.426 . . . . 0.0 110.39 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.67 40.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 122.617 0.367 . . . . 0.0 110.062 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -75.59 -0.33 20.09 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.695 173.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -131.23 120.77 23.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.898 0.879 . . . . 0.0 109.363 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.91 22.91 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.865 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.81 105.73 5.23 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 m -138.59 125.95 21.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.813 0.845 . . . . 0.0 109.944 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtp -96.89 162.19 13.52 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.165 0.586 . . . . 0.0 110.631 -170.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.63 135.12 35.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.013 0.525 . . . . 0.0 111.225 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -73.89 111.84 9.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.554 0.742 . . . . 0.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.95 -53.78 4.88 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.334 0.396 . . . . 0.0 112.347 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.61 129.16 94.14 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 123.856 0.862 . . . . 0.0 110.906 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.31 113.46 1.92 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.435 2.09 . . . . 0.0 110.808 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.41 175.36 35.94 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 121.478 0.488 . . . . 0.0 113.514 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 8.7 p -154.35 131.71 2.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.06 1.344 . . . . 0.0 108.723 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.93 143.4 31.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -156.64 163.32 39.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -98.64 105.99 18.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.85 117.5 23.34 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.6 89.71 1.0 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.471 0.592 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.917 179.448 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 120.534 0.207 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.2 t -104.09 129.35 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.461 0.704 . . . . 0.0 109.657 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.2 m95 -78.76 100.76 7.25 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.19 110.09 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.359 0.6 . . . . 0.0 109.572 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 tp -93.15 93.75 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.742 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' HE2' ' HA ' ' A' ' 95' ' ' VAL . 47.3 t80 -92.97 111.54 23.2 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.715 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -105.3 116.09 31.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.205 0.602 . . . . 0.0 109.463 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 153.63 -175.24 32.05 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.46 112.76 4.24 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' TYR . 46.2 t -79.82 126.35 80.33 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.423 0.689 . . . . 0.0 109.232 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.6 Cg_endo -57.33 142.88 94.96 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.782 2.322 . . . . 0.0 112.519 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.93 -25.7 67.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.583 0.753 . . . . 0.0 111.441 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.2 p -78.22 -6.65 55.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.503 1.121 . . . . 0.0 112.642 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 78.9 t80 -69.99 95.94 0.99 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.294 0.638 . . . . 0.0 109.946 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.4 pttt -110.53 157.41 38.36 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.256 1.023 . . . . 0.0 110.018 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.536 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 16.3 Cg_exo -68.46 112.7 2.9 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.302 2.001 . . . . 0.0 110.714 171.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 59' ' ' VAL . . . 111.58 3.31 27.18 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.911 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 125' ' ' THR . 12.8 p -85.63 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 118.07 0.935 . . . . 0.0 110.278 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.39 110.33 8.59 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.5 HG13 HG13 ' A' ' 103' ' ' VAL . 29.8 m -104.63 148.05 9.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.952 0.882 . . . . 0.0 110.223 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.55 107.19 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.11 144.42 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 138.89 26.66 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.93 -118.35 0.83 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -172.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.54 141.58 6.63 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 117.907 0.853 . . . . 0.0 112.342 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 tp -87.64 129.17 35.22 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -81.58 132.75 54.23 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.75 -18.78 66.08 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.009 2.473 . . . . 0.0 114.055 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.23 -31.92 6.64 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.679 -0.237 . . . . 0.0 112.76 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 3.2 mp0 -94.45 137.26 33.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.945 0.498 . . . . 0.0 111.313 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.26 -26.69 65.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.992 0.917 . . . . 0.0 110.533 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 58.5 p -84.41 130.04 34.81 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.9 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -77.79 120.43 22.68 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.372 1.069 . . . . 0.0 108.619 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -75.74 94.73 3.31 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.22 109.59 18.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.248 0.619 . . . . 0.0 110.13 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -62.38 -42.36 99.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.931 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.2 p -134.83 162.31 32.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.879 0.871 . . . . 0.0 110.192 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.0 tp -150.58 111.43 4.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.361 1.064 . . . . 0.0 108.895 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 ttp -124.48 116.08 21.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.485 0.314 . . . . 0.0 110.939 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 103' ' ' VAL . 70.4 p -74.06 150.27 40.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.389 1.076 . . . . 0.0 110.694 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 N--CA 1.47 0.575 0 C-N-CA 122.741 0.417 . . . . 0.0 110.054 177.588 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.6 t -102.65 145.23 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.183 0.993 . . . . 0.0 109.393 -170.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -115.58 123.2 47.85 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.44 147.35 41.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.637 0.732 . . . . 0.0 110.034 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.96 109.06 10.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.913 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.86 -158.31 8.55 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.455 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 50.2 m -117.12 145.71 43.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.388 1.075 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.9 120.43 32.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.079 0.952 . . . . 0.0 109.08 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.9 47.59 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.744 0.652 . . . . 0.0 111.647 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 101' ' ' PRO . . . -70.3 -28.83 65.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.541 0.736 . . . . 0.0 112.111 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -110.59 42.14 1.64 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.54 51.96 0.22 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 tt -133.65 108.42 8.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 m -114.43 119.51 37.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 109.682 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.1 mmt -80.92 143.62 32.52 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 0.0 110.093 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -75.93 131.96 39.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.641 0.376 . . . . 0.0 110.068 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.38 139.48 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.525 0.73 . . . . 0.0 109.93 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.26 19.84 64.55 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.978 0.799 . . . . 0.0 112.9 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.89 129.29 2.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.959 0.904 . . . . 0.0 109.674 -172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.91 121.78 8.43 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.506 2.137 . . . . 0.0 110.668 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.58 -172.96 30.27 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.606 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.09 139.68 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 109.528 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.749 HH21 ' HB ' ' A' ' 117' ' ' THR . 45.9 ttt180 -111.86 139.86 46.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -154.27 152.58 30.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.251 0.62 . . . . 0.0 109.544 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 13.8 ptm180 -94.66 107.24 19.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -73.32 114.26 11.33 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.856 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.73 87.6 6.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 124.129 0.972 . . . . 0.0 109.042 174.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.849 0.357 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.52 135.57 35.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 70.9 m95 -74.7 161.96 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.241 0.616 . . . . 0.0 109.438 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 84.1 t -138.23 115.07 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.1 tp -93.2 98.5 11.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.067 0.854 . . . . 0.0 108.79 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -96.03 125.21 40.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -119.49 117.52 28.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.236 0.614 . . . . 0.0 109.887 172.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.49 -164.52 30.24 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 115.23 9.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.948 0.499 . . . . 0.0 109.694 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.42 130.24 65.99 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.856 0.862 . . . . 0.0 109.474 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.605 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.9 Cg_endo -61.46 144.91 98.38 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.38 2.054 . . . . 0.0 112.132 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.83 -27.44 67.55 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.237 1.015 . . . . 0.0 111.446 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 p -78.73 -14.53 59.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.509 1.124 . . . . 0.0 112.139 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.6 t80 -68.51 119.94 13.78 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -152.37 161.05 30.39 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.275 1.03 . . . . 0.0 108.716 -174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 57.0 Cg_endo -66.73 111.16 2.07 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.032 1.822 . . . . 0.0 110.845 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.63 -11.48 15.92 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.683 -0.509 . . . . 0.0 113.825 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.07 149.18 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 117.714 0.757 . . . . 0.0 110.002 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.2 mt-10 -83.18 140.96 32.27 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.11 168.46 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.063 0.945 . . . . 0.0 111.851 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.415 ' HB ' ' HG2' ' A' ' 124' ' ' MET . 71.5 mt -132.84 122.71 47.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 126.462 1.905 . . . . 0.0 106.202 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.6 139.56 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.689 0.795 . . . . 0.0 109.827 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.42 132.49 56.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.9 -143.09 7.09 Favored Glycine 0 N--CA 1.47 0.946 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.82 136.18 4.58 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 117.685 0.742 . . . . 0.0 112.662 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.2 tp -93.08 134.41 35.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.289 1.035 . . . . 0.0 108.919 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 115' ' ' GLU . . . -88.86 146.59 37.11 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.264 0.626 . . . . 0.0 110.309 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.49 120.25 7.36 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.878 2.385 . . . . 0.0 112.206 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.12 69.14 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.979 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 112' ' ' ALA . 69.3 mm-40 -101.0 151.32 21.92 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.617 0.767 . . . . 0.0 110.13 172.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -106.55 16.45 24.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.925 0.89 . . . . 0.0 109.864 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.749 ' HB ' HH21 ' A' ' 74' ' ' ARG . 12.7 t -134.7 111.77 10.24 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.959 0.885 . . . . 0.0 109.846 -174.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -74.77 109.34 8.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.119 1.367 . . . . 0.0 108.37 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -77.79 98.74 5.65 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.29 163.53 26.33 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.629 0.771 . . . . 0.0 111.483 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -125.13 -36.47 2.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.091 1.356 . . . . 0.0 108.071 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -132.32 164.3 26.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.22 1.008 . . . . 0.0 109.778 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -156.71 117.94 3.76 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.488 1.115 . . . . 0.0 108.731 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 106' ' ' ILE . 19.2 ptp -137.38 147.82 45.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -91.55 142.85 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.684 0.394 . . . . 0.0 110.235 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 mttp . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 123.073 0.549 . . . . 0.0 110.092 177.055 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.4 124.44 49.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -82.72 105.0 13.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.17 132.21 54.37 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -167.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.98 126.52 55.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.86 -178.96 35.3 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -117.18 142.93 46.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.338 0.655 . . . . 0.0 109.726 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.47 125.01 36.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.346 0.658 . . . . 0.0 110.428 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.13 136.29 38.6 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.14 66.64 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.66 0.6 . . . . 0.0 109.744 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.754 ' HB2' HH21 ' A' ' 76' ' ' ARG . 2.6 m-20 -83.78 133.05 34.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.543 177.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.25 78.86 Favored Glycine 0 N--CA 1.468 0.803 0 O-C-N 123.397 0.436 . . . . 0.0 113.217 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tt -76.67 103.79 6.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.6 m -121.05 127.36 51.63 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.778 1.231 . . . . 0.0 109.57 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 91.8 mmm -83.85 145.0 28.88 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.56 125.28 26.23 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.36 104.08 2.6 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.362 1.065 . . . . 0.0 110.552 -170.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.49 73.5 Favored Glycine 0 C--N 1.342 0.895 0 O-C-N 123.749 0.656 . . . . 0.0 112.784 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.7 132.35 13.02 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 123.917 0.887 . . . . 0.0 109.394 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.96 110.69 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.758 2.305 . . . . 0.0 111.051 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 -176.79 30.17 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.841 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.66 135.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 109.579 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.6 ttm180 -112.48 128.11 56.24 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.0 171.85 14.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -171.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.754 HH21 ' HB2' ' A' ' 62' ' ' ASP . 37.9 mtm180 -96.39 130.16 43.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 tp -103.13 117.05 33.69 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.672 0.789 . . . . 0.0 109.234 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -70.62 91.36 0.79 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 170.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.538 0.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.824 -161.336 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.15 136.42 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.18 127.2 31.73 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 99.3 t -111.94 117.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.429 0.692 . . . . 0.0 109.312 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.38 96.17 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -95.55 123.09 38.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -115.69 112.6 22.31 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.689 0.796 . . . . 0.0 109.425 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.52 -173.43 34.94 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.96 111.77 5.19 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.264 0.626 . . . . 0.0 110.312 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 110.15 19.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.806 0.691 . . . . 0.0 109.497 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 123' ' ' LEU . 74.5 Cg_endo -71.5 157.71 55.61 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.34 2.027 . . . . 0.0 112.147 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.55 -12.27 61.51 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.609 0.764 . . . . 0.0 112.242 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -70.15 -22.68 62.96 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.248 0.619 . . . . 0.0 111.485 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -71.56 95.27 1.39 Allowed 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.51 145.77 38.17 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.72 100.54 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.624 2.216 . . . . 0.0 111.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.78 -8.54 7.7 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.222 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.93 148.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 118.352 1.076 . . . . 0.0 110.038 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.88 115.99 19.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 20.7 m -104.67 155.72 6.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 123.847 0.859 . . . . 0.0 111.253 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mt -117.09 107.63 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.47 141.32 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.1 0.56 . . . . 0.0 109.966 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.41 117.85 30.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 120' ' ' ALA . . . -172.09 -149.47 6.69 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 123.49 0.494 . . . . 0.0 112.265 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.16 145.46 10.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 117.165 0.483 . . . . 0.0 112.479 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.9 tp -88.92 105.36 17.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.46 139.31 41.37 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.058 0.543 . . . . 0.0 111.212 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.93 90.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 123.414 2.743 . . . . 0.0 112.62 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.99 -42.57 0.82 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -95.38 130.46 42.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.542 0.737 . . . . 0.0 110.644 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.77 -17.04 60.03 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.864 0.866 . . . . 0.0 110.523 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 t -86.64 133.2 33.72 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.152 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -77.04 109.86 11.21 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -86.12 94.18 9.2 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . . . -84.12 117.35 23.41 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.635 0.774 . . . . 0.0 111.108 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -61.92 -45.41 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.845 0.858 . . . . 0.0 111.035 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m -127.97 136.24 51.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.66 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 96' ' ' PRO . 33.5 tp -112.99 123.74 51.01 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.6 mtm -132.73 171.01 14.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.226 1.01 . . . . 0.0 108.285 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 35.1 p -130.43 148.92 52.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.771 . . . . 0.0 110.075 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 N--CA 1.476 0.834 0 C-N-CA 123.399 0.68 . . . . 0.0 109.999 173.61 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 43' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.59 162.15 35.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.672 0.789 . . . . 0.0 110.665 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 p -101.26 105.57 40.29 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.74 -176.49 3.2 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.845 2.363 . . . . 0.0 112.743 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -63.85 159.03 20.47 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.121 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.36 145.17 48.85 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.142 0.977 . . . . 0.0 111.379 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.659 0.784 . . . . 0.0 111.73 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.29 27.49 1.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.473 0.709 . . . . 0.0 111.156 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -64.24 95.04 0.12 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.625 0.726 . . . . 0.0 109.894 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m -69.06 151.56 46.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.264 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.66 105.54 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -168.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.79 117.82 26.88 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD22 HD23 ' A' ' 77' ' ' LEU . 3.1 tt -123.62 142.9 50.6 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -121.76 141.25 51.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 0.0 109.302 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.26 -161.35 28.08 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.9 m -127.02 145.08 50.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.434 0.694 . . . . 0.0 110.59 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.35 132.3 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.573 0.749 . . . . 0.0 109.972 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.86 156.56 17.41 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.444 0.698 . . . . 0.0 110.964 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.13 30.63 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.482 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -77.31 108.81 10.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.813 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.36 12.21 61.66 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.756 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.24 90.16 1.59 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.3 m -116.8 116.66 27.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.734 1.214 . . . . 0.0 109.877 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtt -89.98 161.81 15.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 90' ' ' LEU . 79.3 mt -66.94 119.14 11.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.663 0.385 . . . . 0.0 110.681 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.97 98.07 0.27 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.351 1.06 . . . . 0.0 110.724 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.75 22.84 68.44 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.462 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -143.26 149.14 47.25 Favored Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.729 0.812 . . . . 0.0 109.953 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.81 111.52 3.27 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.566 2.178 . . . . 0.0 112.076 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.29 179.33 31.23 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.986 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 11.1 p -149.28 134.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.807 0.843 . . . . 0.0 110.601 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -104.15 138.65 40.33 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -155.28 163.63 39.88 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -97.98 115.16 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.553 HD23 HD22 ' A' ' 55' ' ' LEU . 21.9 tp -79.66 108.87 13.54 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 86' ' ' THR . 58.0 mt-10 -78.01 110.36 12.88 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.298 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.72 129.27 40.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.339 1.056 . . . . 0.0 110.111 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -72.68 -26.83 61.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.565 0.346 . . . . 0.0 111.545 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.65 -49.48 58.74 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.225 0.536 . . . . 0.0 109.97 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -131.47 103.26 6.32 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.1 p -76.07 4.63 8.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.813 0.845 . . . . 0.0 113.132 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 p -102.46 -15.88 16.34 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.433 0.693 . . . . 0.0 109.832 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -77.0 86.63 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 78' ' ' GLU . 35.2 p -107.63 108.02 19.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.468 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.45 129.57 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -81.41 98.21 8.11 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 107' ' ' ILE . 53.2 t -88.99 130.62 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.625 0.77 . . . . 0.0 109.986 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.532 HD11 HD21 ' A' ' 67' ' ' LEU . 37.0 tp -115.64 114.32 24.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.227 1.011 . . . . 0.0 108.939 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -112.86 128.87 56.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.086 1.354 . . . . 0.0 108.008 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 148.07 29.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.411 0.685 . . . . 0.0 109.433 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.78 -168.16 12.51 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.71 112.2 4.67 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.243 0.617 . . . . 0.0 110.582 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.11 117.13 68.18 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.029 0.932 . . . . 0.0 108.754 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 29.9 Cg_endo -59.44 151.3 69.62 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.693 2.262 . . . . 0.0 113.173 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -65.74 -25.12 67.14 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.728 0.811 . . . . 0.0 110.393 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.5 p -71.16 -23.87 62.14 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.992 1.317 . . . . 0.0 111.589 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.492 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.3 t80 -68.46 106.45 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -133.31 155.76 80.5 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.746 0.819 . . . . 0.0 109.101 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.13 110.3 2.17 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.523 2.148 . . . . 0.0 111.456 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.93 -11.71 9.37 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.044 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.2 t -81.55 124.41 38.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.456 0.702 . . . . 0.0 109.532 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.77 118.99 14.26 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 m -120.79 154.38 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.606 0.717 . . . . 0.0 111.785 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.55 115.14 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 89' ' ' VAL . 37.9 pt -100.91 162.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 33.5 tt0 -148.67 132.76 17.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 173.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.18 -117.54 0.69 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 179.76 146.27 6.79 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 117.453 0.626 . . . . 0.0 112.539 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.0 tp -92.98 114.57 27.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.22 134.51 48.82 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 123.593 0.558 . . . . 0.0 110.111 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.7 104.43 0.16 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.871 2.381 . . . . 0.0 111.85 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.07 -29.86 5.42 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' ' HE3' ' A' ' 119' ' ' LYS . 11.0 tp10 -91.29 132.64 36.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.4 -5.31 58.91 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.308 0.643 . . . . 0.0 112.284 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.45 ' H ' ' HG3' ' A' ' 115' ' ' GLU . 40.2 p -114.64 137.46 51.87 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.323 0.511 . . . . 0.0 112.031 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.25 111.61 14.39 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HE3' ' HG2' ' A' ' 115' ' ' GLU . 93.9 mttt -82.29 93.65 7.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.34 108.32 14.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.73 0.812 . . . . 0.0 110.043 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -19.62 57.46 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.589 0.755 . . . . 0.0 111.548 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 22.4 p -138.63 157.14 46.7 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.054 0.941 . . . . 0.0 110.107 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 tp -138.6 140.88 39.14 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.984 1.314 . . . . 0.0 108.235 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.8 ttm -136.53 118.77 15.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.348 0.659 . . . . 0.0 109.587 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -100.4 145.11 28.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.748 0.819 . . . . 0.0 110.157 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.61 -53.76 3.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.432 . . . . 0.0 111.122 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 92.3 m -82.11 124.18 78.95 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 122.552 0.341 . . . . 0.0 111.082 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.05 -158.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.998 2.465 . . . . 0.0 112.533 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.94 80.7 2.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.362 0.665 . . . . 0.0 109.911 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.332 1.053 . . . . 0.0 108.788 178.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.6 mtm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.02 50.66 2.22 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 ' OG1' ' HB1' ' A' ' 112' ' ' ALA . 80.9 p -74.99 146.66 82.85 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.621 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -43.68 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 124.489 3.46 . . . . 0.0 114.987 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' HB2' ' A' ' 112' ' ' ALA . 44.2 tt0 -151.81 80.13 1.27 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.66 163.29 23.71 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.966 0.412 . . . . 0.0 111.225 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.57 -42.06 65.03 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.398 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -22.6 61.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.06 0.144 . . . . 0.0 110.908 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -73.43 88.05 1.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.312 0.645 . . . . 0.0 109.705 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -100.8 121.35 41.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.88 146.13 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -123.33 114.27 19.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.181 0.992 . . . . 0.0 109.043 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tt -114.15 126.15 54.75 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.93 135.7 39.28 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.76 -174.15 38.47 Favored Glycine 0 CA--C 1.506 -0.514 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -124.12 140.84 52.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.225 1.01 . . . . 0.0 109.002 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.1 123.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . . . -75.65 149.52 38.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.07 0.548 . . . . 0.0 111.265 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.53 27.35 1.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.822 0.849 . . . . 0.0 110.562 167.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -143.31 128.16 18.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.723 1.209 . . . . 0.0 107.869 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.76 6.76 88.17 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.694 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.87 85.4 2.82 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.3 m -107.45 111.88 24.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.277 1.431 . . . . 0.0 109.847 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtp -91.79 146.64 23.6 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.55 127.5 32.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.755 0.422 . . . . 0.0 111.677 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -75.51 118.43 18.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.123 0.969 . . . . 0.0 110.316 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.32 18.71 67.71 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 123.88 0.738 . . . . 0.0 114.068 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.52 12.36 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.579 0.752 . . . . 0.0 109.691 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.54 115.98 4.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.399 2.066 . . . . 0.0 111.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.58 -175.51 31.92 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.841 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.27 130.56 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 124.15 0.98 . . . . 0.0 110.399 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.469 HH12 HG21 ' A' ' 117' ' ' THR . 8.9 tpp180 -92.25 131.84 37.15 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 165.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.92 163.33 37.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.531 0.605 . . . . 0.0 109.611 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.12 106.5 17.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.29 115.77 14.18 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.765 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' A' ' 83' ' ' THR . 48.3 mt-10 -73.1 99.35 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.48 101.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.347 1.059 . . . . 0.0 108.65 175.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -61.13 -22.9 65.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -167.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' N ' ' HD2' ' A' ' 80' ' ' LYS . 29.9 t70 -66.43 -36.54 83.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.242 0.617 . . . . 0.0 111.014 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -121.1 -62.28 1.46 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.337 0.655 . . . . 0.0 110.491 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 78' ' ' GLU . 18.9 m 76.9 -22.07 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.88 1.672 . . . . 0.0 111.613 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 p -64.69 -18.37 64.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.49 1.116 . . . . 0.0 110.846 167.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -126.92 113.54 16.67 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.957 0.903 . . . . 0.0 108.826 172.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 78' ' ' GLU . 71.4 p -110.1 139.16 45.53 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.19 137.76 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -79.89 146.27 32.25 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.75 119.53 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.0 94.16 7.82 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -89.56 125.16 35.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -116.41 110.11 18.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.477 0.711 . . . . 0.0 109.416 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.01 -173.98 35.28 Favored Glycine 0 N--CA 1.469 0.89 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.942 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 108.57 1.96 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.626 0.77 . . . . 0.0 111.763 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -81.67 118.03 70.57 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.401 0.681 . . . . 0.0 109.789 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.21 163.93 29.79 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.59 2.193 . . . . 0.0 112.556 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.72 -22.1 66.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.44 0.696 . . . . 0.0 110.691 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.599 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 18.8 p -82.21 -13.8 56.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.134 0.974 . . . . 0.0 111.833 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.06 107.0 6.84 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.5 pttt -151.8 150.42 26.13 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.407 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.53 117.77 4.8 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.273 1.982 . . . . 0.0 111.243 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.35 11.64 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.044 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.682 HG21 ' SG ' ' A' ' 127' ' ' CYS . 8.2 p -90.34 145.29 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 117.866 0.833 . . . . 0.0 110.283 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.04 131.63 39.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 151.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 121.805 0.812 . . . . 0.0 109.65 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.43 119.97 60.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.2 pt -107.94 137.37 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -114.28 145.98 41.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.24 -124.61 1.41 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.98 141.89 6.76 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 117.071 0.435 . . . . 0.0 112.657 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.8 tp -89.33 115.29 26.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.061 0.944 . . . . 0.0 108.592 173.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . . . -89.55 134.41 32.56 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.56 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' ALA . 21.9 Cg_exo -64.74 90.79 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.954 2.436 . . . . 0.0 111.986 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 150.73 -45.48 0.65 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 117' ' ' THR . 2.2 mp0 -91.84 116.36 28.84 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.054 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.04 -17.67 63.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.109 0.563 . . . . 0.0 110.617 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.469 HG21 HH12 ' A' ' 74' ' ' ARG . 8.8 t -78.18 134.21 37.67 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -75.46 109.26 8.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -82.5 94.7 7.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.39 126.62 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.333 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -81.58 -41.19 21.92 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.025 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p -138.57 165.03 27.94 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.741 0.816 . . . . 0.0 110.281 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.3 tp -135.19 137.28 42.52 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.698 1.199 . . . . 0.0 109.051 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 ttp -136.84 117.3 13.74 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.5 p -81.74 142.91 32.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.067 0.947 . . . . 0.0 109.887 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.4 mmpt? -71.1 -25.75 62.73 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.388 0.275 . . . . 0.0 111.599 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.682 ' SG ' HG21 ' A' ' 103' ' ' VAL . 21.4 p -85.32 118.43 70.76 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.56 155.8 56.22 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.554 . . . . 0.0 111.756 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.5 mp -53.63 101.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.807 0.843 . . . . 0.0 111.232 -175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 124.737 1.215 . . . . 0.0 110.466 -173.118 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.1 tpp . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.58 93.03 9.08 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -74.94 117.51 63.29 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.885 0.474 . . . . 0.0 111.587 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -94.41 18.28 0.84 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.367 2.711 . . . . 0.0 112.045 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.52 -173.51 2.97 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.234 1.014 . . . . 0.0 111.618 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.69 89.5 0.26 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.033 0.533 . . . . 0.0 110.45 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.474 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -151.67 -48.9 0.11 Allowed 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.7 pt? -93.84 -2.05 54.02 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.258 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -70.33 135.71 49.11 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 123.787 0.835 . . . . 0.0 109.748 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -128.51 125.47 38.45 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.82 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -137.01 118.95 15.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.852 0.861 . . . . 0.0 109.609 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.74 145.71 46.3 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -117.26 142.42 47.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.754 0.822 . . . . 0.0 109.365 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.32 -165.65 36.2 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.295 0.372 . . . . 0.0 112.828 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.2 m -119.28 147.19 44.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.771 0.828 . . . . 0.0 109.565 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.9 126.14 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 110.275 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.65 156.38 16.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.318 0.647 . . . . 0.0 110.064 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.02 59.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.283 0.633 . . . . 0.0 110.98 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.23 110.89 6.99 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.853 0.861 . . . . 0.0 109.466 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.61 16.16 71.61 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.679 0.612 . . . . 0.0 113.337 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.05 105.52 3.36 Favored 'General case' 0 C--N 1.359 1.022 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -143.74 137.56 28.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.573 1.149 . . . . 0.0 108.281 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.3 mmt -84.03 144.29 29.2 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.51 135.33 52.87 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.469 0.308 . . . . 0.0 110.848 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -65.7 109.89 2.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.97 0.908 . . . . 0.0 111.024 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.45 24.79 67.99 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.719 0.637 . . . . 0.0 113.801 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.5 130.06 10.39 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 123.534 0.734 . . . . 0.0 109.681 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 117.04 3.72 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.585 2.19 . . . . 0.0 110.499 171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.33 176.23 28.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.622 0.576 . . . . 0.0 111.945 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.31 143.83 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.483 0.658 . . . . 0.0 110.489 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -112.44 132.23 55.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -153.86 162.27 41.36 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.832 0.453 . . . . 0.0 110.175 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 39.6 ttp180 -95.88 111.07 23.15 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 107' ' ' ILE . 22.0 tp -79.13 120.58 23.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.032 0.533 . . . . 0.0 109.93 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.33 95.35 2.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -58.5 136.5 57.54 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.33 1.019 . . . . 0.0 112.079 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -98.74 -28.99 13.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.042 0.937 . . . . 0.0 111.322 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.37 -44.29 91.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.194 0.598 . . . . 0.0 111.749 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -121.45 -38.62 2.75 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.545 0.738 . . . . 0.0 110.717 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m 77.38 -19.23 0.44 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.346 1.458 . . . . 0.0 111.774 -173.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.3 p -81.18 9.28 7.09 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.161 0.984 . . . . 0.0 112.609 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.619 ' HE3' HG22 ' A' ' 87' ' ' VAL . 38.0 ttpt -147.84 158.11 43.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.971 0.909 . . . . 0.0 108.762 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 20.9 p -126.79 128.78 47.12 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG22 ' HE3' ' A' ' 85' ' ' LYS . 38.2 t -102.61 122.66 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.749 0.82 . . . . 0.0 110.667 -168.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.6 m95 -77.41 106.69 9.33 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.5 t -88.69 109.89 20.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.4 tp -93.18 97.09 10.43 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.379 1.049 . . . . 0.0 108.234 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -102.57 126.09 49.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.183 0.993 . . . . 0.0 109.026 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -111.7 130.57 55.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.354 0.662 . . . . 0.0 109.265 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.95 -166.49 21.39 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.98 110.84 3.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.546 0.738 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.69 131.89 59.53 Favored Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 109.537 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.02 140.96 58.55 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.802 2.335 . . . . 0.0 112.793 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.03 -24.57 65.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.234 0.54 . . . . 0.0 110.31 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -73.74 -15.06 61.22 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.816 1.246 . . . . 0.0 112.378 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -69.48 134.52 49.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.685 0.794 . . . . 0.0 110.009 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 103' ' ' VAL . 20.0 pttm -168.98 161.01 8.07 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.81 1.244 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.56 107.89 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.904 1.736 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.05 -9.34 8.47 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.811 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 127' ' ' CYS . 10.5 p -84.86 138.43 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 118.11 0.955 . . . . 0.0 109.478 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -79.91 116.28 19.97 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG22 ' A' ' 125' ' ' THR . 22.2 m -113.33 153.26 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.54 0.686 . . . . 0.0 111.683 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.61 115.77 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.49 HD13 HD22 ' A' ' 77' ' ' LEU . 21.9 pt -100.39 139.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -148.71 142.88 26.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.21 -110.07 0.42 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.09 159.29 31.37 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 117.242 0.521 . . . . 0.0 112.445 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -123.85 143.02 50.59 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 0.0 108.813 176.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.76 147.09 54.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.26 0.624 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.61 72.59 4.34 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.079 2.519 . . . . 0.0 111.633 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.81 69.85 0.1 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 119' ' ' LYS . 10.1 tp10 -172.64 141.05 1.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.789 0.835 . . . . 0.0 110.021 -173.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -86.29 -40.46 15.49 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.604 0.762 . . . . 0.0 109.642 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 69.0 p -83.92 121.32 27.2 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.598 -169.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.05 132.61 36.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.095 0.558 . . . . 0.0 110.114 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 115' ' ' GLU . 3.2 mptp? -93.23 96.55 10.07 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.24 99.68 9.44 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.932 0.493 . . . . 0.0 111.023 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -57.1 -33.07 66.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.889 0.875 . . . . 0.0 110.619 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p -138.05 141.15 40.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.579 1.152 . . . . 0.0 109.084 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.3 tp -132.97 118.91 19.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 ptm -129.81 147.6 51.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.385 0.674 . . . . 0.0 109.502 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 HG12 ' A' ' 105' ' ' VAL . 60.4 p -100.53 152.51 20.32 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.804 0.841 . . . . 0.0 109.957 174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.14 -24.22 21.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.479 0.712 . . . . 0.0 110.562 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.528 ' HB2' HG23 ' A' ' 103' ' ' VAL . 58.7 m -106.9 123.06 39.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.306 0.642 . . . . 0.0 110.153 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.08 -174.51 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.828 2.352 . . . . 0.0 112.618 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.92 99.62 0.26 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.314 0.645 . . . . 0.0 110.797 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 124.259 1.024 . . . . 0.0 108.265 179.351 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.14 89.66 1.17 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.268 0.627 . . . . 0.0 109.349 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -109.84 96.19 23.42 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 109.231 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.83 81.54 2.75 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.448 2.099 . . . . 0.0 111.66 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.77 93.57 2.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.04 148.49 28.58 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.515 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.01 -63.26 1.31 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.523 0.729 . . . . 0.0 109.653 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.94 65.89 2.98 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.072 0.549 . . . . 0.0 111.762 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -143.25 59.04 1.4 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 162.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.1 m -92.39 141.65 28.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.172 173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.72 136.84 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.342 0.657 . . . . 0.0 109.492 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.69 133.88 52.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.833 0.853 . . . . 0.0 108.995 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.83 139.56 38.21 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -110.42 143.38 40.8 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.403 1.081 . . . . 0.0 108.668 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.94 -173.76 42.78 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 117.876 0.307 . . . . 0.0 112.615 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.6 m -112.3 134.13 54.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.719 0.808 . . . . 0.0 110.057 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.92 122.56 19.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.188 0.995 . . . . 0.0 110.447 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.95 146.94 25.97 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.25 -10.93 58.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.468 0.707 . . . . 0.0 109.616 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.07 116.61 14.9 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.52 1.128 . . . . 0.0 109.995 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.66 9.91 82.75 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 123.682 0.614 . . . . 0.0 113.727 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 4.3 tt -72.61 111.14 7.5 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 p -132.1 130.69 41.55 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.277 1.431 . . . . 0.0 109.137 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.423 ' SD ' HG23 ' A' ' 73' ' ' VAL . 86.9 mmm -85.0 136.48 33.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.2 mt -63.84 111.52 2.5 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -71.09 110.21 5.63 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 110.57 -167.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.84 22.61 77.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.055 -0.52 . . . . 0.0 113.125 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.5 126.87 7.61 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.36 1.064 . . . . 0.0 108.937 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.68 109.4 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.324 2.016 . . . . 0.0 111.672 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 162.46 175.49 33.55 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 123.381 0.425 . . . . 0.0 112.181 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.423 HG23 ' SD ' ' A' ' 66' ' ' MET . 10.9 p -145.57 148.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.406 0.682 . . . . 0.0 110.451 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -123.72 137.57 54.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.136 . . . . 0.0 108.256 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.714 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 33.3 p90 -159.88 175.73 12.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.848 0.859 . . . . 0.0 108.893 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 35.1 ptt180 -111.76 135.23 52.64 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.476 HD22 HD13 ' A' ' 107' ' ' ILE . 24.9 tp -100.83 120.83 40.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.016 0.526 . . . . 0.0 109.939 -172.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -80.35 97.95 7.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.198 0.599 . . . . 0.0 109.583 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -98.08 149.79 22.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -24.38 18.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.165 0.986 . . . . 0.0 111.285 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.25 -38.07 36.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.532 0.733 . . . . 0.0 110.708 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.83 140.75 36.7 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 t -70.01 81.4 0.49 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.415 1.072 . . . . 0.0 112.19 -167.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 t 60.65 66.32 0.94 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.51 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -158.88 153.76 24.91 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.871 -167.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.8 p -120.47 134.14 55.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.672 0.789 . . . . 0.0 109.566 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.55 123.16 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 80.7 m95 -68.1 138.95 56.15 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.96 109.39 28.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.7 tp -93.9 95.77 9.29 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -98.1 124.56 42.68 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.17 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -110.71 143.23 41.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.194 0.998 . . . . 0.0 108.746 170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.63 15.28 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.28 125.05 22.36 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.062 0.545 . . . . 0.0 110.986 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.29 128.88 74.17 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.615 0.766 . . . . 0.0 110.18 -173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 22.2 Cg_endo -59.47 138.39 83.68 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.642 2.228 . . . . 0.0 111.736 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -68.04 -27.55 66.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.245 0.618 . . . . 0.0 111.808 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 t -71.79 -16.6 62.19 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.922 0.489 . . . . 0.0 111.501 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 84.4 t80 -69.81 137.09 51.54 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 123.105 0.562 . . . . 0.0 109.736 174.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.431 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.2 pttt -164.12 156.0 14.39 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.044 0.938 . . . . 0.0 109.282 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HG3' HD13 ' A' ' 64' ' ' LEU . 29.3 Cg_exo -61.94 113.1 1.72 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.544 2.163 . . . . 0.0 111.129 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.23 -6.19 28.65 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.892 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 100' ' ' LYS . 8.7 p -83.96 150.89 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 118.189 0.995 . . . . 0.0 108.835 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 126' ' ' LYS . 46.9 mt-10 -77.16 145.12 37.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 17.0 m -136.14 154.92 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.224 1.01 . . . . 0.0 111.037 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.62 108.15 24.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 166.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.476 HD13 HD22 ' A' ' 77' ' ' LEU . 43.8 pt -96.73 142.29 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -147.26 139.6 24.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA2' ' HD2' ' A' ' 121' ' ' ARG . . . 163.93 -105.77 0.26 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -175.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.25 163.4 37.13 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.5 tp -134.56 131.45 37.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.24 147.13 33.7 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.328 0.651 . . . . 0.0 110.099 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.24 -37.82 80.91 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.266 2.644 . . . . 0.0 112.561 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.86 41.36 2.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.46 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -166.4 142.13 4.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.568 0.747 . . . . 0.0 110.545 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.86 -30.03 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.962 0.905 . . . . 0.0 110.796 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 t -90.21 134.3 34.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.164 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -75.58 127.16 32.47 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 108.549 171.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -83.97 105.32 14.76 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.39 112.39 19.88 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.422 ' HD2' ' HA2' ' A' ' 109' ' ' GLY . 6.5 ptm180 -68.49 -35.67 77.84 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 p -141.38 148.72 40.08 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.679 1.191 . . . . 0.0 109.094 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.9 tp -127.21 117.53 22.51 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.057 0.943 . . . . 0.0 108.493 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.7 ttp -131.45 145.98 52.04 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 82.5 p -91.07 163.36 14.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.166 0.508 . . . . 0.0 110.807 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 9.1 mtpm? -91.97 10.9 26.98 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.133 0.973 . . . . 0.0 109.893 172.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 40.2 t -114.83 144.29 31.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 0.0 109.286 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.41 -173.92 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.566 2.178 . . . . 0.0 112.424 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.05 123.04 19.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.371 0.668 . . . . 0.0 110.516 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 125.047 1.339 . . . . 0.0 111.321 178.024 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 60.6 mtm . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.413 0.149 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.6 18.89 3.66 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.5 0.72 . . . . 0.0 112.522 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 m -66.01 119.21 59.51 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 123.31 0.644 . . . . 0.0 111.347 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.6 92.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.456 2.77 . . . . 0.0 112.665 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -87.68 39.59 0.89 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.024 0.93 . . . . 0.0 110.801 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 31.5 m-20 -75.15 1.21 13.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.055 0.942 . . . . 0.0 112.357 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -64.73 -38.6 91.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.645 0.778 . . . . 0.0 109.679 169.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.26 -26.03 26.9 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.536 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 48' ' ' ASP . 56.8 m170 -85.3 114.81 22.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.153 0.581 . . . . 0.0 110.676 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.643 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 25.4 p -103.0 109.0 20.38 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.285 1.034 . . . . 0.0 109.658 174.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 85.7 t -100.34 133.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.777 1.231 . . . . 0.0 108.688 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttt85 -96.59 107.74 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 77' ' ' LEU . 4.2 tt -116.66 141.0 48.77 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -120.75 143.6 48.7 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.946 0.898 . . . . 0.0 109.755 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.57 -162.06 27.51 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 7.6 m -131.31 140.28 49.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.005 0.922 . . . . 0.0 109.565 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.0 131.72 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.215 1.006 . . . . 0.0 111.555 -173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.561 ' HB3' ' HG3' ' A' ' 76' ' ' ARG . . . -94.56 154.39 17.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.226 0.611 . . . . 0.0 110.947 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 -36.66 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.584 0.753 . . . . 0.0 110.758 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -80.58 78.52 7.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.233 0.613 . . . . 0.0 109.881 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.8 0.82 2.48 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.022 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.494 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.7 tt -78.37 94.45 4.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 74' ' ' ARG . 86.5 m -103.07 110.63 22.63 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.688 1.195 . . . . 0.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.4 mmt -80.5 117.53 21.31 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.1 mt -59.46 123.86 18.17 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 123.637 0.586 . . . . 0.0 111.223 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -71.61 99.89 2.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.983 0.913 . . . . 0.0 110.405 -171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.25 -36.92 2.89 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.563 -0.29 . . . . 0.0 112.995 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.74 131.41 87.76 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.344 0.657 . . . . 0.0 110.317 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.11 113.03 2.68 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.287 1.991 . . . . 0.0 111.059 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.02 -172.01 29.94 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.798 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.04 133.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.842 0.857 . . . . 0.0 110.179 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 4.8 tpp180 -92.73 141.94 27.91 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -159.27 174.86 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.581 0.752 . . . . 0.0 109.043 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.95 117.0 32.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.419 HD23 HD22 ' A' ' 55' ' ' LEU . 28.9 tp -80.15 109.77 14.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.834 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 60' ' ' ALA . 43.2 mt-10 -71.92 100.87 2.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -59.23 144.0 47.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.972 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -68.16 -17.41 64.34 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.61 -46.2 6.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.542 0.737 . . . . 0.0 110.21 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.53 127.83 43.14 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.792 0.437 . . . . 0.0 111.516 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -117.8 -12.39 10.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.543 0.737 . . . . 0.0 110.503 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 m -61.4 -23.31 65.72 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.397 0.679 . . . . 0.0 110.321 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -138.69 111.7 7.88 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 164.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 75.3 p -83.49 158.63 21.95 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.38 0.672 . . . . 0.0 109.647 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -99.99 115.81 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -77.86 130.72 36.99 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.31 117.58 55.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 123.532 0.733 . . . . 0.0 109.348 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.6 tp -99.86 92.11 5.14 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -86.04 124.22 32.24 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -112.57 123.1 49.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.307 0.643 . . . . 0.0 109.725 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.72 -174.98 22.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.0 114.95 8.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.156 0.582 . . . . 0.0 110.189 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.82 133.46 51.95 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.999 0.92 . . . . 0.0 109.678 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 123' ' ' LEU . 55.4 Cg_endo -67.83 150.81 78.84 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.485 2.124 . . . . 0.0 112.139 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.87 -21.61 64.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.88 0.472 . . . . 0.0 110.459 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.8 p -70.46 -19.4 62.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.233 1.013 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -69.55 105.98 2.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.537 0.735 . . . . 0.0 109.462 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 103' ' ' VAL . 37.1 mtmm -131.99 156.56 79.96 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.74 1.216 . . . . 0.0 109.853 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HG3' HD13 ' A' ' 64' ' ' LEU . 27.9 Cg_exo -63.02 103.51 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.713 2.275 . . . . 0.0 111.509 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.16 -3.36 18.8 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 119.202 -0.776 . . . . 0.0 113.579 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 100' ' ' LYS . 7.9 p -79.17 139.39 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 118.309 1.054 . . . . 0.0 109.777 174.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.8 mt-10 -71.36 138.87 49.56 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 125' ' ' THR . 35.0 m -135.01 152.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-O 121.707 0.765 . . . . 0.0 110.724 175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.66 109.72 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.6 pt -98.15 152.81 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 31.8 tt0 -152.25 132.54 13.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.6 -147.64 11.56 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.44 133.06 9.05 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 118.392 1.096 . . . . 0.0 114.267 -174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.38 124.75 52.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.905 1.282 . . . . 0.0 108.822 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.4 138.48 41.67 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.58 -33.82 93.16 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.03 2.487 . . . . 0.0 113.175 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.74 -11.36 82.97 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.27 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.06 141.98 34.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.011 0.925 . . . . 0.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -88.48 -33.65 17.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.248 0.619 . . . . 0.0 110.534 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -83.89 129.09 34.94 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -79.35 121.22 24.86 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.502 ' HB3' ' NZ ' ' A' ' 119' ' ' LYS . 3.4 ttpm? -89.34 97.26 11.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.93 125.31 28.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.933 0.493 . . . . 0.0 110.591 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -79.58 -38.13 34.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.512 1.125 . . . . 0.0 109.251 172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -133.06 133.81 43.5 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.409 1.084 . . . . 0.0 108.699 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.544 HD23 ' HD2' ' A' ' 96' ' ' PRO . 53.9 tp -117.89 108.99 15.99 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.6 ttm -102.82 125.21 49.47 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.563 ' HA ' HG12 ' A' ' 105' ' ' VAL . 79.5 p -82.25 123.49 29.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -69.46 -40.47 77.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.289 1.035 . . . . 0.0 108.516 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.5 m -83.02 116.13 62.58 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -85.63 173.71 7.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.951 2.434 . . . . 0.0 115.35 -171.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 21.3 tp -72.29 161.56 30.68 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.802 1.241 . . . . 0.0 109.414 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.567 1.598 0 CA-C-O 121.155 0.502 . . . . 0.0 110.146 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.71 99.49 7.35 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.722 0.809 . . . . 0.0 109.522 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 p -73.21 124.18 90.3 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.217 0.607 . . . . 0.0 109.831 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.53 134.59 62.02 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.385 2.057 . . . . 0.0 110.771 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.49 89.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.639 0.776 . . . . 0.0 111.231 -170.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -90.35 114.07 26.08 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.207 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -86.26 -33.1 20.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.976 0.91 . . . . 0.0 109.683 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 pp -77.12 18.71 0.36 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.592 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -67.83 79.22 0.2 Allowed 'General case' 0 C--N 1.364 1.23 0 CA-C-O 122.328 1.061 . . . . 0.0 111.725 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p -125.46 149.2 48.45 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.44 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.2 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -97.79 108.2 20.87 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD22 HD23 ' A' ' 77' ' ' LEU . 4.0 tt -111.86 125.8 54.41 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -172.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.02 144.88 27.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.536 0.735 . . . . 0.0 109.123 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.79 -160.57 29.77 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.522 -0.371 . . . . 0.0 112.599 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 30.0 m -127.82 140.79 51.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.027 0.931 . . . . 0.0 109.676 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.94 133.27 31.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.36 43.55 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.484 0.49 . . . . 0.0 111.662 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.77 36.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.16 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.97 96.04 7.28 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.855 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.17 73.11 0.65 Allowed Glycine 0 N--CA 1.465 0.629 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.138 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.6 tt -150.41 125.99 10.25 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.3 m -140.24 125.28 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.323 1.049 . . . . 0.0 109.332 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.1 mtp -96.91 162.64 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.136 0.574 . . . . 0.0 109.722 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD12 ' HA3' ' A' ' 72' ' ' GLY . 84.5 mt -86.48 105.86 17.08 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -63.71 114.88 4.27 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.915 0.886 . . . . 0.0 111.563 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.97 77.09 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.529 0.518 . . . . 0.0 113.624 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.94 142.23 44.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.38 1.072 . . . . 0.0 109.764 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.44 87.76 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.474 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 175.39 163.66 28.68 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.613 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.1 p -157.26 134.84 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.985 0.914 . . . . 0.0 110.115 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -103.89 137.29 42.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.196 0.998 . . . . 0.0 108.311 169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 46.3 p90 -158.2 173.07 17.26 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -104.91 122.57 46.08 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.629 HD23 HD22 ' A' ' 55' ' ' LEU . 23.5 tp -83.86 116.19 22.63 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.78 118.93 24.76 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -61.75 157.06 18.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.342 0.657 . . . . 0.0 112.486 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -35.11 -55.29 0.61 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.726 2.01 . . . . 0.0 113.343 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -129.88 -30.43 2.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.768 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -77.97 95.83 4.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.751 0.42 . . . . 0.0 110.375 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -65.63 -17.96 64.97 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.366 0.666 . . . . 0.0 110.8 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 p -67.39 -46.64 72.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.484 1.114 . . . . 0.0 111.822 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -74.13 84.04 1.82 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.186 0.594 . . . . 0.0 111.366 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 p -103.16 97.65 7.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.3 134.46 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -79.63 144.02 34.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.29 118.36 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.865 0.866 . . . . 0.0 108.746 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -95.34 93.23 7.14 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -85.37 113.31 21.58 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -111.16 122.94 49.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 148.45 172.53 18.43 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.88 113.5 1.89 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.251 0.526 . . . . 0.0 110.926 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.86 120.4 81.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.82 146.09 80.16 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.896 2.397 . . . . 0.0 113.713 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.87 -27.5 68.27 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.654 0.782 . . . . 0.0 109.835 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.7 p -78.87 -7.66 58.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.96 1.304 . . . . 0.0 112.278 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.7 t80 -75.66 140.61 42.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.805 0.442 . . . . 0.0 109.817 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 61.0 pttt -162.07 161.45 21.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.955 0.902 . . . . 0.0 109.709 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.8 100.34 0.29 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.102 1.868 . . . . 0.0 111.519 167.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.68 -8.57 8.77 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.131 -0.816 . . . . 0.0 114.25 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.512 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 14.5 p -71.46 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 118.54 1.17 . . . . 0.0 111.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 39.7 mt-10 -72.61 125.56 27.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 171.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 103' ' ' VAL . 27.9 m -128.16 155.61 39.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.898 0.856 . . . . 0.0 111.753 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 62.4 mt -114.75 107.93 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 123' ' ' LEU . 29.6 pt -97.82 155.23 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.89 138.19 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 121' ' ' ARG . . . 172.0 -127.04 1.35 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.755 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.37 153.0 24.45 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 117.043 0.421 . . . . 0.0 112.456 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.13 139.9 53.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.474 1.109 . . . . 0.0 108.727 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 136.0 45.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.51 109.69 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.204 . . . . 0.0 113.246 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.61 5.74 53.6 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 113.077 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.573 ' HG2' ' H ' ' A' ' 117' ' ' THR . 48.7 tt0 -96.53 153.09 18.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.596 0.759 . . . . 0.0 109.738 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.97 0.67 23.89 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.237 1.015 . . . . 0.0 111.213 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.573 ' H ' ' HG2' ' A' ' 115' ' ' GLU . 8.8 t -134.05 119.89 19.52 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.413 0.625 . . . . 0.0 110.453 -173.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -84.69 134.41 34.36 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.622 1.169 . . . . 0.0 110.25 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -95.14 111.31 23.16 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -90.71 116.68 28.76 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.42 ' HG3' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -79.03 -23.36 44.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.143 0.577 . . . . 0.0 110.886 173.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -137.71 152.18 48.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.878 0.871 . . . . 0.0 110.045 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 107' ' ' ILE . 23.1 tp -136.92 123.5 20.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.645 1.178 . . . . 0.0 108.233 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.563 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 41.5 ttm -119.87 95.11 4.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.728 0.411 . . . . 0.0 110.282 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.4 p -75.19 137.43 41.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.339 0.656 . . . . 0.0 110.455 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -94.87 -13.48 25.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.906 . . . . 0.0 110.85 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.475 ' SG ' HG23 ' A' ' 103' ' ' VAL . 67.2 m -88.6 105.95 11.29 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.077 0.551 . . . . 0.0 110.449 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.18 86.68 1.4 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.089 2.526 . . . . 0.0 111.125 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.08 111.51 2.22 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.368 0.667 . . . . 0.0 109.836 -178.109 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.537 ' HG3' HG23 ' A' ' 45' ' ' THR . 12.0 tpt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 85.23 6.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.632 0.773 . . . . 0.0 109.75 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 43' ' ' MET . 49.2 p -79.96 123.78 83.44 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.205 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 105.44 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.77 2.313 . . . . 0.0 110.223 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.12 117.71 3.46 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.878 0.871 . . . . 0.0 111.765 -169.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -77.78 119.25 21.02 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.59 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -119.03 -34.83 3.78 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.812 1.245 . . . . 0.0 109.607 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -77.35 -34.9 55.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.73 -169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -88.34 76.22 8.37 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.2 m -72.67 123.28 22.95 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.72 143.89 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -138.34 136.23 36.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.512 0.725 . . . . 0.0 109.814 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.24 163.97 21.35 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.6 0.714 . . . . 0.0 110.549 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -138.44 132.29 31.13 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.801 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.33 -161.39 33.85 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 5.0 m -124.14 146.15 48.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.07 127.83 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.933 0.893 . . . . 0.0 110.277 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.76 140.07 43.8 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.309 0.644 . . . . 0.0 110.13 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.67 -7.02 55.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.084 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.6 124.13 51.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.575 0.75 . . . . 0.0 109.406 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.17 -0.94 43.91 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.567 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.49 96.12 4.02 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.7 m -118.57 121.07 39.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.435 1.094 . . . . 0.0 109.904 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.5 mmt -84.36 136.07 34.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.99 127.95 34.45 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.628 0.58 . . . . 0.0 111.506 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.23 117.25 12.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.678 0.791 . . . . 0.0 110.09 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.83 33.1 84.18 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.456 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.33 136.63 8.77 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 110.102 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.76 109.69 1.51 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.332 2.021 . . . . 0.0 110.709 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.76 171.4 33.68 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.466 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -150.62 153.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.65 0.78 . . . . 0.0 110.062 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 47.4 ttp180 -124.66 142.25 51.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -159.45 172.95 16.96 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.283 0.633 . . . . 0.0 109.316 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.459 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 87.6 mtm-85 -101.58 113.08 25.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.62 111.95 9.25 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 86' ' ' THR . 36.7 mt-10 -72.36 110.44 6.78 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 2.1 m-20 -64.0 146.36 54.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.003 0.521 . . . . 0.0 111.458 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -66.02 -37.41 85.82 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.863 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.64 -55.5 3.75 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.573 0.749 . . . . 0.0 110.229 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 79' ' ' ASP . 94.6 m-20 -75.95 113.16 13.15 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -89.15 -24.59 22.16 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.306 0.643 . . . . 0.0 111.014 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 m -101.27 -3.35 29.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.942 0.897 . . . . 0.0 111.936 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 9.7 mmpt? -126.74 127.96 45.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.916 0.486 . . . . 0.0 110.796 -176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 78' ' ' GLU . 68.3 p -125.54 132.21 52.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.27 1.028 . . . . 0.0 108.339 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.79 143.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -74.92 142.33 44.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 49.1 t -127.62 108.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.5 tp -93.26 92.97 7.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -91.37 116.59 28.96 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.235 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -108.35 114.3 28.04 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.93 170.97 23.31 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 113.0 3.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.778 0.431 . . . . 0.0 110.329 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.5 t -81.67 122.47 80.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 122.955 0.502 . . . . 0.0 110.126 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HD2' HD23 ' A' ' 123' ' ' LEU . 28.4 Cg_endo -60.74 148.49 91.68 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.761 2.307 . . . . 0.0 111.964 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.27 -16.3 61.92 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.417 0.687 . . . . 0.0 110.827 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.3 p -71.6 -23.69 61.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.149 0.98 . . . . 0.0 110.696 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' HA ' HG11 ' A' ' 103' ' ' VAL . 70.4 t80 -71.94 134.75 46.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.831 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -171.36 161.3 5.18 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.8 0.84 . . . . 0.0 109.435 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.1 105.68 0.41 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.276 1.984 . . . . 0.0 111.89 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.78 -10.8 11.17 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.754 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 99' ' ' PHE . 9.6 p -74.55 145.16 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.782 0.791 . . . . 0.0 109.654 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.3 mt-10 -84.32 138.67 32.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.69 155.32 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.036 0.922 . . . . 0.0 111.305 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.6 mt -115.17 108.51 25.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 18.4 pt -100.87 132.6 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.419 0.688 . . . . 0.0 109.859 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -127.97 130.81 49.0 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.57 -108.01 0.27 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.17 142.63 5.86 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.715 0.757 . . . . 0.0 113.222 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.4 tp -93.87 126.4 39.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.903 0.881 . . . . 0.0 109.112 171.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . . . -83.25 138.33 42.19 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 123.436 0.46 . . . . 0.0 109.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.89 -17.68 60.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.887 2.392 . . . . 0.0 113.726 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.68 -10.67 18.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.504 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 28.3 tt0 -117.07 120.98 40.0 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.13 -20.94 63.15 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.562 0.745 . . . . 0.0 112.709 -168.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -88.37 135.62 33.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.42 113.79 14.4 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 26.9 ttmt -85.7 94.57 9.13 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.66 123.05 27.29 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.52 0.728 . . . . 0.0 109.849 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -80.32 -41.22 25.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.255 0.622 . . . . 0.0 109.639 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.7 p -131.53 136.13 47.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.485 1.114 . . . . 0.0 108.843 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 96' ' ' PRO . 59.6 tp -113.11 133.9 54.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.412 1.085 . . . . 0.0 108.632 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.9 ttp -136.29 103.05 5.17 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.786 0.434 . . . . 0.0 110.106 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.4 p -72.56 140.78 48.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.396 0.678 . . . . 0.0 110.012 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -67.84 -48.19 66.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.594 0.758 . . . . 0.0 110.797 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.1 t -75.45 131.59 77.3 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.4 -165.96 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.841 2.361 . . . . 0.0 112.183 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.2 tp -66.41 99.05 0.53 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.135 0.974 . . . . 0.0 109.865 -173.215 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 107.31 5.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.375 0.67 . . . . 0.0 109.271 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -113.83 84.72 8.78 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.277 1.031 . . . . 0.0 109.847 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -87.61 155.8 7.68 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.035 2.49 . . . . 0.0 112.452 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -91.49 118.07 30.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 109.288 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.43 -3.88 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.831 0.852 . . . . 0.0 111.477 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -58.06 -42.39 85.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.779 1.232 . . . . 0.0 111.343 172.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.34 75.99 4.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.74 -172.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -138.73 64.82 1.47 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.379 1.072 . . . . 0.0 108.62 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.4 m -133.1 137.27 46.27 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.554 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 134.19 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.489 HH21 HD13 ' A' ' 106' ' ' ILE . 55.3 ttt180 -122.26 119.71 31.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.513 0.725 . . . . 0.0 109.219 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.43 161.2 20.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.585 0.754 . . . . 0.0 109.912 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -135.43 136.99 41.8 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.938 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 79' ' ' ASP . . . 176.52 -162.8 31.59 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.028 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -122.31 139.21 54.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.006 0.922 . . . . 0.0 109.749 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.64 130.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.618 1.167 . . . . 0.0 110.631 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.98 139.79 38.14 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.922 0.489 . . . . 0.0 110.129 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -72.92 -40.44 65.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.311 0.644 . . . . 0.0 110.092 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -79.35 115.51 19.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.715 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 42.85 5.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.471 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 101' ' ' PRO . 6.7 tt -111.85 99.46 8.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -109.79 116.66 32.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.301 1.04 . . . . 0.0 109.711 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.51 ' HG2' HG23 ' A' ' 73' ' ' VAL . 66.5 mtp -89.48 132.6 34.96 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.495 HD12 ' HA3' ' A' ' 72' ' ' GLY . 76.6 mt -63.39 126.48 27.61 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.658 0.598 . . . . 0.0 111.013 -172.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.63 132.22 33.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.914 0.885 . . . . 0.0 109.762 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.75 68.46 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 123.472 0.482 . . . . 0.0 113.661 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 138.47 10.15 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.07 0.948 . . . . 0.0 109.149 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 112.73 2.8 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.469 2.113 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 167.25 175.14 37.01 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 121.387 0.437 . . . . 0.0 113.402 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.525 ' HB ' HG21 ' A' ' 95' ' ' VAL . 8.1 p -146.91 161.3 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.949 0.9 . . . . 0.0 109.486 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -137.66 136.01 37.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -152.67 161.66 42.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.174 0.59 . . . . 0.0 109.758 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.62 104.98 17.01 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 tp -73.52 132.39 42.82 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.22 100.7 6.65 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -54.03 141.3 28.77 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.097 0.873 . . . . 0.0 111.84 -171.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' H ' ' HA2' ' A' ' 57' ' ' GLY . 62.3 tttm -52.41 -42.68 64.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.388 1.075 . . . . 0.0 111.245 -171.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.99 -55.39 3.36 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.437 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -94.89 67.35 3.16 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.827 0.822 . . . . 0.0 110.555 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -73.3 -15.24 61.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.892 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 m -64.59 -22.98 67.11 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.252 1.021 . . . . 0.0 111.25 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -98.85 96.16 7.68 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.4 p -92.78 104.55 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.66 139.91 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.328 1.051 . . . . 0.0 109.647 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -86.05 133.1 33.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 168.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.91 120.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -103.81 112.22 25.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -107.98 121.55 45.02 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.857 0.863 . . . . 0.0 108.915 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -103.53 117.72 35.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.654 0.782 . . . . 0.0 109.165 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.47 176.59 17.65 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.0 115.67 5.14 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.665 0.386 . . . . 0.0 110.043 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG21 ' HB ' ' A' ' 73' ' ' VAL . 43.2 t -80.11 127.45 76.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.454 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD2' HD23 ' A' ' 123' ' ' LEU . 93.2 Cg_exo -47.22 138.89 16.66 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.495 2.797 . . . . 0.0 112.769 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.01 -24.13 65.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.39 0.676 . . . . 0.0 111.358 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -75.45 -13.23 60.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.959 0.904 . . . . 0.0 111.883 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -72.72 135.83 45.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.3 pttt -156.6 163.42 25.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.195 0.998 . . . . 0.0 108.741 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 28.9 Cg_exo -64.08 111.86 1.7 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.42 2.08 . . . . 0.0 111.41 168.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.49 0.57 37.43 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.727 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 7.4 p -77.87 149.55 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.847 0.824 . . . . 0.0 110.067 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.41 134.8 35.24 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 103' ' ' VAL . 18.6 m -129.89 161.74 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.971 0.908 . . . . 0.0 111.65 -176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.489 HD13 HH21 ' A' ' 54' ' ' ARG . 62.8 mt -119.11 111.7 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 113.452 -1.704 . . . . 0.0 107.016 168.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 118' ' ' PHE . 29.4 pt -100.37 142.1 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.451 0.7 . . . . 0.0 109.27 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HB3' ' OG1' ' A' ' 122' ' ' THR . 8.0 tp10 -139.48 124.99 19.23 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.59 -106.08 0.23 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.55 143.29 5.16 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 117.787 0.793 . . . . 0.0 112.616 170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.2 tp -90.7 116.29 28.45 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.64 126.93 72.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.163 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.66 95.28 0.11 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.845 2.363 . . . . 0.0 111.786 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.56 -41.04 1.27 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.63 135.29 33.57 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.949 0.899 . . . . 0.0 109.985 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.81 -26.86 57.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.132 0.573 . . . . 0.0 110.043 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -84.46 136.04 34.0 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.129 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 107' ' ' ILE . 36.6 t80 -77.6 119.55 21.32 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.27 96.68 10.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -76.91 115.83 17.04 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.432 0.693 . . . . 0.0 110.044 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -79.45 -41.43 27.58 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.056 0.942 . . . . 0.0 109.631 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 108' ' ' GLU . 75.0 p -132.28 140.88 48.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.39 1.076 . . . . 0.0 108.18 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.405 HD23 ' HD2' ' A' ' 96' ' ' PRO . 46.9 tp -127.29 143.38 51.24 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.946 0.499 . . . . 0.0 110.056 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.8 ttp -153.64 148.26 26.26 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 56.9 p -83.11 152.9 25.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -89.16 -34.8 16.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 109.516 175.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 18.9 p -113.1 118.02 44.92 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.753 0.821 . . . . 0.0 109.472 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -82.56 167.69 14.93 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.657 2.238 . . . . 0.0 112.342 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.69 95.03 3.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.269 0.628 . . . . 0.0 110.01 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.955 0.902 . . . . 0.0 109.82 -174.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.45 96.78 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.739 0.816 . . . . 0.0 111.814 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.9 m -64.39 113.97 12.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.955 0.902 . . . . 0.0 110.912 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -98.27 -152.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.563 2.842 . . . . 0.0 110.49 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 70.4 1.38 3.59 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.226 1.01 . . . . 0.0 112.339 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.2 157.53 26.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.284 0.634 . . . . 0.0 110.539 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -97.37 22.07 9.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.492 0.717 . . . . 0.0 111.381 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.1 11.07 10.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.003 0.521 . . . . 0.0 111.474 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -67.36 -36.51 81.54 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.422 0.689 . . . . 0.0 110.054 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -69.94 152.79 44.07 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 167.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 t -96.76 106.02 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.613 ' NH1' HG22 ' A' ' 106' ' ' ILE . 22.5 tpp180 -89.67 127.91 35.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 tt -132.82 130.35 39.71 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.628 ' HB2' ' HD2' ' A' ' 80' ' ' LYS . 42.1 m-85 -108.45 139.0 43.82 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.96 -168.62 36.48 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 143.29 50.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.172 0.589 . . . . 0.0 110.604 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.23 119.59 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' HH21 ' A' ' 76' ' ' ARG . . . -69.89 142.85 52.93 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.664 0.602 . . . . 0.0 110.122 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.2 84.42 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.552 0.692 . . . . 0.0 110.173 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.01 117.72 21.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.126 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.64 64.45 1.06 Allowed Glycine 0 C--N 1.339 0.702 0 O-C-N 123.444 0.465 . . . . 0.0 112.199 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tt -133.33 101.82 5.32 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -111.85 116.95 31.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.684 0.793 . . . . 0.0 110.342 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mmm -85.13 145.07 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.438 0.695 . . . . 0.0 109.959 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.475 HD12 ' HA3' ' A' ' 72' ' ' GLY . 86.6 mt -85.34 126.53 33.82 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.1 140.54 35.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.38 3.4 89.98 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 123.48 0.487 . . . . 0.0 113.433 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.4 140.3 4.13 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.103 0.961 . . . . 0.0 110.093 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.61 113.37 2.7 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.605 2.203 . . . . 0.0 111.734 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 67' ' ' LEU . . . 171.45 173.11 38.16 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.394 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.75 138.15 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.331 1.053 . . . . 0.0 110.223 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 16.3 ttm180 -108.0 137.08 46.62 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 165.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.04 154.27 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.482 HH21 ' HB1' ' A' ' 60' ' ' ALA . 18.6 ttp180 -92.84 96.88 10.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 tp -78.41 138.32 38.44 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.483 0.713 . . . . 0.0 110.225 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.607 ' HG2' HG22 ' A' ' 86' ' ' THR . 31.3 mt-10 -102.96 113.16 26.38 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 13.9 t70 -58.58 130.32 46.25 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 123.81 0.694 . . . . 0.0 109.631 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.628 ' HD2' ' HB2' ' A' ' 56' ' ' PHE . 21.3 ptmt -62.73 -28.63 70.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.935 0.894 . . . . 0.0 113.187 -169.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -92.77 -33.37 14.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.879 0.472 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' ASP . 8.9 t-20 -139.15 95.58 2.97 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.922 0.392 . . . . 0.0 110.156 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -68.76 -16.86 63.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.482 0.713 . . . . 0.0 111.469 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -55.83 -27.07 49.66 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.755 0.822 . . . . 0.0 111.42 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -98.93 82.57 2.78 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.74 0.816 . . . . 0.0 109.161 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.607 HG22 ' HG2' ' A' ' 78' ' ' GLU . 40.9 p -89.96 100.03 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 167.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.5 t -102.85 141.74 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.117 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -79.27 136.63 37.1 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 91.5 t -123.39 118.43 54.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.83 92.28 7.85 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -94.59 116.0 28.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -112.46 144.27 42.19 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.05 -172.31 19.13 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.97 111.38 3.3 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.307 0.643 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.67 123.47 84.03 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.519 0.727 . . . . 0.0 109.09 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.98 145.71 68.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.173 1.915 . . . . 0.0 111.389 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.77 -16.79 64.5 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.591 0.756 . . . . 0.0 111.356 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.3 p -76.45 -19.9 57.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.42 1.088 . . . . 0.0 112.144 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -68.37 126.66 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.223 0.609 . . . . 0.0 109.542 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 103' ' ' VAL . 17.1 ptmt -156.06 165.82 17.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.191 0.596 . . . . 0.0 110.958 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.86 113.01 3.41 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.864 1.709 . . . . 0.0 110.955 170.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.08 -8.01 16.41 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.353 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 105' ' ' VAL . 12.7 p -83.02 142.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 117.425 0.612 . . . . 0.0 111.787 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.84 111.18 9.78 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 103' ' ' VAL . 27.7 m -105.7 153.6 7.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.792 0.805 . . . . 0.0 110.53 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.613 HG22 ' NH1' ' A' ' 54' ' ' ARG . 49.4 mt -122.18 105.59 16.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.2 pt -101.45 154.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.328 0.651 . . . . 0.0 110.246 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.2 tt0 -140.56 123.24 16.23 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 173.56 -121.18 0.84 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.77 166.71 39.9 Favored Glycine 0 C--O 1.241 0.556 0 CA-C-N 117.446 0.623 . . . . 0.0 112.441 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.6 tp -138.3 134.42 34.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.53 129.6 50.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 88.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.922 2.415 . . . . 0.0 111.91 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.65 -36.72 1.42 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -171.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.96 147.95 48.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.762 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.47 -45.02 11.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.728 0.811 . . . . 0.0 111.457 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -109.43 131.87 54.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.12 0.486 . . . . 0.0 111.002 -165.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.75 115.09 16.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.77 96.22 8.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.34 112.07 19.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.902 0.881 . . . . 0.0 110.156 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -60.16 -40.85 91.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.397 1.079 . . . . 0.0 110.399 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 1.7 m -135.41 149.31 49.59 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.885 -167.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.5 tp -137.21 140.33 41.64 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.259 1.024 . . . . 0.0 108.81 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 ttp -152.77 111.97 3.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 109.664 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 105' ' ' VAL . 54.3 p -73.21 124.27 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -81.77 -34.27 30.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 61.7 m -99.15 91.91 1.53 Allowed Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.42 141.35 38.53 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.833 1.689 . . . . 0.0 111.813 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.33 91.14 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 170.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.563 1.447 0 C-N-CA 125.167 1.387 . . . . 0.0 109.916 -175.689 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.64 102.37 14.9 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -110.66 97.78 34.36 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.391 0.677 . . . . 0.0 110.508 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.09 54.44 5.23 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.345 2.697 . . . . 0.0 110.857 170.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.45 99.42 12.0 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.629 0.772 . . . . 0.0 110.387 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.41 170.61 14.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.629 1.172 . . . . 0.0 109.398 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.31 19.33 6.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.666 . . . . 0.0 109.561 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.49 -42.11 83.44 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.891 0.876 . . . . 0.0 108.838 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.32 83.87 5.31 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 166.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.3 m -64.15 144.57 57.02 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.369 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -97.97 112.7 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -104.68 116.99 33.0 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.89 142.68 36.13 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -119.1 147.87 43.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.72 -170.3 43.4 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.7 m -116.37 140.65 49.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.271 1.028 . . . . 0.0 109.083 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -76.98 126.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.38 0.672 . . . . 0.0 110.238 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.62 150.56 26.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.394 0.678 . . . . 0.0 111.043 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.66 -31.69 41.49 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.358 0.599 . . . . 0.0 109.671 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.35 100.11 12.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.435 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.55 71.11 0.97 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 tt -144.82 104.59 4.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.1 m -125.17 119.04 27.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.894 1.278 . . . . 0.0 109.233 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.7 mtp -89.9 142.93 27.23 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.88 122.41 17.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 110.478 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.35 123.21 28.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.375 0.67 . . . . 0.0 109.879 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.64 23.37 72.21 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 123.607 0.567 . . . . 0.0 112.988 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.23 144.18 16.84 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.049 0.939 . . . . 0.0 109.33 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.88 117.29 4.87 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.262 1.975 . . . . 0.0 110.844 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.48 -175.04 30.5 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.287 174.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.44 132.17 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.319 1.048 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -92.98 131.25 38.13 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.1 159.63 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.233 0.54 . . . . 0.0 110.885 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -95.59 112.06 23.86 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.289 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.43 117.57 30.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.453 0.701 . . . . 0.0 109.88 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.45 107.9 18.93 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.241 1.016 . . . . 0.0 109.789 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.54 107.01 1.04 Allowed 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -48.85 -29.96 5.24 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -168.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -92.26 -48.77 6.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.461 0.704 . . . . 0.0 109.321 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.41 50.23 0.83 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.205 1.002 . . . . 0.0 109.296 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -77.6 -6.46 53.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.862 -170.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 m -63.52 -30.84 71.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.457 0.703 . . . . 0.0 110.586 169.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -98.63 83.33 2.97 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.2 p -86.6 111.31 20.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.87 137.15 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.63 144.94 29.95 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.4 t -132.38 121.91 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.87 94.01 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -83.38 118.42 23.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -109.1 111.02 22.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.09 174.22 28.51 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.79 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.27 115.04 5.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.967 0.507 . . . . 0.0 110.161 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -81.25 113.95 45.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.063 0.545 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 123' ' ' LEU . 56.2 Cg_endo -67.28 151.76 80.33 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.443 2.096 . . . . 0.0 111.611 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.01 -16.94 64.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.519 1.127 . . . . 0.0 112.199 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 96' ' ' PRO . 12.2 t -70.55 -24.25 62.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.91 0.884 . . . . 0.0 111.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -68.04 121.6 16.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.752 0.821 . . . . 0.0 109.289 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 103' ' ' VAL . 23.6 pttm -165.62 157.54 12.72 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.431 0.693 . . . . 0.0 110.077 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.22 117.25 3.93 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.178 1.919 . . . . 0.0 111.758 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.49 -17.51 10.32 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.326 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 100' ' ' LYS . 6.0 p -95.06 147.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.863 0.831 . . . . 0.0 110.045 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -85.97 130.37 34.56 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 HG22 ' A' ' 125' ' ' THR . 27.6 m -111.03 155.55 12.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.857 0.837 . . . . 0.0 110.784 175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.78 121.07 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.48 129.71 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.155 0.582 . . . . 0.0 110.503 -171.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.37 151.2 25.82 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.19 -119.63 0.89 Allowed Glycine 0 C--O 1.24 0.53 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.4 163.57 29.58 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.731 0.312 . . . . 0.0 112.606 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.0 tp -130.35 118.61 21.51 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 133.81 44.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.74 -24.3 41.05 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.679 2.253 . . . . 0.0 113.046 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.14 -18.1 78.85 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.558 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -108.61 156.61 19.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.141 0.977 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -109.61 26.39 10.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.715 170.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -133.96 121.22 21.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.353 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.29 130.59 35.61 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 108.945 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.78 117.2 31.55 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.699 0.682 . . . . 0.0 109.186 174.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.76 128.69 55.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.94 0.896 . . . . 0.0 109.974 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.534 ' HD3' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -98.82 -8.87 25.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.8 0.44 . . . . 0.0 110.171 174.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -134.81 152.16 51.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.718 1.207 . . . . 0.0 109.637 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 96' ' ' PRO . 37.3 tp -150.79 109.88 3.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.126 0.97 . . . . 0.0 108.385 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -135.93 114.03 11.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.648 0.779 . . . . 0.0 109.673 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.455 HG22 HG12 ' A' ' 105' ' ' VAL . 77.3 p -78.12 151.25 33.44 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -75.46 -40.09 57.9 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.5 t -101.82 111.39 64.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.983 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.08 153.47 77.58 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.42 2.08 . . . . 0.0 110.621 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.435 ' HB3' ' HA ' ' A' ' 98' ' ' THR . 1.8 pt? -62.22 132.7 53.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.893 0.477 . . . . 0.0 110.755 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.866 0.866 . . . . 0.0 110.453 -174.167 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.56 28.1 0.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.053 0.941 . . . . 0.0 109.583 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.8 p 57.91 123.8 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 126.228 1.811 . . . . 0.0 111.906 -169.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.35 151.9 27.9 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.712 2.275 . . . . 0.0 112.409 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -56.87 130.44 45.8 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.84 0.712 . . . . 0.0 110.693 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.668 ' HB2' ' HB2' ' A' ' 51' ' ' HIS . 7.4 p-10 -55.84 137.99 49.11 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.473 1.108 . . . . 0.0 112.531 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -84.33 -62.99 1.42 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.529 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -117.79 -51.94 2.45 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 13.4 t-80 58.08 20.51 7.0 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.531 1.132 . . . . 0.0 111.509 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -75.14 137.97 41.72 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.265 -171.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -105.87 133.09 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -118.97 127.08 53.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.342 0.657 . . . . 0.0 109.505 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.6 mt -125.86 172.37 9.93 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.903 0.881 . . . . 0.0 109.785 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.424 ' HB2' ' HD2' ' A' ' 80' ' ' LYS . 51.2 m-85 -135.26 147.89 49.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.776 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.78 -170.74 42.15 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.6 m -121.54 144.34 48.78 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.37 115.22 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.34 0.656 . . . . 0.0 110.5 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.56 148.16 31.85 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.54 -5.66 46.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.648 0.779 . . . . 0.0 111.231 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.86 129.79 36.18 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.389 1.076 . . . . 0.0 110.05 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.31 15.69 78.85 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.266 0.354 . . . . 0.0 113.889 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.49 89.56 3.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -111.81 124.85 53.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.523 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.1 mmm -80.78 139.7 35.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.7 mt -67.53 133.26 49.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.3 0.5 . . . . 0.0 110.915 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -86.76 118.49 26.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.372 0.669 . . . . 0.0 109.857 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.54 5.0 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.486 0.491 . . . . 0.0 112.282 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.26 139.9 75.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.074 0.55 . . . . 0.0 110.108 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.64 135.79 24.59 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 121.986 1.791 . . . . 0.0 111.929 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.87 -168.58 26.4 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.631 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.18 132.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.381 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 79.3 ttt180 -102.6 138.17 39.86 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 170.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -158.13 168.21 27.71 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.919 0.488 . . . . 0.0 110.492 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -93.4 124.59 37.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 107' ' ' ILE . 21.0 tp -105.26 125.76 51.34 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.423 0.689 . . . . 0.0 109.351 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.4 97.43 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -59.67 130.57 47.48 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.101 0.875 . . . . 0.0 111.487 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.424 ' HD2' ' HB2' ' A' ' 56' ' ' PHE . 15.1 ptmm? -66.27 -31.68 72.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.824 0.85 . . . . 0.0 111.571 -174.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.82 -50.78 11.63 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.342 0.657 . . . . 0.0 109.978 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -128.8 91.96 3.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.899 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.8 t -78.24 2.86 16.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.087 0.555 . . . . 0.0 111.026 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 m -87.65 16.52 5.54 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.111 0.964 . . . . 0.0 110.858 166.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -153.67 140.04 18.64 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.561 1.144 . . . . 0.0 108.953 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 19.6 p -117.19 127.91 54.58 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.69 134.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -73.77 126.24 29.92 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 86.8 t -107.57 106.25 20.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 tp -91.54 92.01 8.31 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -83.5 150.21 26.14 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.414 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 92' ' ' LYS . 6.7 mtmp? -137.81 122.52 18.69 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.724 1.21 . . . . 0.0 108.71 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 121.46 -169.01 14.41 Favored Glycine 0 C--O 1.245 0.815 0 C-N-CA 123.464 0.554 . . . . 0.0 111.774 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 116.45 7.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.272 0.629 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 50.8 t -79.11 127.83 78.1 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.85 0.86 . . . . 0.0 109.958 -174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' PHE . 19.3 Cg_endo -58.41 132.83 50.97 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.036 1.824 . . . . 0.0 110.856 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.82 -26.36 68.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.109 0.564 . . . . 0.0 111.08 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.473 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 30.8 p -72.85 -13.27 61.25 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.118 0.967 . . . . 0.0 112.122 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' PRO . 63.0 t80 -64.32 121.22 13.78 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.926 0.89 . . . . 0.0 109.055 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -155.04 156.15 30.92 Favored Pre-proline 0 C--O 1.244 0.787 0 C-N-CA 124.002 0.921 . . . . 0.0 109.069 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.08 99.87 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.971 1.781 . . . . 0.0 110.464 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.55 -2.22 6.52 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.985 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -94.35 141.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 118.707 1.253 . . . . 0.0 110.414 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.56 117.38 15.25 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 125' ' ' THR . 18.0 m -110.25 150.23 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.722 0.773 . . . . 0.0 111.183 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.53 HD12 ' SD ' ' A' ' 124' ' ' MET . 47.6 mt -105.51 111.95 36.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.552 HD13 HD22 ' A' ' 77' ' ' LEU . 28.8 pt -98.27 140.91 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.8 133.1 23.19 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 162.44 -102.7 0.21 Allowed Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.93 147.25 5.25 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 117.482 0.641 . . . . 0.0 112.254 170.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -104.0 149.21 25.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.955 0.902 . . . . 0.0 109.584 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.71 151.41 46.22 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.723 0.809 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.44 -42.66 65.87 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.418 2.745 . . . . 0.0 113.682 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.48 29.55 8.25 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.031 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.15 128.62 40.44 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 0.0 110.266 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 -4.05 53.93 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -133.78 139.18 46.16 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -72.97 119.82 17.74 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 24.8 ttpt -70.26 96.23 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 89' ' ' VAL . . . -86.39 102.34 13.94 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.348 0.594 . . . . 0.0 109.524 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -62.98 -41.49 99.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.66 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -135.57 143.4 45.64 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.539 -169.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 tp -136.25 125.13 24.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' HD12 ' A' ' 106' ' ' ILE . 31.9 ttm -121.47 151.42 40.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 HG12 ' A' ' 105' ' ' VAL . 72.5 p -108.6 145.43 34.9 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -85.82 -34.74 21.0 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.773 0.32 . . . . 0.0 110.297 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 14.4 t -121.79 129.47 25.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.424 0.69 . . . . 0.0 110.04 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.55 -170.19 0.89 Allowed 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.213 2.609 . . . . 0.0 113.892 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 98' ' ' THR . 96.3 mt -92.08 102.71 15.25 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.397 0.679 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 123.757 0.823 . . . . 0.0 110.253 176.379 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -56.35 5.59 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -71.79 118.78 69.74 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.582 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.51 121.44 9.87 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.028 2.485 . . . . 0.0 111.767 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -89.83 102.71 15.4 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.51 0.724 . . . . 0.0 109.202 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.63 31.2 0.53 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.485 1.114 . . . . 0.0 112.05 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -16.92 61.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.668 0.787 . . . . 0.0 110.94 174.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.4 11.7 8.06 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.107 0.963 . . . . 0.0 110.899 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -71.72 81.11 0.86 Allowed 'General case' 0 C--N 1.359 1.006 0 CA-C-O 121.469 0.652 . . . . 0.0 109.584 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 p -138.41 159.13 42.86 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.755 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.23 117.33 44.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -116.17 116.53 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -103.18 152.69 21.17 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.883 0.849 . . . . 0.0 109.897 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -128.0 121.4 29.71 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.545 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -171.3 -178.52 41.81 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -173.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -117.76 144.67 45.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.67 121.48 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.709 0.803 . . . . 0.0 110.528 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.6 149.63 40.0 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.074 0.55 . . . . 0.0 111.06 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.88 -32.91 40.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.456 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.53 102.76 14.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 20.68 10.93 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.97 117.62 30.45 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -147.58 137.14 22.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.89 0.876 . . . . 0.0 108.892 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 26.4 mmt -81.29 145.46 30.89 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -72.78 158.6 35.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.866 0.466 . . . . 0.0 112.201 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -115.01 155.96 26.0 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.267 1.027 . . . . 0.0 108.902 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.59 -2.97 28.0 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 116.369 -0.378 . . . . 0.0 113.984 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.96 147.96 1.34 Allowed Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.724 1.21 . . . . 0.0 108.625 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.69 148.41 77.7 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.154 1.903 . . . . 0.0 111.421 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.38 -171.8 25.64 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.37 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.9 129.56 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.121 0.968 . . . . 0.0 109.118 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 45.1 ttp180 -95.14 124.72 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.3 156.05 45.9 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -90.37 100.18 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 107' ' ' ILE . 12.0 tp -72.54 106.75 4.73 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.417 0.687 . . . . 0.0 109.711 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.53 102.43 11.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.93 148.59 49.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.966 0.906 . . . . 0.0 111.602 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.545 ' HG2' ' HA2' ' A' ' 57' ' ' GLY . 14.1 mmmm -88.61 -27.29 21.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.757 0.823 . . . . 0.0 111.301 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.79 -34.05 60.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.914 0.486 . . . . 0.0 110.257 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -142.43 108.19 5.12 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.657 1.183 . . . . 0.0 108.972 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -71.53 -22.37 61.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.791 0.436 . . . . 0.0 110.392 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -70.6 -17.62 62.89 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.95 0.9 . . . . 0.0 111.549 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -101.42 92.54 4.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.402 0.681 . . . . 0.0 109.453 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -104.92 102.03 11.58 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.67 148.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.13 0.972 . . . . 0.0 109.096 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -83.46 145.23 29.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 82.7 t -129.96 121.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.18 0.592 . . . . 0.0 109.493 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.0 tp -93.3 91.25 7.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.396 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -94.31 115.13 27.31 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -105.58 122.92 47.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.97 -162.63 28.35 Favored Glycine 0 C--N 1.34 0.788 0 O-C-N 123.472 0.482 . . . . 0.0 111.95 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.17 111.91 12.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.696 0.798 . . . . 0.0 110.815 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.66 117.12 66.45 Favored Pre-proline 0 N--CA 1.475 0.776 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.46 161.56 43.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.018 1.812 . . . . 0.0 112.591 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.32 -24.77 62.19 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.083 0.953 . . . . 0.0 110.555 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.8 p -70.79 -21.79 62.44 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.357 1.063 . . . . 0.0 111.642 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' HA ' HG11 ' A' ' 103' ' ' VAL . 54.0 t80 -71.66 121.56 19.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.568 ' HG2' ' HB ' ' A' ' 103' ' ' VAL . 64.6 pttt -145.74 159.81 46.15 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.486 1.115 . . . . 0.0 108.932 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.33 96.8 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.513 2.142 . . . . 0.0 111.887 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.7 1.35 10.83 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.277 -0.735 . . . . 0.0 113.956 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 100' ' ' LYS . 8.4 p -75.49 141.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.026 0.913 . . . . 0.0 111.415 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.84 136.26 40.19 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.39 160.86 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.761 0.791 . . . . 0.0 112.598 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.441 HD11 ' HD3' ' A' ' 126' ' ' LYS . 60.7 mt -126.79 107.99 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.46 1.904 . . . . 0.0 105.902 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 77' ' ' LEU . 19.7 pt -111.51 146.68 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.341 0.656 . . . . 0.0 109.422 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -140.66 143.07 34.93 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.99 -122.12 0.99 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.87 140.21 6.64 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 117.409 0.604 . . . . 0.0 112.131 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.92 131.86 53.52 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.772 0.829 . . . . 0.0 109.227 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -84.99 133.51 43.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.69 -31.45 92.04 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.444 2.762 . . . . 0.0 114.093 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.58 80.1 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.648 0.593 . . . . 0.0 113.483 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 36.3 mt-10 -112.85 162.31 15.95 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.837 0.827 . . . . 0.0 113.004 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.17 -43.77 9.16 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.722 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.2 t -90.84 129.1 36.92 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.836 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -77.97 123.96 27.43 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.98 0.912 . . . . 0.0 109.268 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.87 100.8 13.45 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.45 105.67 15.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.438 0.695 . . . . 0.0 109.65 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -70.62 -23.94 62.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.918 0.487 . . . . 0.0 110.346 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.8 p -137.23 152.65 50.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.21 1.004 . . . . 0.0 109.489 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 tt -139.37 136.24 34.55 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 24.3 ttm -136.61 104.8 5.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.031 0.933 . . . . 0.0 108.735 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -70.47 122.75 20.26 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HD3' HD11 ' A' ' 106' ' ' ILE . 56.1 tptt -76.46 -31.4 57.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.932 0.893 . . . . 0.0 109.466 -175.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 43.1 t -85.51 111.95 40.76 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.727 0.811 . . . . 0.0 109.467 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.48 104.31 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.498 2.132 . . . . 0.0 112.125 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.11 144.44 29.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.229 0.612 . . . . 0.0 109.488 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.99 116.49 22.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.074 0.55 . . . . 0.0 109.823 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 m -77.5 130.51 73.93 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.341 0.656 . . . . 0.0 109.389 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.85 174.54 0.29 Allowed 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.993 3.129 . . . . 0.0 114.284 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -73.0 75.39 1.19 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.1 0.96 . . . . 0.0 110.548 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.817 ' HB2' ' HB2' ' A' ' 51' ' ' HIS . 8.3 m-20 -150.18 123.44 8.93 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.16 -46.41 80.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.209 0.604 . . . . 0.0 110.524 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.604 HD22 HG22 ' A' ' 53' ' ' VAL . 84.4 mt -112.15 46.4 1.16 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.679 0.792 . . . . 0.0 110.137 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 15.4 t60 -59.62 -51.11 71.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.4 p -125.16 150.99 46.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 112.734 -2.03 . . . . 0.0 107.864 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG22 HD22 ' A' ' 50' ' ' LEU . 48.1 t -101.12 110.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -109.58 114.19 27.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -111.36 138.0 48.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -112.44 145.29 40.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . 173.93 -159.41 28.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 118.19 0.45 . . . . 0.0 112.763 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -131.67 145.68 51.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.92 0.888 . . . . 0.0 110.28 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.72 119.04 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.224 1.01 . . . . 0.0 110.464 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.98 143.41 47.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.765 0.826 . . . . 0.0 110.185 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.62 -41.05 47.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.533 0.733 . . . . 0.0 110.333 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.84 102.64 10.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.086 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 76' ' ' ARG . . . 104.29 42.95 1.81 Allowed Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.795 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.64 125.47 51.82 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -143.67 144.48 31.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.746 1.218 . . . . 0.0 109.668 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 71.9 mmm -81.29 149.46 28.95 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 mt -66.66 150.18 49.43 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.55 104.96 15.0 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.913 0.885 . . . . 0.0 110.334 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.19 33.92 88.53 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.635 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.51 146.86 20.28 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.44 0.696 . . . . 0.0 110.288 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.44 130.83 16.67 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.351 2.034 . . . . 0.0 110.275 170.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.62 -169.19 23.92 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 116.681 -0.236 . . . . 0.0 112.515 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.65 130.59 3.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 34.3 ttm180 -94.61 129.86 41.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.43 162.31 41.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.422 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 73.4 mtp180 -95.46 124.44 39.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.5 tp -99.76 116.51 32.01 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 109.517 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -79.38 116.89 19.88 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.412 1.085 . . . . 0.0 108.467 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.75 142.48 51.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 10.7 mmpt? -64.77 -36.83 85.59 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.431 0.692 . . . . 0.0 112.115 -174.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.88 -39.41 17.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -115.15 90.29 3.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.405 0.682 . . . . 0.0 111.096 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -89.29 9.38 26.19 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.607 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -92.5 4.8 52.81 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.366 0.666 . . . . 0.0 110.957 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.01 134.77 7.76 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.02 0.528 . . . . 0.0 109.612 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 134.09 55.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 108.777 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.69 141.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.81 154.58 41.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 55.9 t -137.3 118.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 92' ' ' LYS . 59.9 tp -93.01 92.67 7.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 108.77 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -90.91 123.41 34.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 90' ' ' LEU . 98.9 mttt -107.53 129.78 54.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 167.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.51 -165.98 26.27 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.452 0.47 . . . . 0.0 112.072 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.01 118.75 13.24 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.581 0.752 . . . . 0.0 111.224 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.15 115.85 63.54 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.013 0.925 . . . . 0.0 109.232 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.87 157.62 47.22 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.061 2.507 . . . . 0.0 114.19 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.49 -27.63 66.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.935 0.894 . . . . 0.0 110.326 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.2 t -80.58 -14.78 57.91 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.453 ' CD1' HD21 ' A' ' 123' ' ' LEU . 68.5 t80 -78.14 114.05 16.66 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' O ' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -146.48 154.92 49.43 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.174 0.989 . . . . 0.0 109.121 177.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.39 102.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.691 2.261 . . . . 0.0 112.414 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.57 -10.19 5.81 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.372 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 99' ' ' PHE . 13.6 p -78.1 136.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 117.662 0.731 . . . . 0.0 110.699 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -76.09 122.57 24.46 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.83 155.15 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.971 0.891 . . . . 0.0 111.226 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 124' ' ' MET . 61.3 mt -114.34 109.4 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.1 pt -97.19 153.76 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 38.5 tt0 -145.76 134.93 22.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.69 -114.6 0.59 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.53 166.2 39.42 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.96 123.02 42.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.07 0.948 . . . . 0.0 108.961 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.39 132.35 33.95 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.306 0.642 . . . . 0.0 109.785 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.49 89.34 0.21 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.095 2.53 . . . . 0.0 111.611 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.11 -39.65 0.52 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.57 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.95 129.37 35.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.395 0.678 . . . . 0.0 109.197 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.52 -16.29 61.28 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.085 168.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -95.23 126.5 40.59 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 111.871 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -76.48 114.88 15.69 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.013 1.325 . . . . 0.0 109.176 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -74.69 91.42 2.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.08 113.51 25.49 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.861 0.864 . . . . 0.0 110.472 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.441 ' HG3' ' OG1' ' A' ' 122' ' ' THR . 25.6 ptt180 -74.66 -26.82 60.12 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.903 0.481 . . . . 0.0 110.006 172.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 108' ' ' GLU . 17.8 m -126.67 145.9 50.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.745 0.818 . . . . 0.0 109.175 -169.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 99' ' ' PHE . 47.2 tp -137.04 132.95 34.93 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.615 ' HB3' ' HB ' ' A' ' 106' ' ' ILE . 38.8 ttm -134.55 96.56 3.6 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.4 p -72.18 121.87 20.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.716 0.806 . . . . 0.0 109.792 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -94.53 1.11 55.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 0.0 111.388 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 46.2 t -95.47 107.65 34.37 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.39 122.31 9.75 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.424 2.082 . . . . 0.0 110.872 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 35.0 tp -98.4 110.61 23.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.288 0.635 . . . . 0.0 109.716 -174.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.532 0.206 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.76 6.57 2.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 m 55.96 86.65 0.16 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.027 1.331 . . . . 0.0 110.207 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -46.76 119.52 3.36 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.785 2.99 . . . . 0.0 115.516 -169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -149.3 37.65 0.77 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.507 1.123 . . . . 0.0 108.021 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.65 141.2 38.67 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.85 -1.523 . . . . 0.0 112.865 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HD2' HH12 ' A' ' 121' ' ' ARG . 42.5 mmtm -89.9 -25.69 20.84 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.442 -172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -67.1 -38.58 85.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.097 0.559 . . . . 0.0 111.507 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -109.06 22.95 15.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 111.383 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -58.89 139.95 55.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.929 0.492 . . . . 0.0 109.92 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.65 108.26 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -170.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -101.13 109.9 21.85 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.12 136.51 53.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -108.92 131.62 54.85 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.8 -174.26 32.49 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.4 m -128.28 139.4 52.45 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.144 0.978 . . . . 0.0 108.841 173.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.06 120.13 28.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.918 0.887 . . . . 0.0 108.983 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.29 57.58 Favored 'General case' 0 C--O 1.243 0.742 0 O-C-N 123.694 0.621 . . . . 0.0 110.333 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.67 -18.64 59.57 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.667 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.55 109.19 21.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.975 . . . . 0.0 108.944 170.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.94 64.85 0.91 Allowed Glycine 0 C--N 1.346 1.096 0 O-C-N 123.146 0.279 . . . . 0.0 112.486 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -136.0 124.49 23.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 84.7 m -147.25 138.79 24.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.479 0.712 . . . . 0.0 110.128 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 80.1 mmm -82.7 153.29 25.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.341 0.657 . . . . 0.0 109.319 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.96 138.44 48.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.438 0.295 . . . . 0.0 111.008 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.82 112.89 5.81 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.955 0.902 . . . . 0.0 111.669 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.63 30.48 72.32 Favored Glycine 0 C--N 1.347 1.186 0 O-C-N 124.125 0.891 . . . . 0.0 113.349 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.91 138.48 11.9 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.337 0.655 . . . . 0.0 110.213 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 111.0 2.11 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.927 2.418 . . . . 0.0 110.898 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.99 177.43 35.98 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -154.35 138.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -106.29 131.57 53.36 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -144.73 154.8 43.11 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -92.5 91.55 7.66 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.68 120.1 22.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.62 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 86' ' ' THR . 36.5 mt-10 -92.45 105.19 17.41 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 40.9 t0 -59.12 142.28 51.92 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.679 1.192 . . . . 0.0 111.223 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -74.47 -17.05 60.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.144 0.978 . . . . 0.0 111.119 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.35 -55.48 15.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -148.32 134.17 19.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.075 0.95 . . . . 0.0 109.161 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -66.43 -25.38 66.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.29 0.636 . . . . 0.0 111.113 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.93 -29.09 69.99 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.597 0.759 . . . . 0.0 111.227 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 30.8 mmmt -73.91 79.44 1.64 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.506 0.723 . . . . 0.0 110.116 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 78' ' ' GLU . 18.0 p -94.83 98.57 10.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.0 t -108.4 135.5 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.37 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.6 130.77 34.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.46 116.41 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.0 tp -91.93 94.26 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -92.07 114.16 26.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.174 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.16 123.13 34.38 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.13 169.83 12.66 Favored Glycine 0 N--CA 1.467 0.721 0 O-C-N 123.206 0.316 . . . . 0.0 112.653 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 120.18 12.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.235 0.614 . . . . 0.0 110.318 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.28 124.42 78.33 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.179 0.991 . . . . 0.0 110.251 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.5 ' HB2' HG22 ' A' ' 98' ' ' THR . 93.9 Cg_endo -75.61 155.46 40.14 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.726 2.284 . . . . 0.0 112.46 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -65.17 -22.37 66.9 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.788 0.835 . . . . 0.0 112.047 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 129' ' ' LEU . 6.7 t -74.21 -24.44 59.33 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.511 0.724 . . . . 0.0 111.216 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.514 ' HA ' HG11 ' A' ' 103' ' ' VAL . 75.3 t80 -73.32 109.86 7.17 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -141.32 159.76 59.81 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.021 0.929 . . . . 0.0 109.895 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.37 100.11 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.695 2.263 . . . . 0.0 111.574 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.86 -11.28 7.84 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.257 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 99' ' ' PHE . 5.4 p -72.17 146.96 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 117.489 0.644 . . . . 0.0 109.884 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 35.8 mt-10 -81.46 136.42 35.66 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 170.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.616 HG12 HG22 ' A' ' 125' ' ' THR . 19.6 m -128.74 169.58 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 122.152 0.977 . . . . 0.0 111.701 177.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -136.25 107.75 6.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.896 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 118' ' ' PHE . 41.1 pt -98.16 149.51 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.909 0.884 . . . . 0.0 109.471 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 40.7 mt-10 -135.03 139.75 45.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.72 -120.82 0.97 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.2 168.77 41.9 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.808 0.304 . . . . 0.0 112.374 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.29 101.03 7.69 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.49 130.45 58.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.0 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.92 97.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.604 2.869 . . . . 0.0 112.416 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.13 -52.14 0.56 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.87 118.39 24.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.637 0.775 . . . . 0.0 109.886 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.17 -26.56 61.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.378 0.671 . . . . 0.0 109.653 168.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -86.2 141.28 29.43 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.497 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.446 ' CD1' HD12 ' A' ' 107' ' ' ILE . 54.6 t80 -76.5 118.04 18.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.304 0.642 . . . . 0.0 109.702 -177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.32 97.11 4.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.104 0.962 . . . . 0.0 109.409 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.87 114.2 25.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.049 0.54 . . . . 0.0 110.592 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.465 HH12 ' HD2' ' A' ' 49' ' ' LYS . 12.1 ptm180 -78.57 -34.83 46.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.518 0.727 . . . . 0.0 110.802 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 13.6 p -138.4 146.32 42.08 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.775 0.83 . . . . 0.0 109.569 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.5 tp -136.61 111.95 9.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.27 1.028 . . . . 0.0 109.594 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.6 ttp -122.47 119.86 32.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 105' ' ' VAL . 45.8 p -72.23 146.78 47.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -67.91 -34.99 77.69 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 175.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.09 107.17 5.57 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.151 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.56 128.41 6.09 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.323 2.015 . . . . 0.0 112.411 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.606 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 32.5 tp -165.44 29.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.44 1.096 . . . . 0.0 108.546 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.152 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.71 -173.98 4.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.905 0.882 . . . . 0.0 111.281 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 t -113.75 89.29 15.6 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.438 0.695 . . . . 0.0 110.069 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HB3' ' HG3' ' A' ' 113' ' ' PRO . 2.9 Cg_exo -74.47 115.58 4.35 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.607 2.204 . . . . 0.0 110.881 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.6 -177.1 4.06 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.031 0.532 . . . . 0.0 109.961 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -68.08 127.12 31.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.87 0.468 . . . . 0.0 109.909 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.28 -3.54 33.89 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.793 0.837 . . . . 0.0 111.526 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.98 60.17 4.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.83 0.852 . . . . 0.0 110.091 170.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -145.55 153.16 40.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.461 1.504 . . . . 0.0 108.145 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 p -106.65 121.7 44.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.726 . . . . 0.0 110.195 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.73 118.34 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -91.94 121.59 33.68 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.94 138.81 51.07 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -120.35 154.45 35.04 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.277 1.031 . . . . 0.0 109.882 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.19 -155.56 26.97 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 121.805 -0.236 . . . . 0.0 112.932 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -124.32 145.21 49.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.776 0.83 . . . . 0.0 109.737 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.28 120.51 36.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.64 33.47 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 124.017 0.823 . . . . 0.0 111.003 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.31 -17.78 51.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.413 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.75 127.72 33.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.434 0.693 . . . . 0.0 110.477 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.66 8.2 84.03 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.431 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HE2' ' A' ' 99' ' ' PHE . 4.3 tt -69.55 103.83 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 m -116.2 113.7 23.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.518 1.127 . . . . 0.0 108.929 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.4 mtp -89.08 136.56 32.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.23 128.59 37.13 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.468 0.48 . . . . 0.0 110.112 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.58 112.34 24.22 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.43 0.692 . . . . 0.0 109.232 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.02 -30.53 9.91 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.023 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.42 141.99 23.64 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.746 0.818 . . . . 0.0 109.57 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.29 6.35 4.42 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.213 2.608 . . . . 0.0 114.112 -175.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.96 -170.66 44.24 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.424 0.452 . . . . 0.0 113.369 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 95' ' ' VAL . 13.0 p -154.12 154.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.455 0.702 . . . . 0.0 110.73 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -121.78 138.45 54.36 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.624 1.17 . . . . 0.0 108.015 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -151.1 174.63 12.98 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -113.37 111.87 22.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.794 0.807 . . . . 0.0 109.83 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.0 tp -77.62 133.66 38.38 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.007 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HA ' HG22 ' A' ' 86' ' ' THR . 44.6 mt-10 -84.47 124.22 31.11 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.98 105.63 1.08 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.613 0.57 . . . . 0.0 110.555 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.27 -24.39 46.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -63.23 -32.86 74.37 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.28 0.632 . . . . 0.0 110.987 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -156.57 97.0 1.7 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.378 0.671 . . . . 0.0 109.644 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -81.3 70.38 8.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 122.629 1.204 . . . . 0.0 111.193 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -147.11 2.32 0.77 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.078 169.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -146.2 159.88 42.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.52 1.128 . . . . 0.0 109.669 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 78' ' ' GLU . 37.6 p -137.75 139.15 39.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.233 1.013 . . . . 0.0 109.042 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.96 133.25 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -83.1 134.97 34.98 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.13 116.29 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.224 0.61 . . . . 0.0 109.485 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.3 tp -93.61 93.97 8.35 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.4 109.99 18.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.183 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.66 109.93 21.81 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 109.518 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.69 -166.21 37.87 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.11 115.95 27.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG21 ' HB ' ' A' ' 73' ' ' VAL . 97.9 t -80.18 118.69 73.68 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 122.735 0.414 . . . . 0.0 109.884 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.5 162.35 38.24 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 122.299 1.999 . . . . 0.0 112.439 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.3 -22.55 66.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.926 0.89 . . . . 0.0 111.185 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.599 HG22 ' HG ' ' A' ' 129' ' ' LEU . 67.8 p -67.67 -20.91 65.35 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.617 1.167 . . . . 0.0 112.096 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.409 ' HE2' HD21 ' A' ' 64' ' ' LEU . 75.8 t80 -79.79 136.36 36.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.827 0.851 . . . . 0.0 109.521 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -163.89 162.49 16.45 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.969 0.908 . . . . 0.0 110.599 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.24 101.57 0.35 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.435 2.09 . . . . 0.0 110.517 164.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.21 62.51 0.67 Allowed Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HG13 ' A' ' 105' ' ' VAL . 11.6 p -137.7 130.53 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -0.615 . . . . 0.0 110.285 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -69.85 132.65 46.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 165.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG12 HG22 ' A' ' 125' ' ' THR . 15.2 m -139.06 159.37 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-O 122.081 0.943 . . . . 0.0 111.174 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.31 106.46 12.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 113.237 -1.801 . . . . 0.0 106.291 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.0 pt -100.87 161.17 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.254 0.621 . . . . 0.0 110.098 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.89 140.47 20.71 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.19 -108.57 0.27 Allowed Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.26 171.25 41.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.4 tp -128.69 127.71 42.67 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.71 139.03 43.6 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.241 0.616 . . . . 0.0 109.913 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.506 ' HG3' ' HB3' ' A' ' 46' ' ' PRO . 41.2 Cg_endo -65.66 112.12 2.09 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.403 2.069 . . . . 0.0 112.179 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.38 -21.48 19.42 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -89.83 144.21 26.15 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 110.922 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.62 -34.76 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.811 0.444 . . . . 0.0 110.993 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -82.38 126.29 32.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.109 0.48 . . . . 0.0 110.795 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -77.6 122.54 25.44 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.846 0.858 . . . . 0.0 108.693 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -91.54 103.83 16.39 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.4 119.57 25.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -68.42 -42.49 78.88 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.272 1.029 . . . . 0.0 109.799 168.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 m -134.51 141.73 46.81 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 -170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.7 tp -125.82 112.39 15.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.702 1.201 . . . . 0.0 108.566 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 ttp -118.55 106.0 12.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.498 HG22 HG12 ' A' ' 105' ' ' VAL . 77.5 p -71.24 128.06 34.65 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -79.34 -32.53 43.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.811 0.844 . . . . 0.0 109.207 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.6 t -109.27 87.9 5.41 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.502 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 13.5 Cg_exo -67.97 -82.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.065 2.51 . . . . 0.0 113.905 -171.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.599 ' HG ' HG22 ' A' ' 98' ' ' THR . 96.6 mt -138.27 107.63 6.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.298 1.039 . . . . 0.0 109.216 -176.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.164 177.115 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.18 113.36 24.95 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.177 0.591 . . . . 0.0 110.33 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -71.04 127.5 91.56 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.702 0.801 . . . . 0.0 110.452 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.89 97.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.165 2.576 . . . . 0.0 112.481 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -132.85 146.61 51.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.348 1.059 . . . . 0.0 110.501 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.52 94.41 8.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.35 8.71 37.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.297 -173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.46 77.44 1.93 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.603 0.716 . . . . 0.0 109.304 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -79.8 -14.34 58.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.822 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -124.76 143.8 50.59 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.031 1.332 . . . . 0.0 107.705 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' A' ' 110' ' ' GLY . 42.2 t -115.48 132.69 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.588 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 94.6 mtt180 -100.14 146.22 27.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.342 0.657 . . . . 0.0 110.177 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD23 ' A' ' 77' ' ' LEU . 1.5 tt -133.82 126.6 30.89 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -115.66 108.33 16.25 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.98 -152.11 5.57 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 56.6 m -125.38 146.43 49.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.61 0.764 . . . . 0.0 109.815 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -82.68 120.04 33.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 124.012 0.925 . . . . 0.0 109.071 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.14 150.98 43.33 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.905 0.753 . . . . 0.0 111.007 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.55 45.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.624 0.769 . . . . 0.0 110.074 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.78 113.91 26.31 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.88 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.56 -1.14 45.92 Favored Glycine 0 N--CA 1.469 0.883 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.224 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.422 HD13 ' HG3' ' A' ' 101' ' ' PRO . 5.4 tt -69.21 108.96 3.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -121.52 128.62 52.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.211 1.005 . . . . 0.0 108.861 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.7 mmt -83.06 154.91 24.17 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -86.3 35.61 0.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 26.42 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 128.078 2.551 . . . . 0.0 114.44 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.72 38.56 3.2 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.174 0.416 . . . . 0.0 113.05 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.28 133.75 4.38 Favored Pre-proline 0 C--O 1.241 0.618 0 C-N-CA 124.669 1.188 . . . . 0.0 108.694 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.72 115.64 3.51 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.468 2.112 . . . . 0.0 109.901 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.06 -174.4 33.27 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.501 0.5 . . . . 0.0 112.965 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.36 133.77 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.959 0.904 . . . . 0.0 110.057 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 46.2 ttm180 -106.36 124.32 49.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -149.33 160.77 43.12 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -171.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -96.45 111.48 23.57 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.439 HD23 HD22 ' A' ' 55' ' ' LEU . 19.7 tp -79.86 105.05 10.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.75 121.42 19.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.699 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -78.09 147.67 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.176 0.99 . . . . 0.0 110.825 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -108.37 -10.61 15.3 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.408 0.683 . . . . 0.0 111.962 -172.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -83.94 -30.12 26.54 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 175.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -145.95 108.8 4.54 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -73.31 -13.75 61.17 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.277 0.631 . . . . 0.0 111.8 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -84.12 -10.13 58.04 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.243 0.617 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -109.97 110.92 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.647 0.779 . . . . 0.0 109.723 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -113.96 127.59 56.03 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 167.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.03 134.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -85.98 138.39 32.02 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 60.2 t -123.08 116.68 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.4 93.87 8.4 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -98.18 122.58 41.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.91 116.17 31.15 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.01 174.65 33.18 Favored Glycine 0 C--O 1.238 0.346 0 O-C-N 123.994 0.808 . . . . 0.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 112.78 4.13 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.1 117.01 66.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.413 0.685 . . . . 0.0 109.471 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.01 171.23 18.53 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.182 1.921 . . . . 0.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.16 -22.27 59.49 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -63.54 -32.2 73.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.4 1.08 . . . . 0.0 109.796 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -76.52 120.91 22.38 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 166.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.35 155.63 19.25 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.505 0.722 . . . . 0.0 110.173 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 64' ' ' LEU . 41.6 Cg_exo -57.98 107.79 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.649 2.232 . . . . 0.0 111.847 172.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.86 -25.14 5.62 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.237 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.2 p -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 117.44 0.62 . . . . 0.0 110.654 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 40.5 mt-10 -86.62 129.69 34.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 125' ' ' THR . 34.8 m -119.99 144.94 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.611 0.719 . . . . 0.0 111.068 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.92 107.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.66 143.69 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 25.9 mt-10 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.62 -100.29 0.14 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 53' ' ' VAL . . . 166.15 159.2 11.71 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 170.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.84 127.67 39.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.995 0.918 . . . . 0.0 109.237 174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -82.98 135.34 45.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 -28.66 80.96 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.814 2.342 . . . . 0.0 113.377 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.05 -11.26 56.61 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.84 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 42.1 mt-10 -119.14 125.49 49.37 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.562 0.745 . . . . 0.0 110.159 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -61.43 -26.3 67.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.992 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 t -84.67 130.51 34.7 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.23 0.538 . . . . 0.0 111.284 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 10.2 t80 -77.07 116.15 17.47 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -97.51 114.37 26.24 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.28 30.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.165 0.986 . . . . 0.0 110.668 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -75.04 -26.36 59.39 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.142 0.577 . . . . 0.0 110.45 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 108' ' ' GLU . 39.0 p -139.61 155.39 47.48 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.682 1.193 . . . . 0.0 108.836 174.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 tt -137.94 137.11 37.66 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 ttp -133.7 164.97 26.03 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 105' ' ' VAL . 40.0 p -109.86 149.36 29.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.113 0.565 . . . . 0.0 109.913 173.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -78.03 -49.47 13.96 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.67 118.59 58.15 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.751 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -85.68 -173.22 1.29 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.685 2.257 . . . . 0.0 112.042 170.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -126.46 -179.96 5.02 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.313 0.645 . . . . 0.0 109.717 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.82 23.55 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.419 0.687 . . . . 0.0 109.833 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.2 m -117.1 89.84 31.56 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.84 94.61 0.54 Allowed 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.067 1.845 . . . . 0.0 110.425 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -69.22 -10.55 58.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.459 0.704 . . . . 0.0 111.776 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.36 77.77 1.01 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -87.43 -6.33 58.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.895 . . . . 0.0 110.466 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.14 77.06 8.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.061 0.945 . . . . 0.0 109.107 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -164.15 142.92 7.44 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.0 m -70.59 117.66 12.41 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 122.933 0.493 . . . . 0.0 109.925 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.64 127.78 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -113.84 134.27 54.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.792 0.437 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 163.95 16.93 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.222 1.009 . . . . 0.0 110.244 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -139.37 139.82 37.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.652 1.181 . . . . 0.0 108.368 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.94 30.44 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 28.1 m -123.2 148.68 45.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.588 1.155 . . . . 0.0 109.463 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.47 130.87 35.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.34 37.64 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.564 0.54 . . . . 0.0 110.919 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -70.89 -45.44 64.35 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.437 0.695 . . . . 0.0 109.608 170.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.63 120.58 30.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 52.12 1.93 Allowed Glycine 0 N--CA 1.468 0.782 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 75' ' ' PHE . 5.9 tt -135.84 125.76 25.86 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -140.57 142.86 35.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.526 1.13 . . . . 0.0 108.807 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.6 mmt -95.02 147.88 22.93 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.99 123.66 22.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.05 124.88 41.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.351 0.661 . . . . 0.0 109.553 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.92 28.45 70.58 Favored Glycine 0 C--N 1.344 0.989 0 O-C-N 123.726 0.641 . . . . 0.0 111.9 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.33 131.48 2.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.784 1.233 . . . . 0.0 109.007 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 120.77 7.48 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 121.928 1.752 . . . . 0.0 111.771 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -176.85 31.32 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 120.998 0.221 . . . . 0.0 113.546 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.51 139.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.459 1.104 . . . . 0.0 109.431 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 40.5 ttt180 -119.65 125.81 49.62 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.64 0.776 . . . . 0.0 108.991 171.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.442 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 37.5 p90 -151.36 162.35 41.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 30.2 ptt180 -100.18 119.26 38.08 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 107' ' ' ILE . 41.0 tp -73.79 115.78 13.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.702 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.527 ' HA ' HG22 ' A' ' 86' ' ' THR . 34.2 mt-10 -74.21 101.95 4.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.65 158.7 1.79 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.611 0.764 . . . . 0.0 111.797 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -49.57 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.4 1.08 . . . . 0.0 112.058 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 66.9 21.78 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.651 1.18 . . . . 0.0 111.956 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -139.39 86.4 2.12 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.118 0.967 . . . . 0.0 109.463 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -82.21 -10.24 59.21 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.754 173.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -81.29 -0.03 39.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.599 0.76 . . . . 0.0 112.249 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -145.99 88.23 1.8 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 78' ' ' GLU . 39.9 p -98.54 128.26 44.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.948 0.899 . . . . 0.0 110.554 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -101.95 138.82 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 88.8 m95 -73.89 160.63 31.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.951 0.501 . . . . 0.0 110.777 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.3 t -135.71 108.77 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 108.677 -173.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.9 tp -93.98 94.04 8.23 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -99.48 131.86 45.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -118.74 150.84 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.147 0.579 . . . . 0.0 110.622 170.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.18 -172.22 14.12 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.195 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.81 121.13 18.43 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.166 0.587 . . . . 0.0 110.106 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.24 124.64 80.6 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.922 0.889 . . . . 0.0 109.332 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 123' ' ' LEU . 57.8 Cg_endo -68.61 152.58 74.56 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.474 2.116 . . . . 0.0 112.111 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.55 -27.03 63.84 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.524 0.73 . . . . 0.0 111.66 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 96' ' ' PRO . 9.6 t -68.62 -20.02 64.46 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.761 0.425 . . . . 0.0 110.908 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.07 115.33 10.08 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' HG12 ' A' ' 103' ' ' VAL . 47.8 mtmt -132.15 158.66 74.95 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.487 1.115 . . . . 0.0 108.644 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 11.2 Cg_exo -70.99 141.08 39.42 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.204 1.936 . . . . 0.0 109.985 167.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.42 -6.72 79.04 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 100' ' ' LYS . 9.9 p -93.25 149.83 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.388 1.094 . . . . 0.0 108.313 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 37.5 mt-10 -69.99 139.07 52.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 125' ' ' THR . 16.6 m -133.03 156.4 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.916 0.865 . . . . 0.0 111.017 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.8 mt -121.16 127.89 75.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.738 1.615 . . . . 0.0 106.769 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 77' ' ' LEU . 17.6 pt -125.93 145.63 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.26 155.25 46.6 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 109.153 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . 165.88 -114.42 0.59 Allowed Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.02 150.81 20.94 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 117.343 0.571 . . . . 0.0 111.979 173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 45.9 tp -127.66 136.11 51.15 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.533 0.733 . . . . 0.0 109.874 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.3 132.55 37.17 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.64 -19.53 53.43 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.807 2.338 . . . . 0.0 113.728 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.7 -8.28 57.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.792 -0.449 . . . . 0.0 113.768 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -100.68 139.68 36.03 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 117.708 0.754 . . . . 0.0 110.014 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -85.98 -23.14 27.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.994 0.917 . . . . 0.0 111.934 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -99.39 126.47 45.28 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.873 0.844 . . . . 0.0 110.763 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 111' ' ' LEU . 81.2 t80 -75.11 131.02 40.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.762 1.225 . . . . 0.0 108.715 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 60.0 tttm -88.25 108.16 19.17 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.02 113.62 23.84 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.015 0.526 . . . . 0.0 110.111 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.09 -30.51 62.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.468 0.707 . . . . 0.0 109.49 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p -133.4 141.33 47.82 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.85 0.86 . . . . 0.0 109.834 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 96' ' ' PRO . 62.8 tp -124.8 109.58 13.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.5 ttp -124.86 138.45 54.26 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' HG12 ' A' ' 105' ' ' VAL . 65.3 p -89.61 169.01 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.002 0.521 . . . . 0.0 111.231 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 24.9 tptm -62.17 -60.57 3.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.213 1.005 . . . . 0.0 109.995 173.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 66.9 m -99.84 113.8 65.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.378 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.18 79.45 1.07 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.713 2.275 . . . . 0.0 110.218 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.63 100.45 2.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.884 -172.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 123.959 0.903 . . . . 0.0 108.607 -176.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 43' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.59 171.95 19.42 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.7 0.8 . . . . 0.0 110.069 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.5 p -73.91 131.76 81.11 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 122.943 0.497 . . . . 0.0 110.012 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -59.25 151.93 63.86 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.022 2.481 . . . . 0.0 113.505 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -68.98 159.73 32.23 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.666 0.786 . . . . 0.0 111.192 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -77.07 161.21 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.195 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -106.76 11.4 30.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.626 0.771 . . . . 0.0 111.312 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -79.8 -34.49 39.56 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -107.17 62.79 0.62 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 t -81.1 -159.23 0.24 Allowed 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.336 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -97.15 118.85 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.336 -0.853 . . . . 0.0 109.521 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -120.1 138.0 53.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.67 140.47 40.82 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.77 134.04 52.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.211 1.005 . . . . 0.0 108.606 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.9 177.38 41.04 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -113.4 140.19 48.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.763 0.825 . . . . 0.0 109.074 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 102' ' ' GLY . 59.6 t -74.6 132.25 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.764 0.426 . . . . 0.0 110.39 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.67 40.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 122.617 0.367 . . . . 0.0 110.062 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . . . -75.59 -0.33 20.09 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.695 173.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -131.23 120.77 23.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.898 0.879 . . . . 0.0 109.363 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.91 22.91 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.865 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.81 105.73 5.23 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.9 m -138.59 125.95 21.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.813 0.845 . . . . 0.0 109.944 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 63.5 mtp -96.89 162.19 13.52 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.165 0.586 . . . . 0.0 110.631 -170.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.63 135.12 35.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.013 0.525 . . . . 0.0 111.225 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -73.89 111.84 9.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.554 0.742 . . . . 0.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.95 -53.78 4.88 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.334 0.396 . . . . 0.0 112.347 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.61 129.16 94.14 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 123.856 0.862 . . . . 0.0 110.906 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.31 113.46 1.92 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.435 2.09 . . . . 0.0 110.808 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.41 175.36 35.94 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 121.478 0.488 . . . . 0.0 113.514 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' MET . 8.7 p -154.35 131.71 2.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.06 1.344 . . . . 0.0 108.723 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.93 143.4 31.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -156.64 163.32 39.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -98.64 105.99 18.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.85 117.5 23.34 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -71.6 89.71 1.0 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.38 131.03 47.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.917 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -72.57 -37.91 68.06 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.627 0.579 . . . . 0.0 110.973 -171.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.47 -44.89 70.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 111.115 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.34 89.98 2.43 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 t -77.43 -18.44 57.22 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.923 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -68.35 -18.88 64.59 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.641 0.777 . . . . 0.0 111.556 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -132.18 88.77 2.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.069 0.948 . . . . 0.0 108.919 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.4 p -80.78 151.36 28.83 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.766 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.2 t -104.09 129.35 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.461 0.704 . . . . 0.0 109.657 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.2 m95 -78.76 100.76 7.25 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.19 110.09 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.359 0.6 . . . . 0.0 109.572 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 tp -93.15 93.75 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.742 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' HE2' ' HA ' ' A' ' 95' ' ' VAL . 47.3 t80 -92.97 111.54 23.2 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.715 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -105.3 116.09 31.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.205 0.602 . . . . 0.0 109.463 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 153.63 -175.24 32.05 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.46 112.76 4.24 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' TYR . 46.2 t -79.82 126.35 80.33 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.423 0.689 . . . . 0.0 109.232 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.6 Cg_endo -57.33 142.88 94.96 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.782 2.322 . . . . 0.0 112.519 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.93 -25.7 67.25 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.583 0.753 . . . . 0.0 111.441 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 33.2 p -78.22 -6.65 55.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.503 1.121 . . . . 0.0 112.642 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 78.9 t80 -69.99 95.94 0.99 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.294 0.638 . . . . 0.0 109.946 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.601 ' HB3' HD22 ' A' ' 129' ' ' LEU . 48.4 pttt -110.53 157.41 38.36 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.256 1.023 . . . . 0.0 110.018 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.536 ' HB3' ' HA ' ' A' ' 61' ' ' ALA . 16.3 Cg_exo -68.46 112.7 2.9 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.302 2.001 . . . . 0.0 110.714 171.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 59' ' ' VAL . . . 111.58 3.31 27.18 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.911 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 125' ' ' THR . 12.8 p -85.63 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 118.07 0.935 . . . . 0.0 110.278 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.39 110.33 8.59 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.5 HG13 HG13 ' A' ' 103' ' ' VAL . 29.8 m -104.63 148.05 9.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.952 0.882 . . . . 0.0 110.223 177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.55 107.19 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 35.2 pt -98.11 144.42 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 138.89 26.66 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.93 -118.35 0.83 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -172.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.54 141.58 6.63 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 117.907 0.853 . . . . 0.0 112.342 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 tp -87.64 129.17 35.22 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 115' ' ' GLU . . . -81.58 132.75 54.23 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.75 -18.78 66.08 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.009 2.473 . . . . 0.0 114.055 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.23 -31.92 6.64 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.679 -0.237 . . . . 0.0 112.76 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 3.2 mp0 -94.45 137.26 33.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.945 0.498 . . . . 0.0 111.313 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.26 -26.69 65.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.992 0.917 . . . . 0.0 110.533 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 58.5 p -84.41 130.04 34.81 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.9 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -77.79 120.43 22.68 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.372 1.069 . . . . 0.0 108.619 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -75.74 94.73 3.31 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.22 109.59 18.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.248 0.619 . . . . 0.0 110.13 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -62.38 -42.36 99.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.931 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.2 p -134.83 162.31 32.74 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.879 0.871 . . . . 0.0 110.192 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.0 tp -150.58 111.43 4.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.361 1.064 . . . . 0.0 108.895 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 ttp -124.48 116.08 21.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.485 0.314 . . . . 0.0 110.939 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 103' ' ' VAL . 70.4 p -74.06 150.27 40.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.389 1.076 . . . . 0.0 110.694 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -90.75 -63.84 1.21 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.741 0.417 . . . . 0.0 110.054 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.54 114.27 26.79 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.984 0.513 . . . . 0.0 110.618 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.99 135.27 31.84 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.018 2.479 . . . . 0.0 111.924 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 100' ' ' LYS . 56.9 tp -102.9 135.44 44.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.884 0.874 . . . . 0.0 109.505 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 124.453 1.101 . . . . 0.0 109.709 -176.591 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 43' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.58 8.64 21.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.484 0.714 . . . . 0.0 110.678 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -66.13 108.43 2.25 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 125.0 1.32 . . . . 0.0 112.114 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -90.79 25.84 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.315 2.676 . . . . 0.0 113.118 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 60.46 33.83 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.283 1.033 . . . . 0.0 111.341 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -74.84 -29.13 60.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.62 0.768 . . . . 0.0 110.317 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt 66.08 12.92 8.82 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.551 1.54 . . . . 0.0 113.55 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -111.55 6.92 20.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.378 0.671 . . . . 0.0 110.311 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -70.3 -50.66 37.15 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.7 m -106.39 116.07 31.3 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 165.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.6 t -102.65 145.23 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.183 0.993 . . . . 0.0 109.393 -170.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -115.58 123.2 47.85 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.44 147.35 41.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.637 0.732 . . . . 0.0 110.034 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.96 109.06 10.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.913 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.86 -158.31 8.55 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.455 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 50.2 m -117.12 145.71 43.62 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.388 1.075 . . . . 0.0 109.747 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.9 120.43 32.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.079 0.952 . . . . 0.0 109.08 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.9 47.59 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.744 0.652 . . . . 0.0 111.647 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 101' ' ' PRO . . . -70.3 -28.83 65.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.541 0.736 . . . . 0.0 112.111 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -110.59 42.14 1.64 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.54 51.96 0.22 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 tt -133.65 108.42 8.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 m -114.43 119.51 37.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 109.682 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.1 mmt -80.92 143.62 32.52 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 0.0 110.093 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -75.93 131.96 39.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.641 0.376 . . . . 0.0 110.068 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -100.38 139.48 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.525 0.73 . . . . 0.0 109.93 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.26 19.84 64.55 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.978 0.799 . . . . 0.0 112.9 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.89 129.29 2.66 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.959 0.904 . . . . 0.0 109.674 -172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.91 121.78 8.43 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.506 2.137 . . . . 0.0 110.668 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.58 -172.96 30.27 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.606 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.09 139.68 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.162 0.985 . . . . 0.0 109.528 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.749 HH21 ' HB ' ' A' ' 117' ' ' THR . 45.9 ttt180 -111.86 139.86 46.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -154.27 152.58 30.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.251 0.62 . . . . 0.0 109.544 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' TRP . 13.8 ptm180 -94.66 107.24 19.24 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -73.32 114.26 11.33 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.856 -174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.73 87.6 6.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.65 94.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.129 0.972 . . . . 0.0 109.042 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 80' ' ' LYS . 4.1 ttpm? 51.75 58.07 5.86 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.996 0.918 . . . . 0.0 111.127 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 63.93 31.43 13.83 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.372 1.069 . . . . 0.0 113.072 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -83.68 50.1 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.597 -0.69 . . . . 0.0 110.185 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.3 t -59.49 -21.96 60.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.941 0.897 . . . . 0.0 112.4 -170.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.4 m -85.81 -6.64 59.07 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.1 0.96 . . . . 0.0 112.245 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -156.36 48.2 0.47 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.885 0.874 . . . . 0.0 110.448 -177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p -75.94 136.97 40.05 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.329 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.52 135.57 35.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 70.9 m95 -74.7 161.96 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.241 0.616 . . . . 0.0 109.438 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 84.1 t -138.23 115.07 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.1 tp -93.2 98.5 11.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.067 0.854 . . . . 0.0 108.79 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -96.03 125.21 40.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -119.49 117.52 28.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.236 0.614 . . . . 0.0 109.887 172.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 151.49 -164.52 30.24 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 115.23 9.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.948 0.499 . . . . 0.0 109.694 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.42 130.24 65.99 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.856 0.862 . . . . 0.0 109.474 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.605 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 18.9 Cg_endo -61.46 144.91 98.38 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.38 2.054 . . . . 0.0 112.132 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.83 -27.44 67.55 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.237 1.015 . . . . 0.0 111.446 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 p -78.73 -14.53 59.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.509 1.124 . . . . 0.0 112.139 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 71.6 t80 -68.51 119.94 13.78 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -152.37 161.05 30.39 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.275 1.03 . . . . 0.0 108.716 -174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 57.0 Cg_endo -66.73 111.16 2.07 Favored 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.032 1.822 . . . . 0.0 110.845 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.63 -11.48 15.92 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.683 -0.509 . . . . 0.0 113.825 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.07 149.18 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 117.714 0.757 . . . . 0.0 110.002 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 45.2 mt-10 -83.18 140.96 32.27 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.11 168.46 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.063 0.945 . . . . 0.0 111.851 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.415 ' HB ' ' HG2' ' A' ' 124' ' ' MET . 71.5 mt -132.84 122.71 47.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 126.462 1.905 . . . . 0.0 106.202 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.6 139.56 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.689 0.795 . . . . 0.0 109.827 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.42 132.49 56.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.9 -143.09 7.09 Favored Glycine 0 N--CA 1.47 0.946 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.82 136.18 4.58 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 117.685 0.742 . . . . 0.0 112.662 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.2 tp -93.08 134.41 35.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.289 1.035 . . . . 0.0 108.919 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 115' ' ' GLU . . . -88.86 146.59 37.11 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.264 0.626 . . . . 0.0 110.309 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.49 120.25 7.36 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.878 2.385 . . . . 0.0 112.206 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.12 69.14 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.979 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 112' ' ' ALA . 69.3 mm-40 -101.0 151.32 21.92 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.617 0.767 . . . . 0.0 110.13 172.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -106.55 16.45 24.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.925 0.89 . . . . 0.0 109.864 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.749 ' HB ' HH21 ' A' ' 74' ' ' ARG . 12.7 t -134.7 111.77 10.24 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.959 0.885 . . . . 0.0 109.846 -174.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -74.77 109.34 8.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.119 1.367 . . . . 0.0 108.37 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -77.79 98.74 5.65 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.29 163.53 26.33 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.629 0.771 . . . . 0.0 111.483 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -125.13 -36.47 2.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.091 1.356 . . . . 0.0 108.071 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -132.32 164.3 26.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.22 1.008 . . . . 0.0 109.778 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -156.71 117.94 3.76 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.488 1.115 . . . . 0.0 108.731 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 106' ' ' ILE . 19.2 ptp -137.38 147.82 45.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -91.55 142.85 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.684 0.394 . . . . 0.0 110.235 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -68.74 -30.12 68.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.073 0.549 . . . . 0.0 110.092 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 43.8 t -84.46 107.52 11.38 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.858 0.863 . . . . 0.0 109.22 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.43 160.32 44.81 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.984 2.456 . . . . 0.0 111.47 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.88 123.28 18.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.381 0.672 . . . . 0.0 110.247 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 CA--C 1.562 1.404 0 C-N-CA 123.916 0.887 . . . . 0.0 111.187 178.141 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.094 0.473 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.878 1.271 . . . . 0.0 107.883 170.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.4 m -80.52 114.93 51.58 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-N 117.985 0.357 . . . . 0.0 110.876 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.22 117.4 3.8 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.072 1.848 . . . . 0.0 109.99 166.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 71.6 112.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.707 1.203 . . . . 0.0 109.791 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.69 117.37 9.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.934 0.894 . . . . 0.0 108.818 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -72.08 -15.33 62.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.634 1.174 . . . . 0.0 112.288 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -113.06 30.9 6.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.6 0.76 . . . . 0.0 110.431 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -121.36 120.51 35.26 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 108.88 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 m -72.53 117.22 13.94 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.4 124.44 49.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -82.72 105.0 13.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.17 132.21 54.37 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -167.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.98 126.52 55.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.86 -178.96 35.3 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -117.18 142.93 46.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.338 0.655 . . . . 0.0 109.726 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.47 125.01 36.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.346 0.658 . . . . 0.0 110.428 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.13 136.29 38.6 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.14 66.64 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.66 0.6 . . . . 0.0 109.744 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.754 ' HB2' HH21 ' A' ' 76' ' ' ARG . 2.6 m-20 -83.78 133.05 34.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.543 177.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.25 78.86 Favored Glycine 0 N--CA 1.468 0.803 0 O-C-N 123.397 0.436 . . . . 0.0 113.217 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tt -76.67 103.79 6.83 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.6 m -121.05 127.36 51.63 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.778 1.231 . . . . 0.0 109.57 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 91.8 mmm -83.85 145.0 28.88 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -69.56 125.28 26.23 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -70.36 104.08 2.6 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.362 1.065 . . . . 0.0 110.552 -170.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.49 73.5 Favored Glycine 0 C--N 1.342 0.895 0 O-C-N 123.749 0.656 . . . . 0.0 112.784 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.7 132.35 13.02 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 123.917 0.887 . . . . 0.0 109.394 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.96 110.69 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.758 2.305 . . . . 0.0 111.051 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 -176.79 30.17 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.841 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.66 135.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.379 1.072 . . . . 0.0 109.579 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.6 ttm180 -112.48 128.11 56.24 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.0 171.85 14.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -171.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.754 HH21 ' HB2' ' A' ' 62' ' ' ASP . 37.9 mtm180 -96.39 130.16 43.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 tp -103.13 117.05 33.69 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.672 0.789 . . . . 0.0 109.234 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -70.62 91.36 0.79 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 170.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.72 91.31 2.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.824 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' NZ ' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 51.76 81.7 0.07 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.759 1.223 . . . . 0.0 111.618 173.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 74.5 17.2 3.12 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.18 1.392 . . . . 0.0 114.355 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.11 123.97 18.71 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.41 0.55 . . . . 0.0 111.257 173.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 86' ' ' THR . 14.4 t -97.8 -28.11 14.01 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.343 1.057 . . . . 0.0 112.224 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.7 t -71.66 -38.84 70.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -92.87 94.77 9.12 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.527 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 83' ' ' THR . 28.4 p -111.36 138.07 48.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.551 0.741 . . . . 0.0 109.798 174.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.15 136.42 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.18 127.2 31.73 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 99.3 t -111.94 117.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.429 0.692 . . . . 0.0 109.312 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.38 96.17 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -95.55 123.09 38.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -115.69 112.6 22.31 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.689 0.796 . . . . 0.0 109.425 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.52 -173.43 34.94 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.96 111.77 5.19 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.264 0.626 . . . . 0.0 110.312 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 110.15 19.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 123.806 0.691 . . . . 0.0 109.497 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 123' ' ' LEU . 74.5 Cg_endo -71.5 157.71 55.61 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.34 2.027 . . . . 0.0 112.147 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' HD22 ' A' ' 129' ' ' LEU . 10.3 m-20 -69.55 -12.27 61.51 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.609 0.764 . . . . 0.0 112.242 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -70.15 -22.68 62.96 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.248 0.619 . . . . 0.0 111.485 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -71.56 95.27 1.39 Allowed 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -118.51 145.77 38.17 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.72 100.54 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.624 2.216 . . . . 0.0 111.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.78 -8.54 7.7 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.222 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.93 148.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 118.352 1.076 . . . . 0.0 110.038 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.88 115.99 19.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 20.7 m -104.67 155.72 6.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 123.847 0.859 . . . . 0.0 111.253 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mt -117.09 107.63 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.47 141.32 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.1 0.56 . . . . 0.0 109.966 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.41 117.85 30.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 120' ' ' ALA . . . -172.09 -149.47 6.69 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 123.49 0.494 . . . . 0.0 112.265 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.16 145.46 10.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 117.165 0.483 . . . . 0.0 112.479 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.9 tp -88.92 105.36 17.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.46 139.31 41.37 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.058 0.543 . . . . 0.0 111.212 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.93 90.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 123.414 2.743 . . . . 0.0 112.62 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.99 -42.57 0.82 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -95.38 130.46 42.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.542 0.737 . . . . 0.0 110.644 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.77 -17.04 60.03 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.864 0.866 . . . . 0.0 110.523 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.6 t -86.64 133.2 33.72 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.152 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -77.04 109.86 11.21 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -86.12 94.18 9.2 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . . . -84.12 117.35 23.41 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.635 0.774 . . . . 0.0 111.108 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -61.92 -45.41 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.845 0.858 . . . . 0.0 111.035 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m -127.97 136.24 51.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.66 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 96' ' ' PRO . 33.5 tp -112.99 123.74 51.01 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.6 mtm -132.73 171.01 14.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.226 1.01 . . . . 0.0 108.285 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 35.1 p -130.43 148.92 52.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.771 . . . . 0.0 110.075 174.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.77 -33.15 74.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.399 0.68 . . . . 0.0 109.999 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 50.2 t -117.52 101.12 52.73 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.892 0.877 . . . . 0.0 108.959 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.3 167.58 9.2 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.019 2.48 . . . . 0.0 112.524 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 97' ' ' ASP . 37.6 tp -57.3 101.23 0.06 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.146 0.979 . . . . 0.0 110.676 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.897 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -173.496 . . . . . . . . 1 1 . 1 stop_ save_